Details of Disease

General Information of Disease (ID: DISTSB4J)

• Disease Name: Rheumatoid arthritis
• Synonyms: rheumatoid arthritis, susceptibility to; atrophic arthritis; rheumatoid arthritis, progression of; arthritis, rheumatoid; RA; rheumatoid arthritis; autoimmune arthritis; arthritis or polyarthritis, rheumatic
• Disease Class: FA20: Rheumatoid arthritis
• Definition: A chronic, systemic autoimmune disorder characterized by inflammation in the synovial membranes and articular surfaces. It manifests primarily as a symmetric, erosive polyarthritis that spares the axial skeleton and is typically associated with the presence in the serum of rheumatoid factor.
• Disease Hierarchy:
  DIST1YEL: Arthritis
  DIS77ACK: Rheumatic disorder
  DISSDQ8O: Autoimmune disorder of musculoskeletal system
  DISTSB4J: Rheumatoid arthritis
• ICD Code:
  ICD-11: ICD-11: FA20
  ICD-9: ICD-9: 729
  Expand ICD-9: 729
• Disease Identifiers:
  MONDO ID: MONDO_0008383
  MESH ID: D001172
  UMLS CUI: C0003873
  OMIM ID: 180300
  MedGen ID: 2078
  HPO ID: HP:0001370
  Orphanet ID: 284130
  SNOMED CT ID: 69896004

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 50 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Abatacept	DMSA8RU	Approved	NA	[1]
Adalimumab	DMQMV1B	Approved	Antibody	[2]
Alclofenac	DM8CY9X	Approved	Small molecular drug	[3]
Anakinra	DMU8KOD	Approved	NA	[4]
Baricitinib	DM4ONW5	Approved	Small molecular drug	[5]
Belumosudil	DM548TK	Approved	NA	[6]
Betamethasone	DMAHJEF	Approved	Small molecular drug	[7]
Canakinumab	DM8HLO5	Approved	Antibody	[8]
Careram	DM2VU92	Approved	Small molecular drug	[9]
Celecoxib	DM6LOQU	Approved	Small molecular drug	[10]
Certolizumab	DM5CL9Z	Approved	Monoclonal antibody	[11]
Cortisone Acetate	DMG8K57	Approved	Small molecular drug	[12]
Denosumab	DMNI0KO	Approved	Antibody	[13]
Dexamethasone	DMMWZET	Approved	Small molecular drug	[14]
Dimethyl Sulfoxide	DMX3ZFP	Approved	Small molecular drug	[3]
Etofenamate	DMZLO2I	Approved	Small molecular drug	[3]
Etoricoxib	DM6A4NW	Approved	Small molecular drug	[15]
Fenoprofen	DML5VQ0	Approved	Small molecular drug	[16]
Flurbiprofen	DMGN4BY	Approved	Small molecular drug	[17]
Fostamatinib	DM6AUHV	Approved	Small molecular drug	[18]
Gold sodium thiomalate	DMKHHT1	Approved	Small molecular drug	[3]
Golimumab	DMHZV7X	Approved	Antibody	[19]
Hydrocortisone	DMGEMB7	Approved	Small molecular drug	[20]
Indomethacin	DMSC4A7	Approved	Small molecular drug	[3]
Infliximab	DMH7OIA	Approved	Antibody	[21]
Inosine pranobex	DM2P6R0	Approved	Small molecular drug	[3]
Methotrexate	DM2TEOL	Approved	Small molecular drug	[22]
Methylprednisolone	DM4BDON	Approved	Small molecular drug	[3]
Niflumic Acid	DMJ3I1Q	Approved	Small molecular drug	[23]
Ofatumumab	DM295PR	Approved	Antibody	[24]
OM-89	DMG5EHN	Approved	NA	[3]
Oxaprozin	DM9UB0P	Approved	Small molecular drug	[3]
Penicillamine	DM40EF6	Approved	Small molecular drug	[25]
Prednisone	DM2HG4X	Approved	Small molecular drug	[26]
Salicyclic acid	DM2F8XZ	Approved	Small molecular drug	[27]
Salsalate	DM13P4C	Approved	Small molecular drug	[3]
Sarilumab	DMOGNXY	Approved	Monoclonal antibody	[3]
Secukinumab	DMYXT2U	Approved	Monoclonal antibody	[28]
Siponimod	DM2R86O	Approved	Small molecular drug	[29]
Sirolimus	DMGW1ID	Approved	Small molecular drug	[30]
Sulfasalazine	DMICA9H	Approved	Small molecular drug	[31]
Sulindac	DM2QHZU	Approved	Small molecular drug	[32]
Tenoxicam	DMVAZP9	Approved	Small molecular drug	[33]
Teriflunomide	DMQ2FKJ	Approved	Small molecular drug	[34]
Tocilizumab	DM7J6OR	Approved	Monoclonal antibody	[35]
Tofacitinib	DMBS370	Approved	Small molecular drug	[36]
Tolmetin	DMWUIJE	Approved	Small molecular drug	[37]
Triamcinolone	DM98IXF	Approved	Small molecular drug	[38]
Upadacitinib	DM32B5U	Approved	NA	[39]
Vamorolone	DM047HI	Approved	NA	[29]

This Disease is Treated as An Indication in 170 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ABP 501	DM2J4YB	Phase 3	Antibody	[40]
ABP 798	DMSX35S	Phase 3	NA	[29]
ABT-874	DMYHSO2	Phase 3	NA	[11]
ASP-015K	DMZ1UOI	Phase 3	Small molecular drug	[29]
Atacicept	DM8GFEV	Phase 3	NA	[41]
BI 695501	DMBS0QU	Phase 3	NA	[42]
BI-695500	DMT0NTL	Phase 3	NA	[29]
Cartistem	DM11TX7	Phase 3	NA	[43]
CEP-41750	DMPR0LU	Phase 3	NA	[44]
CHS-0214	DM11R0Z	Phase 3	NA	[29]
Cilengitide	DMEAOZ0	Phase 3	Small molecular drug	[45]
CIPEMASTAT	DM803GL	Phase 3	Small molecular drug	[46]
CPL-7075	DM62E7C	Phase 3	Small molecular drug	[29]
Flobufen	DMPSG4D	Phase 3	Small molecular drug	[47]
GP-2017	DMR670F	Phase 3	NA	[29]
GP2013	DMZB45J	Phase 3	NA	[29]
GS-5745	DMP8MDW	Phase 3	NA	[29]
IB-MECA	DM9G5XD	Phase 3	Small molecular drug	[29]
MK-8808	DMT8IAJ	Phase 3	NA	[48]
Nipocalimab	DM0622O	Phase 3	Monoclonal antibody	[49]
Nipocalimab?	DM0DYAX	Phase 3	Monoclonal antibody	[49]
Olokizumab	DM4Z9QI	Phase 3	Monoclonal antibody	[29]
PF-06410293	DM2GF14	Phase 3	Antibody	[29]
PF-06438179	DMM4C95	Phase 3	NA	[29]
RAVAX	DMGJ8ES	Phase 3	NA	[50]
Resveratrol	DM3RWXL	Phase 3	Small molecular drug	[29]
SA-237	DM7F2VG	Phase 3	NA	[51]
Sirukumab	DMK8AQP	Phase 3	Monoclonal antibody	[52]
Sivelestat	DM6BZCV	Phase 3	Small molecular drug	[29]
Spermidine	DMVJNFI	Phase 3	Small molecular drug	[29]
STI-002	DMHI77P	Phase 3	NA	[29]
Tenidap	DMHQRYE	Phase 3	Small molecular drug	[53]
Vanadate	DMQL0KF	Phase 3	Small molecular drug	[29]
Varespladib methyl	DMLIMEA	Phase 3	Small molecular drug	[54]
LY3090106	DM0DLGO	Phase 2/3	Antibody	[55]
VX-509	DM2U3MX	Phase 2/3	Small molecular drug	[56]
CreaVax-RA	DMT7URP	Phase 2a	NA	[57]
RhuDex	DMGM1IR	Phase 2a	NA	[41]
VX-702	DMKJDR6	Phase 2a	Small molecular drug	[58]
A223	DMHRS2O	Phase 2	Small molecule	[59]
ABBV-154	DMVWLET	Phase 2	Antibody drug conjugate	[60]
ABT-122	DM23UQ9	Phase 2	Monoclonal antibody	[61]
AD-452	DMMFLXN	Phase 2	NA	[62]
ADL-5859	DMDQH9A	Phase 2	Small molecular drug	[63]
AK-106-001616	DM6VA14	Phase 2	NA	[64]
ALD-518	DMPWSBL	Phase 2	NA	[65]
ALX-0061	DMO1VHC	Phase 2	Antibody	[29]
AMG-714	DM1T3KQ	Phase 2	Antibody	[11]
AMG0714	DM77N7C	Phase 2	NA	[66]
Anti-LT alpha	DMQ58YH	Phase 2	Antibody	[67]
Apratastat	DM8W4N9	Phase 2	Small molecular drug	[68]
APX-001	DMAIJC9	Phase 2	NA	[69]
Baminercept	DMSZOXQ	Phase 2	NA	[70]
BI 655064	DMF86P2	Phase 2	Antibody	[71]
BIIB 023	DM9OXEJ	Phase 2	NA	[72]
BMS-817399	DMT8L6P	Phase 2	NA	[73]
BMS-945429	DMCIQEP	Phase 2	NA	[74]
BMS-986142	DMZB8AJ	Phase 2	NA	[29]
Branebrutinib	DM97I5L	Phase 2	Small molecule	[75]
BT-016	DMTH56Y	Phase 2	NA	[76]
CCX-354	DMSHV9C	Phase 2	NA	[29]
CDP-6038	DM3YB2C	Phase 2	NA	[65]
CDP323	DMXYLTI	Phase 2	Small molecular drug	[11]
Cenplacel-L	DMVL9KP	Phase 2	NA	[77]
Cevidoplenib	DM9QU5G	Phase 2	Small molecule	[78]
CFZ533	DM1TWIE	Phase 2	NA	[79]
CH-4051	DMLQRYH	Phase 2	NA	[80]
CNT0-1959	DMOR8SY	Phase 2	Antibody	[81]
CNTO-6785	DM6RQXB	Phase 2	Antibody	[82]
Dazodalibep	DM7YII9	Phase 2	NA	[83]
DE-098	DM5XT3G	Phase 2	Antibody	[84]
EQ121	DMJN8UW	Phase 2	Small molecule	[85]
F-8-IL-10 fusion protein	DMBFPO1	Phase 2	NA	[29]
FK-3311	DML5AE4	Phase 2	Small molecular drug	[86]
Fosbretabulin	DMKSI2I	Phase 2	Small molecular drug	[87]
GLPG-0634	DMPHCDL	Phase 2	Small molecular drug	[88]
GS-4059	DMHQV6R	Phase 2	NA	[29]
GS-5718	DMRKU0L	Phase 2	Small molecule	[89]
GS-9876	DM9Q2B6	Phase 2	NA	[29]
GSK2982772	DM7HNFV	Phase 2	NA	[29]
GSK315234	DMVL1WZ	Phase 2	NA	[90]
GSK3196165	DMEXKF4	Phase 2	NA	[29]
IMO-8400	DMDPNCJ	Phase 2	NA	[29]
IRL201805	DM0S9C3	Phase 2	NA	[91]
JNJ-38518168	DM9UMIO	Phase 2	NA	[92]
K-832	DMMSTCF	Phase 2	Small molecular drug	[11]
KB002/003	DM60G5O	Phase 2	NA	[93]
KPL-404	DMQJODL	Phase 2	Antibody	[94]
LX2931	DMLA8H3	Phase 2	Small molecular drug	[95]
M2951	DMC5MQD	Phase 2	NA	[29]
Mavrilimumab	DMMVFRC	Phase 2	Antibody	[96]
Meninge ACYW	DMJCA5X	Phase 2	NA	[97]
MGCD-290	DMAJV1J	Phase 2	Small molecular drug	[98]
MK-8457	DMIDVZ3	Phase 2	NA	[99]
MPC-300-IV	DMRWDG9	Phase 2	NA	[29]
MRC-375	DMKG9EW	Phase 2	NA	[100]
NN8555	DM3IEHP	Phase 2	NA	[101]
NN8765	DMCFPBE	Phase 2	NA	[102]
NNC-0151-0000-0000	DMU3KOH	Phase 2	Antibody	[103]
ONO-4641	DMLUM3Y	Phase 2	NA	[104]
Ozoralizumab	DMFCL3E	Phase 2	Monoclonal antibody	[106]
PD-360324	DM6F5EV	Phase 2	NA	[107]
Pegsunercept	DMTDANB	Phase 2	NA	[108]
Peresolimab	DMYT8E0	Phase 2	Monoclonal antibody	[109]
PF-04171327	DM5G3B0	Phase 2	Small molecular drug	[110]
PF-06823859	DM8C1H4	Phase 2	NA	[111]
PG-760564	DMSUMNC	Phase 2	NA	[112]
Piclamilast	DMYL7VR	Phase 2	Small molecular drug	[113]
PRALNACASAN	DM73UTG	Phase 2	Small molecular drug	[114]
PTC299	DMP9TKE	Phase 2	Small molecular drug	[115]
QAL964	DMK3V4O	Phase 2	NA	[116]
Rabeximod	DMFPHYI	Phase 2	NA	[117]
Rimacalib	DMSC7TN	Phase 2	Small molecular drug	[118]
SAN-300	DMP5Z9N	Phase 2	NA	[119]
SBI-087	DMSUQFJ	Phase 2	NA	[120]
SR-31747	DMQSN7B	Phase 2	Small molecular drug	[121]
SSR-180575	DMA0QZH	Phase 2	Small molecular drug	[122]
SSR-240612	DMFNZPY	Phase 2	Small molecular drug	[123]
STA-5326	DMH4C3M	Phase 2	Small molecular drug	[124]
TAK-715	DMZKPI8	Phase 2	Small molecular drug	[125]
TAK-783	DMK64PY	Phase 2	NA	[126]
VAY736	DML2CPW	Phase 2	Antibody	[29]
Vidofludimus	DM0POWG	Phase 2	Small molecular drug	[127]
Vobarilizumab	DM9KNJT	Phase 2	Antibody	[128]
VX-745	DMJAEG6	Phase 2	Small molecular drug	[129]
Xmab 5871	DMLIPY1	Phase 2	NA	[130]
Zunsemetinib	DMNFNK7	Phase 2	Small molecule	[131]
[L/D]-aminopterin	DMK9X88	Phase 2	NA	[132]
ART621	DMI17NX	Phase 1/2	NA	[133]
BIO-300	DMJ7NVI	Phase 1/2	NA	[134]
Cx-611	DML4B3D	Phase 1/2	NA	[135]
PRTX-100	DMF2XCC	Phase 1/2	NA	[29]
ABBV-257	DMCZI8L	Phase 1	NA	[29]
Aminoguanidine	DMJQDUC	Phase 1	Small molecular drug	[136]
ARG301	DM6EA4G	Phase 1	NA	[137]
ASP2408	DMUGZKI	Phase 1	NA	[138]
ASP5094	DMCYA8C	Phase 1	NA	[29]
AVE1701	DMJY35M	Phase 1	NA	[11]
AXS-06	DMSMZMU	Phase 1	NA	[139]
AZD9567	DMAXHC0	Phase 1	NA	[29]
BF-389	DMHELFU	Phase 1	Small molecular drug	[140]
BMS-986104	DMZ4WMT	Phase 1	NA	[29]
BX-U001	DM65N6Y	Phase 1	Cell therapy	[141]
Cadherin-11	DM5PMQ7	Phase 1	NA	[142]
EVT 401	DMOG8IE	Phase 1	NA	[143]
Gerilimzumab	DMA9UX2	Phase 1	NA	[29]
GSK-1827771	DMA41JD	Phase 1	Antibody	[144]
GSK3117391	DMQZSXD	Phase 1	Small molecular drug	[145]
HM71224	DME4D7H	Phase 1	Small molecular drug	[146]
IA-14069	DM15SXV	Phase 1	Small molecule	[147]
JNJ-67484703	DMYSCXF	Phase 1	NA	[148]
LABP-104	DMMYYB9	Phase 1	Small molecule	[149]
MEDI4920	DME7BMT	Phase 1	NA	[29]
MEDI5117	DM3IJQ5	Phase 1	NA	[150]
MORAb-022	DMM7TBO	Phase 1	Antibody	[29]
NCX-1015	DMKJRQS	Phase 1	NA	[151]
ONS-3010	DMVMZ8M	Phase 1	NA	[29]
ORTD-1	DMR1PQI	Phase 1	Small molecule	[152]
PF-05230905	DM7OC9K	Phase 1	NA	[153]
RG6125	DMX8YO1	Phase 1	NA	[29]
RPI-78M	DMXKFOQ	Phase 1	NA	[154]
RX-10001	DMQZ3T4	Phase 1	NA	[155]
Sc Veltuzumab	DM2S8W3	Phase 1	Monoclonal antibody	[156]
SCH-900117	DM7A6R5	Phase 1	NA	[157]
SKI-O-703	DMTSKXR	Phase 1	NA	[29]
TAK-020	DM6OKH4	Phase 1	NA	[29]
VEL-0230	DMDSC63	Phase 1	Small molecular drug	[158]
VGX-1027	DMM1N5C	Phase 1	Small molecular drug	[159]
VI7734	DMWKFRC	Phase 1	NA	[111]
AZ-4217	DMGPTFL	Clinical trial	Small molecular drug	[160]

This Disease is Treated as An Indication in 2 Drugs in Phase 2 Trial

Drug Name	Drug ID	Highest Status	Drug Type	REF
Clazakizumab	DM6ZOUV	Phase 2 Trial	Monoclonal antibody	[29]
Otilimab	DM1AQLW	Phase 2 Trial	Monoclonal antibody	[105]

This Disease is Treated as An Indication in 1 Patented Agent(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
PMID27998201-Compound-9	DM1JOZN	Patented	Small molecular drug	[161]

This Disease is Treated as An Indication in 69 Discontinued Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Amiprilose	DM8JD3O	Discontinued in Preregistration	Small molecular drug	[162]
Nerelimomab	DM1QAGC	Discontinued in Phase 3	Monoclonal antibody	[163]
AMG 108	DMMUS8X	Discontinued in Phase 2	Small molecular drug	[164]
AnergiX.RA	DM869ZM	Discontinued in Phase 2	NA	[165]
Apricoxib	DMR3Q82	Discontinued in Phase 2	Small molecular drug	[166]
BR3-Fc	DMFN1WI	Discontinued in Phase 2	NA	[167]
Camobucol	DMS3ECJ	Discontinued in Phase 2	Small molecular drug	[168]
CBF-BS2	DM2FAH0	Discontinued in Phase 2	NA	[169]
CP-195543	DM1OSUR	Discontinued in Phase 2	Small molecular drug	[170]
Fontolizumab	DMEH6LV	Discontinued in Phase 2	Antibody	[11]
GLPG-0259	DMC87DR	Discontinued in Phase 2	NA	[171]
HR325	DM51GZS	Discontinued in Phase 2	Small molecular drug	[172]
IDEC-151	DMILUHA	Discontinued in Phase 2	Antibody	[173]
INCB47986	DMNRQA9	Discontinued in Phase 2	NA	[174]
ISIS 104838	DMURWPH	Discontinued in Phase 2	Antisense drug	[175]
IX207-887	DM4TE8R	Discontinued in Phase 2	NA	[176]
KC706	DMBX6C7	Discontinued in Phase 2	NA	[177]
MLN3897	DMRA3EZ	Discontinued in Phase 2	NA	[11]
MP-435	DMMKHGN	Discontinued in Phase 2	NA	[178]
NN8209	DM2TDE7	Discontinued in Phase 2	NA	[179]
PAMAPIMOD	DM9SYUT	Discontinued in Phase 2	Small molecular drug	[180]
PRO-515	DMV1ZQO	Discontinued in Phase 2	NA	[181]
S-2474	DMMSZ1A	Discontinued in Phase 2	Small molecular drug	[182]
SC-106	DMTZ7E4	Discontinued in Phase 2	Small molecular drug	[183]
T-5224	DMD3CUJ	Discontinued in Phase 2	Small molecular drug	[184]
AD-121	DMB8XJM	Discontinued in Phase 1/2	NA	[185]
AME-527	DMR8XEN	Discontinued in Phase 1/2	Antibody	[186]
AVE-9940	DMIB3AT	Discontinued in Phase 1	NA	[187]
AZD-2315	DMG9HM8	Discontinued in Phase 1	NA	[188]
AZD-6703	DM9KLD3	Discontinued in Phase 1	Small molecular drug	[189]
AZD-7140	DMX63W1	Discontinued in Phase 1	NA	[190]
AZD-8309	DMW6IUB	Discontinued in Phase 1	NA	[191]
AZD8566	DMIYEZG	Discontinued in Phase 1	NA	[192]
C-5997	DM0G88H	Discontinued in Phase 1	Small molecular drug	[193]
CI-972	DM9ZBO0	Discontinued in Phase 1	Small molecular drug	[194]
IL-18BP	DMRSJ49	Discontinued in Phase 1	NA	[195]
NN8210	DM8Z5VH	Discontinued in Phase 1	NA	[196]
PF-251802	DM2V7WH	Discontinued in Phase 1	NA	[197]
PF-4629991	DMNLAU7	Discontinued in Phase 1	NA	[198]
PF-755616	DMWNV6C	Discontinued in Phase 1	NA	[199]
R-1487	DM7WPI0	Discontinued in Phase 1	Small molecular drug	[200]
R1295	DMT8V9G	Discontinued in Phase 1	Small molecular drug	[11]
Roquinimex	DMMK42O	Discontinued in Phase 1	Small molecular drug	[201]
SC-57666	DMIVRWS	Discontinued in Phase 1	Small molecular drug	[202]
AZD-0275	DMJH7IX	Terminated	NA	[207]
AZD-0902	DMS7INR	Terminated	NA	[208]
AZD-6942	DMZ90OV	Terminated	NA	[209]
AZD5672	DMQUX28	Terminated	Small molecular drug	[210]
CI-986	DMI0TD8	Terminated	Small molecular drug	[211]
D-5410	DMXHN6U	Terminated	NA	[212]
DPC-333	DM4JBQD	Terminated	Small molecular drug	[213]
FR-123826	DM0582D	Terminated	NA	[214]
GDC-0834	DMOAURL	Terminated	Small molecular drug	[215]
NOX-200	DM78P4X	Terminated	Small molecular drug	[216]
NPC-17923	DMD01GK	Terminated	Small molecular drug	[217]
PXS-2076	DM1AXZ6	Terminated	NA	[218]
RO-319790	DML3NEU	Terminated	Small molecular drug	[219]
RP-54745	DMVUP8F	Terminated	Small molecular drug	[220]
RPR 200765A	DM1U0TB	Terminated	Small molecular drug	[221]
S-16276-1	DMHF2HS	Terminated	NA	[222]
SAN-18	DM66J4T	Terminated	NA	[223]
SDZ-224-015	DMY1KE8	Terminated	NA	[224]
SKF-104351	DM8MWFZ	Terminated	Small molecular drug	[225]
SR-26831	DM1GKTS	Terminated	Small molecular drug	[226]
TM-31	DMWRX6O	Terminated	NA	[227]
VE-16084	DMHG70W	Terminated	NA	[228]
WY-28342	DMAG86C	Terminated	NA	[229]
WY-48989	DMGJNQW	Terminated	Small molecular drug	[230]
YM-26734	DMEHAI2	Terminated	Small molecular drug	[231]

This Disease is Treated as An Indication in 6 Preclinical Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
GP2015	DMVYFTQ	Application submitted	NA	[29]
CLIK-148	DM0BHL8	Preclinical	Small molecular drug	[203]
CLIK-181	DMXKN6R	Preclinical	Small molecular drug	[203]
MCP-1	DMYEFKH	Preclinical	NA	[204]
Romazarit	DMZOUX4	Preclinical	Small molecular drug	[205]
SR1555	DMZV9JX	Preclinical	Small molecular drug	[206]

This Disease is Treated as An Indication in 32 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
ADR58	DMQBCPK	Investigative	Aptamer	[232]
Ankinara	DMZKC7S	Investigative	NA	[204]
Anti-CD40-XTEN	DMGZM6V	Investigative	NA	[233]
Anti-CD97 mab	DMPJJ6K	Investigative	Monoclonal antibody	[69]
Arthromir	DM06780	Investigative	NA	[69]
AVX-002	DMPG926	Investigative	NA	[69]
BFPT-16864	DM46LXH	Investigative	NA	[69]
CAT-2200	DMWHP52	Investigative	Antibody	[234]
CEL-2000	DM0CN4O	Investigative	NA	[69]
CIGB-55	DME2DF2	Investigative	NA	[69]
CIGB-814	DM0PCTV	Investigative	NA	[69]
CTLA-4-XTEN	DMKEIAS	Investigative	NA	[235]
Dendritic cell-based immunotherapy	DMVOR1V	Investigative	NA	[69]
DMARDs	DM7LLQI	Investigative	NA	[69]
DWJ-425	DMG67AR	Investigative	NA	[69]
ETP-46321	DMO2PY8	Investigative	Small molecular drug	[236]
FHT-401	DMV3TC7	Investigative	NA	[69]
FKB327	DML5QF9	Investigative	NA	[29]
FM-201	DMOI3OY	Investigative	NA	[69]
HL-1020	DMOFTV4	Investigative	NA	[69]
IG-AI-025	DMQZGCG	Investigative	NA	[69]
Nano-steroid	DM3G0LL	Investigative	NA	[69]
NM-2014	DM6RA20	Investigative	NA	[237]
NM-9405	DMKMBSJ	Investigative	Antibody	[237]
ODN-1411	DM0GVZO	Investigative	Oligonucleotide	[238]
ROSMARINIC ACID	DMQ6SJT	Investigative	Small molecular drug	[239]
TCH-013	DMZY17R	Investigative	NA	[69]
TENOSAL	DMMLSZ4	Investigative	Small molecular drug	[240]
TNFcept	DMAGI7K	Investigative	NA	[241]
TNFmab	DM4T0ZF	Investigative	Antibody	[241]
TX-RAD	DM59IZI	Investigative	NA	[69]
UR-5269	DMHA0R2	Investigative	NA	[69]

Molecular Interaction Atlas (MIA) of This Disease

This Disease Is Related to 691 DTT Molecule(s)

Gene Name	DTT ID	Evidence Level	Mode of Inheritance	REF
ABCC2	TTFLHJV	Limited	Biomarker	[243]
ABCG2	TTIMJ02	Limited	Biomarker	[243]
AGER	TTMO9HF	Limited	Biomarker	[244]
ALOX12	TT12ABZ	Limited	Altered Expression	[245]
AMACR	TTLN1AP	Limited	Altered Expression	[246]
AMD1	TTBFROQ	Limited	Biomarker	[247]
APCS	TTB7VAT	Limited	Biomarker	[248]
APOA2	TTGQA9W	Limited	Biomarker	[249]
ARG2	TTV1AG6	Limited	Altered Expression	[250]
ASIC1	TTRJYB6	Limited	Biomarker	[251]
ATP1A1	TTWK8D0	Limited	Altered Expression	[252]
BIRC2	TTQ5LRD	Limited	Biomarker	[253]
BLK	TTNDSC3	Limited	Biomarker	[254]
BMP6	TT07RIB	Limited	Biomarker	[255]
BMX	TTN2I9E	Limited	Biomarker	[256]
BPI	TTXCSDR	Limited	Biomarker	[257]
BTK	TTGM6VW	Limited	Biomarker	[258]
CA2	TTANPDJ	Limited	Genetic Variation	[259]
CA3	TTXUK5D	Limited	Biomarker	[260]
CCL23	TTHAPJK	Limited	Altered Expression	[261]
CD209	TTBXIM9	Limited	Genetic Variation	[262]
CD5	TTEGYK1	Limited	Biomarker	[263]
CD58	TT5KSBY	Limited	Biomarker	[264]
CD9	TTZEIBV	Limited	Altered Expression	[265]
CDKN2C	TTBRUGA	Limited	Genetic Variation	[266]
CEBPB	TTUI35N	Limited	Biomarker	[267]
CLEC6A	TTQ02HK	Limited	Genetic Variation	[268]
CMKLR1	TT4UGZL	Limited	Altered Expression	[269]
CSE1L	TTTRULD	Limited	Biomarker	[270]
CSF2RA	TT6MP2Z	Limited	Altered Expression	[271]
CSNK1E	TTA8PLI	Limited	Biomarker	[253]
CXCL13	TT0NIZ1	Limited	Altered Expression	[272]
CXCR5	TTIW59R	Limited	Biomarker	[272]
CYP3A5	TTHS0OK	Limited	Biomarker	[273]
DCK	TTJOCE4	Limited	Biomarker	[274]
DEK	TT1NMGV	Limited	Genetic Variation	[275]
DKK2	TTST5KX	Limited	Biomarker	[276]
DUSP8	TTK0TF2	Limited	Genetic Variation	[277]
EIF2AK2	TTXEZJ4	Limited	Biomarker	[278]
EPHA1	TTLFZVU	Limited	Biomarker	[279]
ERAP2	TTVGS1C	Limited	Altered Expression	[280]
EREG	TTYSB89	Limited	Biomarker	[281]
FCGRT	TTKLPHO	Limited	Genetic Variation	[282]
FGF4	TTCEKVZ	Limited	Altered Expression	[283]
FGF7	TTFY134	Limited	Altered Expression	[284]
FPR1	TT5Y4EM	Limited	Genetic Variation	[285]
GART	TTEXB9Z	Limited	Biomarker	[243]
GRIK4	TTQV6BO	Limited	Biomarker	[286]
GRK5	TTTCXO0	Limited	Altered Expression	[287]
HDC	TTV9GOF	Limited	Altered Expression	[288]
HDGF	TTKGV26	Limited	Biomarker	[289]
HEXA	TTJI5JW	Limited	Altered Expression	[290]
HEXB	TTKIBKM	Limited	Altered Expression	[290]
ICOSLG	TTB9Z8R	Limited	Biomarker	[291]
IFNGR2	TT13TL0	Limited	Altered Expression	[292]
IL11	TTGUYTR	Limited	Biomarker	[293]
IL1R2	TT51DEV	Limited	Altered Expression	[294]
IRF3	TTYR7OH	Limited	Altered Expression	[295]
IRF8	TTHUBNK	Limited	Biomarker	[263]
ITPR2	TTK9OV3	Limited	Biomarker	[296]
LCAT	TTGZ91P	Limited	Biomarker	[249]
LILRB2	TTHC6XU	Limited	Altered Expression	[297]
LPAR3	TTE2YJR	Limited	Biomarker	[298]
LRP6	TTSXOWE	Limited	Altered Expression	[276]
LYZ	TTAOZBW	Limited	Biomarker	[299]
MAPK9	TT3IVG2	Limited	Biomarker	[300]
MARCKS	TTHRM39	Limited	Biomarker	[301]
MASP2	TTR01E9	Limited	Genetic Variation	[302]
MIA	TT5HNVS	Limited	Biomarker	[303]
MMP14	TTJ4QE7	Limited	Biomarker	[304]
MMP15	TTNSTO3	Limited	Biomarker	[305]
MMP17	TTVSZKN	Limited	Biomarker	[306]
MMP8	TTGA1IV	Limited	Genetic Variation	[307]
MUC17	TTVO0JU	Limited	Altered Expression	[308]
NEDD9	TT1UREA	Limited	Biomarker	[309]
NELL1	TT7H4BF	Limited	Biomarker	[310]
NPPB	TTY63XT	Limited	Altered Expression	[311]
NTN1	TT0AH4L	Limited	Biomarker	[312]
ODC1	TTUMGNO	Limited	Altered Expression	[313]
OPRK1	TTQW87Y	Limited	Altered Expression	[314]
PCSK1	TTED9LZ	Limited	Altered Expression	[315]
PDE4D	TTSKMI8	Limited	Biomarker	[316]
PDGFD	TTSN0GA	Limited	Biomarker	[317]
PIM2	TT69J2Z	Limited	Biomarker	[318]
PKN1	TTSL41O	Limited	Altered Expression	[319]
PLD1	TT3T17P	Limited	Altered Expression	[320]
PPM1A	TTLA7IX	Limited	Biomarker	[321]
PRCP	TTTJZ4M	Limited	Biomarker	[322]
PRDX5	TTLPJWH	Limited	Biomarker	[323]
PRKCH	TTONI0R	Limited	Genetic Variation	[324]
PSMB5	TT68GPI	Limited	Genetic Variation	[325]
PSMB6	TT8EPLT	Limited	Genetic Variation	[326]
PSMB8	TTEAD9J	Limited	Genetic Variation	[327]
PSMB9	TTOUSTQ	Limited	Genetic Variation	[327]
PTGER2	TT1ZAVI	Limited	Biomarker	[328]
PTGER4	TT79WV3	Limited	Biomarker	[329]
PTGS1	TT8NGED	Limited	Biomarker	[330]
PTPN14	TTNIR6C	Limited	Altered Expression	[331]
PTPN2	TTY8PUS	Limited	Genetic Variation	[324]
PTPRC	TTUS45N	Limited	Biomarker	[332]
QPCT	TTJ7YTV	Limited	Biomarker	[333]
RARG	TT1Q3IE	Limited	Altered Expression	[334]
RGS12	TTP9AV7	Limited	Altered Expression	[335]
RPS6KA5	TTYXEPL	Limited	Biomarker	[336]
RXRA	TT6PEUO	Limited	Biomarker	[337]
S1PR2	TTVSMOH	Limited	Biomarker	[338]
S1PR3	TTDYP7I	Limited	Biomarker	[338]
SEMA4D	TT5UT28	Limited	Altered Expression	[339]
SFRP4	TTX8I1Y	Limited	Biomarker	[340]
SIRPA	TTBRJS9	Limited	Biomarker	[341]
SMAD7	TT0J32Z	Limited	Biomarker	[342]
SPHK2	TTCN0M9	Limited	Biomarker	[343]
STC2	TT4EFTR	Limited	Biomarker	[344]
TDGF1	TTN7HMG	Limited	Altered Expression	[345]
TF	TT8WXAV	Limited	Altered Expression	[346]
TFF1	TTNOJIZ	Limited	Altered Expression	[347]
TGFB3	TTWOMY8	Limited	Biomarker	[348]
THBD	TTAPV67	Limited	Biomarker	[349]
TNFRSF4	TTL31H0	Limited	Biomarker	[350]
TPH2	TT3KLDP	Limited	Biomarker	[351]
TPT1	TT3PTB6	Limited	Biomarker	[352]
TRPC1	TTA76X0	Limited	Altered Expression	[353]
TRPC5	TT32NQ1	Limited	Altered Expression	[353]
TRPM3	TTO3TD8	Limited	Biomarker	[354]
TRPV2	TTBECWA	Limited	Biomarker	[355]
TXNIP	TTTLDZK	Limited	Biomarker	[301]
TYK2	TTBYWP2	Limited	Genetic Variation	[356]
TYMS	TTP1UKZ	Limited	Altered Expression	[357]
UGCG	TTPHEX3	Limited	Altered Expression	[358]
VCAM1	TTHCEF6	Limited	Biomarker	[359]
VIPR1	TTCL30I	Limited	Altered Expression	[360]
ALOX5	TTSJ6Q4	Disputed	Altered Expression	[361]
ARG1	TT7ZQEV	Disputed	Biomarker	[362]
ARRB1	TTMVD4A	Disputed	Biomarker	[363]
ASPA	TT6TLZP	Disputed	Biomarker	[364]
BRD3	TTHE657	Disputed	Biomarker	[365]
C3AR1	TTI6B3F	Disputed	Biomarker	[366]
CYSLTR1	TTGKOY9	Disputed	Biomarker	[367]
EGLN1	TT9ISBX	Disputed	Biomarker	[368]
ESRRB	TTKF0XS	Disputed	Altered Expression	[369]
F10	TTCIHJA	Disputed	Biomarker	[370]
HDAC5	TTUELN5	Disputed	Biomarker	[371]
IL25	TTVMO5W	Disputed	Altered Expression	[372]
LAG3	TTNVXAW	Disputed	Biomarker	[373]
LCK	TT860QF	Disputed	Biomarker	[374]
LYVE1	TTG8DNU	Disputed	Altered Expression	[375]
MCAM	TTHRE05	Disputed	Altered Expression	[376]
MSMB	TTYH1ZK	Disputed	Altered Expression	[377]
MTA1	TTO4HUS	Disputed	Biomarker	[378]
NCF1	TTZ4JC3	Disputed	Biomarker	[379]
PTPRJ	TTWMKXP	Disputed	Altered Expression	[380]
SPHK1	TTOHFIY	Disputed	Altered Expression	[381]
TEC	TT1ZV49	Disputed	Biomarker	[332]
ADORA2A	TTM2AOE	moderate	Genetic Variation	[382]
AIF1	TT12MEP	moderate	Biomarker	[383]
ASRGL1	TT4WT91	moderate	Altered Expression	[384]
ATIC	TT9NVXQ	moderate	Genetic Variation	[385]
BGN	TT0JPVF	moderate	Altered Expression	[386]
BMP4	TTD3BSX	moderate	Biomarker	[387]
C3	TTJGY7A	moderate	Biomarker	[364]
C5	TTKANGO	moderate	Genetic Variation	[388]
C9orf72	TTA4SHR	moderate	Genetic Variation	[389]
CD22	TTM6QSK	moderate	Biomarker	[390]
CXCL2	TTZF0K2	moderate	Altered Expression	[391]
CYP26A1	TTD7Q0R	moderate	Altered Expression	[392]
DNAJB1	TTPXAWS	moderate	Biomarker	[393]
DUSP1	TTG8HIM	moderate	Biomarker	[394]
EBI3	TTJF68X	moderate	Biomarker	[395]
EIF4EBP1	TTKGEBL	moderate	Altered Expression	[396]
FASLG	TTO7014	moderate	Genetic Variation	[397]
FKBP5	TT0J5KQ	moderate	Altered Expression	[398]
FLT4	TTDCBX5	moderate	Biomarker	[399]
GATA3	TT45KOB	moderate	Genetic Variation	[324]
GGH	TTZJRL0	moderate	Genetic Variation	[400]
GPX1	TTYAHBP	moderate	Altered Expression	[401]
GRK2	TTAZ3MN	moderate	Biomarker	[402]
HSD11B1	TTN7BL9	moderate	Biomarker	[403]
ID1	TTBXVDE	moderate	Biomarker	[404]
IGFBP1	TTCJTWF	moderate	Altered Expression	[405]
IKZF3	TTCZVFZ	moderate	Biomarker	[406]
IL1RAP	TTWS50K	moderate	Biomarker	[407]
KCNMA1	TTE87WJ	moderate	Biomarker	[408]
KDM6B	TTDIJUQ	moderate	Biomarker	[409]
KNG1	TTDJ4MY	moderate	Altered Expression	[410]
MMP10	TTXLEG7	moderate	Biomarker	[301]
NLRC5	TTWZC78	moderate	Altered Expression	[411]
NOX4	TTQRBSJ	moderate	Altered Expression	[412]
NR4A1	TTMXE2Q	moderate	Biomarker	[413]
PAK1	TTFN95D	moderate	Biomarker	[414]
PAM	TTF4ZPC	moderate	Biomarker	[415]
PDE2A	TTJGW1Z	moderate	Genetic Variation	[416]
PDE7A	TT1BC3A	moderate	Altered Expression	[417]
PLAUR	TTNOSTX	moderate	Biomarker	[418]
PPARGC1B	TTKSQ3W	moderate	Altered Expression	[419]
PRKCQ	TT1MS7X	moderate	Biomarker	[420]
RBPJ	TT72D4Z	moderate	Altered Expression	[421]
RHBDF2	TTH1ZOP	moderate	Biomarker	[422]
RORC	TTGV6LY	moderate	Biomarker	[396]
SHCBP1	TTZ9WGL	moderate	Biomarker	[423]
SLC40A1	TT6Y1PG	moderate	Genetic Variation	[424]
SPRY1	TT0PSN6	moderate	Altered Expression	[425]
STS	TTHM0R1	moderate	Biomarker	[426]
TBX21	TTNF9PH	moderate	Altered Expression	[427]
THBS1	TTKI0H1	moderate	Biomarker	[428]
TLR9	TTSHG0T	moderate	Biomarker	[429]
TNFRSF18	TTG6LA7	moderate	Altered Expression	[430]
TNNC1	TT8RDXP	moderate	Biomarker	[431]
TREM2	TTQRMSJ	moderate	Altered Expression	[432]
VEGFD	TTOM5H4	moderate	Altered Expression	[423]
VIP	TTGTWLF	moderate	Altered Expression	[433]
ABCC3	TTVLG21	Strong	Biomarker	[243]
ABCC4	TTUEAFL	Strong	Genetic Variation	[434]
ABCC8	TTP835K	Strong	Biomarker	[435]
ACKR3	TTRQJTC	Strong	Altered Expression	[436]
ACR	TTAHE2N	Strong	Biomarker	[437]
ACTG1	TTGAZF9	Strong	Biomarker	[438]
ADA	TTLP57V	Strong	Biomarker	[439]
ADAM10	TTVXEGU	Strong	Altered Expression	[440]
ADAM17	TT6AZXG	Strong	Biomarker	[422]
ADAM8	TTQWYMD	Strong	Biomarker	[441]
ADAMTS4	TTYG6BU	Strong	Biomarker	[442]
ADAMTS5	TTXSU2Y	Strong	Biomarker	[443]
ADM	TTV14YH	Strong	Biomarker	[244]
ADRB2	TTG8ZWP	Strong	Biomarker	[444]
ADRB3	TTMXGCW	Strong	Genetic Variation	[445]
AGPAT1	TTPL1TK	Strong	Genetic Variation	[446]
AICDA	TTKRTP6	Strong	Altered Expression	[447]
AIMP2	TTXWHGF	Strong	Biomarker	[448]
ALCAM	TT2AFT6	Strong	Biomarker	[449]
ALOX15	TTN9T81	Strong	Biomarker	[450]
ALOX5AP	TTDMBF5	Strong	Biomarker	[451]
AMOT	TTI48OS	Strong	Altered Expression	[452]
ANG	TTURHFP	Strong	Altered Expression	[453]
ANGPT1	TTWNQ1T	Strong	Altered Expression	[454]
ANGPT2	TTKLQTJ	Strong	Genetic Variation	[455]
ANGPTL4	TTWALY5	Strong	Altered Expression	[456]
ANXA1	TTUCK4B	Strong	Biomarker	[457]
AOC1	TTM3B5R	Strong	Biomarker	[458]
APLN	TT87D3J	Strong	Biomarker	[459]
APOB	TTN1IE2	Strong	Biomarker	[460]
AQP1	TTSF1KH	Strong	Biomarker	[461]
AQP9	TTQEI32	Strong	Altered Expression	[462]
ARRB2	TT8SO2I	Strong	Biomarker	[463]
ASIC3	TTLGDIS	Strong	Biomarker	[464]
ATAT1	TTWUHQ1	Strong	Genetic Variation	[327]
BAK1	TTFM7V0	Strong	Biomarker	[465]
BCL2A1	TTGT9C7	Strong	Biomarker	[466]
BDKRB2	TTGY8IW	Strong	Biomarker	[467]
BRS3	TTKYEPM	Strong	Biomarker	[468]
BSG	TT5UJWD	Strong	Biomarker	[469]
BTLA	TTER58P	Strong	Altered Expression	[470]
C5AR1	TTHXFA1	Strong	Biomarker	[471]
CA1	TTHQPL7	Strong	Biomarker	[472]
CACNA1S	TT94HRF	Strong	Biomarker	[473]
CALR	TTUZ7OA	Strong	Altered Expression	[474]
CAMP	TTULOB6	Strong	Biomarker	[475]
CASP1	TTCQIBE	Strong	Biomarker	[476]
CASP10	TTX5HEK	Strong	Genetic Variation	[477]
CCL17	TTMPHAE	Strong	Biomarker	[478]
CCL20	TT2XAZY	Strong	Biomarker	[479]
CCL22	TTBTWI1	Strong	Altered Expression	[480]
CCL3	TT8I4WB	Strong	Biomarker	[481]
CCN2	TTIL516	Strong	Altered Expression	[482]
CCR1	TTC24WT	Strong	Biomarker	[483]
CCR3	TTD3XFU	Strong	Biomarker	[484]
CCR4	TT7HQD0	Strong	Biomarker	[485]
CCR7	TT2GIDQ	Strong	Biomarker	[486]
CCR9	TTIPS8B	Strong	Biomarker	[487]
CD160	TTOFEAS	Strong	Genetic Variation	[488]
CD163	TTTZ9DE	Strong	Altered Expression	[489]
CD19	TTW640A	Strong	Biomarker	[490]
CD2	TTJDUNO	Strong	Genetic Variation	[491]
CD248	TTYJWT7	Strong	Altered Expression	[492]
CD276	TT6CQUM	Strong	Altered Expression	[493]
CD38	TTPURFN	Strong	Biomarker	[494]
CD3E	TTZAT79	Strong	Biomarker	[467]
CD4	TTN2JFW	Strong	Genetic Variation	[495]
CD44	TTWFBT7	Strong	Altered Expression	[496]
CD46	TTMS7DF	Strong	Biomarker	[497]
CD55	TT5Z9WY	Strong	Biomarker	[498]
CD6	TTMF6KC	Strong	Genetic Variation	[449]
CD69	TTPQE9F	Strong	Altered Expression	[499]
CD70	TTNCIE0	Strong	Altered Expression	[500]
CD74	TTCMYP9	Strong	Biomarker	[501]
CD80	TT89Z17	Strong	Biomarker	[502]
CDA	TTQ12RK	Strong	Biomarker	[503]
CDK5R1	TTBYM6V	Strong	Biomarker	[504]
CFLAR	TTJZQYH	Strong	Altered Expression	[505]
CHAT	TTKYFSB	Strong	Biomarker	[506]
CHUK	TT1F8OQ	Strong	Altered Expression	[507]
CLIC1	TT8KZG6	Strong	Genetic Variation	[446]
CNR2	TTMSFAW	Strong	Biomarker	[508]
CNTFR	TTT2F9E	Strong	Genetic Variation	[327]
CNTN2	TT2Z1WB	Strong	Genetic Variation	[509]
CPB1	TT4UJX5	Strong	Biomarker	[510]
CR1	TTEA8OW	Strong	Altered Expression	[511]
CR2	TT0HUN7	Strong	Biomarker	[512]
CREB1	TTH4AN3	Strong	Biomarker	[513]
CRHR1	TT7EFHR	Strong	Biomarker	[514]
CRHR2	TTIY658	Strong	Biomarker	[514]
CRK	TTFEUYR	Strong	Biomarker	[448]
CSF1	TT0IQER	Strong	Biomarker	[515]
CSF1R	TT7MRDV	Strong	Biomarker	[516]
CSF2	TTNYZG2	Strong	Altered Expression	[517]
CSF3R	TTC70AJ	Strong	Biomarker	[518]
CSK	TTX6F0Q	Strong	Altered Expression	[519]
CTH	TTLQUZS	Strong	Biomarker	[409]
CTSC	TT4H0V2	Strong	Altered Expression	[520]
CTSD	TTPT2QI	Strong	Biomarker	[467]
CTSK	TTDZN01	Strong	Biomarker	[429]
CTSL	TT36ETB	Strong	Biomarker	[521]
CTSS	TTUMQVO	Strong	Altered Expression	[522]
CXCL1	TTLK1RW	Strong	Biomarker	[523]
CXCL11	TTWG0RE	Strong	Biomarker	[524]
CXCL9	TTWE5PB	Strong	Genetic Variation	[525]
CXCR1	TTMWT8Z	Strong	Biomarker	[526]
CXCR2	TT30C9G	Strong	Genetic Variation	[527]
CXCR3	TT1UCIJ	Strong	Biomarker	[524]
CXCR6	TT2BVUA	Strong	Altered Expression	[528]
CYBB	TT5T8MR	Strong	Biomarker	[307]
CYP21A2	TTP4GLG	Strong	Genetic Variation	[446]
DDIT4	TTVEOY6	Strong	Biomarker	[529]
DDR1	TTI1FPZ	Strong	Genetic Variation	[327]
DDR2	TTU98HG	Strong	Biomarker	[530]
DHODH	TTLVP78	Strong	Biomarker	[531]
DICER1	TTTEOPU	Strong	Altered Expression	[532]
DKK1	TTE3RAC	Strong	Altered Expression	[533]
DKK3	TTY2ZV6	Strong	Genetic Variation	[534]
DLL1	TT9CFQD	Strong	Biomarker	[535]
DMD	TTWLFXU	Strong	Biomarker	[536]
DNASE1	TTYWGOJ	Strong	Altered Expression	[537]
DNMT3B	TT6VZ78	Strong	Genetic Variation	[538]
DPEP1	TTYUENF	Strong	Biomarker	[539]
E2F2	TT5FYX0	Strong	Biomarker	[540]
EBP	TT4VQZX	Strong	Biomarker	[541]
EHMT1	TTOFXD7	Strong	Biomarker	[542]
EHMT2	TTS6RZT	Strong	Genetic Variation	[446]
ELAVL1	TTPC9D0	Strong	Altered Expression	[543]
ELK3	TT5OJMV	Strong	Biomarker	[544]
ENPP2	TTSCIM2	Strong	Altered Expression	[545]
ENTPD1	TTYM8DJ	Strong	Genetic Variation	[546]
EPHB1	TT8MDAC	Strong	Biomarker	[544]
ETS1	TTTGPSD	Strong	Biomarker	[530]
ETS2	TT9AH0M	Strong	Altered Expression	[547]
F3	TT38MDJ	Strong	Biomarker	[548]
F9	TTFEZ5Q	Strong	Altered Expression	[549]
FADS2	TTT2VDU	Strong	Genetic Variation	[324]
FCGR1A	TTZK4I3	Strong	Biomarker	[550]
FGF1	TTMY81X	Strong	Altered Expression	[551]
FGF2	TTGKIED	Strong	Altered Expression	[552]
FGF21	TTQ916P	Strong	Biomarker	[553]
FHL1	TTI7ENL	Strong	Altered Expression	[554]
FLT1	TT1VAUK	Strong	Biomarker	[555]
FN1	TTPJ921	Strong	Biomarker	[556]
FOLR2	TTT54CI	Strong	Altered Expression	[557]
FOS	TTOM5AU	Strong	Biomarker	[530]
FOSL1	TTY8LZG	Strong	Biomarker	[558]
FOXC1	TTNT3YA	Strong	Biomarker	[559]
FPR2	TTOJ1NF	Strong	Biomarker	[560]
FTO	TTFW3BT	Strong	Genetic Variation	[561]
FURIN	TTH9WF6	Strong	Altered Expression	[562]
FUT4	TTNV1KZ	Strong	Biomarker	[563]
G3BP1	TTG0R8Z	Strong	Biomarker	[564]
GADD45B	TTMDW9L	Strong	Genetic Variation	[565]
GAS6	TT69QD2	Strong	Altered Expression	[566]
GCK	TTDLNGZ	Strong	Altered Expression	[567]
GDF15	TT4MXVG	Strong	Altered Expression	[568]
GDF5	TT37XV9	Strong	Biomarker	[569]
GLB1	TTNGJPH	Strong	Altered Expression	[570]
GLP1R	TTVIMDE	Strong	Biomarker	[412]
GPBAR1	TTSDVTR	Strong	Biomarker	[571]
GPI	TT19JIZ	Strong	Biomarker	[572]
GPR3	TTHZVSK	Strong	Altered Expression	[573]
GRB2	TTEYRJ9	Strong	Altered Expression	[574]
GUSB	TTHS7CM	Strong	Biomarker	[575]
GZMB	TTKEPHX	Strong	Biomarker	[576]
HAMP	TTRV5YJ	Strong	Altered Expression	[577]
HDAC1	TT6R7JZ	Strong	Altered Expression	[578]
HDAC3	TT4YWTO	Strong	Altered Expression	[579]
HLA-A	TTHONFT	Strong	Biomarker	[580]
HLA-B	TTGS10J	Strong	Biomarker	[581]
HLA-DQB2	TTL7VOU	Strong	Genetic Variation	[446]
HMGB1	TTWQYB7	Strong	Biomarker	[582]
HNRNPA2B1	TT8UPW6	Strong	ModifyingMutation	[583]
HPGDS	TTCYE56	Strong	Genetic Variation	[584]
HPSE	TTR7GJO	Strong	Altered Expression	[585]
HRH4	TTXJ178	Strong	Biomarker	[586]
HSD11B2	TT9H85R	Strong	Biomarker	[587]
HSPB8	TTY0OJN	Strong	Genetic Variation	[588]
HSPD1	TT9HL5R	Strong	Biomarker	[589]
HTR2A	TTJQOD7	Strong	Genetic Variation	[590]
HTRA1	TT8POQR	Strong	Biomarker	[591]
ICA1	TTMX06B	Strong	Biomarker	[592]
ICOS	TTE5VP6	Strong	Biomarker	[593]
IDO1	TTZJYKH	Strong	Biomarker	[594]
IFNB1	TT4TZ8J	Strong	Biomarker	[595]
IGFBP5	TTDWEA8	Strong	Biomarker	[596]
IGFBP6	TTLAYV8	Strong	Biomarker	[597]
IKBKB	TTJ3E9X	Strong	Biomarker	[598]
IL10RB	TTJTRMK	Strong	Altered Expression	[599]
IL12A	TTRTK6Y	Strong	Biomarker	[600]
IL12RB2	TT4SWR8	Strong	Genetic Variation	[601]
IL13	TT0GVCH	Strong	Biomarker	[602]
IL15	TTJFA35	Strong	Biomarker	[603]
IL15RA	TTGN89I	Strong	Altered Expression	[604]
IL16	TTW4R0B	Strong	Altered Expression	[605]
IL17D	TTC5LTG	Strong	Biomarker	[606]
IL18RAP	TTZUJVE	Strong	Altered Expression	[462]
IL19	TT87RWS	Strong	Biomarker	[607]
IL1A	TTPM6HI	Strong	Altered Expression	[608]
IL1R1	TTWOTEA	Strong	Altered Expression	[609]
IL21R	TTZO9B0	Strong	Biomarker	[610]
IL23A	TTC1GLB	Strong	Biomarker	[611]
IL32	TTD4G7L	Strong	Biomarker	[612]
IL33	TT5MD4P	Strong	Biomarker	[613]
IL37	TTQTX98	Strong	Biomarker	[614]
IL4R	TTDWHC3	Strong	Genetic Variation	[615]
IL7	TT8FRMO	Strong	Biomarker	[616]
IL7R	TTAWI51	Strong	Biomarker	[617]
IL9	TT0JTFD	Strong	Biomarker	[602]
INPP5D	TTTP2Z1	Strong	Altered Expression	[618]
IRAK3	TTBPJOK	Strong	Genetic Variation	[619]
IRAK4	TTILUKB	Strong	Biomarker	[620]
IRF1	TT4TU3L	Strong	Altered Expression	[371]
IRS1	TTAJSQ0	Strong	Biomarker	[621]
ISG15	TTVOH3T	Strong	Biomarker	[622]
ITCH	TT5SEWD	Strong	Biomarker	[623]
ITGA1	TTPERWV	Strong	Biomarker	[624]
ITGA4	TTJMF9P	Strong	Genetic Variation	[625]
ITGA6	TT165T3	Strong	Biomarker	[529]
ITGAE	TTH0Z37	Strong	Biomarker	[624]
ITGAL	TT48WR6	Strong	Altered Expression	[500]
ITGAV	TTT1R2L	Strong	Biomarker	[626]
ITGB1	TTBVIQC	Strong	Biomarker	[624]
ITGB2	TTIJWR7	Strong	Biomarker	[627]
ITPR3	TTH1769	Strong	Genetic Variation	[446]
JAK1	TT6DM01	Strong	Biomarker	[628]
JAK2	TTRMX3V	Strong	Biomarker	[629]
JUN	TTS7IR5	Strong	Posttranslational Modification	[630]
KDR	TTUTJGQ	Strong	Biomarker	[555]
KHDRBS1	TTAT6C7	Strong	Altered Expression	[631]
KIF26B	TTQWICZ	Strong	Genetic Variation	[632]
KIF5A	TTCJPAH	Strong	Genetic Variation	[633]
KIR2DL1	TT4UXPE	Strong	Biomarker	[634]
KIR2DL2	TTU0P73	Strong	Biomarker	[635]
KIR2DL3	TTEX3SI	Strong	Biomarker	[634]
KIR2DS1	TTVWAGF	Strong	Genetic Variation	[636]
KIR2DS2	TTV3CFI	Strong	Biomarker	[637]
KLK1	TT5T3P6	Strong	Altered Expression	[638]
KLK3	TTS78AZ	Strong	Biomarker	[639]
KLRC1	TTC4IMS	Strong	Genetic Variation	[640]
KLRK1	TTLRN4A	Strong	Genetic Variation	[641]
LAIR1	TTSI7A8	Strong	Biomarker	[642]
LANCL1	TTZW8NS	Strong	Altered Expression	[643]
LBP	TTVQJLY	Strong	Genetic Variation	[644]
LCN2	TTKTLAI	Strong	Biomarker	[645]
LDLR	TTH0DUS	Strong	Biomarker	[646]
LGALS1	TTO3NYT	Strong	Biomarker	[647]
LIF	TTGZ5WN	Strong	Biomarker	[648]
LILRB1	TTC0QRJ	Strong	Biomarker	[649]
LNPEP	TTY2KP7	Strong	Altered Expression	[650]
LOX	TTQHNAM	Strong	Biomarker	[651]
LPA	TTU9LGY	Strong	Biomarker	[652]
LPAR1	TTQ6S1K	Strong	Altered Expression	[653]
LPAR2	TTB7Y8I	Strong	Altered Expression	[654]
LRP5	TT7VMG4	Strong	Genetic Variation	[655]
LTB	TTHQ6US	Strong	Biomarker	[656]
LTB4R	TTN53ZF	Strong	Biomarker	[657]
LTB4R2	TTVJX54	Strong	Biomarker	[658]
LTBR	TTFO0PM	Strong	Biomarker	[659]
LY96	TT8S9AV	Strong	Biomarker	[529]
MALT1	TTCI81G	Strong	Biomarker	[660]
MANF	TT56RYE	Strong	Biomarker	[661]
MAP2K7	TT6QY3J	Strong	Biomarker	[662]
MAP3K11	TTETX6Q	Strong	Altered Expression	[663]
MAP3K2	TTIX0ZU	Strong	Biomarker	[663]
MAP3K3	TTJZNIG	Strong	Altered Expression	[663]
MAP3K4	TT1RSX7	Strong	Genetic Variation	[534]
MAP3K5	TTOQCD8	Strong	Biomarker	[664]
MAP3K7	TTJQT60	Strong	Biomarker	[665]
MAP4K3	TTI0AHJ	Strong	Altered Expression	[567]
MAPK14	TTQBR95	Strong	Biomarker	[448]
MAPK8	TT0K6EO	Strong	Biomarker	[662]
MARK2	TTAJ45Y	Strong	Biomarker	[666]
MCL1	TTL53M6	Strong	Biomarker	[474]
MDK	TTV8UE7	Strong	Altered Expression	[667]
MECP2	TTTAU9R	Strong	Genetic Variation	[668]
MMP12	TTXZ0KQ	Strong	Biomarker	[301]
MMP13	TTHY57M	Strong	Altered Expression	[669]
MOBP	TTYUK4F	Strong	Biomarker	[670]
MOG	TTQAFX5	Strong	Genetic Variation	[671]
MPO	TTVCZPI	Strong	Biomarker	[672]
MSI1	TTSM4BA	Strong	Genetic Variation	[673]
MSTN	TTM8I2X	Strong	Biomarker	[674]
MTF1	TTTQDEO	Strong	Genetic Variation	[324]
MTR	TTUTO39	Strong	Genetic Variation	[675]
MUTYH	TTNB0ZK	Strong	Genetic Variation	[676]
MYD88	TTB6Q2O	Strong	Biomarker	[481]
NAMPT	TTD1WIG	Strong	Biomarker	[677]
NCAM1	TTVXPHT	Strong	Biomarker	[678]
NFKBIA	TTSHAEB	Strong	Biomarker	[485]
NME1	TTDY8JH	Strong	Genetic Variation	[679]
NOD1	TTYSRXM	Strong	Genetic Variation	[680]
NOTCH3	TTVX7IA	Strong	Altered Expression	[681]
NOTCH4	TTXDIK2	Strong	Genetic Variation	[682]
NPSR1	TTV1C0Z	Strong	Genetic Variation	[683]
NR1I2	TT7LCTF	Strong	Altered Expression	[684]
NR4A2	TT9HKN3	Strong	Altered Expression	[685]
NR4A3	TTJQB49	Strong	Biomarker	[301]
NRP1	TTIPJCB	Strong	Biomarker	[310]
OLR1	TTKSND3	Strong	Altered Expression	[686]
ORAI1	TTE76YK	Strong	Biomarker	[687]
OSCAR	TT71Q5Y	Strong	Altered Expression	[688]
OSM	TTIVXSE	Strong	Altered Expression	[689]
OSMR	TTAH0KM	Strong	Genetic Variation	[690]
P2RX1	TTJW7B3	Strong	Biomarker	[691]
P2RX3	TT2THBD	Strong	Biomarker	[691]
P2RX4	TT1NLOA	Strong	Biomarker	[691]
P2RY1	TTA93TL	Strong	Biomarker	[691]
P2RY2	TTOZHQC	Strong	Biomarker	[691]
PAX5	TTA4REJ	Strong	Biomarker	[692]
PCSK6	TT75LN9	Strong	Biomarker	[693]
PCSK9	TTNIZ2B	Strong	Biomarker	[694]
PDE4A	TTZ97H5	Strong	Biomarker	[695]
PF4	TTSG7Q5	Strong	Altered Expression	[696]
PFKFB3	TTTHMQJ	Strong	Altered Expression	[697]
PGF	TT48I1Y	Strong	Biomarker	[698]
PIK3CB	TT9H4P3	Strong	Biomarker	[699]
PLA2G1B	TT9V5JH	Strong	Biomarker	[700]
PLA2G4A	TTT1JVS	Strong	Altered Expression	[701]
PLG	TTP86E2	Strong	Biomarker	[702]
PPIA	TTL2ADK	Strong	Biomarker	[703]
PRG4	TTSKF4V	Strong	Biomarker	[704]
PRKCA	TTFJ8Q1	Strong	Biomarker	[705]
PRKCB	TTYPXQF	Strong	Altered Expression	[706]
PRKCZ	TTBSN0L	Strong	Biomarker	[707]
PRL	TTJ2TSA	Strong	Altered Expression	[708]
PROC	TTZUXYS	Strong	Biomarker	[709]
PSIP1	TTH9LDP	Strong	Biomarker	[710]
PTGES	TTYLQ8V	Strong	Biomarker	[711]
PTH	TT6F7GZ	Strong	Altered Expression	[712]
PTK2	TTON5IT	Strong	Biomarker	[467]
PTN	TTA9EJK	Strong	Altered Expression	[713]
PTPN11	TT7WUAV	Strong	Genetic Variation	[601]
RAC1	TT2M9CG	Strong	Biomarker	[355]
RARA	TTW38KT	Strong	Biomarker	[714]
RECK	TTRZBW7	Strong	Altered Expression	[715]
RHO	TTH0KSX	Strong	Biomarker	[716]
RORA	TT1TYN7	Strong	Altered Expression	[717]
RPS6KA3	TTUM2ZR	Strong	Altered Expression	[718]
RPSA	TTLUW5B	Strong	Biomarker	[719]
RUNX2	TTD6SZ8	Strong	Biomarker	[255]
S100A12	TTQ4ESF	Strong	Biomarker	[696]
S100A4	TTPR5SX	Strong	Altered Expression	[720]
S100B	TTQ0V86	Strong	Biomarker	[721]
S1PR1	TT9JZCK	Strong	Biomarker	[722]
SDC1	TTYDSVG	Strong	Biomarker	[723]
SDC2	TT5H2F0	Strong	Altered Expression	[724]
SELL	TT2IYXF	Strong	Altered Expression	[725]
SEMA3A	TTVKD3S	Strong	Biomarker	[726]
SENP1	TTW9HY5	Strong	Biomarker	[727]
SERPINC1	TT4QPUL	Strong	Biomarker	[728]
SERPINF1	TTR59S1	Strong	Genetic Variation	[729]
SERPINH1	TTPSWQG	Strong	Biomarker	[730]
SIK1	TT1H6LC	Strong	Biomarker	[731]
SIRT6	TTUXYWF	Strong	Altered Expression	[732]
SLC16A3	TTG6VD5	Strong	Biomarker	[733]
SLC17A5	TTFSUIA	Strong	Biomarker	[734]
SLC19A1	TT09I7D	Strong	Genetic Variation	[735]
SLC22A1	TTM5Q4V	Strong	Biomarker	[736]
SLC22A2	TT0XOJN	Strong	Biomarker	[737]
SLC38A1	TT1YE9Z	Strong	Altered Expression	[738]
SLC44A4	TT0NYDG	Strong	Genetic Variation	[446]
SLC5A7	TTRV7W3	Strong	Biomarker	[739]
SLC6A11	TT8RXO5	Strong	Genetic Variation	[534]
SLC6A2	TTAWNKZ	Strong	Biomarker	[544]
SLC7A5	TTPH2JB	Strong	Altered Expression	[740]
SOCS1	TT8COJM	Strong	Altered Expression	[741]
SOX5	TTXHSZK	Strong	Biomarker	[742]
SP1	TTZEP6S	Strong	Biomarker	[409]
SQSTM1	TTOT2RY	Strong	Genetic Variation	[743]
SSRP1	TTETDKQ	Strong	Biomarker	[744]
SSTR4	TTAE1BR	Strong	Biomarker	[468]
STAT6	TTWOE1T	Strong	Genetic Variation	[745]
SYVN1	TT8XKYM	Strong	Biomarker	[746]
TACR1	TTZPO1L	Strong	Altered Expression	[747]
TACR2	TTYO0A3	Strong	Biomarker	[748]
TACR3	TTBPGLU	Strong	Altered Expression	[748]
TAGLN	TTDRZ9H	Strong	Altered Expression	[749]
TAP1	TT7JZI8	Strong	Biomarker	[750]
TEC	TT1ZV49	Strong	Genetic Variation	[751]
TEK	TT9VGXW	Strong	Altered Expression	[752]
TIE1	TTT4236	Strong	Biomarker	[753]
TIRAP	TTKU0LS	Strong	Biomarker	[754]
TLR1	TTW14D0	Strong	Genetic Variation	[755]
TLR3	TTD24Y0	Strong	Biomarker	[756]
TLR5	TTCXP8J	Strong	Altered Expression	[757]
TLR7	TTRJ1K4	Strong	Genetic Variation	[758]
TLR8	TT8CWFK	Strong	Genetic Variation	[758]
TNC	TTUCPMY	Strong	Biomarker	[759]
TNFAIP3	TT5W0IO	Strong	Biomarker	[760]
TNFRSF10B	TTW20TU	Strong	Biomarker	[761]
TNFRSF12A	TTKPS7V	Strong	Biomarker	[762]
TNFRSF13C	TT7NJSE	Strong	Genetic Variation	[763]
TNFRSF17	TTZ3P4W	Strong	Altered Expression	[764]
TNFRSF25	TTDV6BQ	Strong	Genetic Variation	[765]
TNFRSF8	TT2GM5R	Strong	Altered Expression	[766]
TNFRSF9	TTPW9LJ	Strong	Altered Expression	[261]
TNFSF11	TT9E8HR	Strong	Biomarker	[767]
TNFSF12	TTBTDM1	Strong	Biomarker	[768]
TNFSF13	TTOI1RM	Strong	Biomarker	[769]
TNFSF13B	TTWMIDN	Strong	Biomarker	[291]
TNFSF14	TTKVENM	Strong	Altered Expression	[470]
TNFSF15	TTEST6I	Strong	Genetic Variation	[770]
TNFSF4	TTBW580	Strong	Genetic Variation	[771]
TPP1	TTOVYPT	Strong	Altered Expression	[772]
TPSAB1	TTM1TDX	Strong	Altered Expression	[773]
TSLP	TTHMW3T	Strong	Biomarker	[774]
TSPO	TTPTXIN	Strong	Biomarker	[775]
TXN	TTZJ5U9	Strong	Biomarker	[776]
TYMP	TTO0IB8	Strong	Biomarker	[307]
TYRP1	TTFRV98	Strong	Biomarker	[777]
VEGFC	TT0QUFV	Strong	Biomarker	[778]
VTCN1	TTCK85E	Strong	Biomarker	[779]
VWF	TT3SZBT	Strong	Biomarker	[780]
WNK1	TTJ9UMX	Strong	Biomarker	[781]
WNT5A	TTKG7F8	Strong	Biomarker	[782]
ZAP70	TTUMHT8	Strong	Altered Expression	[783]
ABHD6	TTSINOV	Definitive	Genetic Variation	[784]
ADCYAP1R1	TT5OREU	Definitive	Biomarker	[785]
ADORA3	TTJFY5U	Definitive	Genetic Variation	[382]
AHSG	TTKF4WV	Definitive	Altered Expression	[786]
AZGP1	TTUPYLV	Definitive	Biomarker	[787]
BMP10	TTTG6H1	Definitive	Altered Expression	[788]
BRD1	TTT09OB	Definitive	Biomarker	[789]
CCR6	TTFDB30	Definitive	Genetic Variation	[324]
CD28	TTQ13FT	Definitive	Biomarker	[790]
CDK7	TTQYF7G	Definitive	Biomarker	[791]
CHN2	TT39YVO	Definitive	Posttranslational Modification	[792]
CHRNA7	TTLA931	Definitive	Altered Expression	[793]
COL1A2	TTUABC1	Definitive	Biomarker	[794]
CPA1	TT3LJ6G	Definitive	Biomarker	[795]
CPB2	TTP18AY	Definitive	Altered Expression	[796]
DOT1L	TTSZ8T1	Definitive	Altered Expression	[797]
F2	TT6L509	Definitive	Biomarker	[798]
F2RL1	TTQR74A	Definitive	Biomarker	[799]
FABP5	TTNT2S6	Definitive	Biomarker	[800]
GDF2	TTAP4T1	Definitive	Altered Expression	[801]
GPER1	TTDSB34	Definitive	Biomarker	[802]
GPR39	TTTPCNU	Definitive	Biomarker	[803]
GRIA1	TTVPQTF	Definitive	Biomarker	[804]
GRPR	TTC1MVT	Definitive	Biomarker	[805]
HCRTR1	TT60Q8D	Definitive	Altered Expression	[806]
IAPP	TTHN8EM	Definitive	Biomarker	[807]
IDO2	TTALN9W	Definitive	Biomarker	[808]
IKZF2	TTKT5NV	Definitive	Altered Expression	[809]
IL11RA	TTZPLJS	Definitive	Biomarker	[293]
IL2RA	TT10Y9E	Definitive	Biomarker	[810]
ITGA5	TTHIZP9	Definitive	Biomarker	[626]
KYNU	TTWQM3J	Definitive	Biomarker	[811]
LIFR	TTID542	Definitive	Biomarker	[812]
LONP1	TTM1VPZ	Definitive	Biomarker	[813]
MAPK10	TT056SO	Definitive	Biomarker	[814]
MBP	TT2RY5P	Definitive	Genetic Variation	[815]
MERTK	TTO7LKR	Definitive	Biomarker	[802]
NDUFA13	TTRU1NG	Definitive	Altered Expression	[816]
NT5E	TTK0O6Y	Definitive	Biomarker	[817]
P2RY11	TTYXPCO	Definitive	Biomarker	[818]
P2RY12	TTZ1DT0	Definitive	Biomarker	[819]
PARP2	TTQ4V96	Definitive	Biomarker	[820]
PDK1	TTCZOF2	Definitive	Altered Expression	[718]
PDPK1	TTYMGWX	Definitive	Altered Expression	[718]
PKD2L1	TTAHD89	Definitive	Biomarker	[399]
PLTP	TTZF6SN	Definitive	Altered Expression	[821]
PML	TTLH9NY	Definitive	Biomarker	[822]
PPM1D	TTENJAB	Definitive	Biomarker	[823]
PRMT1	TTVOJAI	Definitive	Altered Expression	[417]
PRMT5	TTR1D7X	Definitive	Biomarker	[824]
RARB	TTISP28	Definitive	Genetic Variation	[632]
ROBO1	TTND1YP	Definitive	Biomarker	[825]
RRM2	TT1S4LJ	Definitive	Altered Expression	[826]
SGCG	TTSMT9W	Definitive	Biomarker	[827]
SLC3A2	TT5CZSM	Definitive	Altered Expression	[828]
SLC46A1	TTY8Z2E	Definitive	Altered Expression	[417]
SMAD1	TT9GR53	Definitive	Biomarker	[829]
TNNI3	TTNLDK6	Definitive	Biomarker	[830]
TRAF6	TTCDR6M	Definitive	Genetic Variation	[831]
TRPM2	TTEBMN7	Definitive	Biomarker	[832]
TYRO3	TTIEMFN	Definitive	Biomarker	[833]
UTS2R	TTW5UDX	Definitive	Genetic Variation	[834]
VDAC1	TTAMKGB	Definitive	Biomarker	[835]

This Disease Is Related to 12 DTP Molecule(s)

Gene Name	DTP ID	Evidence Level	Mode of Inheritance	REF
SLC8A3	DTYFRQT	Disputed	Genetic Variation	[836]
SLC2A3	DT9SQ3L	moderate	Genetic Variation	[837]
ABCC11	DTWN7FC	Strong	Biomarker	[435]
ABCC5	DTYVM24	Strong	Biomarker	[243]
ABCC6	DT582KR	Strong	Genetic Variation	[838]
SLC17A2	DTRF4L3	Strong	Genetic Variation	[839]
SLC17A4	DTHE530	Strong	Biomarker	[646]
SLC22A5	DT3HUVD	Strong	Genetic Variation	[840]
SLC25A12	DT85HYR	Strong	Biomarker	[467]
SLC52A1	DT7NOKR	Strong	Altered Expression	[841]
SLC7A9	DTP7AEQ	Strong	Biomarker	[842]
SLC14A2	DT8QC7K	Definitive	Genetic Variation	[834]

This Disease Is Related to 45 DME Molecule(s)

Gene Name	DME ID	Evidence Level	Mode of Inheritance	REF
B4GALT7	DEKRS6L	Limited	Biomarker	[843]
CYB5A	DE9A2LB	Limited	Genetic Variation	[844]
CYP2R1	DEBIHM3	Limited	Genetic Variation	[845]
CYP7B1	DE36TMY	Limited	Altered Expression	[846]
FADS1	DE05S8C	Limited	Genetic Variation	[324]
GCLC	DESYL1F	Limited	Altered Expression	[358]
GGCT	DEKW6PB	Limited	Genetic Variation	[847]
HAGH	DE05IKP	Limited	Genetic Variation	[848]
HK1	DEDMAGE	Limited	Altered Expression	[638]
HPRT1	DEVXTP5	Limited	Biomarker	[849]
NADSYN1	DELF8BA	Limited	Genetic Variation	[845]
NDUFS3	DE741FI	Limited	Genetic Variation	[850]
PCYT1A	DEQYXD4	Limited	Genetic Variation	[851]
UGT1A10	DEL5N6Y	Limited	Genetic Variation	[852]
UGT1A4	DELOY3P	Limited	Genetic Variation	[852]
UGT1A6	DESD26P	Limited	Genetic Variation	[852]
UGT1A7	DEZO4N3	Limited	Genetic Variation	[852]
UGT1A8	DE2GB8N	Limited	Genetic Variation	[852]
FPGS	DECWT2V	moderate	Genetic Variation	[400]
NAT10	DEZV4AP	moderate	Altered Expression	[384]
WARS1	DEPVE0M	moderate	Altered Expression	[853]
WARS2	DEPTKBQ	moderate	Altered Expression	[853]
ABO	DESIA7R	Strong	Biomarker	[854]
ACP5	DESITDW	Strong	Biomarker	[855]
CPA4	DEXKD7J	Strong	Genetic Variation	[673]
DHCR7	DEL7GFA	Strong	Genetic Variation	[856]
GLS	DE3E0VT	Strong	Altered Expression	[857]
GPT	DER5HFI	Strong	Biomarker	[858]
MSRA	DEU2ZBY	Strong	Genetic Variation	[859]
NAT2	DER7TA0	Strong	Genetic Variation	[860]
PGM1	DEA3VM1	Strong	Biomarker	[861]
PON2	DEHJU7E	Strong	Biomarker	[862]
SAT1	DEMWO83	Strong	Biomarker	[863]
SCLY	DEH4TD6	Strong	Genetic Variation	[864]
SPR	DEJVDAT	Strong	Biomarker	[865]
SULT2A1	DE0P6LK	Strong	Biomarker	[866]
THOP1	DE95LJC	Strong	Genetic Variation	[784]
TPMT	DEFQ8VO	Strong	Genetic Variation	[867]
UBASH3B	DE10BJ5	Strong	Genetic Variation	[868]
VARS1	DEUPF5K	Strong	Genetic Variation	[446]
AKR1D1	DEVON3M	Definitive	Biomarker	[869]
ALDH1A2	DEKN1H4	Definitive	Altered Expression	[870]
CYP26B1	DEZT8FM	Definitive	Altered Expression	[871]
NMNAT3	DERBKPU	Definitive	Altered Expression	[872]
SMOX	DEOH5V3	Definitive	Biomarker	[873]

This Disease Is Related to 992 DOT Molecule(s)

Gene Name	DOT ID	Evidence Level	Mode of Inheritance	REF
A2M	OTFTX90K	Limited	Altered Expression	[874]
AAAS	OTJT9T23	Limited	Biomarker	[875]
ADAD1	OTXRDF3Z	Limited	Genetic Variation	[876]
ADAMTS3	OT2U6VF5	Limited	Biomarker	[442]
ADAMTS7	OTVKZ1DV	Limited	Biomarker	[877]
ADGRE2	OTUYJVYG	Limited	Biomarker	[878]
ADGRE5	OTTSB84Q	Limited	Biomarker	[878]
AFF3	OTR0705Z	Limited	Genetic Variation	[563]
AIRE	OTA7G1Y1	Limited	Altered Expression	[879]
AKIRIN2	OTQ6WSKW	Limited	Biomarker	[880]
ALDH1A3	OT1C9NKQ	Limited	Biomarker	[881]
ANKRD55	OT62KZII	Limited	Genetic Variation	[324]
ANXA3	OTDD8OI7	Limited	Genetic Variation	[416]
ARC	OTN2QQPG	Limited	Genetic Variation	[882]
ARHGEF7	OT9BPJCL	Limited	Altered Expression	[883]
ATN1	OTNZFLKY	Limited	Genetic Variation	[884]
ATOH1	OTBZYG2R	Limited	Altered Expression	[885]
ATP6V1G1	OTBT1O58	Limited	Biomarker	[886]
ATP6V1G2	OTM1DSKL	Limited	Genetic Variation	[446]
B3GNTL1	OTYWGHF1	Limited	Genetic Variation	[887]
BAIAP2L1	OTZ71SK9	Limited	Biomarker	[888]
BCL3	OT1M5B95	Limited	Altered Expression	[889]
BMP5	OTC0Y6E0	Limited	Altered Expression	[890]
BTN1A1	OTSQWC36	Limited	Biomarker	[891]
BTNL2	OTTTEMZA	Limited	Genetic Variation	[682]
C2	OTHMF4YM	Limited	Genetic Variation	[446]
CABIN1	OT4G5CIK	Limited	Biomarker	[892]
CALD1	OTNJKJ6Q	Limited	Biomarker	[893]
CALHM6	OTLX9B4Y	Limited	Biomarker	[280]
CARD9	OTJ81AWD	Limited	Biomarker	[894]
CASP12	OTY2W6FG	Limited	Biomarker	[895]
CAVIN2	OTFHHDRU	Limited	Biomarker	[896]
CBLL2	OTB4AD3V	Limited	Biomarker	[746]
CCRL2	OT5PX0RX	Limited	Altered Expression	[897]
CCT3	OTL6EOS1	Limited	Genetic Variation	[898]
CD247	OT45FGUX	Limited	Altered Expression	[899]
CD63	OT2UGZA9	Limited	Biomarker	[900]
CD84	OTAY5B0F	Limited	Genetic Variation	[901]
CD93	OT6HZT6H	Limited	Altered Expression	[902]
CDKN3	OTBE3H07	Limited	Genetic Variation	[266]
CDSN	OTQW4HV6	Limited	Altered Expression	[903]
CENPJ	OTZCQZN5	Limited	Altered Expression	[904]
CHID1	OT4DIUKC	Limited	Altered Expression	[905]
CHP1	OTHTXN1A	Limited	Altered Expression	[265]
CIC	OTFXCHNZ	Limited	Biomarker	[906]
CLEC10A	OTD8HQT6	Limited	Altered Expression	[907]
CLEC1B	OTO38TRG	Limited	Biomarker	[908]
CLTA	OTLHOXMQ	Limited	Genetic Variation	[909]
COG2	OTKQH4N4	Limited	Biomarker	[910]
COL11A2	OT3BQUBH	Limited	Genetic Variation	[891]
COL12A1	OTHLTV53	Limited	Altered Expression	[911]
COX5A	OTP0961M	Limited	Biomarker	[912]
CPQ	OTTNZNLD	Limited	Altered Expression	[913]
CRABP1	OTISDG5X	Limited	Biomarker	[914]
CREB3	OT9617UO	Limited	Biomarker	[915]
CREBRF	OT2GK1HI	Limited	Altered Expression	[880]
CREG1	OTRHJ8HK	Limited	Biomarker	[916]
CRKL	OTOYSD1R	Limited	Biomarker	[917]
CXCL6	OTFTCQ4O	Limited	Biomarker	[893]
CYCS	OTBFALJD	Limited	Biomarker	[918]
CYLD	OT37FKH0	Limited	Biomarker	[919]
DAXX	OTX6O7PL	Limited	Genetic Variation	[446]
DBR1	OTLTWLTE	Limited	Genetic Variation	[920]
DCLRE1C	OTW3KB1I	Limited	Biomarker	[921]
DEFA1	OT5N1B9B	Limited	Biomarker	[257]
DEFA3	OTO3N8E1	Limited	Biomarker	[257]
DHX32	OTDYB66V	Limited	Altered Expression	[335]
DLEU7	OTVKX1YP	Limited	Biomarker	[922]
DNAH8	OTGES2OU	Limited	Biomarker	[875]
DNAJA2	OTKF1VBT	Limited	Biomarker	[923]
DNAJB4	OTUD01BK	Limited	Altered Expression	[924]
DNAJB6	OTMHIIAN	Limited	Biomarker	[923]
DNAJC14	OT7DPIVN	Limited	Biomarker	[923]
DST	OTHZBM4X	Limited	Genetic Variation	[925]
EBAG9	OTTQLQCP	Limited	Biomarker	[926]
EFNB1	OT7JJW8P	Limited	Altered Expression	[927]
EGR2	OTAVQ78J	Limited	Biomarker	[928]
EIF4G1	OT2CF1E6	Limited	Biomarker	[929]
EMCN	OTS03CZC	Limited	Genetic Variation	[561]
ENGASE	OTKXNR5B	Limited	Biomarker	[930]
ETFA	OTXX61VZ	Limited	Biomarker	[931]
EXOC4	OT5EWXAN	Limited	Biomarker	[932]
EXOSC1	OTB1QQJJ	Limited	Genetic Variation	[933]
FAM167A	OT9JF3JQ	Limited	Genetic Variation	[934]
FBXO2	OTF3677S	Limited	Biomarker	[935]
FCRL4	OT3DVTRV	Limited	Biomarker	[936]
FOXJ3	OTXAUJ47	Limited	Biomarker	[937]
GAB2	OTBFN705	Limited	Altered Expression	[938]
GDPD5	OTUM65JL	Limited	Altered Expression	[939]
GIN1	OT6L79OO	Limited	Biomarker	[263]
GLCCI1	OTU0R1CU	Limited	Altered Expression	[940]
GNA12	OT3IRZH3	Limited	Biomarker	[941]
GNB3	OTA6HYBA	Limited	Genetic Variation	[942]
GPC1	OTQKRSSV	Limited	Altered Expression	[943]
GPLD1	OTUUQOVY	Limited	Biomarker	[320]
GPSM3	OT2MO458	Limited	Genetic Variation	[944]
GRHL3	OT1V4ZEH	Limited	Biomarker	[945]
GRK1	OT7MPSG7	Limited	Biomarker	[287]
GRP	OT8JDFNI	Limited	Biomarker	[946]
GSDMB	OTWA7P10	Limited	Genetic Variation	[947]
HAPLN1	OTXWR9TJ	Limited	Biomarker	[888]
HAS3	OTPM8IL8	Limited	Altered Expression	[948]
HESX1	OT5E2Z4G	Limited	Biomarker	[949]
HIP1	OT7AKCFQ	Limited	Biomarker	[950]
HLA-DQB1	OTVVI3UI	Limited	Posttranslational Modification	[951]
HOOK1	OTTTKV7V	Limited	Altered Expression	[638]
HOXD11	OT9XGA4G	Limited	Biomarker	[888]
HOXD4	OTQR4WCG	Limited	Altered Expression	[952]
HSPA1L	OTC2V1K6	Limited	Genetic Variation	[446]
HSPBP1	OTRS37HK	Limited	Altered Expression	[953]
IFI35	OTV9RZ53	Limited	Altered Expression	[954]
IFI44	OTOKSZVA	Limited	Altered Expression	[954]
IFNLR1	OTWWWK45	Limited	Altered Expression	[599]
IGFBP4	OT2HZRBD	Limited	Altered Expression	[955]
IL20RA	OTSIVBVS	Limited	Altered Expression	[498]
IL27RA	OTSQBAKI	Limited	Altered Expression	[956]
IL34	OTZ15VVK	Limited	Altered Expression	[957]
IL36B	OTYT4LP5	Limited	Altered Expression	[958]
IL4I1	OTK54C63	Limited	Biomarker	[959]
IRF4	OT1DHQ1P	Limited	Altered Expression	[960]
ISYNA1	OT49ONSE	Limited	Genetic Variation	[961]
ITGA2B	OT4Y17PY	Limited	Altered Expression	[962]
IVNS1ABP	OTYHL4I7	Limited	Biomarker	[963]
KCNA4	OTTIGYN7	Limited	Altered Expression	[638]
KCNIP3	OTCQPEM4	Limited	Genetic Variation	[964]
KIR2DL5A	OT09FZE1	Limited	Genetic Variation	[634]
KIR2DL5B	OTSV0JL9	Limited	Genetic Variation	[634]
KIR2DS3	OT3PSLDL	Limited	Genetic Variation	[965]
KIR2DS4	OT00N6UJ	Limited	Biomarker	[966]
KIR3DS1	OTJWIO4T	Limited	Genetic Variation	[965]
KL	OTD4VWU6	Limited	Biomarker	[967]
KPNA2	OTU7FOE6	Limited	Biomarker	[968]
KRT16	OTGA0EQN	Limited	Altered Expression	[315]
KRTAP5-9	OTJ9E3R7	Limited	Biomarker	[969]
LECT2	OTSFZ9JD	Limited	Genetic Variation	[970]
LILRA1	OTZ4NA7Q	Limited	Biomarker	[971]
LILRA2	OT1O2K47	Limited	Altered Expression	[297]
LRAT	OTB7CJKY	Limited	Altered Expression	[972]
LRG1	OTLD0KWA	Limited	Biomarker	[973]
LSP1	OTSPSIFO	Limited	Altered Expression	[974]
LVRN	OTHBF42S	Limited	Altered Expression	[975]
MAB21L2	OTZM5VMX	Limited	Biomarker	[888]
MACIR	OTPSW8Y8	Limited	Genetic Variation	[324]
MAGEE1	OTOQQO2X	Limited	Biomarker	[976]
MAL	OTBM30SW	Limited	Biomarker	[256]
MAPK13	OT0W9GE7	Limited	Altered Expression	[977]
MFSD4B	OTHHKWRT	Limited	Genetic Variation	[978]
MGARP	OTL90XO8	Limited	Biomarker	[888]
MGAT5	OTU4DD4G	Limited	Biomarker	[979]
MICA	OTPEIEAR	Limited	Genetic Variation	[980]
MINDY4	OTBZ2SZB	Limited	Altered Expression	[461]
MMP19	OTLSTT2B	Limited	Biomarker	[981]
MMP20	OT16S5S3	Limited	Biomarker	[305]
MMP25	OT3BG37V	Limited	Biomarker	[305]
MPIG6B	OTVNKQWA	Limited	Genetic Variation	[446]
MRPL17	OTBPCPVW	Limited	Altered Expression	[904]
MSH6	OT46FP09	Limited	Biomarker	[982]
MUC3A	OTI4XUDY	Limited	Altered Expression	[308]
MUL1	OT2JC9YR	Limited	Biomarker	[746]
MYO18B	OTGYY4NK	Limited	Altered Expression	[983]
NDUFA4L2	OTK0PG7R	Limited	Biomarker	[301]
NDUFA7	OT8CV3H5	Limited	Biomarker	[984]
NELFCD	OTOLTZPU	Limited	Biomarker	[985]
NFATC2	OTK5T6HZ	Limited	Altered Expression	[986]
NFIL3	OTQH9HM3	Limited	Biomarker	[987]
NFKBIL1	OTYFTPS0	Limited	Genetic Variation	[446]
NKAP	OT7K7I8Q	Limited	Genetic Variation	[988]
NLRP2	OTJA81JU	Limited	Genetic Variation	[989]
NPC2	OTE9UEJC	Limited	Biomarker	[990]
NR2F1	OTGWZWYL	Limited	Altered Expression	[991]
NRSN1	OT1KKXC8	Limited	Altered Expression	[265]
NUMB	OTMB586Q	Limited	Biomarker	[992]
OAZ1	OTPT0PKZ	Limited	Altered Expression	[993]
ODF1	OTTSURLA	Limited	Altered Expression	[994]
OR2AG1	OTEITRP4	Limited	Genetic Variation	[995]
ORMDL3	OTAB7MZF	Limited	Genetic Variation	[947]
OSCP1	OTZ4IFGJ	Limited	Altered Expression	[883]
PDIA3	OTHPQ0Q3	Limited	Biomarker	[996]
PER3	OTVKYVJA	Limited	Biomarker	[997]
PGK1	OT6V1ICH	Limited	Altered Expression	[998]
PIGR	OT6GLSUL	Limited	Biomarker	[999]
PIR	OT8ALXHU	Limited	Altered Expression	[1000]
PKD1	OT5ALRZ5	Limited	Altered Expression	[315]
PLA2G10	OTRZ2L5A	Limited	Biomarker	[700]
POLD1	OTWO4UCJ	Limited	Biomarker	[1001]
POU2AF1	OTOO6WHL	Limited	Biomarker	[1002]
POU2F1	OTK7ELJ0	Limited	Altered Expression	[1003]
POU3F1	OTYARA94	Limited	Biomarker	[263]
PRAP1	OT48QD82	Limited	Biomarker	[1004]
PRELP	OT9EEBUJ	Limited	Altered Expression	[386]
PRF1	OTFVXD7H	Limited	Biomarker	[1005]
PTMA	OT2W4T1M	Limited	Biomarker	[1006]
PTPN22	OTDCNTC3	Limited	Unknown	[1007]
QPCTL	OTJD4K8A	Limited	Altered Expression	[333]
RABGEF1	OTWC3Z3R	Limited	Altered Expression	[1008]
RAG1	OTV131E4	Limited	Altered Expression	[1009]
RAG2	OTG9UYTW	Limited	Altered Expression	[1009]
RAP1A	OT5RH6TI	Limited	Altered Expression	[1008]
REM1	OTUXL0HC	Limited	Biomarker	[1010]
REV3L	OT0OP8EJ	Limited	Genetic Variation	[978]
REXO1	OTZT6RAW	Limited	Altered Expression	[1011]
RGMB	OT2DROYU	Limited	Biomarker	[888]
RNASE1	OTKZ7CO9	Limited	Biomarker	[1012]
ROBO3	OTPVG40S	Limited	Genetic Variation	[1013]
RPP14	OT4OYFSK	Limited	Genetic Variation	[324]
RPS4X	OTIH80EK	Limited	Biomarker	[1014]
RPS6KA4	OTTK8MUO	Limited	Biomarker	[336]
RRAS	OTBBF28C	Limited	Biomarker	[669]
RSPO2	OT3HHXU0	Limited	Altered Expression	[724]
RTKN2	OTV2AXQM	Limited	Genetic Variation	[1015]
SAAL1	OTRTVFVO	Limited	Biomarker	[1016]
SACM1L	OT6ORKTD	Limited	Genetic Variation	[1017]
SAPCD1	OTUJT8F9	Limited	Genetic Variation	[891]
SELENOS	OTUEWIU9	Limited	Genetic Variation	[1018]
SERPINB2	OT72QLZB	Limited	Altered Expression	[1019]
SFRP5	OTLCVVSH	Limited	Biomarker	[1020]
SH3BP2	OT90JNBS	Limited	Biomarker	[1021]
SH3PXD2A	OTYRQJIH	Limited	Genetic Variation	[673]
SIAE	OTDQUESH	Limited	Genetic Variation	[1022]
SIGLEC1	OTNWSQA9	Limited	Biomarker	[954]
SLAMF1	OTBTT3ZQ	Limited	Biomarker	[1023]
SLC7A4	OTAVC6QS	Limited	Genetic Variation	[1024]
SLIT3	OTU8MKEU	Limited	Altered Expression	[1013]
SMG1	OTTS3SXE	Limited	Altered Expression	[315]
SMTNL2	OTOZL9IG	Limited	Biomarker	[1025]
SNAPIN	OT2FBS5N	Limited	Biomarker	[1026]
SPA17	OT8J7T7U	Limited	Altered Expression	[1027]
SPAG11A	OTNQ9UB0	Limited	Biomarker	[328]
SPAG16	OTIFUPYD	Limited	Altered Expression	[1028]
SRF	OTW18FQN	Limited	Altered Expression	[1029]
SSB	OTCCTPBR	Limited	Biomarker	[1030]
STATH	OTQHBHM9	Limited	Biomarker	[1031]
STRA6	OT2IDF27	Limited	Altered Expression	[1032]
STXBP6	OTUEKTIP	Limited	Biomarker	[1033]
SUPT20H	OTTMC0LH	Limited	Genetic Variation	[1034]
SYNGR1	OT0MBUK5	Limited	Genetic Variation	[324]
TAB2	OTPZK76F	Limited	Genetic Variation	[1035]
TAC4	OTYWPPM3	Limited	Altered Expression	[638]
TAT	OT2CJ91O	Limited	Biomarker	[1036]
TEF	OTY3LAD9	Limited	Biomarker	[987]
TERF2IP	OT3M5P3G	Limited	Altered Expression	[1008]
TESPA1	OTEGT4GI	Limited	Biomarker	[1037]
TET1	OTZDHT1D	Limited	Biomarker	[1038]
TFF2	OTRXB19X	Limited	Altered Expression	[347]
TG	OT3ELHIJ	Limited	Biomarker	[1039]
THNSL2	OTLXYPYV	Limited	Biomarker	[1040]
TLE3	OTR9PH95	Limited	Biomarker	[263]
TMED2	OTBLO7RW	Limited	Altered Expression	[265]
TMEM187	OTOE4G8T	Limited	Genetic Variation	[1041]
TNFAIP2	OTRZH80H	Limited	Biomarker	[301]
TNFSF9	OTV9L89D	Limited	Altered Expression	[1042]
TNIP3	OTSAE5UE	Limited	Biomarker	[1043]
TNXB	OTVBWAV5	Limited	Genetic Variation	[446]
TPD52	OTPKSK43	Limited	Genetic Variation	[324]
TPPP	OTCFMSUF	Limited	Altered Expression	[265]
TRAF5	OTSBTLO0	Limited	Biomarker	[1044]
TRIM21	OTA4UJCF	Limited	Biomarker	[1045]
A1CF	OTJBKFA1	Disputed	Biomarker	[364]
AKAP12	OTCVRDDX	Disputed	Genetic Variation	[1046]
APOL6	OTYTBJEG	Disputed	Genetic Variation	[377]
ASAH1	OT1DNGXL	Disputed	Genetic Variation	[1047]
ASPM	OTKXQMNA	Disputed	Biomarker	[364]
CCDC88C	OTIU02BS	Disputed	Genetic Variation	[377]
CIZ1	OT3UKHPI	Disputed	Altered Expression	[1048]
COG6	OTDLQITC	Disputed	Genetic Variation	[1049]
CXCL3	OTSL94KH	Disputed	Biomarker	[523]
FGD1	OTV3T64P	Disputed	Biomarker	[1050]
GGT6	OTAQWSCC	Disputed	Biomarker	[1025]
GPR65	OTCF5O4G	Disputed	Biomarker	[1051]
HIVEP3	OTM3QT3L	Disputed	Biomarker	[1052]
HOXD13	OTWSC8TF	Disputed	Altered Expression	[1053]
IFI16	OT4SPU0U	Disputed	Biomarker	[1054]
IFIT2	OTI4EOAR	Disputed	Altered Expression	[398]
IL9R	OTILCLXA	Disputed	Biomarker	[1055]
ITGA9	OTHN1IKA	Disputed	Altered Expression	[1056]
KAT7	OTUN98IC	Disputed	Altered Expression	[1057]
KRT5	OTVGI9HT	Disputed	Biomarker	[1058]
LAMA3	OTFME7HT	Disputed	Biomarker	[370]
LMLN	OTQF0JPY	Disputed	Altered Expression	[377]
MARCHF1	OTI2EYO6	Disputed	Biomarker	[1059]
MX1	OT6X8G5T	Disputed	Biomarker	[1060]
NFIA	OTDHQ9CG	Disputed	Biomarker	[254]
NFKBIB	OTY1ZJXH	Disputed	Biomarker	[332]
NONO	OTN36Q6U	Disputed	Altered Expression	[398]
NPPA	OTMQNTNX	Disputed	Biomarker	[503]
PCLAF	OTMVIOUU	Disputed	Biomarker	[1061]
PCNP	OTJUQ122	Disputed	Biomarker	[1062]
PLEKHO1	OTMVUQ9W	Disputed	Altered Expression	[1063]
PLK3	OT19CT2Z	Disputed	Biomarker	[1064]
PPP1R15A	OTYG179K	Disputed	Altered Expression	[1065]
PPP1R1A	OTGTAGCV	Disputed	Altered Expression	[365]
PRDX6	OTS8KC8A	Disputed	Altered Expression	[1066]
PTPRU	OTHDO0QG	Disputed	Biomarker	[1067]
RAB40B	OTCA9ZF5	Disputed	Altered Expression	[1068]
ROPN1L	OTRWZJ68	Disputed	Biomarker	[364]
SAA4	OTCE1WXO	Disputed	Biomarker	[1069]
SRSF11	OTZSV6CZ	Disputed	Altered Expression	[398]
THEMIS	OTXODBXJ	Disputed	Biomarker	[1070]
TMPRSS13	OTMAOAP3	Disputed	Altered Expression	[377]
TNFAIP8L2	OTII0RM0	Disputed	Altered Expression	[1062]
AGXT2	OTO6QUTM	moderate	Biomarker	[1071]
ALPP	OTZU4G9W	moderate	Altered Expression	[384]
ANKH	OTCN25R5	moderate	Genetic Variation	[1072]
APOBEC3C	OTPL0AI1	moderate	Biomarker	[1073]
ARL15	OT00YSWZ	moderate	Biomarker	[1074]
ATF2	OTNIZPEA	moderate	Genetic Variation	[1075]
ATG5	OT4T5SMS	moderate	Genetic Variation	[324]
ATRNL1	OTY5JUX2	moderate	Altered Expression	[384]
BCS1L	OT5PY5CY	moderate	Biomarker	[1076]
C1QTNF3	OTOJMWW0	moderate	Altered Expression	[1077]
CAPG	OTJ86KI6	moderate	Biomarker	[1078]
CAV2	OT1FGRQX	moderate	Biomarker	[529]
CBLIF	OTNE20WU	moderate	Altered Expression	[1079]
CCL7	OTDIS99H	moderate	Biomarker	[1080]
CCL8	OTCTWYN8	moderate	Genetic Variation	[424]
CEP70	OTMY5KAE	moderate	Altered Expression	[1081]
CHD7	OTHNIZWZ	moderate	Altered Expression	[1082]
CIAO1	OTCU8PFI	moderate	Biomarker	[1083]
CIRBP	OTXWTPBL	moderate	Biomarker	[1084]
CLN8	OT0D4CB5	moderate	Genetic Variation	[1072]
DNER	OT2GH2E5	moderate	Biomarker	[1085]
FAM107A	OTBG61YZ	moderate	Genetic Variation	[416]
GATA1	OTX1R7O1	moderate	Biomarker	[1086]
GCFC2	OTC7FRXL	moderate	Altered Expression	[1087]
GNS	OTNFKYGB	moderate	Biomarker	[1088]
GPRC5A	OTPOCWR7	moderate	Biomarker	[529]
HMMR	OT4M0JTZ	moderate	Altered Expression	[1089]
IL17RA	OTVVI8ER	moderate	Biomarker	[1090]
INSRR	OT3F75WA	moderate	Biomarker	[1091]
ITIH1	OTSXJGQF	moderate	Altered Expression	[1092]
KAT5	OTL7257A	moderate	Biomarker	[1093]
KIDINS220	OTLBH2MA	moderate	Biomarker	[1094]
LILRA3	OTBNQCOS	moderate	Genetic Variation	[1095]
LRIT1	OTNEQPMZ	moderate	Biomarker	[423]
MBD2	OTUQPP0R	moderate	Biomarker	[409]
MFAP4	OT5W64QY	moderate	Biomarker	[1096]
MRE11	OTGU8TZM	moderate	Biomarker	[1097]
NFAT5	OTKIE59S	moderate	Biomarker	[1098]
NFKBIE	OTLAYEL9	moderate	Altered Expression	[1099]
NHS	OTKE8QAT	moderate	Genetic Variation	[1100]
NLRC3	OTWLLFFN	moderate	Biomarker	[1101]
OXA1L	OTS0BFRD	moderate	Biomarker	[1102]
PDLIM3	OTVXQC81	moderate	Altered Expression	[384]
PGLYRP1	OTBTPR2T	moderate	Biomarker	[1103]
PRSS2	OTOMVUWL	moderate	Biomarker	[1104]
RAC2	OTAOHFNH	moderate	Altered Expression	[1105]
RASGRP2	OTABVLVQ	moderate	Altered Expression	[1106]
S100A11	OTI57KDN	moderate	Biomarker	[1107]
SMR3A	OT6NAJJI	moderate	Biomarker	[1073]
SMS	OT8JYKNH	moderate	Biomarker	[1108]
SUMO2	OT1Y5IKN	moderate	Altered Expression	[414]
SUMO3	OTTUJQJ1	moderate	Altered Expression	[414]
TBCA	OTCCWMGK	moderate	Biomarker	[1109]
TGIF1	OTN9VHAG	moderate	Altered Expression	[1110]
THY1	OTVONVTB	moderate	Biomarker	[1111]
ABCF1	OT6Q079J	Strong	Genetic Variation	[327]
ACAN	OTUOCW8K	Strong	Biomarker	[1112]
ACOT7	OT7C68YV	Strong	Biomarker	[438]
ACOXL	OTW680HT	Strong	Genetic Variation	[751]
ACP1	OTJ9CKLU	Strong	Genetic Variation	[1113]
ACSBG1	OTM040MW	Strong	Altered Expression	[1114]
ACTB	OT1MCP2F	Strong	Biomarker	[1115]
ACTBL2	OTD6B81U	Strong	Biomarker	[438]
ACTG2	OTRDWUO0	Strong	Biomarker	[438]
ACTN1	OTUCLNXH	Strong	Biomarker	[1116]
ADA2	OTGCV24S	Strong	Genetic Variation	[1117]
ADAM11	OTPTVW5W	Strong	Biomarker	[1118]
ADAM15	OTZ7VLTP	Strong	Altered Expression	[1119]
ADAMTS12	OTG7HEA2	Strong	Biomarker	[1120]
ADAR	OTQNOHR8	Strong	Altered Expression	[1121]
ADI1	OT8IOD03	Strong	Biomarker	[1122]
ADIPOR1	OT65ZFZN	Strong	Altered Expression	[1123]
ADIPOR2	OT2HDTL8	Strong	Altered Expression	[1123]
ADRM1	OTOU4EY6	Strong	Biomarker	[1124]
AGBL3	OTVH64PO	Strong	Biomarker	[1125]
AHI1	OT8K2YWY	Strong	Altered Expression	[977]
AHNAK	OT6KH1WG	Strong	Biomarker	[1126]
AHSA1	OTC7AFHT	Strong	Biomarker	[448]
AIFM2	OT57XWXO	Strong	Genetic Variation	[673]
ALPK1	OTBW6SGD	Strong	Genetic Variation	[673]
AMPD1	OTU17BCI	Strong	Biomarker	[1127]
ANO8	OT07SRRX	Strong	Genetic Variation	[751]
ANP32B	OT3SQMLU	Strong	Biomarker	[769]
ANXA6	OT9KIQ0Y	Strong	Genetic Variation	[868]
APOM	OTI3FQQC	Strong	Genetic Variation	[1128]
ARHGEF2	OTBQTFRT	Strong	Altered Expression	[643]
ARHGEF5	OTUVGFT9	Strong	Genetic Variation	[1129]
ARID5B	OTUQ4CQY	Strong	Genetic Variation	[324]
ARMH1	OTTJC0D6	Strong	Altered Expression	[643]
ASB15	OTI0ZVLJ	Strong	Genetic Variation	[327]
ASCC1	OTH4VAP9	Strong	Biomarker	[1130]
ASF1A	OT4S44GP	Strong	Biomarker	[699]
ATF6B	OTT2ZGSR	Strong	Genetic Variation	[446]
ATF7IP	OTU6ZA7F	Strong	Biomarker	[1131]
ATG16L1	OTEOYC5D	Strong	Biomarker	[743]
ATP6V1H	OTX17GQ9	Strong	Biomarker	[1132]
B3GAT1	OTXFP98E	Strong	Altered Expression	[1133]
B3GNT2	OTE69HV8	Strong	Genetic Variation	[1134]
B3GNT9	OTO385AU	Strong	Biomarker	[529]
BACH2	OT17GS18	Strong	Genetic Variation	[406]
BAG6	OT4Z0S2U	Strong	Genetic Variation	[446]
BANP	OT1JMTBD	Strong	Biomarker	[1135]
BATF	OT9VSD2D	Strong	Biomarker	[692]
BCL2L15	OTD943W0	Strong	Genetic Variation	[327]
BCR	OTCN76C1	Strong	Biomarker	[1136]
BEST1	OTWHE1ZC	Strong	Biomarker	[536]
BGLAP	OTK1YLWQ	Strong	Biomarker	[1137]
BHLHE41	OTY9GJ1Y	Strong	Biomarker	[1138]
BTG3	OT9ANHVT	Strong	Biomarker	[1139]
C1QTNF6	OT57EPQC	Strong	Altered Expression	[1140]
C4A	OTXMOYXU	Strong	Biomarker	[1141]
C6orf47	OTMKBNDD	Strong	Genetic Variation	[446]
CAMKMT	OTLJBRUW	Strong	Biomarker	[359]
CAPRIN1	OTEJAMS3	Strong	Biomarker	[1142]
CASC3	OTLK3K4U	Strong	Altered Expression	[1143]
CAST	OTBXZZGF	Strong	Biomarker	[1144]
CASTOR1	OTYIH7WK	Strong	Genetic Variation	[633]
CCHCR1	OT22C116	Strong	Genetic Variation	[327]
CCL1	OT23NON8	Strong	Biomarker	[480]
CCL13	OTNX0JD0	Strong	Biomarker	[1145]
CCL14	OT8QETQU	Strong	Biomarker	[480]
CCL18	OT7JYSK9	Strong	Altered Expression	[609]
CCL19	OTQ2UJMH	Strong	Biomarker	[1146]
CCL24	OT9LGHV0	Strong	Genetic Variation	[1147]
CCL25	OTLWJ8CJ	Strong	Biomarker	[487]
CCL27	OTUZYC61	Strong	Altered Expression	[384]
CCL28	OTY6XNQ7	Strong	Altered Expression	[1148]
CCL4	OT6B8P25	Strong	Altered Expression	[1149]
CCL4L2	OTDBSXOU	Strong	Altered Expression	[1149]
CCN5	OTADU8JJ	Strong	Altered Expression	[1150]
CCN6	OTRFHQ2Z	Strong	Altered Expression	[1150]
CCNG2	OTII38K2	Strong	Genetic Variation	[534]
CCR10	OT7ZWSSD	Strong	Altered Expression	[1148]
CD1C	OT4XINUJ	Strong	Altered Expression	[1151]
CD1D	OT3ROU4J	Strong	Altered Expression	[1152]
CD48	OT83ZNPP	Strong	Genetic Variation	[1153]
CD68	OTOYEY3J	Strong	Biomarker	[1154]
CD82	OTH8MC64	Strong	Biomarker	[1155]
CDAN1	OTCVZRG6	Strong	Biomarker	[1156]
CDC42	OT5QBC5M	Strong	Altered Expression	[1157]
CDC42EP3	OTUZ3U9Z	Strong	Genetic Variation	[673]
CDCA5	OTZLCQ5U	Strong	Biomarker	[504]
CDCP1	OTD7RRWK	Strong	Altered Expression	[1158]
CDK2AP2	OTR99SJ8	Strong	Altered Expression	[1159]
CDK5RAP2	OTRKEVTY	Strong	Genetic Variation	[1160]
CDKN2D	OT2TTZPZ	Strong	Altered Expression	[549]
CEBPD	OTNBIPMY	Strong	Biomarker	[1161]
CEMIP	OTK80FYN	Strong	Altered Expression	[911]
CEP89	OT1VEFSL	Strong	Genetic Variation	[1162]
CFDP1	OTXY7J96	Strong	Altered Expression	[678]
CHST4	OTESMIW5	Strong	Biomarker	[1163]
CIAO3	OT0V91PK	Strong	Biomarker	[1164]
CILP	OTKEY2NJ	Strong	Biomarker	[1165]
CIP2A	OTVS2GXA	Strong	Biomarker	[1166]
CISH	OT8T5NYL	Strong	Biomarker	[1167]
CLEC5A	OT19WV30	Strong	Altered Expression	[1168]
CLEC7A	OTRTBH27	Strong	Altered Expression	[1169]
CLOCK	OTNEOJY7	Strong	Biomarker	[1170]
CLSTN2	OT2PJYHX	Strong	Genetic Variation	[327]
CLYBL	OTXZLTST	Strong	Genetic Variation	[1171]
COLQ	OT4BHUGQ	Strong	Biomarker	[1172]
COMP	OTS2FPMI	Strong	Biomarker	[704]
COTL1	OT6YCNLF	Strong	Genetic Variation	[1173]
COX1	OTG3O9BN	Strong	Altered Expression	[1174]
COX2	OTTMVBJJ	Strong	Altered Expression	[401]
CP	OTM8JE4Y	Strong	Altered Expression	[1175]
CRABP2	OTY01V9G	Strong	Altered Expression	[800]
CRISP2	OT8HLTV5	Strong	Biomarker	[1176]
CRISP3	OTBSWMPL	Strong	Genetic Variation	[307]
CSMD3	OTAT75SW	Strong	Genetic Variation	[561]
CSNK2B	OT2WW7R1	Strong	Genetic Variation	[446]
CSTF3	OT1Y7B5U	Strong	Genetic Variation	[534]
CTHRC1	OTV88X2G	Strong	Altered Expression	[1177]
CTIF	OT7DU7WN	Strong	Genetic Variation	[327]
CUL1	OTXPE1UZ	Strong	Genetic Variation	[1178]
CUL5	OTMTZD47	Strong	Genetic Variation	[324]
CXCL16	OTD49T9R	Strong	Altered Expression	[528]
CXCL5	OTZOUPCA	Strong	Altered Expression	[1179]
CYRIB	OTLRN4L1	Strong	Genetic Variation	[673]
DBP	OTE0W7LN	Strong	Genetic Variation	[1180]
DCDC2C	OTK5F95W	Strong	Genetic Variation	[534]
DCTN4	OTM7C943	Strong	Altered Expression	[631]
DDA1	OTAZIAIH	Strong	Genetic Variation	[751]
DDX39A	OT0Z6E1K	Strong	Biomarker	[842]
DDX39B	OTEVCFVU	Strong	Genetic Variation	[446]
DDX6	OTKWXVDY	Strong	Altered Expression	[398]
DECR1	OTCDIR6X	Strong	Biomarker	[1181]
DEDD	OTIL349E	Strong	Biomarker	[1182]
DENND1A	OTONDAA0	Strong	Genetic Variation	[673]
DGKQ	OT8OEPYT	Strong	Genetic Variation	[601]
DHX16	OTW8KZAU	Strong	Genetic Variation	[327]
DHX40	OTOL02QN	Strong	Altered Expression	[1183]
DLG2	OTQ3BD8U	Strong	Genetic Variation	[561]
DNASE1L3	OTEUIMC2	Strong	Genetic Variation	[601]
DNASE2	OT6RC1BL	Strong	Altered Expression	[1184]
DOCK2	OTZTS3PA	Strong	Biomarker	[1185]
DR1	OTR081M4	Strong	Biomarker	[1186]
EBF3	OTB0IWLW	Strong	Posttranslational Modification	[1187]
EBNA1BP2	OTBRVMZH	Strong	Altered Expression	[643]
EFEMP2	OT0I2B4J	Strong	Altered Expression	[1188]
EFHC2	OTI459M8	Strong	Biomarker	[1189]
EGFL8	OTECTJ7K	Strong	Genetic Variation	[446]
ELAVL2	OT6EJ8MQ	Strong	Biomarker	[253]
ELF3	OTUTLEQO	Strong	Altered Expression	[1190]
ELMO1	OTY2ORXK	Strong	Genetic Variation	[563]
ENHO	OT91QASK	Strong	Altered Expression	[1191]
ENOX1	OT4WOLA8	Strong	Genetic Variation	[534]
ERG	OTOTX9VU	Strong	Biomarker	[1192]
ERICH1	OTYGUU10	Strong	Genetic Variation	[1193]
EXT1	OTRPALJK	Strong	Biomarker	[1194]
FADD	OTV7GFHH	Strong	Altered Expression	[1195]
FAM53B	OTVD7OU6	Strong	Biomarker	[1196]
FBL	OTRODIE5	Strong	Genetic Variation	[1197]
FCGR2C	OTNLMNYB	Strong	Biomarker	[1198]
FCRLA	OT6MK4M1	Strong	Genetic Variation	[377]
FGB	OT6RKLI9	Strong	Biomarker	[1199]
FGF13	OTHNNVSG	Strong	Altered Expression	[1200]
FHL2	OT0OAYWT	Strong	Altered Expression	[1201]
FHL5	OT6C00Z1	Strong	Biomarker	[438]
FIP1L1	OTF91GTL	Strong	Biomarker	[1202]
FLACC1	OTZN9TZV	Strong	Genetic Variation	[324]
FLG	OTE9QDV6	Strong	Biomarker	[1125]
FLNB	OTPCOYL6	Strong	Biomarker	[1203]
FLT3LG	OTU0YGC4	Strong	Biomarker	[1204]
FOSB	OTW6C05J	Strong	Biomarker	[530]
FOXJ1	OT7LLBZ7	Strong	Genetic Variation	[1205]
FOXO4	OT90X9LN	Strong	Altered Expression	[1206]
FTL	OTYQA8A6	Strong	Altered Expression	[1207]
G0S2	OT8FL49L	Strong	Biomarker	[1208]
GABBR1	OTU5A52J	Strong	Genetic Variation	[327]
GABBR2	OT67RIFY	Strong	Genetic Variation	[561]
GADD45A	OTDRV63V	Strong	Genetic Variation	[565]
GADD45GIP1	OT4IZ4TP	Strong	Biomarker	[1209]
GALNT18	OTKIIELC	Strong	Genetic Variation	[534]
GCHFR	OTEOT8GI	Strong	Biomarker	[504]
GDAP1	OTQE1O25	Strong	Genetic Variation	[534]
GDE1	OTU6FSBF	Strong	Biomarker	[1210]
GDF11	OTOSNMND	Strong	Biomarker	[1211]
GFRA1	OT3WBVYB	Strong	Genetic Variation	[1212]
GNL1	OTWTVIVM	Strong	Genetic Variation	[327]
GORASP1	OTQS91S7	Strong	Biomarker	[781]
GPANK1	OT1TN2KT	Strong	Genetic Variation	[446]
GPC5	OT8NR7GC	Strong	Genetic Variation	[324]
GPR15	OTK8674M	Strong	Biomarker	[1213]
GPR42	OTEB0ROY	Strong	Biomarker	[468]
GRAP2	OTS5NIZ3	Strong	Biomarker	[448]
GRK6	OT4LZTP9	Strong	Altered Expression	[287]
GSDME	OT1ZWY32	Strong	Biomarker	[529]
GSTM2	OTG4WT05	Strong	Genetic Variation	[1214]
GTF2H1	OTCRXC6B	Strong	Altered Expression	[631]
GTF2I	OTUYL1TQ	Strong	Genetic Variation	[1215]
GTF2IRD1	OTEG9KU1	Strong	Genetic Variation	[1215]
GZMA	OT43R33L	Strong	Biomarker	[1216]
GZMM	OTEC5CWT	Strong	Biomarker	[1217]
H4C1	OTB71W46	Strong	Biomarker	[1218]
HARS1	OTHOEOTS	Strong	Altered Expression	[1219]
HARS2	OTC8X3H9	Strong	Altered Expression	[1219]
HAS1	OTJIAG1W	Strong	Altered Expression	[1220]
HAVCR1	OT184CRZ	Strong	Genetic Variation	[1129]
HCLS1	OTX7WGYN	Strong	Biomarker	[467]
HCP5	OTV0YRI8	Strong	Genetic Variation	[327]
HFE	OTDD93KB	Strong	Genetic Variation	[1221]
HLA-DOA	OTZE5Q7R	Strong	Genetic Variation	[1222]
HLA-DOB	OTKADDUB	Strong	Genetic Variation	[1223]
HLA-DQA2	OT1DH0N9	Strong	Genetic Variation	[446]
HLA-DRA	OT7KZMP2	Strong	Genetic Variation	[446]
HLA-DRB5	OTUX5TWM	Strong	Genetic Variation	[1224]
HLA-E	OTX1CTFB	Strong	Genetic Variation	[1225]
HNRNPC	OT47AK4C	Strong	Biomarker	[1226]
HNRNPDL	OTB3BFCV	Strong	Biomarker	[1226]
HOXB2	OTTD6HMV	Strong	Biomarker	[1227]
HOXC6	OTBCRAZV	Strong	Biomarker	[1228]
HOXD10	OT0NOWU2	Strong	Biomarker	[1229]
HOXD9	OTZ4GVR1	Strong	Altered Expression	[1230]
HSD17B8	OTX1DWEF	Strong	Genetic Variation	[327]
HSPA14	OTZCA5LK	Strong	Altered Expression	[393]
HYAL2	OTTVINXW	Strong	Altered Expression	[1220]
ICAM3	OTTZ5A5D	Strong	Genetic Variation	[1049]
IER3	OTZJI5FZ	Strong	Altered Expression	[1231]
IFI44L	OTXKORJP	Strong	Genetic Variation	[1232]
IKBKE	OT5VYOSM	Strong	Altered Expression	[1233]
IL10RA	OTOX3D1D	Strong	Genetic Variation	[1234]
IL18BP	OTW0LRYZ	Strong	Biomarker	[1235]
IL1F10	OTJAASGC	Strong	Altered Expression	[1236]
IL1RAPL1	OTW3T4B2	Strong	Biomarker	[407]
IL22RA1	OTGVKLBR	Strong	Biomarker	[1237]
IL27	OTIS3OF8	Strong	Biomarker	[606]
IL2RG	OTRZ3OMY	Strong	Altered Expression	[678]
ILF3	OTKMZ5K5	Strong	Genetic Variation	[324]
IMPACT	OTQ923OB	Strong	Biomarker	[1238]
IP6K3	OTKUIVQZ	Strong	Genetic Variation	[446]
IRX1	OT0ZN9EJ	Strong	Biomarker	[1239]
IRX5	OT05J514	Strong	Altered Expression	[1240]
ISG20	OTCWRJJW	Strong	Biomarker	[1241]
ISL1	OTVNVKAX	Strong	Altered Expression	[1201]
ITGAX	OTOGIMHE	Strong	Biomarker	[1242]
JAM3	OTX0F9QL	Strong	Altered Expression	[1243]
JAZF1	OTXTYSYD	Strong	Genetic Variation	[751]
JUNB	OTG2JXV5	Strong	Biomarker	[530]
JUND	OTNKACJD	Strong	Biomarker	[530]
KANK4	OT5WC0Q8	Strong	Altered Expression	[678]
KHSRP	OTDHZARB	Strong	Altered Expression	[1244]
KIFBP	OT1XADKG	Strong	Biomarker	[1245]
KIR2DS5	OTXLEN11	Strong	Biomarker	[634]
KLF2	OTIP1UFX	Strong	Biomarker	[1246]
KLRB1	OTQ2959Y	Strong	Altered Expression	[499]
KLRC2	OTT4N86S	Strong	Altered Expression	[1247]
KLRD1	OTMYLOV4	Strong	Genetic Variation	[1248]
KPNA1	OTEMVAJ6	Strong	Genetic Variation	[1249]
KRIT1	OT58AP1I	Strong	Biomarker	[359]
KRT13	OTTYSKGX	Strong	Biomarker	[1250]
LAIR2	OTKCADXC	Strong	Altered Expression	[1251]
LAMTOR2	OTHEDISB	Strong	Altered Expression	[1159]
LBH	OT87AT1X	Strong	Genetic Variation	[1252]
LBR	OT1HG3HG	Strong	Altered Expression	[853]
LGALS3BP	OT9AGQKH	Strong	Biomarker	[564]
LGALS8	OT71LJ8T	Strong	Genetic Variation	[1253]
LGALS9	OT7MF91K	Strong	Biomarker	[1254]
LHX2	OTK61NP8	Strong	Altered Expression	[888]
LIG4	OT40DNXU	Strong	Biomarker	[1255]
LRIG1	OTY5HZN5	Strong	Biomarker	[646]
LRPAP1	OT6DVD2Q	Strong	Biomarker	[1256]
LRRC18	OTC8M35N	Strong	Genetic Variation	[327]
LST1	OTUVG424	Strong	Altered Expression	[280]
LY6G5B	OTW89R8K	Strong	Genetic Variation	[446]
LY6G5C	OTC5GIUX	Strong	Genetic Variation	[327]
LY6G6C	OTV7F59X	Strong	Genetic Variation	[446]
LY6G6D	OTG75QOC	Strong	Genetic Variation	[446]
LY6G6F	OT5W9Q4B	Strong	Genetic Variation	[327]
MAGI3	OTDJ5QUH	Strong	Genetic Variation	[327]
MAP2K4	OTZPZX11	Strong	Genetic Variation	[1257]
MAST3	OT6VVQ84	Strong	Altered Expression	[1258]
MCCD1	OTLS95WO	Strong	Genetic Variation	[446]
MDC1	OTEUQH4J	Strong	Genetic Variation	[327]
MDGA2	OTIJ0T5J	Strong	Genetic Variation	[534]
MIA3	OTBVIZQD	Strong	Biomarker	[1259]
MIB1	OT5C404P	Strong	Genetic Variation	[1260]
MICB	OTS2DVDW	Strong	Biomarker	[980]
MIP	OTEBLU3E	Strong	Altered Expression	[1261]
MMRN1	OT7ZNYHT	Strong	Altered Expression	[556]
MNAT1	OTXLOYCB	Strong	Biomarker	[504]
MOK	OTQK7M9V	Strong	Biomarker	[244]
MON2	OTCSVMAR	Strong	Biomarker	[1262]
MOS	OTNMQPFJ	Strong	Genetic Variation	[1263]
MPG	OTAHW80B	Strong	Biomarker	[1264]
MPP1	OTA2ENZQ	Strong	Biomarker	[1192]
MSC	OTBRPZL5	Strong	Biomarker	[1265]
MSH5	OTDARQT3	Strong	Genetic Variation	[446]
MST1	OTOC4UNG	Strong	Altered Expression	[377]
MUC5B	OTPW6K5C	Strong	Genetic Variation	[1266]
MUCL3	OTGAD3I0	Strong	Genetic Variation	[327]
MYBBP1A	OTIVEMIU	Strong	Biomarker	[982]
MYDGF	OT9HRPL6	Strong	Biomarker	[606]
MYO9B	OTQ94R5K	Strong	Genetic Variation	[1267]
N4BP1	OTN2TL6N	Strong	Genetic Variation	[534]
NAA25	OTS3QVF1	Strong	Genetic Variation	[1268]
NAF1	OTMJKJAK	Strong	Altered Expression	[1269]
NAV2	OTGAOL01	Strong	Genetic Variation	[561]
NCF4	OTX007YL	Strong	Genetic Variation	[1270]
NCKIPSD	OT24UORN	Strong	Biomarker	[1271]
NCOA1	OTLIUJQD	Strong	Biomarker	[982]
NCOA5	OTOGWTWB	Strong	Biomarker	[699]
NCOR1	OT04XNOU	Strong	Biomarker	[862]
ND1	OTCLGIXV	Strong	Genetic Variation	[1272]
NDST1	OT9E10W2	Strong	Biomarker	[1273]
NEBL	OT2WH1NC	Strong	Genetic Variation	[561]
NECAB2	OT6PITM9	Strong	Genetic Variation	[673]
NEU1	OTH9BY8Y	Strong	Altered Expression	[1274]
NEU3	OTQ5PQOW	Strong	Biomarker	[1274]
NFATC1	OT4TMERS	Strong	Biomarker	[419]
NFYA	OTWFFOVH	Strong	Biomarker	[1275]
NKAPL	OTIU393R	Strong	Genetic Variation	[327]
NLRP6	OTEREN4W	Strong	Biomarker	[1276]
NMT1	OT42GQ3D	Strong	Biomarker	[1277]
NNAT	OTNRLO7G	Strong	Biomarker	[1278]
NPAS2	OTMRT2TS	Strong	Altered Expression	[1138]
NR2C2	OTDZWVOJ	Strong	Biomarker	[665]
NRM	OTK7F9XZ	Strong	Genetic Variation	[1279]
NUP62	OTMN63DH	Strong	Altered Expression	[631]
NUP88	OT647WOR	Strong	Genetic Variation	[324]
NXF1	OTEFHXG6	Strong	Biomarker	[1203]
OLIG3	OTU8XLAF	Strong	Genetic Variation	[1280]
OR12D3	OTQ9XNBB	Strong	Genetic Variation	[327]
OR2H2	OTOSTYE2	Strong	Genetic Variation	[327]
OR5V1	OTSYXOD6	Strong	Genetic Variation	[327]
OS9	OTB5B2TY	Strong	Genetic Variation	[324]
P2RX2	OT0LF34A	Strong	Biomarker	[691]
P2RX5	OTLBR20R	Strong	Biomarker	[691]
P2RX6	OT1FNTXA	Strong	Biomarker	[691]
P4HB	OTTYNYPF	Strong	Biomarker	[1192]
PADI6	OTS42I3K	Strong	Altered Expression	[1281]
PAK3	OT80M3BV	Strong	Genetic Variation	[838]
PAPOLA	OTPHD65D	Strong	Genetic Variation	[327]
PARD6A	OTWLV3X1	Strong	Altered Expression	[1282]
PBX2	OTEBYCAW	Strong	Genetic Variation	[446]
PCDH15	OTU9C2EH	Strong	Genetic Variation	[534]
PDC	OT1UUVYY	Strong	Biomarker	[1283]
PDCD5	OT6T2DDL	Strong	Altered Expression	[1284]
PDPN	OTBUV19I	Strong	Biomarker	[1285]
PDS5A	OT34P56Z	Strong	Genetic Variation	[327]
PELP1	OTVXQNOT	Strong	Biomarker	[982]
PER2	OTU2B1DJ	Strong	Altered Expression	[1286]
PGBD1	OTSJX9UU	Strong	Genetic Variation	[327]
PHACTR3	OTUN0OAY	Strong	Genetic Variation	[673]
PHRF1	OT21KEGX	Strong	Biomarker	[978]
PHTF1	OTYCZ84A	Strong	Genetic Variation	[327]
PI3	OT47MTC3	Strong	Altered Expression	[1287]
PIEZO1	OTBG1FU4	Strong	Genetic Variation	[1260]
PIK3R2	OTZSUQK5	Strong	Biomarker	[1288]
PIK3R3	OTXGJ8N1	Strong	Biomarker	[1192]
PITX2	OTWMXAOY	Strong	Genetic Variation	[1289]
PIWIL1	OT7CRGZ3	Strong	Biomarker	[1290]
PIWIL2	OT1PXQIF	Strong	Altered Expression	[1290]
PIWIL4	OTDA9MY0	Strong	Biomarker	[1290]
PLAAT4	OTI66SAJ	Strong	Biomarker	[1291]
PLB1	OTZ6TTYV	Strong	Biomarker	[1292]
PLCL1	OTJL2C79	Strong	Genetic Variation	[673]
PLCL2	OTK5FDF6	Strong	Genetic Variation	[324]
PLD3	OTL07SP2	Strong	Genetic Variation	[1293]
PLD4	OT5I74II	Strong	Biomarker	[1293]
PLEK	OTB73XXA	Strong	Biomarker	[467]
POLDIP2	OT8SZSJ6	Strong	Biomarker	[448]
POLG2	OTDBMZJB	Strong	Biomarker	[1192]
POT1	OTNBXJCQ	Strong	Altered Expression	[772]
POTEF	OTV3WXYE	Strong	Biomarker	[743]
POTEM	OT7L2HGH	Strong	Biomarker	[438]
POU2F2	OTPV0J0C	Strong	Altered Expression	[737]
POU5F1	OTDHHN7O	Strong	Genetic Variation	[1279]
PPCDC	OT9C76GS	Strong	Genetic Variation	[839]
PPIL4	OTFTLFJS	Strong	Genetic Variation	[324]
PPP1R10	OT7GE3BN	Strong	Genetic Variation	[327]
PPT2	OTD5VJ9A	Strong	Genetic Variation	[446]
PRAM1	OTZN3DWD	Strong	Altered Expression	[1294]
PRDM10	OTDDWU5Q	Strong	Genetic Variation	[632]
PRDM16	OT0BGA27	Strong	Genetic Variation	[673]
PRKN	OTJBN41W	Strong	Biomarker	[746]
PRORP	OTWIS44P	Strong	Genetic Variation	[561]
PRR12	OTY2ILFT	Strong	Genetic Variation	[601]
PRRC2A	OTBX6FM5	Strong	Genetic Variation	[446]
PRRT1	OTN0YIS3	Strong	Genetic Variation	[446]
PRRT2	OTCJUBDO	Strong	Altered Expression	[706]
PRSS55	OTXXWI5Y	Strong	Biomarker	[1176]
PSG5	OTHTU98X	Strong	Biomarker	[529]
PSMA4	OTAD2XXI	Strong	Genetic Variation	[534]
PSMD12	OTWICA51	Strong	Biomarker	[1192]
PSMD7	OT7PZZ4K	Strong	Altered Expression	[643]
PSORS1C1	OT9HK436	Strong	Genetic Variation	[1295]
PSTPIP1	OT4PGEAB	Strong	Genetic Variation	[1296]
PTHLH	OTI1JF13	Strong	Altered Expression	[1297]
PTPRK	OTAP5AT3	Strong	Biomarker	[1298]
PUF60	OTG90DYF	Strong	Biomarker	[1299]
PXK	OTSP1WLK	Strong	Genetic Variation	[784]
PYCARD	OT67RON3	Strong	Biomarker	[1300]
PYDC1	OTC2DD7L	Strong	Genetic Variation	[1301]
RAB14	OTF1J0TB	Strong	Genetic Variation	[327]
RAB8A	OTPB54Y3	Strong	Biomarker	[467]
RABEP1	OTQROTGT	Strong	Genetic Variation	[324]
RABEPK	OTCZSREH	Strong	Altered Expression	[643]
RAD51B	OTCJVRMY	Strong	Genetic Variation	[324]
RAP2A	OT0JB5S4	Strong	Biomarker	[467]
RAPH1	OTMQXW7S	Strong	Altered Expression	[1114]
RARRES2	OT1BJE8K	Strong	Altered Expression	[1302]
RASGRP1	OTX9WN2E	Strong	Genetic Variation	[324]
RAVER1	OTMHBTLE	Strong	Genetic Variation	[263]
RBFOX1	OTFPKEL7	Strong	Genetic Variation	[324]
RBP2	OTR8QG5V	Strong	Biomarker	[1303]
RCAN1	OT1MVXC7	Strong	Genetic Variation	[324]
RCHY1	OTAE7504	Strong	Genetic Variation	[534]
RDX	OTNSYUN6	Strong	Altered Expression	[1304]
REG1A	OTMHUH1D	Strong	Altered Expression	[549]
RFC1	OT3L5PK3	Strong	Genetic Variation	[735]
RGS1	OTGXJYMG	Strong	Biomarker	[620]
RHCE	OTS18IZ5	Strong	Biomarker	[1202]
RIPOR2	OTXB6LIR	Strong	Genetic Variation	[327]
RIT2	OTSNYG0D	Strong	Genetic Variation	[534]
RMC1	OT7K8MTJ	Strong	Altered Expression	[568]
RNASE2	OT8Z4FNE	Strong	Biomarker	[307]
RNASEH2B	OT8KHYFY	Strong	Genetic Variation	[1171]
RNF19A	OTKWCV80	Strong	Biomarker	[448]
RNF2	OTFPLOIN	Strong	Biomarker	[1305]
RNF5	OTDQGI37	Strong	Genetic Variation	[446]
RO60	OTLGM5A8	Strong	Biomarker	[1045]
RPL17	OTTYMPS6	Strong	Biomarker	[1306]
RPL37A	OTAMQLY7	Strong	Genetic Variation	[1212]
RPP21	OT53MDNE	Strong	Genetic Variation	[327]
RPS18	OTFO45UM	Strong	Genetic Variation	[327]
RPS19	OTBKGP48	Strong	Biomarker	[1307]
RSBN1	OT2HBRLJ	Strong	Genetic Variation	[327]
S100A1	OT1F2G4J	Strong	Biomarker	[721]
SAA2	OTYAVJWG	Strong	Altered Expression	[1308]
SAMD9	OTDG48P0	Strong	Altered Expression	[1309]
SAR1A	OTSSRVGV	Strong	Altered Expression	[1310]
SARDH	OTQ49Q27	Strong	Biomarker	[1311]
SATB2	OT2W80XC	Strong	Biomarker	[1312]
SCD5	OTSSUQ3Z	Strong	Altered Expression	[1313]
SCG2	OTXWUQQL	Strong	Altered Expression	[1314]
SCO2	OTJQQDRS	Strong	Biomarker	[307]
SDC3	OT1P0LJM	Strong	Biomarker	[1080]
SDC4	OTKUVUGZ	Strong	Biomarker	[1315]
SDF2L1	OTE7JIO2	Strong	Genetic Variation	[673]
SEC14L2	OTJST64D	Strong	Biomarker	[1203]
SEMA3C	OTEGUY7F	Strong	Biomarker	[1316]
SEMA4A	OT8901H3	Strong	Altered Expression	[1317]
SEMA6A	OTDQ7QAW	Strong	Biomarker	[1318]
SEMA7A	OT0ZJK64	Strong	Altered Expression	[726]
SERPINA3	OT9BP2S0	Strong	Biomarker	[438]
SERPINF2	OTZGAF8B	Strong	Altered Expression	[728]
SF3B6	OTPRKS6S	Strong	Altered Expression	[1159]
SFRP2	OT8GZ0CA	Strong	Altered Expression	[574]
SFTA2	OTVRIUIV	Strong	Genetic Variation	[327]
SFTPA2	OT6SFOMU	Strong	Biomarker	[1319]
SGCZ	OTVGTEOD	Strong	Genetic Variation	[1193]
SGSM3	OTIB1P8A	Strong	Biomarker	[1320]
SH2D1A	OTLU49I5	Strong	Genetic Variation	[1321]
SH3BP4	OTVIRKW7	Strong	Biomarker	[1322]
SHBG	OTPWU5IW	Strong	Biomarker	[458]
SIGIRR	OTNC3XFD	Strong	Biomarker	[407]
SIGLEC7	OTNDLURR	Strong	Altered Expression	[1244]
SLC12A9	OTR7VRAK	Strong	Altered Expression	[1323]
SLC16A4	OT1YXBKC	Strong	Biomarker	[733]
SLPI	OTUNFUU8	Strong	Altered Expression	[384]
SLURP1	OT89YD2E	Strong	Biomarker	[1324]
SMG7	OTZDB0JX	Strong	Genetic Variation	[601]
SOAT1	OTB4Y5RJ	Strong	Biomarker	[1325]
SOCS2	OTBPNKJQ	Strong	Biomarker	[1326]
SOD3	OTIOZQAB	Strong	Biomarker	[1327]
SPATA2	OTOA45GL	Strong	Biomarker	[1306]
SPRED2	OTUX685J	Strong	Genetic Variation	[324]
SPRY2	OTH0CRCZ	Strong	Altered Expression	[1328]
SPSB1	OTGY26U4	Strong	Genetic Variation	[534]
SPZ1	OTQH8HJ5	Strong	Biomarker	[1176]
SRL	OT7IEBWZ	Strong	Biomarker	[1311]
SRP54	OT9SGF3X	Strong	Genetic Variation	[1329]
ST6GAL1	OT7US3NO	Strong	Biomarker	[1274]
ST6GALNAC5	OTH91ETM	Strong	Biomarker	[529]
STAG1	OT564IX4	Strong	Genetic Variation	[324]
STAT5B	OTZVPEBT	Strong	Biomarker	[1330]
STEAP4	OTFTLAEZ	Strong	Altered Expression	[1331]
STK19	OTYM6437	Strong	Genetic Variation	[446]
SUMO1	OTJFD4P5	Strong	Altered Expression	[1002]
SUOX	OTEJQ9FC	Strong	Genetic Variation	[324]
SYNGAP1	OT41HVYQ	Strong	Genetic Variation	[327]
SYNM	OTOI8TRJ	Strong	Biomarker	[1332]
SYT1	OTVTPOI6	Strong	Biomarker	[781]
TAC1	OTM842YW	Strong	Biomarker	[1333]
TADA1	OTV9RKSL	Strong	Genetic Variation	[1117]
TAGAP	OTHJNNO2	Strong	Biomarker	[1334]
TAP2	OTWSYFI7	Strong	Genetic Variation	[1223]
TAPBP	OTL81AVZ	Strong	Genetic Variation	[446]
TAX1BP3	OTQ6IB4T	Strong	Biomarker	[1335]
TBC1D9	OTSSCTB5	Strong	Genetic Variation	[1336]
TBX3	OTM64N7K	Strong	Biomarker	[1337]
TBX5	OT70PISV	Strong	Biomarker	[1338]
TCEA1	OTBFO594	Strong	Biomarker	[1339]
TCF19	OT7NKLF9	Strong	Genetic Variation	[327]
TCN2	OT41D0L3	Strong	Genetic Variation	[1340]
TCP11L1	OTL9X02U	Strong	Genetic Variation	[534]
TFDP1	OT6RZ7VT	Strong	Biomarker	[1341]
TFF3	OTJJDRTU	Strong	Altered Expression	[347]
TFPI2	OTZCRWOR	Strong	Biomarker	[529]
TIA1	OTGPN3P8	Strong	Biomarker	[543]
TIMELESS	OTD8DCBJ	Strong	Genetic Variation	[1129]
TIMP1	OTOXC51H	Strong	Biomarker	[1342]
TIMP3	OTDGQAD1	Strong	Biomarker	[1132]
TINAGL1	OTZZO56M	Strong	Biomarker	[1343]
TLR10	OTQ1KVJO	Strong	Altered Expression	[1344]
TM7SF2	OTILU5S7	Strong	Altered Expression	[454]
TMEM147	OTMKZ4PV	Strong	Biomarker	[1345]
TMEM158	OT0KUBBI	Strong	Altered Expression	[1346]
TMEM179	OTHB07OM	Strong	Genetic Variation	[673]
TMEM235	OTNHWPUE	Strong	Genetic Variation	[673]
TMEM60	OTRJU667	Strong	Biomarker	[1347]
TMPO	OTL68EL4	Strong	Biomarker	[467]
TNFRSF6B	OTKAN9G7	Strong	Altered Expression	[1081]
TNIP1	OTRAOTEW	Strong	Genetic Variation	[601]
TNPO3	OTOT3HH0	Strong	Genetic Variation	[601]
TPI1	OT14KP4B	Strong	Genetic Variation	[1129]
TRAF3IP2	OTLLZERL	Strong	Biomarker	[1295]
TREX1	OTQG7K12	Strong	Biomarker	[1348]
TRIM10	OTEO4UCZ	Strong	Genetic Variation	[327]
TRIM15	OTNYAKP6	Strong	Genetic Variation	[327]
TRIM26	OTS0DJIP	Strong	Genetic Variation	[327]
TRIM3	OT704FQ0	Strong	Altered Expression	[1349]
TRIM31	OT7VW6RP	Strong	Genetic Variation	[327]
TRIM39	OTESLVP9	Strong	Genetic Variation	[327]
TRIM40	OTLKKKA5	Strong	Genetic Variation	[327]
TRPS1	OT7XPPEL	Strong	Genetic Variation	[534]
TSC22D3	OT03UM03	Strong	Biomarker	[1350]
TSPAN5	OTHCCHHV	Strong	Genetic Variation	[534]
ADAMTS9	OTV3Q0DS	Definitive	Altered Expression	[1351]
ADGRG1	OTQBB8NT	Definitive	Altered Expression	[1352]
AFF1	OTT2C78E	Definitive	Biomarker	[1353]
AIMP1	OTTA5C3U	Definitive	Altered Expression	[1354]
AMH	OT5FH4BD	Definitive	Biomarker	[1355]
ANXA4	OTUCRYXL	Definitive	Biomarker	[1356]
ARPC1A	OTAEEXGQ	Definitive	Altered Expression	[1357]
ASPSCR1	OTXTOD10	Definitive	Biomarker	[426]
B4GALT1	OTBCXEK7	Definitive	Biomarker	[1358]
BCL2L12	OTS6IFZY	Definitive	Altered Expression	[1359]
CCDC134	OT70OQQV	Definitive	Biomarker	[1360]
CCN4	OT69BER9	Definitive	Biomarker	[1361]
CD109	OTDADBM4	Definitive	Biomarker	[1362]
CD2AP	OTC76KQM	Definitive	Genetic Variation	[1363]
CD79A	OTOJC8DV	Definitive	Altered Expression	[936]
CDKAL1	OTA0SGNE	Definitive	Genetic Variation	[1364]
CEACAM8	OTLL9WWO	Definitive	Biomarker	[1365]
CELF2	OTLJJ4VT	Definitive	Genetic Variation	[477]
CLDN1	OT27KV99	Definitive	Altered Expression	[1366]
CLDN7	OTNE0XHQ	Definitive	Altered Expression	[1366]
CNN2	OTH3CSXA	Definitive	Biomarker	[1367]
COL4A1	OTL6D1YE	Definitive	Genetic Variation	[839]
COL4A5	OTHG60RE	Definitive	Genetic Variation	[1368]
COMMD1	OT7WUD5R	Definitive	Altered Expression	[1369]
CRIP3	OT7H1YOY	Definitive	Biomarker	[1161]
CSRP3	OTECBJMV	Definitive	Biomarker	[1161]
CYBA	OT16N9ZO	Definitive	Biomarker	[379]
CYP4V2	OTQKNK0D	Definitive	Biomarker	[1370]
DEF6	OTIRBYVK	Definitive	Altered Expression	[1371]
DSPP	OT1TYNDN	Definitive	Genetic Variation	[1372]
DUSP2	OTH54FMR	Definitive	Biomarker	[785]
DUSP22	OTEZ3U85	Definitive	Genetic Variation	[1373]
DVL2	OTMNYNCM	Definitive	Biomarker	[1374]
EFNB2	OT0DCUOM	Definitive	Altered Expression	[927]
EMD	OTR8ZANE	Definitive	Biomarker	[1375]
EOMES	OTB9VQFA	Definitive	Biomarker	[1376]
EPB41L5	OTPPQPLU	Definitive	Biomarker	[1377]
FBXW8	OTJG15EO	Definitive	Genetic Variation	[477]
FGF9	OT2SKDGM	Definitive	Biomarker	[811]
GARS1	OT5B6R9Y	Definitive	Biomarker	[829]
GIT2	OTQ2EQJ1	Definitive	Genetic Variation	[1378]
GYS1	OTJZJRWK	Definitive	Altered Expression	[1379]
HRG	OTPLUFOG	Definitive	Altered Expression	[1380]
IBTK	OTB2GM4G	Definitive	Biomarker	[1381]
IFIT1	OTXOQDSG	Definitive	Biomarker	[1382]
IFNL2	OT4BMJF7	Definitive	Altered Expression	[1383]
IL17RD	OTKD9XST	Definitive	Altered Expression	[1384]
IL26	OT2WYCW4	Definitive	Biomarker	[1385]
IRAK2	OT6Y1QZN	Definitive	Genetic Variation	[1386]
ITIH4	OT460OO1	Definitive	Altered Expression	[1387]
ITSN1	OT8YF3S5	Definitive	Altered Expression	[1388]
JTB	OT314JB6	Definitive	Altered Expression	[684]
KAT2A	OTN0W2SW	Definitive	Biomarker	[1389]
LAT	OTZC1XZ1	Definitive	Biomarker	[792]
LPIN2	OTRRTMXX	Definitive	Altered Expression	[1390]
LRRC31	OT7VCU13	Definitive	Biomarker	[869]
MAP1LC3A	OTPMGIU4	Definitive	Altered Expression	[1391]
MAP1LC3B	OTUYHB84	Definitive	Genetic Variation	[1392]
MARCO	OT0NW2Q0	Definitive	Biomarker	[1393]
MARF1	OTYRJ4V2	Definitive	Altered Expression	[1394]
MARK1	OTP7KL47	Definitive	Biomarker	[1395]
MASP1	OTWWCNZP	Definitive	Biomarker	[1396]
MBNL1	OTOV7J85	Definitive	Altered Expression	[1397]
METTL3	OTSXP1M3	Definitive	Altered Expression	[1398]
MTMR3	OTBIT23O	Definitive	Altered Expression	[1392]
NCF2	OTAUW7L2	Definitive	Genetic Variation	[601]
NCR3	OT20M764	Definitive	Altered Expression	[1399]
NUCB2	OTHO6JWN	Definitive	Altered Expression	[1400]
OCLN	OTSUTVWL	Definitive	Altered Expression	[1366]
OPN1LW	OTFNUZ7O	Definitive	Biomarker	[1401]
PAEP	OTQA0NV4	Definitive	Genetic Variation	[1402]
PAG1	OTFOJUIQ	Definitive	Biomarker	[1401]
PARP9	OT7K4494	Definitive	Posttranslational Modification	[1403]
PBOV1	OT67PERT	Definitive	Biomarker	[1404]
PCBP1	OTHN0TD7	Definitive	Biomarker	[1405]
PCBP4	OTDLL4NB	Definitive	Biomarker	[1401]
PHEX	OTG7N3J7	Definitive	Biomarker	[1406]
PLCG2	OTGVC9MY	Definitive	Biomarker	[1407]
PPAN	OT0UFQBZ	Definitive	Biomarker	[818]
PPBP	OT1FHGQS	Definitive	Altered Expression	[1408]
PPIG	OTZ8BTTM	Definitive	Genetic Variation	[1409]
PPP1R11	OTSHYPPW	Definitive	Biomarker	[1410]
PRDM8	OTRA3265	Definitive	Altered Expression	[1411]
PROP1	OT8GF6N8	Definitive	Altered Expression	[1412]
PSMG1	OTZ5I6UM	Definitive	Biomarker	[785]
RASL12	OTNAK9X4	Definitive	Biomarker	[1413]
RCAN3	OTTS3CQA	Definitive	Biomarker	[1414]
RGCC	OTYJMLWM	Definitive	Biomarker	[811]
RMDN1	OTE1NB6U	Definitive	Biomarker	[631]
RMDN2	OTK5WSFI	Definitive	Biomarker	[631]
RMDN3	OTKO7AUM	Definitive	Biomarker	[631]
RTL1	OTOT33IM	Definitive	Biomarker	[1415]
S100A10	OTI71243	Definitive	Biomarker	[472]
SEMA6B	OT3VVVUO	Definitive	Biomarker	[1213]
SESN2	OT889IXY	Definitive	Biomarker	[1416]
SETMAR	OTE2MIMZ	Definitive	Biomarker	[1415]
SIGLEC9	OTZC7SIM	Definitive	Biomarker	[1417]
SNW1	OTKWG3PS	Definitive	Biomarker	[1418]
SPESP1	OTWXKKTJ	Definitive	Biomarker	[1419]
SRGAP1	OTL89HGW	Definitive	Genetic Variation	[1420]
SYBU	OT3FQV7N	Definitive	Biomarker	[631]
TRAF3	OT5TQBGV	Definitive	Biomarker	[1421]
TTC38	OTKE53HT	Definitive	Biomarker	[1390]

References

• [1] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6891).
• [2] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4860).
• [3] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [4] FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 103950.
• [5] 2018 FDA drug approvals.Nat Rev Drug Discov. 2019 Feb;18(2):85-89.
• [6] ClinicalTrials.gov (NCT02317627) Study of of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-Line Therapy. U.S. National Institutes of Health.
• [7] Betamethasone FDA Label
• [8] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6773).
• [9] Clinical pipeline report, company report or official report of Eisai.
• [10] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2892).
• [11] Emerging drugs for rheumatoid arthritis. Expert Opin Emerg Drugs. 2008 Mar;13(1):175-96.
• [12] Cortisone acetate FDA Label
• [13] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6886).
• [14] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3447).
• [15] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2896).
• [16] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4820).
• [17] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4194).
• [18] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7796).
• [19] ClinicalTrials.gov (NCT02390700) Observational Study of Golimumab Intravenous Infusion
• [20] Hydrocortisone FDA Label
• [21] ClinicalTrials.gov (NCT00029042) Infliximab to Treat Children With Juvenile Rheumatoid Arthritis
• [22] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034238)
• [23] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2439).
• [24] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6778).
• [25] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7264).
• [26] Prednisone FDA Label
• [27] Protein binding of tolmetin. Clin Pharmacol Ther. 1978 Dec;24(6):694-705.
• [28] ClinicalTrials.gov (NCT01359943) Efficacy, Safety and Tolerability of Secukinumab in Patients With Rheumatoid Arthritis Taking Methotrexate
• [29] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [30] Sirolimus FDA Label
• [31] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 4840).
• [32] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5425).
• [33] In vivo effect of celecoxib and tenoxicam on oxidant/ anti-oxidant status of patients with knee osteoarthritis. Ann Clin Lab Sci. 2005 Spring;35(2):137-43.
• [34] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6844).
• [35] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6881).
• [36] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5677).
• [37] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7311).
• [38] Triamcinolone FDA Label
• [39] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health Human Services. 2019
• [40] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800038738)
• [41] New developments in immunosuppressive therapy for heart transplantation. Expert Opin Emerg Drugs. 2009 Mar;14(1):1-21.
• [42] ClinicalTrials.gov (NCT02137226) BI 695501 Compared to Adalimumab in Patients With Active Rheumatoid Arthritis. U.S. National Institutes of Health.
• [43] ClinicalTrials.gov (NCT01626677) Follow-Up Study of CARTISTEM Versus Microfracture for the Treatment of Knee Articular Cartilage Injury or Defect. U.S. National Institutes of Health.
• [44] ClinicalTrials.gov (NCT02032004) The Purpose of This Study is to Evaluate the Efficacy and Safety of a Allogeneic Mesenchymal Precursor Cells (CEP-41750) for the Treatment of Chronic Heart Failure.. U.S. National Institutes of Health.
• [45] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6597).
• [46] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6466).
• [47] Pharmacological profile of the novel potent antirheumatic 4-(2',4'-difluorobiphenyl-4-yl)-2-methyl-4-oxobutanoic acid. Arzneimittelforschung. 1997 May;47(5):648-52.
• [48] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034367)
• [49] ClinicalTrials.gov (NCT04991753) A Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Proof-of-concept Study Evaluating the Efficacy and Safety of Nipocalimab Administered Intravenously in Participants With Active Rheumatoid Arthritis Despite Standard Therapy. U.S.National Institutes of Health.
• [50] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [51] ClinicalTrials.gov (NCT02073279) Efficacy and Safety Study as Monotherapy of SA237 to Treat NMO and NMOSD. U.S. National Institutes of Health.
• [52] ClinicalTrials.gov (NCT01689532) A Study of CNTO 136 (Sirukumab) Administered Subcutaneously in Japanese Patients With Active Rheumatoid Arthritis Unresponsive to Methotrexate or Sulfasalazine. U.S. National Institutes of Health.
• [53] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2395).
• [54] ClinicalTrials.gov (NCT01130246) VISTA-16 Trial: Evaluation of Safety and Efficacy of Short-term A-002 Treatment in Subjects With Acute Coronary Syndrome. U.S. National Institutes of Health.
• [55] ClinicalTrials.gov (NCT01925157) A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA). U.S. National Institutes of Health.
• [56] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8309).
• [57] Clinical pipeline report, company report or official report of CreaGene Inc.
• [58] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6059).
• [59] Clinical pipeline report, company report or official report of Klus Pharma
• [60] ClinicalTrials.gov (NCT04888585) A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects With Moderately to Severely Active Rheumatoid Arthritis With Inadequate Response to Biologic and/or Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs (b/tsDMARDs). U.S.National Institutes of Health.
• [61] ClinicalTrials.gov (NCT02349451) A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis Who Have an Inadequate Response to Methotrexate. U.S. National Institutes of Health.
• [62] ClinicalTrials.gov (NCT00141934) A Multicentre Trial to Determine the Efficacy of AD 452 in RA Subjects.. U.S. National Institutes of Health.
• [63] ClinicalTrials.gov (NCT00626275) Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Subjects With Rheumatoid Arthritis. U.S. National Institutes of Health.
• [64] ClinicalTrials.gov (NCT00902369) A Study of AK106-001616 in Patients With Rheumatoid Arthritis (RA). U.S. National Institutes of Health.
• [65] Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
• [66] Clinical pipeline report, company report or official report of Celimmune.
• [67] Clinical pipeline report, company report or official report of Genentech (2011).
• [68] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6482).
• [69] The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954.
• [70] ClinicalTrials.gov (NCT01552681) Baminercept in Sj ren's Syndrome. U.S. National Institutes of Health.
• [71] ClinicalTrials.gov (NCT02009761) Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).. U.S. National Institutes of Health.
• [72] ClinicalTrials.gov (NCT01930890) BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis. U.S. National Institutes of Health.
• [73] ClinicalTrials.gov (NCT01404585) Proof-of-Concept Study With BMS-817399 to Treat Moderate to Severe Rheumatoid Arthritis. U.S. National Institutes of Health.
• [74] ClinicalTrials.gov (NCT01545050) Dose Ranging Study of BMS-945429 in Subjects With Moderate to Severe Crohn's Disease. U.S. National Institutes of Health.
• [75] ClinicalTrials.gov (NCT04186871) A Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Assess the Efficacy and Safety of Branebrutinib Treatment in Subjects With Active Systemic Lupus Erythematosus or Primary Sj?gren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Subjects With Active Rheumatoid Arthritis. U.S.National Institutes of Health.
• [76] ClinicalTrials.gov (NCT01999192) Study to Investigate the Safety and Efficacy of Tregalizumab in Subjects (MTX-IR) With Active Rheumatoid Arthritis. U.S. National Institutes of Health.
• [77] ClinicalTrials.gov (NCT01310114) Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke. U.S. National Institutes of Health.
• [78] Clinical pipeline report, company report or official report of Genosco
• [79] ClinicalTrials.gov (NCT02291029) Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sj ren's Syndrome. U.S. National Institutes of Health.
• [80] ClinicalTrials.gov (NCT01116141) A Study of CH-4051 in Patients With Rheumatoid Arthritis (RA). U.S. National Institutes of Health.
• [81] Anti-Interleukin-23 Monoclonal Antibody Guselkumab Shows Significant Efficacy in Treatment of Moderate to Severe Plaque Psoriasis. Janssen Research & Development, LLC (Janssen). Mar 24, 2014.
• [82] ClinicalTrials.gov (NCT01909427) An Efficacy And Safety Study of CNTO 6785 In Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy. U.S. National Institutes of Health.
• [83] ClinicalTrials.gov (NCT04163991) A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Mechanistic Insight and Dosage Optimization Study of the Efficacy and Safety of VIB4920 in Patients With Rheumatoid Arthritis (RA). U.S.National Institutes of Health.
• [84] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016731)
• [85] Clinical pipeline report, company report or official report of EQRx
• [86] Effects of the COX-2 inhibitor FK3311 on ischemia - reperfusion injury in the rat lung. J Invest Surg. 2007 May-Jun;20(3):175-80.
• [87] ClinicalTrials.gov (NCT02279602) Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study. U.S. National Institutes of Health.
• [88] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7913).
• [89] ClinicalTrials.gov (NCT05165771) A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Proof-of-Concept Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 on Background Therapy With Conventional Synthetic Disease-modifying Antirheumatic Drug(s) (csDMARDs) in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Biologic DMARD(s) Treatment. U.S.National Institutes of Health.
• [90] ClinicalTrials.gov (NCT00674635) Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis. U.S. National Institutes of Health.
• [91] The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases. J Cell Mol Med. 2023 Feb;27(3):322-339.
• [92] ClinicalTrials.gov (NCT02295865) A Study to Evaluate Safety and Efficacy of Toreforant (JNJ-38518168) in Participants With Moderate to Severe Plaque-type Psoriasis. U.S. National Institutes of Health.
• [93] Clinical pipeline report, company report or official report of KaloBios Pharmaceuticals.
• [94] ClinicalTrials.gov (NCT05198310) A Phase 2, Multicenter, Randomized, Double-blind, Placebo Controlled Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Subjects With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase Inhibitor. U.S.National Institutes of Health.
• [95] ClinicalTrials.gov (NCT00903383) Study of LX3305 in Subjects With Active Rheumatoid Arthritis on Stable Methotrexate. U.S. National Institutes of Health.
• [96] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7785).
• [97] Clinical pipeline report, company report or official report of Sanofi Pasteur.
• [98] ClinicalTrials.gov (NCT01497223) MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis. U.S. National Institutes of Health.
• [99] ClinicalTrials.gov (NCT01569152) Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (MK-8457-008). U.S. National Institutes of Health.
• [100] ClinicalTrials.gov (NCT01408602) A Study of Two Doses of MRC375 in Moderate to Severe Rheumatoid Arthritis Patients. U.S. National Institutes of Health.
• [101] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030434)
• [102] Clinical pipeline report, company report or official report of Innate Pharma.
• [103] Complement-targeted therapeutics. Nat Biotechnol. 2007 Nov;25(11):1265-75.
• [104] ClinicalTrials.gov (NCT01226745) A Safety and Efficacy Extension Study of ONO-4641 (MSC2430913A) in Patients With Relapsing-Remitting Multiple Sclerosis. U.S. National Institutes of Health.
• [105] ClinicalTrials.gov (NCT04333147) Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA). U.S. National Institutes of Health.
• [106] ClinicalTrials.gov (NCT01063803) Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis. U.S. National Institutes of Health.
• [107] ClinicalTrials.gov (NCT01732211) A Phase 2, Safety, Tolerability, and Efficacy Study of PD 0360324 in Chronic Pulmonary Sarcoidosis. U.S. National Institutes of Health.
• [108] ClinicalTrials.gov (NCT00537667) The SPECTRA Study. U.S. National Institutes of Health.
• [109] ClinicalTrials.gov (NCT05516758) A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Peresolimab in Adult Participants With Moderately-to-Severely Active Rheumatoid Arthritis. U.S.National Institutes of Health.
• [110] ClinicalTrials.gov (NCT00938587) A Study Of PF-04171327 In The Treatment Of The Signs And Symptoms Of Rheumatoid Arthritis. U.S. National Institutes of Health.
• [111] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [112] ClinicalTrials.gov (NCT00369928) Evaluation of 2 Oral Doses of PG-760564 in Rheumatoid Arthritis (RA) Patients Receiving Methotrexate. U.S. National Institutes of Health.
• [113] Effect of food and gender on the pharmacokinetics of RP 73401, a phosphodiesterase IV inhibitor. Int J Clin Pharmacol Ther. 2000 Dec;38(12):588-94.
• [114] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6467).
• [115] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6040).
• [116] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800040434)
• [117] ClinicalTrials.gov (NCT00525213) Study to Evaluate the Efficacy and Safety of Orally Administered Rob 803 When Added to Methotrexate. U.S. National Institutes of Health.
• [118] CaMKII inhibitors: from research tools to therapeutic agents. Front Pharmacol. 2014; 5: 21.
• [119] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015778)
• [120] ClinicalTrials.gov (NCT01008852) Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis. U.S. National Institutes of Health.
• [121] Both the immunosuppressant SR31747 and the antiestrogen tamoxifen bind to an emopamil-insensitive site of mammalian Delta8-Delta7 sterol isomerase. J Pharmacol Exp Ther. 1998 Jun;285(3):1296-302.
• [122] ClinicalTrials.gov (NCT00502515) Dose-effect of SSR180575 in Diabetic Neuropathy. U.S. National Institutes of Health.
• [123] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 662).
• [124] A phase 1/2A trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease. Inflamm Bowel Dis. 2006 Jul;12(7):558-65.
• [125] ClinicalTrials.gov (NCT00760864) Safety and Efficacy of TAK-715 in Subjects With Rheumatoid Arthritis. U.S. National Institutes of Health.
• [126] ClinicalTrials.gov (NCT00760968) Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis. U.S. National Institutes of Health.
• [127] 2011 Pipeline of 4SC AG.
• [128] ClinicalTrials.gov (NCT02518620) An Open-Label Extension Study Assessing the Long-Term Efficacy and Safety of ALX-0061 in Subjects With Rheumatoid Arthritis. U.S. National Institutes of Health.
• [129] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5719).
• [130] ClinicalTrials.gov (NCT02867098) XmAb5871 Bioavailability Study
• [131] ClinicalTrials.gov (NCT04247815) A Phase 2a, Randomized, Investigator and Patient-blind, Sponsor-unblinded, Parallel Group, Placebo-controlled Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe Active Rheumatoid Arthritis. U.S.National Institutes of Health.
• [132] LD-aminopterin in the canine homologue of human atopic dermatitis: a randomized, controlled trial reveals dosing factors affecting optimal therapy. PLoS One. 2014 Sep 25;9(9):e108303.
• [133] Emerging drugs for psoriasis. Expert Opin Emerg Drugs. 2009 Mar;14(1):145-63.
• [134] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [135] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034187)
• [136] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018258)
• [137] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800031251)
• [138] ClinicalTrials.gov (NCT02052375) A Study To Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of ASP2408 After Multiple Dose Subcutaneous Injections in Patients With RheumatoidArthritis on Methotrexate. U.S. National Institutes of Health.
• [139] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [140] Antiarthritic profile of BF-389--a novel anti-inflammatory agent with low ulcerogenic liability. Agents Actions. 1992 Sep;37(1-2):90-8.
• [141] ClinicalTrials.gov (NCT03828344) A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety and Tolerability of a Single Intravenous Infusion of BX-U001, a Human Umbilical Cord Tissue Derived Mesenchymal Stem Cell Product, for Refractory Rheumatoid Arthritis. U.S.National Institutes of Health.
• [142] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800039530)
• [143] Clinical pipeline report, company report or official report of Evotec.
• [144] ClinicalTrials.gov (NCT00539760) A Phase I Rheumatoid Arthritis Study in Healthy Volunteers. U.S. National Institutes of Health.
• [145] Clinical pipeline report, company report or official report of GlaxoSmithKline.
• [146] ClinicalTrials.gov (NCT01765478) Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers. U.S. National Institutes of Health.
• [147] ClinicalTrials.gov (NCT05533372) Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IA-14069 in Healthy Subjects, With an Extension to Explore Any Drug-Drug Interaction Potential With Methotrexate (Part 1), and in Patients With Rheumatoid Arthritis, With Preliminary Assessment of Efficacy in Patients (Part 2). U.S.National Institutes of Health.
• [148] ClinicalTrials.gov (NCT04985812) A Multicenter, Double-blind, Placebo-controlled, Randomized, Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of JNJ-67484703 in Participants With Active Rheumatoid Arthritis. U.S.National Institutes of Health.
• [149] ClinicalTrials.gov (NCT05019950) A Randomized, Placebo-Controlled, Double-Blind, Single-Center Study to Evaluate Safety Tolerability and Pharmacokinetics of Oral NIM-1324 in Healthy Adult Male and Female Volunteers. U.S.National Institutes of Health.
• [150] ClinicalTrials.gov (NCT01559103) Study to Assess the Safety and Tolerability of MEDI5117 in Rheumatoid Arthritis Patients. U.S. National Institutes of Health.
• [151] Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands. J Immunol. 2003 Sep 15;171(6):3245-52.
• [152] ClinicalTrials.gov (NCT04286789) A Randomized, Double-blind, Parallel, Vehicle Controlled, Repeat Dose Comparative Phase 1b Study to Evaluate the Safety, Tolerability and Pharmacokinetics of ORTD-1 in Rheumatoid Arthritis Patients With Mild Disease Managed With DMARDs. U.S.National Institutes of Health.
• [153] ClinicalTrials.gov (NCT01284036) A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects. U.S. National Institutes of Health.
• [154] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032595)
• [155] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030399)
• [156] Subcutaneous injections of low doses of humanized anti-CD20 veltuzumab: a phase I study in chronic lymphocytic leukemia. Leuk Lymphoma. 2015 Oct 19:1-9.
• [157] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029914)
• [158] Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid Arthritis Patients. Velcura Therapeutics, Inc. JANUARY 07, 2009.
• [159] Effects of the immunomodulator, VGX-1027, in endotoxin-induced uveitis in Lewis rats. Br J Pharmacol. 2008 Nov;155(5):722-30.
• [160] AZ-4217: a high potency BACE inhibitor displaying acute central efficacy in different in vivo models and reduced amyloid deposition in Tg2576 mice. J Neurosci. 2013 Jun 12;33(24):10075-84.
• [161] Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
• [162] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000926)
• [163] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002733)
• [164] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020487)
• [165] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001452)
• [166] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800026002)
• [167] Emerging drugs for idiopathic thrombocytopenic purpura in adults. Expert Opin Emerg Drugs. 2008 Jun;13(2):237-54.
• [168] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015375)
• [169] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007279)
• [170] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6155).
• [171] Clinical pipeline report, company report or official report of Galapagos.
• [172] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005016)
• [173] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007359)
• [174] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800038032)
• [175] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013426)
• [176] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002363)
• [177] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023346)
• [178] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027730)
• [179] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800022053)
• [180] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800018538)
• [181] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030380)
• [182] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010176)
• [183] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007225)
• [184] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016746)
• [185] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800015041)
• [186] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019215)
• [187] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023206)
• [188] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800009741)
• [189] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7687).
• [190] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017126)
• [191] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017125)
• [192] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027710)
• [193] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800020402)
• [194] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002367)
• [195] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013227)
• [196] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800036376)
• [197] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029003)
• [198] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030004)
• [199] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800025504)
• [200] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800017105)
• [201] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001478)
• [202] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006813)
• [203] Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019 Dec;18(12):923-948.
• [204] Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91.
• [205] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000969)
• [206] Circadian rhythm as a therapeutic target. Nat Rev Drug Discov. 2021 Apr;20(4):287-307.
• [207] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019127)
• [208] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019129)
• [209] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800016328)
• [210] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7686).
• [211] Role of leukotrienes on coronary vasoconstriction in isolated hearts of arthritic rats: effect of in vivo treatment with CI-986, a dual inhibitor of cyclooxygenase and lipoxygenase. Pharmacology. 2000 Jan;60(1):41-6.
• [212] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007275)
• [213] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6509).
• [214] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007983)
• [215] Antiarthritis effect of a novel Bruton's tyrosine kinase (BTK) inhibitor in rat collagen-induced arthritis and mechanism-based pharmacokinetic/pharmacodynamic modeling: relationships between inhibition of BTK phosphorylation and efficacy. J Pharmacol Exp Ther. 2011 Jul;338(1):154-63.
• [216] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010855)
• [217] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002734)
• [218] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800021746)
• [219] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002350)
• [220] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001772)
• [221] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800013076)
• [222] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005018)
• [223] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029797)
• [224] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006085)
• [225] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800000933)
• [226] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001260)
• [227] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007333)
• [228] Interleukin-1 beta converting enzyme inhibition blocks progression of type II collagen-induced arthritis in mice. Cytokine. 1996 May;8(5):377-86.
• [229] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005582)
• [230] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003820)
• [231] Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800005488)
• [232] Therapeutic applications of aptamers. Expert Opin Investig Drugs. 2008 Jan;17(1):43-60.
• [233] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1874).
• [234] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2294).
• [235] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2743).
• [236] ETP-46321, a dual p110alpha/ class IA phosphoinositide 3-kinase inhibitor modulates T lymphocyte activation and collagen-induced arthritis. Biochem Pharmacol. 2016 Apr 15;106:56-69.
• [237] URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1870).
• [238] Oligodeoxynucleotide inhibition of Toll-like receptors 3, 7, 8, and 9 suppresses cytokine production in a human rheumatoid arthritis model. Eur J Immunol. 2016 Mar;46(3):772-81.
• [239] A novel ring-expanded product with enhanced tyrosinase inhibitory activity from classical Fe-catalyzed oxidation of rosmarinic acid, a potent antio... Bioorg Med Chem Lett. 2010 Dec 15;20(24):7393-6.
• [240] US patent application no. 6,274,627, Conjugates of dithiocarbamate disulfides with pharmacologically active agents and uses therefor.
• [241] Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. J Virol. 2004 Nov;78(22):12355-65.
• [242] ClinicalTrials.gov (NCT01612377) Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis. U.S. National Institutes of Health.
• [243] Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. Arthritis Rheum. 2013 Nov;65(11):2791-802.
• [244] HMGB1-LPS complex promotes transformation of osteoarthritis synovial fibroblasts to a rheumatoid arthritis synovial fibroblast-like phenotype.Cell Death Dis. 2014 Feb 20;5(2):e1077. doi: 10.1038/cddis.2014.48.
• [245] Expression of arachidonate platelet-type 12-lipoxygenase in human rheumatoid arthritis type B synoviocytes.FEBS Lett. 1997 Sep 1;414(1):159-64. doi: 10.1016/s0014-5793(97)00904-6.
• [246] Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids.Br J Rheumatol. 1998 Jul;37(7):721-8. doi: 10.1093/rheumatology/37.7.721.
• [247] Increased Nonexudative Age-Related Macular Degeneration Diagnosis Among Medicare Beneficiaries With Rheumatoid Arthritis.Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3520-3526. doi: 10.1167/iovs.18-26444.
• [248] Pectenotoxin-2 induces G1 arrest of the cell cycle in synovial fibroblasts of patients with rheumatoid arthritis.Int J Mol Med. 2011 Jun;27(6):783-7. doi: 10.3892/ijmm.2011.636. Epub 2011 Mar 3.
• [249] Serum paraoxonase activity decreases in rheumatoid arthritis.Life Sci. 2003 May 9;72(25):2877-85. doi: 10.1016/s0024-3205(03)00195-4.
• [250] Increased expression of arginase II in patients with different forms of arthritis. Implications of the regulation of nitric oxide.J Rheumatol. 2002 Nov;29(11):2261-5.
• [251] Acid-sensing ion channel 3 decreases phosphorylation of extracellular signal-regulated kinases and induces synoviocyte cell death by increasing intracellular calcium.Arthritis Res Ther. 2014 Jun 12;16(3):R121. doi: 10.1186/ar4577.
• [252] Serum E-selectin and erythrocyte membrane Na+K+ ATPase levels in patients with rheumatoid arthritis.Cell Biochem Funct. 2005 Jul-Aug;23(4):285-9. doi: 10.1002/cbf.1155.
• [253] Analysis of differentially expressed genes in rheumatoid arthritis and osteoarthritis by integrated microarray analysis.J Cell Biochem. 2019 Aug;120(8):12653-12664. doi: 10.1002/jcb.28533. Epub 2019 Mar 4.
• [254] Replication of Associations of Genetic Loci Outside the HLA Region With Susceptibility to Anti-Cyclic Citrullinated Peptide-Negative Rheumatoid Arthritis.Arthritis Rheumatol. 2016 Jul;68(7):1603-13. doi: 10.1002/art.39619.
• [255] Peripheral blood expression profiles of bone morphogenetic proteins, tumor necrosis factor-superfamily molecules, and transcription factor Runx2 could be used as markers of the form of arthritis, disease activity, and therapeutic responsiveness. J Rheumatol. 2010 Feb;37(2):246-56. doi: 10.3899/jrheum.090167. Epub 2009 Dec 15.
• [256] Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways.J Immunol. 2008 Mar 1;180(5):3485-91. doi: 10.4049/jimmunol.180.5.3485.
• [257] Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis.J Rheumatol. 2003 Aug;30(8):1719-24.
• [258] Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models.J Immunol. 2019 May 15;202(10):2888-2906. doi: 10.4049/jimmunol.1800583. Epub 2019 Apr 15.
• [259] HLA-DQB1 CAR1/CAR2, TNFa IR2/IR4 and CTLA-4 polymorphisms in Tunisian patients with rheumatoid arthritis and Sjgren's syndrome.Rheumatology (Oxford). 2001 Dec;40(12):1370-4. doi: 10.1093/rheumatology/40.12.1370.
• [260] Improved serological detection of rheumatoid arthritis: a highly antigenic mimotope of carbonic anhydrase III selected in a murine model by phage display.Arthritis Res Ther. 2015 Jun 23;17(1):168. doi: 10.1186/s13075-015-0685-3.
• [261] Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.Arthritis Rheum. 2008 Aug;58(8):2257-67. doi: 10.1002/art.23667.
• [262] Lack of association with rheumatoid arthritis of selected polymorphisms in 4 candidate genes: CFH, CD209, eotaxin-3, and MHC2TA.J Rheumatol. 2009 Aug;36(8):1590-5. doi: 10.3899/jrheum.090022. Epub 2009 Jun 30.
• [263] High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis.Nat Genet. 2012 Dec;44(12):1336-40. doi: 10.1038/ng.2462. Epub 2012 Nov 11.
• [264] Characterization of a soluble form of CD58 in synovial fluid of patients with rheumatoid arthritis (RA).Clin Exp Immunol. 1996 Jun;104(3):460-6. doi: 10.1046/j.1365-2249.1996.41749.x.
• [265] Cellular basis and oncogene expression of rheumatoid joint destruction.Rheumatol Int. 1989;9(3-5):105-13. doi: 10.1007/BF00271866.
• [266] Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.Arthritis Rheum. 2006 Jul;54(7):2074-83. doi: 10.1002/art.21927.
• [267] CCAAT/enhancer-binding protein promotes receptor activator of nuclear factor-kappa-B ligand (RANKL) expression and osteoclast formation in the synovium in rheumatoid arthritis.Arthritis Res Ther. 2015 Feb 17;17(1):31. doi: 10.1186/s13075-015-0532-6.
• [268] Gender-specific effects of genetic variants within Th1 and Th17 cell-mediated immune response genes on the risk of developing rheumatoid arthritis.PLoS One. 2013 Aug 30;8(8):e72732. doi: 10.1371/journal.pone.0072732. eCollection 2013.
• [269] Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis.Exp Mol Pathol. 2012 Feb;92(1):90-6. doi: 10.1016/j.yexmp.2011.10.006. Epub 2011 Oct 19.
• [270] Rheumatoid arthritis synovial T cells regulate transcription of several genes associated with antigen-induced anergy.J Clin Invest. 2001 Feb;107(4):519-28. doi: 10.1172/JCI8027.
• [271] Molecular cloning of a soluble form of the granulocyte-macrophage colony-stimulating factor receptor alpha chain from a myelomonocytic cell line. Expression, biologic activity, and preliminary analysis of transcript distribution.Arthritis Rheum. 1994 Oct;37(10):1468-78. doi: 10.1002/art.1780371010.
• [272] Increased circulating CXCL13 levels in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis.Clin Rheumatol. 2020 Jan;39(1):281-290. doi: 10.1007/s10067-019-04775-z. Epub 2019 Sep 16.
• [273] Sex Differences in the Blood Concentration of Tacrolimus in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients with CYP3A5*3/*3. Biochem Genet. 2017 Jun;55(3):268-277.
• [274] Deoxycytidine kinase promotes the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.Int J Clin Exp Pathol. 2013 Nov 15;6(12):2733-44. eCollection 2013.
• [275] Evidence for a novel rheumatoid arthritis susceptibility locus on chromosome 6p.Arthritis Rheum. 2004 Dec;50(12):3823-30. doi: 10.1002/art.20670.
• [276] Rheumatoid arthritis bone fragility is associated with upregulation of IL17 and DKK1 gene expression.Clin Rev Allergy Immunol. 2014 Aug;47(1):38-45. doi: 10.1007/s12016-013-8366-y.
• [277] B lymphocyte involvement in ankylosing spondylitis: the heavy chain variable segment gene repertoire of B lymphocytes from germinal center-like foci in the synovial membrane indicates antigen selection.Arthritis Res. 2001;3(3):189-95. doi: 10.1186/ar297. Epub 2001 Mar 1.
• [278] PKR and HMGB1 expression and function in rheumatoid arthritis.Genet Mol Res. 2015 Dec 22;14(4):17864-70. doi: 10.4238/2015.December.22.11.
• [279] Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis.Am J Physiol Cell Physiol. 2008 Jan;294(1):C189-96. doi: 10.1152/ajpcell.00314.2007. Epub 2007 Oct 17.
• [280] Expression of ERAP2 and LST1 is increased before start of therapy in rheumatoid arthritis patients with good clinical response to glucocorticoids.Clin Exp Rheumatol. 2016 Jul-Aug;34(4):685-9. Epub 2016 Jun 22.
• [281] Aryl hydrocarbon receptor antagonism attenuates growth factor expression, proliferation, and migration in fibroblast-like synoviocytes from patients with rheumatoid arthritis.J Pharmacol Exp Ther. 2014 Feb;348(2):236-45. doi: 10.1124/jpet.113.209726. Epub 2013 Dec 5.
• [282] FCGR polymorphisms in the treatment of rheumatoid arthritis with Fc-containing TNF inhibitors.Pharmacogenomics. 2015;16(4):333-45. doi: 10.2217/pgs.14.175.
• [283] FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.Oncogene. 1998 Aug 13;17(6):761-7. doi: 10.1038/sj.onc.1201992.
• [284] Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cells.Arthritis Rheum. 1992 Nov;35(11):1296-303. doi: 10.1002/art.1780351109.
• [285] Variable responses of formyl peptide receptor haplotypes toward bacterial peptides.Immunogenetics. 2008 Feb;60(2):83-93. doi: 10.1007/s00251-008-0277-3. Epub 2008 Feb 6.
• [286] Detecting local haplotype sharing and haplotype association.Genetics. 2014 Jul;197(3):823-38. doi: 10.1534/genetics.114.164814. Epub 2014 May 8.
• [287] Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis.FASEB J. 1999 Apr;13(6):715-25. doi: 10.1096/fasebj.13.6.715.
• [288] Retinoic acid enhances histamine content and H1 receptor expression in human neuroblastoma cell line Paju.Anticancer Res. 2004 May-Jun;24(3a):1657-63.
• [289] Midkine, a heparin-binding growth factor, is fundamentally involved in the pathogenesis of rheumatoid arthritis.Arthritis Rheum. 2004 May;50(5):1420-9. doi: 10.1002/art.20175.
• [290] Plasma and peripheral leukocyte beta-N-acetylhexosaminidase isoenzymes and disease activity in rheumatoid arthritis.Clin Biochem. 2002 Sep;35(6):483-8. doi: 10.1016/s0009-9120(02)00339-9.
• [291] Development of an ICOSL and BAFF bispecific inhibitor AMG 570 for systemic lupus erythematosus treatment. Clin Exp Rheumatol. Nov-Dec 2019;37(6):906-914.
• [292] Expression of Interferon- Receptor Genes in Peripheral Blood Mononuclear Cells Is Associated With Rheumatoid Arthritis and Its Radiographic Severity in African Americans.Arthritis Rheumatol. 2015 May;67(5):1165-70. doi: 10.1002/art.39056.
• [293] IL-11 facilitates a novel connection between RA joint fibroblasts and endothelial cells.Angiogenesis. 2018 May;21(2):215-228. doi: 10.1007/s10456-017-9589-y. Epub 2018 Jan 11.
• [294] Transcription factor Zbtb38 downregulates the expression of anti-inflammatory IL1r2 in mouse model of rheumatoid arthritis.Biochim Biophys Acta Gene Regul Mech. 2018 Nov;1861(11):1040-1047. doi: 10.1016/j.bbagrm.2018.09.007. Epub 2018 Sep 15.
• [295] Antiviral gene expression in rheumatoid arthritis: role of IKKepsilon and interferon regulatory factor 3.Arthritis Rheum. 2007 Mar;56(3):743-52. doi: 10.1002/art.22421.
• [296] Inositol 1,4,5-trisphosphate receptors are autoantibody target antigens in patients with Sjgren's syndrome and other systemic rheumatic diseases.Mod Rheumatol. 2007;17(2):137-43. doi: 10.1007/s10165-006-0555-6. Epub 2007 Apr 20.
• [297] The co-expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium.Am J Pathol. 2002 Feb;160(2):425-31. doi: 10.1016/S0002-9440(10)64861-4.
• [298] Regulation of lysophosphatidic acid receptor expression and function in human synoviocytes: implications for rheumatoid arthritis?.Mol Pharmacol. 2008 Feb;73(2):587-600. doi: 10.1124/mol.107.038216. Epub 2007 Nov 15.
• [299] Localisation of lysozyme mRNA in rheumatoid synovial membrane by in situ hybridisation.Ann Rheum Dis. 1989 Nov;48(11):912-7. doi: 10.1136/ard.48.11.912.
• [300] Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.Arthritis Rheum. 2007 Jun;56(6):1787-97. doi: 10.1002/art.22705.
• [301] Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
• [302] Association of MASP-2 levels and MASP2 gene polymorphisms with rheumatoid arthritis in patients and their relatives.PLoS One. 2014 Mar 14;9(3):e90979. doi: 10.1371/journal.pone.0090979. eCollection 2014.
• [303] Endogenous HLA-DR-restricted presentation of the cartilage antigens human cartilage gp-39 and melanoma inhibitory activity in the inflamed rheumatoid joint.Arthritis Rheum. 2007 Jul;56(7):2150-9. doi: 10.1002/art.22651.
• [304] BRAF splice variants in rheumatoid arthritis synovial fibroblasts activate MAPK through CRAF.Mol Immunol. 2013 Oct;55(3-4):247-52. doi: 10.1016/j.molimm.2013.02.001. Epub 2013 Mar 19.
• [305] Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis.Ann Rheum Dis. 1999 Nov;58(11):691-7. doi: 10.1136/ard.58.11.691.
• [306] Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.Arthritis Rheum. 2000 Jun;43(6):1226-32. doi: 10.1002/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4.
• [307] Caught in a Trap? Proteomic Analysis of Neutrophil Extracellular Traps in Rheumatoid Arthritis and Systemic Lupus Erythematosus.Front Immunol. 2019 Mar 11;10:423. doi: 10.3389/fimmu.2019.00423. eCollection 2019.
• [308] Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.Arthritis Rheum. 2008 Jan;58(1):46-52. doi: 10.1002/art.23174.
• [309] Role of Crk-associated substrate lymphocyte type in the pathophysiology of rheumatoid arthritis in tax transgenic mice and in humans.Arthritis Rheum. 2003 Jul;48(7):1890-900. doi: 10.1002/art.11047.
• [310] Gene expression profiling and functional analysis of angiogenic markers in murine collagen-induced arthritis.Arthritis Res Ther. 2012 Jul 20;14(4):R169. doi: 10.1186/ar3922.
• [311] The association between disease activity and NT-proBNP in 238 patients with rheumatoid arthritis: a 10-year longitudinal study.Arthritis Res Ther. 2008;10(3):R70. doi: 10.1186/ar2442. Epub 2008 Jun 23.
• [312] Role of the netrin system of repellent factors on synovial fibroblasts in rheumatoid arthritis and osteoarthritis.Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):715-22. doi: 10.1177/039463200902200317.
• [313] Effects of lentivirus-mediated ornithine decarboxylase gene on the proliferation and apoptosis of fibroblast-like synoviocytes in rats with arthritis.Life Sci. 2018 Feb 1;194:224-230. doi: 10.1016/j.lfs.2017.10.004. Epub 2017 Oct 3.
• [314] Expression of kappa-opioid receptor mRNA in human peripheral blood lymphocytes and the relationship between its expression and the inflammatory changes in rheumatoid arthritis.Rheumatol Int. 2000;19(3):95-100. doi: 10.1007/s002960050110.
• [315] IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA).Clin Exp Immunol. 2001 Jan;123(1):147-54. doi: 10.1046/j.1365-2249.2001.01432.x.
• [316] Higher expression of TNF-induced genes in the synovium of patients with early rheumatoid arthritis correlates with disease activity, and predicts absence of response to first line therapy.Arthritis Res Ther. 2016 Jan 20;18:19. doi: 10.1186/s13075-016-0919-z.
• [317] Novel application of multi-stimuli network inference to synovial fibroblasts of rheumatoid arthritis patients.BMC Med Genomics. 2014 Jul 3;7:40. doi: 10.1186/1755-8794-7-40.
• [318] Pim-2/mTORC1 Pathway Shapes Inflammatory Capacity in Rheumatoid Arthritis Synovial Cells Exposed to Lipid Peroxidations.Biomed Res Int. 2015;2015:240210. doi: 10.1155/2015/240210. Epub 2015 May 4.
• [319] Role of p21-activated kinase 1 in regulating the migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.Rheumatology (Oxford). 2012 Jul;51(7):1170-80. doi: 10.1093/rheumatology/kes031. Epub 2012 Mar 13.
• [320] IL-15 promotes osteoclastogenesis via the PLD pathway in rheumatoid arthritis.Immunol Lett. 2011 Sep 30;139(1-2):42-51. doi: 10.1016/j.imlet.2011.04.013. Epub 2011 May 19.
• [321] Protein phosphatase magnesium-dependent 1A induces inflammation in rheumatoid arthritis.Biochem Biophys Res Commun. 2020 Feb 12;522(3):731-735. doi: 10.1016/j.bbrc.2019.11.112. Epub 2019 Nov 30.
• [322] Prolylcarboxypeptidase: a cardioprotective enzyme.Int J Biochem Cell Biol. 2009 Mar;41(3):477-81. doi: 10.1016/j.biocel.2008.02.022. Epub 2008 Feb 29.
• [323] Impairment of thioredoxin reductase activity by oxidative stress in human rheumatoid synoviocytes.Free Radic Res. 2007 Jun;41(6):688-98. doi: 10.1080/10715760701294468.
• [324] Genetic influences on susceptibility to rheumatoid arthritis in African-Americans.Hum Mol Genet. 2019 Mar 1;28(5):858-874. doi: 10.1093/hmg/ddy395.
• [325] Inactivating PSMB5 mutations and P-glycoprotein (multidrug resistance-associated protein/ATP-binding cassette B1) mediate resistance to proteasome inhibitors: ex vivo efficacy of (immuno)proteasome inhibitors in mononuclear blood cells from patients with rheumatoid arthritis.J Pharmacol Exp Ther. 2012 Apr;341(1):174-82. doi: 10.1124/jpet.111.187542. Epub 2012 Jan 10.
• [326] Dominant T-cell receptor beta-chain gene rearrangements indicate clonal expansion in the rheumatoid joint.Scand J Immunol. 1990 Jan;31(1):121-6. doi: 10.1111/j.1365-3083.1990.tb02750.x.
• [327] REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis.Nat Genet. 2009 Jul;41(7):820-3. doi: 10.1038/ng.395. Epub 2009 Jun 7.
• [328] Prostaglandin E2 differentially modulates proinflammatory/prodestructive effects of TNF-alpha on synovial fibroblasts via specific E prostanoid receptors/cAMP.J Immunol. 2009 Jul 15;183(2):1328-36. doi: 10.4049/jimmunol.0900801. Epub 2009 Jun 19.
• [329] PTGER4 gene variant rs76523431 is a candidate risk factor for radiological joint damage in rheumatoid arthritis patients: a genetic study of six cohorts.Arthritis Res Ther. 2015 Nov 5;17:306. doi: 10.1186/s13075-015-0830-z.
• [330] Induction of cyclooxygenase-1 in cultured synovial cells isolated from rheumatoid arthritis patients. Inflamm Res. 2004 Jun;53(6):217-22. doi: 10.1007/s00011-004-1260-6. Epub 2004 May 12.
• [331] PTPN14 phosphatase and YAP promote TGF signalling in rheumatoid synoviocytes.Ann Rheum Dis. 2019 May;78(5):600-609. doi: 10.1136/annrheumdis-2018-213799. Epub 2019 Feb 26.
• [332] Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis.Pharmacogenomics J. 2017 Oct;17(5):403-411. doi: 10.1038/tpj.2017.26. Epub 2017 Jun 13.
• [333] Expression of human and Porphyromonas gingivalis glutaminyl cyclases in periodontitis and rheumatoid arthritis-A pilot study.Arch Oral Biol. 2019 Jan;97:223-230. doi: 10.1016/j.archoralbio.2018.10.022. Epub 2018 Oct 28.
• [334] Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling.Oncotarget. 2015 Nov 3;6(34):35830-42. doi: 10.18632/oncotarget.5767.
• [335] Variation at FCGR2A and functionally related genes is associated with the response to anti-TNF therapy in rheumatoid arthritis.PLoS One. 2015 Apr 7;10(4):e0122088. doi: 10.1371/journal.pone.0122088. eCollection 2015.
• [336] Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes.Biochem Pharmacol. 2014 Jul 1;90(1):62-72. doi: 10.1016/j.bcp.2014.04.012. Epub 2014 Apr 30.
• [337] Expression and Regulation of Retinoic Acid Receptor Responders in the Human Placenta.Reprod Sci. 2018 Sep;25(9):1357-1370. doi: 10.1177/1933719117746761. Epub 2017 Dec 15.
• [338] Specific and overlapping sphingosine-1-phosphate receptor functions in human synoviocytes: impact of TNF-alpha.J Lipid Res. 2008 Nov;49(11):2323-37. doi: 10.1194/jlr.M800143-JLR200. Epub 2008 Jul 24.
• [339] Circulating Semaphorin 4D as a Marker for Predicting Radiographic Progression in Patients with Rheumatoid Arthritis.Dis Markers. 2018 Nov 14;2018:2318386. doi: 10.1155/2018/2318386. eCollection 2018.
• [340] MicroRNA-152 modulates the canonical Wnt pathway activation by targeting DNA methyltransferase 1 in arthritic rat model.Biochimie. 2014 Nov;106:149-56. doi: 10.1016/j.biochi.2014.08.016. Epub 2014 Sep 4.
• [341] Resistance to collagen-induced arthritis in SHPS-1 mutant mice.Biochem Biophys Res Commun. 2008 Jul 4;371(3):561-6. doi: 10.1016/j.bbrc.2008.04.124. Epub 2008 May 1.
• [342] Loss of Smad7 Promotes Inflammation in Rheumatoid Arthritis.Front Immunol. 2018 Nov 2;9:2537. doi: 10.3389/fimmu.2018.02537. eCollection 2018.
• [343] Expression of sphingosine kinase 2 in synovial fibroblasts of rheumatoid arthritis contributing to apoptosis by a sphingosine analogue, FTY720.Pathol Int. 2009 Jun;59(6):382-9. doi: 10.1111/j.1440-1827.2009.02381.x.
• [344] Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.J Endocrinol. 2008 Jun;197(3):517-29. doi: 10.1677/JOE-08-0043.
• [345] Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line.Int J Cancer. 1996 May 16;66(4):538-43. doi: 10.1002/(SICI)1097-0215(19960516)66:4<538::AID-IJC19>3.0.CO;2-3.
• [346] Levels of antioxidant proteins and soluble intercellular adhesion molecule-1 in serum of patients with rheumatoid arthritis.Ann Clin Lab Sci. 2002 Summer;32(3):264-70.
• [347] Human Synovia Contains Trefoil Factor Family (TFF) Peptides 1-3 Although Synovial Membrane Only Produces TFF3: Implications in Osteoarthritis and Rheumatoid Arthritis.Int J Mol Sci. 2019 Dec 3;20(23):6105. doi: 10.3390/ijms20236105.
• [348] GDF-5 is suppressed by IL-1beta and enhances TGF-beta3-mediated chondrogenic differentiation in human rheumatoid fibroblast-like synoviocytes.Exp Mol Pathol. 2010 Feb;88(1):163-70. doi: 10.1016/j.yexmp.2009.09.019. Epub 2009 Oct 8.
• [349] Phenotypic and Transcriptomic Analysis of Peripheral Blood Plasmacytoid and Conventional Dendritic Cells in Early Drug Nave Rheumatoid Arthritis.Front Immunol. 2018 May 9;9:755. doi: 10.3389/fimmu.2018.00755. eCollection 2018.
• [350] Potential involvement of OX40 in the regulation of autoantibody sialylation in arthritis.Ann Rheum Dis. 2019 Nov;78(11):1488-1496. doi: 10.1136/annrheumdis-2019-215195. Epub 2019 Jul 12.
• [351] Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis.Mol Biol Rep. 2012 Dec;39(12):10627-35. doi: 10.1007/s11033-012-1952-x. Epub 2012 Oct 7.
• [352] Histamine releasing factor (HRF) in pannus of joints affected by rheumatoid arthritis.Inflamm Res. 2008;57 Suppl 1:S61-2. doi: 10.1007/s00011-007-0630-2.
• [353] TRPC channel activation by extracellular thioredoxin.Nature. 2008 Jan 3;451(7174):69-72. doi: 10.1038/nature06414.
• [354] TRPM3 channel stimulated by pregnenolone sulphate in synovial fibroblasts and negatively coupled to hyaluronan.BMC Musculoskelet Disord. 2010 Jun 4;11:111. doi: 10.1186/1471-2474-11-111.
• [355] TRPV2 suppresses Rac1 and RhoA activation and invasion in rheumatoid arthritis fibroblast-like synoviocytes.Int Immunopharmacol. 2019 May;70:268-273. doi: 10.1016/j.intimp.2019.02.051. Epub 2019 Mar 6.
• [356] Computational Molecular Phenotypic Analysis of PTPN22 (W620R), IL6R (D358A), and TYK2 (P1104A) Gene Mutations of Rheumatoid Arthritis.Front Genet. 2019 Mar 7;10:168. doi: 10.3389/fgene.2019.00168. eCollection 2019.
• [357] Complete clinical and functional recovery following low-dose methotrexate related paraparesis in a patient with compound c.1298A>C AND c.677C>T MTHFR polymorphism: A case report.Medicine (Baltimore). 2018 Dec;97(49):e13350. doi: 10.1097/MD.0000000000013350.
• [358] Neuroendocrine, immunologic, and microvascular systems interactions in rheumatoid arthritis: physiopathogenetic and therapeutic perspectives.Semin Arthritis Rheum. 1999 Oct;29(2):65-81. doi: 10.1016/s0049-0172(99)80039-0.
• [359] Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review.Inflammopharmacology. 2020 Apr;28(2):363-384. doi: 10.1007/s10787-019-00674-6. Epub 2019 Dec 9.
• [360] Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.Arthritis Rheum. 2008 Apr;58(4):1010-9. doi: 10.1002/art.23482.
• [361] Comparative Expression Analyses of Pro- versus Anti-Inflammatory Mediators within Synovium of Patients with Joint Trauma, Osteoarthritis, and Rheumatoid Arthritis.Mediators Inflamm. 2017;2017:9243736. doi: 10.1155/2017/9243736. Epub 2017 Feb 20.
• [362] Vascular Arginase Is a Relevant Target to Improve Cerebrovascular Endothelial Dysfunction in Rheumatoid Arthritis: Evidence from the Model of Adjuvant-Induced Arthritis.Transl Stroke Res. 2020 Feb;11(1):4-15. doi: 10.1007/s12975-019-00699-7. Epub 2019 Mar 18.
• [363] Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation.Mol Immunol. 2011 Oct;49(1-2):64-74. doi: 10.1016/j.molimm.2011.07.021. Epub 2011 Aug 19.
• [364] High rates of tuberculin skin test positivity due to methotrexate therapy: False positive results?.Semin Arthritis Rheum. 2018 Dec;48(3):538-546. doi: 10.1016/j.semarthrit.2018.03.018. Epub 2018 Mar 29.
• [365] The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts.Ann Rheum Dis. 2016 Feb;75(2):422-9. doi: 10.1136/annrheumdis-2014-205809. Epub 2014 Dec 2.
• [366] Monitoring C3aR Expression Using a Floxed tdTomato-C3aR Reporter Knock-in Mouse.J Immunol. 2017 Jul 15;199(2):688-706. doi: 10.4049/jimmunol.1700318. Epub 2017 Jun 16.
• [367] CysLT1 receptor antagonist alleviates pathogenesis of collagen-induced arthritis mouse model.Oncotarget. 2017 Nov 26;8(65):108418-108429. doi: 10.18632/oncotarget.22664. eCollection 2017 Dec 12.
• [368] Prolyl hydroxylase domain enzyme 2 is the major player in regulating hypoxic responses in rheumatoid arthritis.Arthritis Rheum. 2012 Sep;64(9):2856-67. doi: 10.1002/art.34479.
• [369] Semaphorin 7A as a potential immune regulator and promising therapeutic target in rheumatoid arthritis.Arthritis Res Ther. 2017 Jan 21;19(1):10. doi: 10.1186/s13075-016-1217-5.
• [370] Identification of key genes associated with rheumatoid arthritis with bioinformatics approach.Medicine (Baltimore). 2017 Aug;96(31):e7673. doi: 10.1097/MD.0000000000007673.
• [371] Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression.Ann Rheum Dis. 2016 Feb;75(2):430-8. doi: 10.1136/annrheumdis-2014-205635. Epub 2014 Dec 1.
• [372] Interleukin-25 Produced by Synoviocytes Has Anti-inflammatory Effects by Acting As a Receptor Antagonist for Interleukin-17A Function.Front Immunol. 2017 May 31;8:647. doi: 10.3389/fimmu.2017.00647. eCollection 2017.
• [373] Interleukin-10-producing LAG3(+) regulatory T cells are associated with disease activity and abatacept treatment in rheumatoid arthritis.Arthritis Res Ther. 2017 May 16;19(1):97. doi: 10.1186/s13075-017-1309-x.
• [374] Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders.Eur J Med Chem. 2017 Dec 1;141:657-675. doi: 10.1016/j.ejmech.2017.10.003. Epub 2017 Oct 4.
• [375] Exosomal amyloid A and lymphatic vessel endothelial hyaluronic acid receptor-1 proteins are associated with disease activity in rheumatoid arthritis.Arthritis Res Ther. 2017 May 31;19(1):119. doi: 10.1186/s13075-017-1334-9.
• [376] Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon- by CD4(+) T cells in patients with inflammatory arthritis.Clin Exp Immunol. 2015 Mar;179(3):378-91. doi: 10.1111/cei.12434.
• [377] Identification of pathogenic genes related to rheumatoid arthritis through integrated analysis of DNA methylation and gene expression profiling.Gene. 2017 Nov 15;634:62-67. doi: 10.1016/j.gene.2017.08.032. Epub 2017 Sep 4.
• [378] Metastasis-associated protein 1 (MTA1) signaling in rheumatoid synovium: Regulation of inflammatory response and cytokine-mediated production of prostaglandin E2 (PGE2).Biochem Biophys Res Commun. 2016 Apr 29;473(2):442-8. doi: 10.1016/j.bbrc.2016.03.027. Epub 2016 Mar 10.
• [379] Resveratrol strongly enhances the retinoic acid-induced superoxide generating activity via up-regulation of gp91-phox gene expression in U937cells.Biochem Biophys Res Commun. 2018 Jan 1;495(1):1195-1200. doi: 10.1016/j.bbrc.2017.11.161. Epub 2017 Nov 26.
• [380] Differential expression of CD148 on leukocyte subsets in inflammatory arthritis.Arthritis Res Ther. 2013;15(5):R108. doi: 10.1186/ar4288.
• [381] Impairment of chemical hypoxia-induced sphingosine kinase-1 expression and activation in rheumatoid arthritis synovial fibroblasts: A signature of exhaustion?.Biochem Pharmacol. 2019 Jul;165:249-262. doi: 10.1016/j.bcp.2019.02.009. Epub 2019 Feb 10.
• [382] ADORA2A Polymorphisms Influence Methotrexate Adverse Events in Rheumatoid Arthritis.Isr Med Assoc J. 2019 May;21(5):333-338.
• [383] Role of allograft inflammatory factor-1 in bleomycin-induced lung fibrosis.Biochem Biophys Res Commun. 2018 Jan 8;495(2):1901-1907. doi: 10.1016/j.bbrc.2017.12.035. Epub 2017 Dec 7.
• [384] Rosmarinic acid exerts an antagonistic effect on vascular calcification by regulating the Nrf2 signalling pathway.Free Radic Res. 2019 Feb;53(2):187-197. doi: 10.1080/10715762.2018.1558447. Epub 2019 Mar 13.
• [385] ATIC 347C>G gene polymorphism may be associated with methotrexate-induced adverse events in south Indian Tamil rheumatoid arthritis.Pharmacogenomics. 2016 Feb;17(3):241-8. doi: 10.2217/pgs.15.170. Epub 2016 Jan 22.
• [386] Identification of prolargin expression in articular cartilage and its significance in rheumatoid arthritis pathology.Int J Biol Macromol. 2018 Apr 15;110:558-566. doi: 10.1016/j.ijbiomac.2018.01.141. Epub 2018 Feb 1.
• [387] Distinct roles of retinoic acid and BMP4 pathways in the formation of chicken primordial germ cells and spermatogonial stem cells.Food Funct. 2019 Nov 1;10(11):7152-7163. doi: 10.1039/c9fo01485c. Epub 2019 Oct 9.
• [388] Association study of TRAF1/C5 polymorphism (rs10818488) with susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis.Gene. 2013 Mar 15;517(1):46-54. doi: 10.1016/j.gene.2012.12.092. Epub 2013 Jan 13.
• [389] C9orf72 Intermediate Alleles in Patients with Amyotrophic Lateral Sclerosis, Systemic Lupus Erythematosus, and Rheumatoid Arthritis.Neuromolecular Med. 2019 Jun;21(2):150-159. doi: 10.1007/s12017-019-08528-8. Epub 2019 Mar 11.
• [390] Exploiting CD22 To Selectively Tolerize Autoantibody Producing B-Cells in Rheumatoid Arthritis.ACS Chem Biol. 2019 Apr 19;14(4):644-654. doi: 10.1021/acschembio.8b01018. Epub 2019 Mar 20.
• [391] Differential impact of obesity on the pathogenesis of RA or preclinical models is contingent on the disease status.Ann Rheum Dis. 2017 Apr;76(4):731-739. doi: 10.1136/annrheumdis-2016-209206. Epub 2016 Oct 18.
• [392] Delayed onset of smooth muscle cell differentiation leads to hydroureter formation in mice with conditional loss of the zinc finger transcription factor gene Gata2 in the ureteric mesenchyme.J Pathol. 2019 Aug;248(4):452-463. doi: 10.1002/path.5270. Epub 2019 Apr 30.
• [393] Autoantibodies to heat shock proteins 60, 70, and 90 in patients with rheumatoid arthritis.Cell Stress Chaperones. 2019 Jan;24(1):283-287. doi: 10.1007/s12192-018-0951-9. Epub 2018 Nov 21.
• [394] Overexpression of miR-101 May Target DUSP1 to Promote the Cartilage Degradation in Rheumatoid Arthritis.J Comput Biol. 2019 Oct;26(10):1067-1079. doi: 10.1089/cmb.2019.0021. Epub 2019 Jun 26.
• [395] Are There Any Common Genetic Risk Markers for Rheumatoid Arthritis and Periodontal Diseases? A Case-Control Study.Mediators Inflamm. 2019 Feb 12;2019:2907062. doi: 10.1155/2019/2907062. eCollection 2019.
• [396] Metformin inhibits the proliferation of rheumatoid arthritis fibroblast-like synoviocytes through IGF-IR/PI3K/AKT/m-TOR pathway.Biomed Pharmacother. 2019 Jul;115:108875. doi: 10.1016/j.biopha.2019.108875. Epub 2019 Apr 24.
• [397] Association between the CTLA-4, CD226, FAS polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis.Hum Immunol. 2015 Mar;76(2-3):83-9. doi: 10.1016/j.humimm.2015.01.023. Epub 2015 Jan 30.
• [398] P54/nrb prompts rheumatoid arthritis progression mainly by transcriptionally activating NF-B signaling.Pharmazie. 2017 May 1;72(5):260-264. doi: 10.1691/ph.2017.6904.
• [399] Notch-1 siRNA and Methotrexate towards a Multifunctional Approach in Rhematoid Arthritis Management: a Nanomedicine Approach.Pharm Res. 2018 Apr 20;35(6):123. doi: 10.1007/s11095-018-2401-x.
• [400] Folyl polyglutamate synthethase (FPGS) gene polymorphisms may influence methotrexate adverse events in South Indian Tamil Rheumatoid Arthritis patients.Pharmacogenomics J. 2020 Apr;20(2):342-349. doi: 10.1038/s41397-019-0097-x. Epub 2019 Oct 14.
• [401] Selenium Nanoparticles Dispersed in Phytochemical Exert Anti-Inflammatory Activity by Modulating Catalase, GPx1, and COX-2 Gene Expression in a Rheumatoid Arthritis Rat Model.Med Sci Monit. 2019 Feb 5;25:991-1000. doi: 10.12659/MSM.912545.
• [402] CP-25 reverses prostaglandin E4 receptor desensitization-induced fibroblast-like synoviocyte dysfunction via the G protein-coupled receptor kinase 2 in autoimmune arthritis.Acta Pharmacol Sin. 2019 Aug;40(8):1029-1039. doi: 10.1038/s41401-018-0196-2. Epub 2019 Jan 14.
• [403] 11 Beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis.J Autoimmun. 2018 Aug;92:104-113. doi: 10.1016/j.jaut.2018.05.010. Epub 2018 Jun 8.
• [404] Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis.Arthritis Rheumatol. 2019 Aug;71(8):1241-1251. doi: 10.1002/art.40886. Epub 2019 Jun 21.
• [405] TXNDC5 contributes to rheumatoid arthritis by down-regulating IGFBP1 expression.Clin Exp Immunol. 2018 Apr;192(1):82-94. doi: 10.1111/cei.13080. Epub 2017 Dec 21.
• [406] Genetic variants associated with rheumatoid arthritis patients and serotypes in European populations.Clin Exp Rheumatol. 2016 Mar-Apr;34(2):236-41. Epub 2016 Mar 3.
• [407] Revealed heterogeneity in rheumatoid arthritis based on multivariate innate signature analysis.Clin Exp Rheumatol. 2020 Mar-Apr;38(2):289-298. doi: 10.55563/clinexprheumatol/qb2ha3. Epub 2019 Aug 3.
• [408] Targeting KCa1.1 Channels with a Scorpion Venom Peptide for the Therapy of Rat Models of Rheumatoid Arthritis.J Pharmacol Exp Ther. 2018 May;365(2):227-236. doi: 10.1124/jpet.117.245118. Epub 2018 Feb 16.
• [409] Cystathionine--lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis.Cell Mol Immunol. 2019 Aug;16(8):694-705. doi: 10.1038/s41423-018-0037-8. Epub 2018 May 29.
• [410] Bradykinin system is involved in endometriosis-related pain through endothelin-1 production.Eur J Pain. 2018 Mar;22(3):501-510. doi: 10.1002/ejp.1133. Epub 2017 Oct 16.
• [411] Long noncoding RNA FER1L4 regulates rheumatoid arthritis via targeting NLRC5.Clin Exp Rheumatol. 2020 Jul-Aug;38(4):713-723. Epub 2019 Oct 30.
• [412] Exenatide ameliorates inflammatory response in human rheumatoid arthritis fibroblast-like synoviocytes.IUBMB Life. 2019 Jul;71(7):969-977. doi: 10.1002/iub.2031. Epub 2019 Mar 21.
• [413] Reporters of TCR signaling identify arthritogenic T cells in murine and human autoimmune arthritis.Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18517-18527. doi: 10.1073/pnas.1904271116. Epub 2019 Aug 27.
• [414] Role of small ubiquitin-like modifier proteins-1 (SUMO-1) in regulating migration and invasion of fibroblast-like synoviocytes from patients with rheumatoid arthritis.Exp Cell Res. 2019 Feb 1;375(1):52-61. doi: 10.1016/j.yexcr.2018.12.011. Epub 2018 Dec 15.
• [415] Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy.Theranostics. 2019 Jul 9;9(18):5282-5297. doi: 10.7150/thno.32268. eCollection 2019.
• [416] Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population.Nat Genet. 2012 Mar 25;44(5):511-6. doi: 10.1038/ng.2231.
• [417] Anti -citrullinated peptide antibodies profiling in established rheumatoid arthritis.Joint Bone Spine. 2018 Jul;85(4):441-445. doi: 10.1016/j.jbspin.2017.07.009. Epub 2017 Aug 5.
• [418] uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis.Cell Mol Immunol. 2018 Feb;15(2):171-181. doi: 10.1038/cmi.2016.60. Epub 2017 Jan 16.
• [419] Activation of the Peroxisome Proliferator-Activated Receptor Coactivator 1/NFATc1 Pathway in Circulating Osteoclast Precursors Associated With Bone Destruction in Rheumatoid Arthritis.Arthritis Rheumatol. 2019 Aug;71(8):1252-1264. doi: 10.1002/art.40868. Epub 2019 Jul 3.
• [420] Discovery of 2,4-diamino-5-cyanopyrimidine derivatives as protein kinase C theta inhibitors with mitigated time-dependent drug-drug interactions.Bioorg Med Chem. 2019 Mar 1;27(5):790-799. doi: 10.1016/j.bmc.2019.01.019. Epub 2019 Jan 23.
• [421] Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells.Hum Mol Genet. 2016 Jan 15;25(2):404-17. doi: 10.1093/hmg/ddv474. Epub 2015 Nov 24.
• [422] Novel functions of inactive rhomboid proteins in immunity and disease.J Leukoc Biol. 2019 Oct;106(4):823-835. doi: 10.1002/JLB.3VMR0219-069R. Epub 2019 Aug 1.
• [423] Vascular endothelial growth factors C and D and their VEGFR-2 and 3 receptors in blood and lymphatic vessels in healthy and arthritic synovium.J Rheumatol. 2002 Jan;29(1):39-45.
• [424] What is the additional value of MRI of the foot to the hand in undifferentiated arthritis to predict rheumatoid arthritis development?.Arthritis Res Ther. 2019 Feb 14;21(1):56. doi: 10.1186/s13075-019-1845-7.
• [425] MicroRNA-421 promotes inflammatory response of fibroblast-like synoviocytes in rheumatoid arthritis by targeting SPRY1.Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8186-8193. doi: 10.26355/eurrev_201910_19125.
• [426] Sarcopenia in osteoarthritis and rheumatoid arthritis: The association with self-reported fatigue, physical function and obesity.PLoS One. 2019 Jun 6;14(6):e0217462. doi: 10.1371/journal.pone.0217462. eCollection 2019.
• [427] Methylation of H3K27 and H3K4 in key gene promoter regions of thymus in RA mice is involved in the abnormal development and differentiation of iNKT cells.Immunogenetics. 2019 Jul;71(7):489-499. doi: 10.1007/s00251-019-01124-x. Epub 2019 Jul 11.
• [428] Decreased serum thrombospondin-1 and elevation of its autoantibody are associated with multiple exacerbated clinical manifestations in systemic lupus erythematosus.Clin Rheumatol. 2018 Oct;37(10):2707-2714. doi: 10.1007/s10067-018-4188-x. Epub 2018 Jul 11.
• [429] Inhibition of Ctsk modulates periodontitis with arthritis via downregulation of TLR9 and autophagy.Cell Prolif. 2020 Jan;53(1):e12722. doi: 10.1111/cpr.12722. Epub 2019 Nov 18.
• [430] Reverse signaling initiated from GITRL induces NF-kappaB activation through ERK in the inflammatory activation of macrophages.Mol Immunol. 2008 Jan;45(2):523-33. doi: 10.1016/j.molimm.2007.05.013. Epub 2007 Jun 28.
• [431] Role of tenascin-C in articular cartilage.Mod Rheumatol. 2018 Mar;28(2):215-220. doi: 10.1080/14397595.2017.1349560. Epub 2017 Jul 19.
• [432] Expression of TREM-2 and its inhibitory effects on TNF- induced inflammation in fibroblast-like synoviocytes via inhibiting p38 pathway activation.Clin Exp Rheumatol. 2018 Mar-Apr;36(2):185-194. Epub 2017 Aug 31.
• [433] Vasoactive intestinal peptide is required in the maintenance of immune regulatory competency of immune regulatory monocytes.Clin Exp Immunol. 2019 May;196(2):276-286. doi: 10.1111/cei.13259. Epub 2019 Jan 30.
• [434] Effect of genetic polymorphisms of azathioprine-metabolizing enzymes on response to rheumatoid arthritis treatment.Pharmazie. 2017 Jan 10;72(1):22-28. doi: 10.1691/ph.2017.6799.
• [435] Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12months of tapering anti-rheumatic drugs.Arthritis Res Ther. 2019 Dec 5;21(1):268. doi: 10.1186/s13075-019-2064-y.
• [436] Pathogenic role of CXCR7 in rheumatoid arthritis.Arthritis Rheum. 2010 Nov;62(11):3211-20. doi: 10.1002/art.27650.
• [437] Comparative Profiling of Serum Protein Biomarkers in Rheumatoid Arthritis-Associated Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis.Arthritis Rheumatol. 2020 Mar;72(3):409-419. doi: 10.1002/art.41123. Epub 2020 Feb 5.
• [438] Efficacy of tocilizumab monotherapy after response to combined tocilizumab and methotrexate in patients with rheumatoid arthritis: the randomised JUST-ACT study.Clin Exp Rheumatol. 2019 May-Jun;37(3):437-444. Epub 2018 Sep 17.
• [439] Probing inhibition mechanisms of adenosine deaminase by using molecular dynamics simulations.PLoS One. 2018 Nov 16;13(11):e0207234. doi: 10.1371/journal.pone.0207234. eCollection 2018.
• [440] miR?52 inhibits rheumatoid arthritis synovial fibroblast proliferation and induces apoptosis by targeting ADAM10.Int J Mol Med. 2018 Jul;42(1):643-650. doi: 10.3892/ijmm.2018.3636. Epub 2018 Apr 20.
• [441] Neutralization of ADAM8 ameliorates liver injury and accelerates liver repair in carbon tetrachloride-induced acute liver injury.J Toxicol Sci. 2014 Apr;39(2):339-51. doi: 10.2131/jts.39.339.
• [442] Semaphorin 4D Contributes to Rheumatoid Arthritis by Inducing Inflammatory Cytokine Production: Pathogenic and Therapeutic Implications.Arthritis Rheumatol. 2015 Jun;67(6):1481-90. doi: 10.1002/art.39086.
• [443] Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis.Int J Rheum Dis. 2012 Feb;15(1):36-44. doi: 10.1111/j.1756-185X.2011.01656.x. Epub 2011 Sep 14.
• [444] Norepinephrine Inhibits Th17 Cells via 2-Adrenergic Receptor (2-AR) Signaling in a Mouse Model of Rheumatoid Arthritis.Med Sci Monit. 2018 Feb 27;24:1196-1204. doi: 10.12659/msm.906184.
• [445] Polymorphism of the beta3-adrenergic receptor and lipid profile in patients with rheumatoid arthritis and systemic lupus erythematosus treated with chloroquine.Rheumatol Int. 2003 May;23(3):99-103. doi: 10.1007/s00296-002-0266-z. Epub 2003 Mar 12.
• [446] A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis.Ann Rheum Dis. 2011 Feb;70(2):259-65. doi: 10.1136/ard.2009.126821. Epub 2010 Dec 14.
• [447] TP53 mutations coincide with the ectopic expression of activation-induced cytidine deaminase in the fibroblast-like synoviocytes derived from a fraction of patients with rheumatoid arthritis.Clin Exp Immunol. 2010 Jul 1;161(1):71-80. doi: 10.1111/j.1365-2249.2010.04163.x. Epub 2010 May 10.
• [448] Protective Effects of Prunasin A against the Differentiation of Osteoclasts and Destruction of Cartilage via the Receptor Activator of Nuclear Factor-Kappa- Ligand/Mitogen-Activated Protein Kinase/Osteoprotegerin Pathway in a Rat Model of Arthritis.Pharmacology. 2019;104(5-6):216-225. doi: 10.1159/000502537. Epub 2019 Sep 12.
• [449] The Link Between CD6 and Autoimmunity: Genetic and Cellular Associations.Curr Drug Targets. 2016;17(6):651-65. doi: 10.2174/1389450117666160201105934.
• [450] Enhancement of PLGF production by 15-(S)-HETE via PI3K-Akt, NF-B and COX-2 pathways in rheumatoid arthritis synovial fibroblast.Eur J Pharmacol. 2013 Aug 15;714(1-3):388-96. doi: 10.1016/j.ejphar.2013.07.010. Epub 2013 Jul 17.
• [451] Lipoxygenase products and expression of 5-lipoxygenase and 5-lipoxygenase-activating protein in human cultured synovial cells.Prostaglandins. 1995 Sep;50(3):127-35. doi: 10.1016/0090-6980(95)00085-2.
• [452] Relationship of angiogenic factors to disease activity and radiographic damage in rheumatoid arthritis.Clin Exp Rheumatol. 2008 Sep-Oct;26(5):881-6.
• [453] Elevated angiogenin levels in synovial fluid from patients with inflammatory arthritis and secretion of angiogenin by cultured synovial fibroblasts.Clin Exp Immunol. 2003 Apr;132(1):163-8. doi: 10.1046/j.1365-2249.2003.02117.x.
• [454] Angiopoietin-2 promotes inflammatory activation of human macrophages and is essential for murine experimental arthritis.Ann Rheum Dis. 2012 Aug;71(8):1402-10. doi: 10.1136/annrheumdis-2011-200718. Epub 2012 Jun 22.
• [455] Correlation between genetic polymorphism of angiopoietin-2 gene and clinical aspects of rheumatoid arthritis.Int J Med Sci. 2019 Jan 1;16(2):331-336. doi: 10.7150/ijms.30582. eCollection 2019.
• [456] High Concentrations of Angiopoietin-Like Protein 4 Detected in Serum from Patients with Rheumatoid Arthritis Can Be Explained by Non-Specific Antibody Reactivity.PLoS One. 2017 Jan 20;12(1):e0168922. doi: 10.1371/journal.pone.0168922. eCollection 2017.
• [457] Reciprocal regulation of pro-inflammatory Annexin A2 and anti-inflammatory Annexin A1 in the pathogenesis of rheumatoid arthritis.Mol Biol Rep. 2019 Feb;46(1):83-95. doi: 10.1007/s11033-018-4448-5. Epub 2018 Nov 13.
• [458] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis.Arthritis Res Ther. 2019 Mar 29;21(1):84. doi: 10.1186/s13075-019-1857-3.
• [459] Associations between Adipokines in Arthritic Disease and Implications for Obesity.Int J Mol Sci. 2019 Mar 26;20(6):1505. doi: 10.3390/ijms20061505.
• [460] Association of apolipoprotein B/apolipoprotein A1 ratio and cardiovascular events in rheumatoid arthritis: results of the CARMA study.Clin Exp Rheumatol. 2020 Jul-Aug;38(4):662-669. Epub 2019 Oct 30.
• [461] Therapeutic effect of acetazolamide, an aquaporin 1 inhibitor, on adjuvant-induced arthritis in rats by inhibiting NF-B signal pathway.Immunopharmacol Immunotoxicol. 2018 Apr;40(2):117-125. doi: 10.1080/08923973.2017.1417998. Epub 2018 Jan 5.
• [462] Rheumatoid arthritis complicates noninvasive whole blood gene expression testing for coronary artery disease.Am Heart J. 2017 Oct;192:13-18. doi: 10.1016/j.ahj.2017.06.013. Epub 2017 Jul 2.
• [463] Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating -arrestin 2.Exp Ther Med. 2019 May;17(5):3299-3306. doi: 10.3892/etm.2019.7371. Epub 2019 Mar 12.
• [464] Dual role of acid-sensing ion channels 3 in rheumatoid arthritis: destruction or protection?.Immunopharmacol Immunotoxicol. 2018 Aug;40(4):273-277. doi: 10.1080/08923973.2018.1485156. Epub 2018 Jul 23.
• [465] Stable expression of infliximab in CRISPR/Cas9-mediated BAK1-deficient CHO cells.Biotechnol Lett. 2018 Aug;40(8):1209-1218. doi: 10.1007/s10529-018-2578-4. Epub 2018 Jun 18.
• [466] European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).Autoimmun Rev. 2017 May;16(5):548-554. doi: 10.1016/j.autrev.2017.03.002. Epub 2017 Mar 6.
• [467] From transcriptome to proteome: differentially expressed proteins identified in synovial tissue of patients suffering from rheumatoid arthritis and osteoarthritis by an initial screen with a panel of 791 antibodies.Proteomics. 2003 Jun;3(6):991-1002. doi: 10.1002/pmic.200300412.
• [468] Increased expression of G-protein-coupled receptor kinases 3 and 4 in hyperfunctioning thyroid nodules.J Endocrinol. 2004 Jul;182(1):173-82. doi: 10.1677/joe.0.1820173.
• [469] A critical epitope in CD147 facilitates memory CD4(+) T-cell hyper-activation in rheumatoid arthritis.Cell Mol Immunol. 2019 Jun;16(6):568-579. doi: 10.1038/s41423-018-0012-4. Epub 2018 Mar 21.
• [470] Correction: The Expression of LIGHT Was Increased and the Expression of HVEM and BTLA Were Decreased in the T Cells of Patients with Rheumatoid Arthritis.PLoS One. 2017 Mar 2;12(3):e0173531. doi: 10.1371/journal.pone.0173531. eCollection 2017.
• [471] Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.Nature. 2018 Jan 3;553(7686):111-114. doi: 10.1038/nature25025.
• [472] Discovery of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Management of Rheumatoid Arthritis.J Med Chem. 2018 Jun 14;61(11):4961-4977. doi: 10.1021/acs.jmedchem.8b00420. Epub 2018 May 21.
• [473] Microarray analyses of peripheral blood cells identifies unique gene expression signature in psoriatic arthritis.Mol Med. 2005 Jan-Dec;11(1-12):21-9. doi: 10.2119/2006-00003.Gulko.
• [474] Bcl-XL and Mcl-1 upregulation by calreticulin promotes apoptosis resistance of fibroblast-like synoviocytes via activation of PI3K/Akt and STAT3 pathways in rheumatoid arthritis.Clin Exp Rheumatol. 2018 Sep-Oct;36(5):841-849. Epub 2018 Apr 13.
• [475] Neutrophil extracellular traps exert both pro- and anti-inflammatory actions in rheumatoid arthritis that are modulated by C1q and LL-37.J Autoimmun. 2019 Mar;98:122-131. doi: 10.1016/j.jaut.2019.01.003. Epub 2019 Jan 28.
• [476] Modeling caspase-1 inhibition: Implications for catalytic mechanism and drug design.Eur J Med Chem. 2019 May 1;169:159-167. doi: 10.1016/j.ejmech.2019.02.064. Epub 2019 Feb 27.
• [477] Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.Genet Epidemiol. 2019 Oct;43(7):844-863. doi: 10.1002/gepi.22242. Epub 2019 Aug 13.
• [478] Targeting CD1c-expressing classical dendritic cells to prevent thymus and activation-regulated chemokine (TARC)-mediated T-cell chemotaxis in rheumatoid arthritis.Scand J Rheumatol. 2017 Jan;46(1):11-16. doi: 10.3109/03009742.2016.1158311. Epub 2016 Jun 2.
• [479] The rheumatoid synovial environment alters fatty acid metabolism in human monocytes and enhances CCL20 secretion.Rheumatology (Oxford). 2020 Apr 1;59(4):869-878. doi: 10.1093/rheumatology/kez378.
• [480] An initial investigation into endothelial CC chemokine expression in the human rheumatoid synovium.Cytokine. 2017 Sep;97:133-140. doi: 10.1016/j.cyto.2017.05.023.
• [481] Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis.Sci Rep. 2019 Jul 18;9(1):10420. doi: 10.1038/s41598-019-46927-w.
• [482] Role of microRNA-26a in cartilage injury and chondrocyte proliferation and apoptosis in rheumatoid arthritis rats by regulating expression of CTGF.J Cell Physiol. 2020 Feb;235(2):979-992. doi: 10.1002/jcp.29013. Epub 2019 Jul 2.
• [483] Potent and selective CC chemokine receptor 1 antagonists labeled with carbon-13, carbon-14, and tritium.J Labelled Comp Radiopharm. 2018 May 15. doi: 10.1002/jlcr.3635. Online ahead of print.
• [484] Upregulated expression of CCR3 in rheumatoid arthritis and CCR3-dependent activation of fibroblast-like synoviocytes.Cell Biol Toxicol. 2017 Feb;33(1):15-26. doi: 10.1007/s10565-016-9356-7. Epub 2016 Aug 5.
• [485] Comparison of rheumatoid arthritis (RA) and osteoarthritis (OA) based on microarray profiles of human joint fibroblast-like synoviocytes.Cell Biochem Funct. 2019 Jan;37(1):31-41. doi: 10.1002/cbf.3370. Epub 2018 Nov 23.
• [486] The chemokine receptor CCR7 is a promising target for rheumatoid arthritis therapy.Cell Mol Immunol. 2019 Oct;16(10):791-799. doi: 10.1038/s41423-018-0056-5. Epub 2018 Jul 4.
• [487] Abrogation of CC chemokine receptor 9 ameliorates collagen-induced arthritis of mice.Arthritis Res Ther. 2014 Sep 24;16(5):445. doi: 10.1186/s13075-014-0445-9.
• [488] Mining functional gene modules linked with rheumatoid arthritis using a SNP-SNP network.Genomics Proteomics Bioinformatics. 2012 Feb;10(1):23-34. doi: 10.1016/S1672-0229(11)60030-2.
• [489] Psoriatic Synovitis: Singularity and Potential Clinical Implications.Front Med (Lausanne). 2019 Feb 11;6:14. doi: 10.3389/fmed.2019.00014. eCollection 2019.
• [490] Resistin Gene Expression is Downregulated in CD4(+) THelper Lymphocytes and CD14(+) Monocytes in Rheumatoid Arthritis Responding to TNF- Inhibition.Scand J Immunol. 2016 Oct;84(4):229-36. doi: 10.1111/sji.12464.
• [491] A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis.Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):43-48. Epub 2016 Jul 1.
• [492] CD248 and its cytoplasmic domain: a therapeutic target for arthritis.Arthritis Rheum. 2010 Dec;62(12):3595-606. doi: 10.1002/art.27701.
• [493] B7-H3 modulates endothelial cell angiogenesis through the VEGF cytokine.Immunol Res. 2019 Jun;67(2-3):202-211. doi: 10.1007/s12026-019-09084-w.
• [494] Potential therapeutic effects of cyanidin-3-O-glucoside on rheumatoid arthritis by relieving inhibition of CD38+ NK cells on Treg cell differentiation.Arthritis Res Ther. 2019 Oct 28;21(1):220. doi: 10.1186/s13075-019-2001-0.
• [495] Association of CD4 enhancer gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus in Taiwan.J Rheumatol. 2008 Nov;35(11):2113-8. doi: 10.3899/jrheum.070993.
• [496] Targeted delivery of hyaluronic acid-coated solid lipid nanoparticles for rheumatoid arthritis therapy.Drug Deliv. 2018 Nov;25(1):716-722. doi: 10.1080/10717544.2018.1447050.
• [497] Correlation between cellular expression of complement regulatory proteins with depletion and repopulation of B-lymphocytes in peripheral blood of patients with rheumatoid arthritis treated with rituximab.Rev Bras Reumatol Engl Ed. 2017 Sep-Oct;57(5):385-391. doi: 10.1016/j.rbre.2016.09.007. Epub 2016 Oct 18.
• [498] Promotion of osteoclastogenesis by IL-26 in rheumatoid arthritis.Arthritis Res Ther. 2019 Dec 12;21(1):283. doi: 10.1186/s13075-019-2070-0.
• [499] Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis.Arthritis Res Ther. 2019 Jan 5;21(1):3. doi: 10.1186/s13075-018-1799-1.
• [500] Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKC/ERK Signaling Pathway.Cell Physiol Biochem. 2016;40(3-4):743-756. doi: 10.1159/000453135. Epub 2016 Dec 5.
• [501] CD74 is a T cell antigen in spondyloarthritis.Clin Exp Rheumatol. 2020 Mar-Apr;38(2):195-202. doi: 10.55563/clinexprheumatol/lezc69. Epub 2019 May 22.
• [502] Current treatment options for psoriatic arthritis: spotlight on abatacept.Ther Clin Risk Manag. 2018 Jun 6;14:1053-1059. doi: 10.2147/TCRM.S148586. eCollection 2018.
• [503] Selective inhibition of the p38 MAPK-MK2 axis inhibits inflammatory cues including inflammasome priming signals.J Exp Med. 2018 May 7;215(5):1315-1325. doi: 10.1084/jem.20172063. Epub 2018 Mar 16.
• [504] Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis.Cytokine. 2015 May;73(1):36-43. doi: 10.1016/j.cyto.2015.01.019. Epub 2015 Feb 16.
• [505] Association of Increased F4/80(high) Macrophages With Suppression of Serum-Transfer Arthritis in Mice With Reduced FLIP in Myeloid Cells.Arthritis Rheumatol. 2017 Sep;69(9):1762-1771. doi: 10.1002/art.40151. Epub 2017 Aug 1.
• [506] Expression of the non-neuronal cholinergic system in human knee synovial tissue from patients with rheumatoid arthritis and osteoarthritis.Life Sci. 2012 Nov 27;91(21-22):1048-52. doi: 10.1016/j.lfs.2012.04.032. Epub 2012 May 1.
• [507] MiR-23a inhibited IL-17-mediated proinflammatory mediators expression via targeting IKK in articular chondrocytes.Int Immunopharmacol. 2017 Feb;43:1-6. doi: 10.1016/j.intimp.2016.11.031. Epub 2016 Dec 6.
• [508] Role of cannabinoid receptor 2 in mediating interleukin-1-induced inflammation in rheumatoid arthritis synovial fibroblasts.Clin Exp Rheumatol. 2019 Nov-Dec;37(6):1026-1035. Epub 2019 Mar 18.
• [509] Prevalence of HTLV-I Tax in a subset of patients with rheumatoid arthritis.Clin Exp Rheumatol. 2002 Mar-Apr;20(2):161-9.
• [510] Brief report: carboxypeptidase B serves as a protective mediator in osteoarthritis.Arthritis Rheumatol. 2014 Jan;66(1):101-106. doi: 10.1002/art.38213.
• [511] Leucocyte complement receptor 1 (CR1/CD35) transcript and its correlation with the clinical disease activity in rheumatoid arthritis patients.Clin Exp Immunol. 2014 Jun;176(3):327-35. doi: 10.1111/cei.12274.
• [512] Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients.Int Immunol. 2013 Jan;25(1):25-33. doi: 10.1093/intimm/dxs090. Epub 2012 Sep 7.
• [513] Differential Effects of Inhibitor Combinations on Lysophosphatidic Acid-Mediated Chemokine Secretion in Unprimed and Tumor Necrosis Factor--Primed Synovial Fibroblasts.Front Pharmacol. 2017 Nov 21;8:848. doi: 10.3389/fphar.2017.00848. eCollection 2017.
• [514] Mapping the CRF-urocortins system in human osteoarthritic and rheumatoid synovial fibroblasts: effect of vasoactive intestinal peptide.J Cell Physiol. 2011 Dec;226(12):3261-9. doi: 10.1002/jcp.22687.
• [515] Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors.J Immunol. 2019 Oct 1;203(7):1766-1775. doi: 10.4049/jimmunol.1900386. Epub 2019 Sep 4.
• [516] Imatinib inhibits CSF1R that stimulates proliferation of rheumatoid arthritis fibroblast-like synoviocytes.Clin Exp Immunol. 2019 Feb;195(2):237-250. doi: 10.1111/cei.13220. Epub 2018 Oct 23.
• [517] The Secretome Derived From 3D-Cultured Umbilical Cord Tissue MSCs Counteracts Manifestations Typifying Rheumatoid Arthritis.Front Immunol. 2019 Feb 5;10:18. doi: 10.3389/fimmu.2019.00018. eCollection 2019.
• [518] Therapeutic Targeting of the G-CSF Receptor Reduces Neutrophil Trafficking and Joint Inflammation in Antibody-Mediated Inflammatory Arthritis.J Immunol. 2016 Dec 1;197(11):4392-4402. doi: 10.4049/jimmunol.1600121. Epub 2016 Nov 2.
• [519] Protein tyrosine phosphatase non-receptor 22 and C-Src tyrosine kinase genes are down-regulated in patients with rheumatoid arthritis.Sci Rep. 2017 Sep 5;7(1):10525. doi: 10.1038/s41598-017-10915-9.
• [520] Inhibitory effect of Triperygium wilfordii polyglucoside on dipeptidyl peptidase I in vivo and in vitro.Biomed Pharmacother. 2017 Dec;96:466-470. doi: 10.1016/j.biopha.2017.09.139. Epub 2017 Oct 12.
• [521] Targeting cathepsin L (CL) by specific ribozymes decreases CL protein synthesis and cartilage destruction in rheumatoid arthritis.Gene Ther. 2004 Jul;11(13):1040-7. doi: 10.1038/sj.gt.3302265.
• [522] Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.Arthritis Rheum. 2002 Mar;46(3):663-74. doi: 10.1002/art.10114.
• [523] Tumor Necrosis Factor dynamically regulates the mRNA stabilome in rheumatoid arthritis fibroblast-like synoviocytes.PLoS One. 2017 Jul 14;12(7):e0179762. doi: 10.1371/journal.pone.0179762. eCollection 2017.
• [524] JN-2, a C-X-C motif chemokine receptor 3 antagonist, ameliorates arthritis progression in an animal model.Eur J Pharmacol. 2018 Mar 15;823:1-10. doi: 10.1016/j.ejphar.2018.01.037. Epub 2018 Feb 4.
• [525] CXCL9 and CXCL10 gene polymorphisms in patients with rheumatoid arthritis.Rheumatol Int. 2015 Aug;35(8):1319-23. doi: 10.1007/s00296-015-3234-0. Epub 2015 Feb 22.
• [526] Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.Pharmacol Res. 2019 Apr;142:140-150. doi: 10.1016/j.phrs.2019.02.015. Epub 2019 Feb 20.
• [527] Genetic variants within immune-modulating genes influence the risk of developing rheumatoid arthritis and anti-TNF drug response: a two-stage case-control study.Pharmacogenet Genomics. 2015 Sep;25(9):432-43. doi: 10.1097/FPC.0000000000000155.
• [528] CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.Inflamm Res. 2016 Mar;65(3):193-202. doi: 10.1007/s00011-015-0905-y. Epub 2015 Nov 30.
• [529] Gene expression profiling of rheumatoid arthritis synovial cells treated with antirheumatic drugs. J Biomol Screen. 2007 Apr;12(3):328-40. doi: 10.1177/1087057107299261. Epub 2007 Mar 22.
• [530] DDR2-CYR61-MMP1 Signaling Pathway Promotes Bone Erosion in Rheumatoid Arthritis Through Regulating Migration and Invasion of Fibroblast-Like Synoviocytes.J Bone Miner Res. 2017 Feb;32(2):407-418. doi: 10.1002/jbmr.2993. Epub 2016 Nov 3.
• [531] An in silico Workflow that Yields Experimentally Comparable Inhibitors for Human Dihydroorotate Dehydrogenase.Curr Comput Aided Drug Des. 2020;16(3):340-350. doi: 10.2174/1573409915666190528114703.
• [532] DICER1: A Key Player in Rheumatoid Arthritis, at the Crossroads of Cellular Stress, Innate Immunity, and Chronic Inflammation in Aging.Front Immunol. 2018 Jul 24;9:1647. doi: 10.3389/fimmu.2018.01647. eCollection 2018.
• [533] MiR-613 inhibits proliferation and invasion and induces apoptosis of rheumatoid arthritis synovial fibroblasts by direct down-regulation of DKK1.Cell Mol Biol Lett. 2019 Apr 19;24:8. doi: 10.1186/s11658-018-0130-0. eCollection 2019.
• [534] Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.Pharmacogenomics J. 2013 Jun;13(3):235-41. doi: 10.1038/tpj.2012.8. Epub 2012 Apr 10.
• [535] Immunohistological localization of Notch receptors and their ligands Delta and Jagged in synovial tissues of rheumatoid arthritis.J Orthop Sci. 2005 Nov;10(6):589-94. doi: 10.1007/s00776-005-0943-3.
• [536] Zoledronic acid ameliorates the effects of secondary osteoporosis in rheumatoid arthritis patients.J Orthop Surg Res. 2019 Dec 10;14(1):421. doi: 10.1186/s13018-019-1492-3.
• [537] Influence of HumDN1 VNTR polymorphism on DNASE1 expression in systemic lupus erythematosus and rheumatoid arthritis.Immunol Invest. 2014;43(5):411-23. doi: 10.3109/08820139.2013.864666. Epub 2014 Feb 24.
• [538] Linguistic validation, validity and reliability of the British English versions of the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire and QuickDASH in people with rheumatoid arthritis.BMC Musculoskelet Disord. 2018 Apr 16;19(1):118. doi: 10.1186/s12891-018-2032-8.
• [539] Novel treatment of 99Tc-MDP improves clinical and radiographic results for patients with osteochondral lesions of the talus.Q J Nucl Med Mol Imaging. 2019 Jun;63(2):199-206. doi: 10.23736/S1824-4785.16.02872-7. Epub 2016 Jun 21.
• [540] A critical role of E2F transcription factor 2 in proinflammatory cytokines-dependent proliferation and invasiveness of fibroblast-like synoviocytes in rheumatoid Arthritis.Sci Rep. 2018 Feb 8;8(1):2623. doi: 10.1038/s41598-018-20782-7.
• [541] Novel role of Pin1 induction in type II collagen-mediated rheumatoid arthritis.J Immunol. 2009 Nov 15;183(10):6689-97. doi: 10.4049/jimmunol.0901431. Epub 2009 Oct 21.
• [542] HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING.Endocr Pract. 2018 Mar;24(3):273-287. doi: 10.4158/EP-2017-0066.
• [543] Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.Arthritis Rheum. 2007 Jul;56(7):2160-9. doi: 10.1002/art.22724.
• [544] Neutrophil proteases degrade autoepitopes of NET-associated proteins.Clin Exp Immunol. 2020 Jan;199(1):1-8. doi: 10.1111/cei.13392. Epub 2019 Nov 15.
• [545] Understanding the Multifaceted Role of Ectonucleotide Pyrophosphatase/Phosphodiesterase 2 (ENPP2) and its Altered Behaviour in Human Diseases.Curr Mol Med. 2015;15(10):932-43. doi: 10.2174/1566524015666150921104804.
• [546] Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for CD40 and CD39.Ann Rheum Dis. 2019 Aug;78(8):1055-1061. doi: 10.1136/annrheumdis-2018-214877. Epub 2019 Apr 29.
• [547] Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli.Bone. 2001 Mar;28(3):303-9. doi: 10.1016/s8756-3282(00)00454-3.
• [548] Transcription Factor NFAT5 Promotes Migration and Invasion of Rheumatoid Synoviocytes via Coagulation Factor III and CCL2.J Immunol. 2018 Jul 15;201(2):359-370. doi: 10.4049/jimmunol.1701097. Epub 2018 May 23.
• [549] Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis.Ann Rheum Dis. 2009 Jan;68(1):143-50. doi: 10.1136/ard.2007.082081. Epub 2008 Feb 14.
• [550] Neuronal FcRI mediates acute and chronic joint pain.J Clin Invest. 2019 Jun 18;129(9):3754-3769. doi: 10.1172/JCI128010.
• [551] Splice variants VEGF121 and VEGF165 of the angiogenic peptide vascular endothelial cell growth factor are expressed in the synovial tissue of patients with rheumatoid arthritis.J Rheumatol. 2001 Jul;28(7):1482-5.
• [552] Interleukin-35 inhibits angiogenesis through STAT1 signalling in rheumatoid synoviocytes.Clin Exp Rheumatol. 2018 Mar-Apr;36(2):223-227. Epub 2017 Aug 28.
• [553] FGF21 exerts comparable pharmacological efficacy with Adalimumab in ameliorating collagen-induced rheumatoid arthritis by regulating systematic inflammatory response.Biomed Pharmacother. 2017 May;89:751-760. doi: 10.1016/j.biopha.2017.02.059. Epub 2017 Mar 6.
• [554] Role of Zebrafish fhl1A in Satellite Cell and Skeletal Muscle Development.Curr Mol Med. 2017;17(9):627-636. doi: 10.2174/1566524018666180308113909.
• [555] IL-35 prevent bone loss through promotion of bone formation and angiogenesis in rheumatoid arthritis.Clin Exp Rheumatol. 2019 Sep-Oct;37(5):820-825. Epub 2019 Feb 11.
• [556] Citrullination of fibronectin alters integrin clustering and focal adhesion stability promoting stromal cell invasion.Matrix Biol. 2019 Sep;82:86-104. doi: 10.1016/j.matbio.2019.04.002. Epub 2019 Apr 17.
• [557] The folate receptor as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis.Drug Deliv Transl Res. 2019 Feb;9(1):366-378. doi: 10.1007/s13346-018-0589-2.
• [558] Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis.J Clin Invest. 2019 Apr 16;129(7):2669-2684. doi: 10.1172/JCI96832.
• [559] Foxc1 promotes the proliferation of fibroblast-like synoviocytes in rheumatoid arthritis via PI3K/AKT signalling pathway.Tissue Cell. 2018 Aug;53:15-22. doi: 10.1016/j.tice.2018.05.011. Epub 2018 May 22.
• [560] A novel antimicrobial peptide acting via formyl peptide receptor 2 shows therapeutic effects against rheumatoid arthritis.Sci Rep. 2018 Oct 2;8(1):14664. doi: 10.1038/s41598-018-32963-5.
• [561] Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis.Pharmacogenomics J. 2018 Sep;18(5):657-664. doi: 10.1038/s41397-018-0040-6. Epub 2018 Aug 31.
• [562] Increased expression of the proprotein convertase enzyme FURIN in rheumatoid arthritis.Scand J Rheumatol. 2019 May;48(3):173-177. doi: 10.1080/03009742.2018.1520294. Epub 2018 Nov 26.
• [563] Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis.Hum Mol Genet. 2016 Jan 1;25(1):180-90. doi: 10.1093/hmg/ddv455. Epub 2015 Nov 5.
• [564] Galectin 3 and its binding protein in rheumatoid arthritis.Arthritis Rheum. 2003 Oct;48(10):2788-95. doi: 10.1002/art.11287.
• [565] GADD45a and GADD45b Genes in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients.J Clin Med. 2019 Jun 5;8(6):801. doi: 10.3390/jcm8060801.
• [566] Diminished soluble levels of growth arrest specific protein 6 and tyrosine kinase receptor Axl in patients with rheumatoid arthritis.Int J Rheum Dis. 2017 Jan;20(1):53-59. doi: 10.1111/1756-185X.12367. Epub 2014 Apr 7.
• [567] Germinal center kinase-like kinase overexpression in T cells as a novel biomarker in rheumatoid arthritis.Arthritis Rheum. 2013 Oct;65(10):2573-82. doi: 10.1002/art.38067.
• [568] Biomarkers associated with cardiovascular disease in patients with early rheumatoid arthritis.PLoS One. 2019 Aug 5;14(8):e0220531. doi: 10.1371/journal.pone.0220531. eCollection 2019.
• [569] Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium. Scand J Rheumatol. 2008 Nov-Dec;37(6):401-9. doi: 10.1080/03009740802120010.
• [570] Possible role of -galactosidase in rheumatoid arthritis.Mod Rheumatol. 2020 Jul;30(4):671-680. doi: 10.1080/14397595.2019.1640175. Epub 2019 Jul 22.
• [571] Activation of TGR5 alleviates inflammation in rheumatoid arthritis peripheral blood mononuclear cells and in mice with collagen IIinduced arthritis.Mol Med Rep. 2019 Nov;20(5):4540-4550. doi: 10.3892/mmr.2019.10711. Epub 2019 Sep 26.
• [572] Revisit of autoimmunity to glucose-6-phosphate isomerase in experimental and rheumatoid arthritis.Mod Rheumatol. 2020 Mar;30(2):232-238. doi: 10.1080/14397595.2019.1659539. Epub 2019 Sep 9.
• [573] Evaluating IBD-specific antiglycan antibodies in serum of patients with spondyloarthritis and rheumatoid arthritis: are they really specific?.Clin Exp Rheumatol. 2019 Jan-Feb;37(1):32-36. Epub 2018 Jun 25.
• [574] Regulation of GRB2 and FLICE2 expression by TNF-alpha in rheumatoid synovium.Immunol Lett. 2003 Dec 15;90(2-3):93-6. doi: 10.1016/j.imlet.2003.07.002.
• [575] Lysosomal -glucuronidase regulates Lyme and rheumatoid arthritis severity.J Clin Invest. 2014 Jan;124(1):311-20. doi: 10.1172/JCI72339. Epub 2013 Dec 16.
• [576] RETRACTED: GZMB gene silencing confers protection against synovial tissue hyperplasia and articular cartilage tissue injury in rheumatoid arthritis through the MAPK signaling pathway.Biomed Pharmacother. 2018 Jul;103:346-354. doi: 10.1016/j.biopha.2018.04.023. Epub 2018 Apr 24.
• [577] Etanercept improved anemia and decreased hepcidin gene expression in a rat model of rheumatoid arthritis.Biomed Pharmacother. 2019 Apr;112:108740. doi: 10.1016/j.biopha.2019.108740. Epub 2019 Mar 1.
• [578] Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis.Hum Mol Genet. 2015 Oct 1;24(19):5367-77. doi: 10.1093/hmg/ddv258. Epub 2015 Jul 7.
• [579] Reduced Activity of HDAC3 and Increased Acetylation of Histones H3 in Peripheral Blood Mononuclear Cells of Patients with Rheumatoid Arthritis.J Immunol Res. 2018 Oct 3;2018:7313515. doi: 10.1155/2018/7313515. eCollection 2018.
• [580] Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity.Am J Hum Genet. 2014 Apr 3;94(4):522-32. doi: 10.1016/j.ajhg.2014.02.013. Epub 2014 Mar 20.
• [581] MMP-2 silencing reduces the osteogenic transformation of fibroblasts by inhibiting the activation of the BMP/Smad pathway in ankylosing spondylitis.Oncol Lett. 2018 Mar;15(3):3281-3286. doi: 10.3892/ol.2017.7714. Epub 2017 Dec 29.
• [582] Clinical diagnostic significance of 14-3-3 protein, high-mobility group box-1, anti-cyclic citrullinated peptide antibodies, anti-mutated citrullinated vimentin antibodies and rheumatoid factor in rheumatoid arthritis.Br J Biomed Sci. 2020 Jan;77(1):19-23. doi: 10.1080/09674845.2019.1658425. Epub 2019 Sep 16.
• [583] The rheumatoid arthritis-associated autoantigen hnRNP-A2 (RA33) is a major stimulator of autoimmunity in rats with pristane-induced arthritis.J Immunol. 2007 Dec 1;179(11):7568-76. doi: 10.4049/jimmunol.179.11.7568.
• [584] Investigation of candidate gene copy number identifies FCGR3B as a potential biomarker for rheumatoid arthritis.Clin Exp Rheumatol. 2019 Nov-Dec;37(6):923-928. Epub 2019 Mar 7.
• [585] Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis.Sci Rep. 2017 Apr 12;7:46229. doi: 10.1038/srep46229.
• [586] Histamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis.Sci Rep. 2017 Apr 26;7(1):1197. doi: 10.1038/s41598-017-01101-y.
• [587] 11-hydroxysteroid dehydrogenase enzymes modulate effects of glucocorticoids in rheumatoid arthritis synovial cells.Neuroimmunomodulation. 2015;22(1-2):40-5. doi: 10.1159/000362725. Epub 2014 Sep 12.
• [588] The functional variant (Asp299gly) of toll-like receptor 4 (TLR4) influences TLR4-mediated cytokine production in rheumatoid arthritis.J Rheumatol. 2008 Apr;35(4):558-61. Epub 2008 Mar 15.
• [589] Biodistribution and pharmacokinetic profiles of an altered peptide ligand derived from heat-shock proteins 60 in Lewis rats.Cell Stress Chaperones. 2020 Jan;25(1):133-140. doi: 10.1007/s12192-019-01054-3. Epub 2019 Dec 4.
• [590] Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis.Genes Immun. 2013 Mar;14(2):83-9. doi: 10.1038/gene.2012.56. Epub 2012 Dec 20.
• [591] Anti-rheumatoid arthritis effects in adjuvant-induced arthritis in rats and molecular docking studies of Polygonum orientale L. extracts.Immunol Lett. 2018 Sep;201:59-69. doi: 10.1016/j.imlet.2018.11.009. Epub 2018 Nov 22.
• [592] Production of the islet cell antigen ICA69 (p69) with baculovirus expression system: analysis with a solid-phase time-resolved fluorescence method of sera from patients with IDDM and rheumatoid arthritis.Autoimmunity. 1999;29(4):281-9. doi: 10.3109/08916939908994748.
• [593] ICOS Signaling Controls Induction and Maintenance of Collagen-Induced Arthritis.J Immunol. 2018 May 1;200(9):3067-3076. doi: 10.4049/jimmunol.1701305. Epub 2018 Mar 26.
• [594] Synovial Fibroblasts Selectively Suppress Th1 Cell Responses through IDO1-Mediated Tryptophan Catabolism.J Immunol. 2017 Apr 15;198(8):3109-3117. doi: 10.4049/jimmunol.1600600. Epub 2017 Mar 6.
• [595] Bone protection by inhibition of microRNA-182.Nat Commun. 2018 Oct 5;9(1):4108. doi: 10.1038/s41467-018-06446-0.
• [596] miR-143-3p regulates cell proliferation and apoptosis by targeting IGF1R and IGFBP5 and regulating the Ras/p38 MAPK signaling pathway in rheumatoid arthritis.Exp Ther Med. 2018 Apr;15(4):3781-3790. doi: 10.3892/etm.2018.5907. Epub 2018 Feb 28.
• [597] Insulin-Like Growth Factor Binding Protein 6 in Rheumatoid Arthritis: A Possible Novel Chemotactic Factor?.Front Immunol. 2017 May 18;8:554. doi: 10.3389/fimmu.2017.00554. eCollection 2017.
• [598] A mutation of cysteine 46 in IKK- promotes mPGES-1 and caveolin-1 expression to exacerbate osteoclast differentiation and osteolysis.Biochem Pharmacol. 2020 Feb;172:113762. doi: 10.1016/j.bcp.2019.113762. Epub 2019 Dec 14.
• [599] IL-29 enhances Toll-like receptor-mediated IL-6 and IL-8 production by the synovial fibroblasts from rheumatoid arthritis patients.Arthritis Res Ther. 2013 Oct 29;15(5):R170. doi: 10.1186/ar4357.
• [600] Decreased Gene Expression of Epstein-Barr Virus-Induced Gene 3 (EBI-3) may Contribute to the Pathogenesis of Rheumatoid Arthritis.Immunol Invest. 2019 May;48(4):367-377. doi: 10.1080/08820139.2018.1549066. Epub 2018 Dec 4.
• [601] Genome-wide meta-analysis reveals shared new loci in systemic seropositive rheumatic diseases.Ann Rheum Dis. 2019 Mar;78(3):311-319. doi: 10.1136/annrheumdis-2018-214127. Epub 2018 Dec 20.
• [602] Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis.Nat Rev Rheumatol. 2019 Jan;15(1):9-17. doi: 10.1038/s41584-018-0109-2.
• [603] Potential therapeutic effect of curcumin loaded hyalurosomes against inflammatory and oxidative processes involved in the pathogenesis of rheumatoid arthritis: The use of fibroblast-like synovial cells cultured in synovial fluid.Eur J Pharm Biopharm. 2019 Mar;136:84-92. doi: 10.1016/j.ejpb.2019.01.012. Epub 2019 Jan 17.
• [604] Beyond Autoantibodies: Biologic Roles of Human Autoreactive B Cells in Rheumatoid Arthritis Revealed by RNA-Sequencing.Arthritis Rheumatol. 2019 Apr;71(4):529-541. doi: 10.1002/art.40772. Epub 2019 Feb 23.
• [605] Transforming growth factor beta1 and laminin-111 cooperate in the induction of interleukin-16 expression in synovial fibroblasts from patients with rheumatoid arthritis.Ann Rheum Dis. 2010 Jan;69(1):270-5. doi: 10.1136/ard.2008.091116.
• [606] The IL-12 cytokine family in cardiovascular diseases.Cytokine. 2019 Oct;122:154188. doi: 10.1016/j.cyto.2017.10.010. Epub 2017 Oct 23.
• [607] The roles of IL-19 and IL-20 in the inflammation of degenerative lumbar spondylolisthesis.J Inflamm (Lond). 2018 Sep 18;15:19. doi: 10.1186/s12950-018-0195-6. eCollection 2018.
• [608] T-96 attenuates inflammation by inhibiting NF-B in adjuvant-induced arthritis.Front Biosci (Landmark Ed). 2020 Jan 1;25(3):498-512. doi: 10.2741/4816.
• [609] Arthritic and non-arthritic synovial fluids modulate IL10 and IL1RA gene expression in differentially activated primary human monocytes.Osteoarthritis Cartilage. 2015 Nov;23(11):1853-7. doi: 10.1016/j.joca.2015.06.003.
• [610] Berberine mitigates IL-21/IL-21R mediated autophagic influx in fibroblast-like synoviocytes and regulates Th17/Treg imbalance in rheumatoid arthritis.Apoptosis. 2019 Aug;24(7-8):644-661. doi: 10.1007/s10495-019-01548-6.
• [611] Evolving concepts of the pathogenesis of rheumatoid arthritis with focus on the early and late stages.Curr Opin Rheumatol. 2020 Jan;32(1):57-63. doi: 10.1097/BOR.0000000000000664.
• [612] Genetic variant in IL-32 is associated with the ex vivo cytokine production of anti-TNF treated PBMCs from rheumatoid arthritis patients.Sci Rep. 2018 Sep 19;8(1):14050. doi: 10.1038/s41598-018-32485-0.
• [613] Interleukin-33 serum levels in postmenopausal women with osteoporosis.Sci Rep. 2019 Mar 7;9(1):3786. doi: 10.1038/s41598-019-40212-6.
• [614] Elevated expression of interleukin-37 in patients with rheumatoid arthritis.Int J Rheum Dis. 2019 Jun;22(6):1123-1129. doi: 10.1111/1756-185X.13539. Epub 2019 Mar 6.
• [615] Increased Th17 cell frequency and poor clinical outcome in rheumatoid arthritis are associated with a genetic variant in the IL4R gene, rs1805010.Arthritis Rheumatol. 2014 May;66(5):1165-75. doi: 10.1002/art.38343.
• [616] Macrophages are the primary effector cells in IL-7-induced arthritis.Cell Mol Immunol. 2020 Jul;17(7):728-740. doi: 10.1038/s41423-019-0235-z. Epub 2019 Jun 13.
• [617] Identification of potential biomarkers for differential diagnosis between rheumatoid arthritis and osteoarthritis via integrative genomewide gene expression profiling analysis.Mol Med Rep. 2019 Jan;19(1):30-40. doi: 10.3892/mmr.2018.9677. Epub 2018 Nov 20.
• [618] MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis.Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11193-8. doi: 10.1073/pnas.1019536108. Epub 2011 Jun 20.
• [619] Confirmation of an IRAK3 polymorphism as a genetic marker predicting response to anti-TNF treatment in rheumatoid arthritis.Pharmacogenomics J. 2018 Jan;18(1):81-86. doi: 10.1038/tpj.2016.66. Epub 2016 Oct 4.
• [620] RGS1 silencing inhibits the inflammatory response and angiogenesis in rheumatoid arthritis rats through the inactivation of Toll-like receptor signaling pathway.J Cell Physiol. 2019 Nov;234(11):20432-20442. doi: 10.1002/jcp.28645. Epub 2019 Apr 22.
• [621] Inflammation in the hippocampus affects IGF1 receptor signaling and contributes to neurological sequelae in rheumatoid arthritis.Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E12063-E12072. doi: 10.1073/pnas.1810553115. Epub 2018 Dec 3.
• [622] Screening of gene signatures for rheumatoid arthritis and osteoarthritis based on bioinformatics analysis.Mol Med Rep. 2016 Aug;14(2):1587-93. doi: 10.3892/mmr.2016.5423. Epub 2016 Jun 23.
• [623] Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis.Cell Cycle. 2008 Nov 15;7(22):3607-9. doi: 10.4161/cc.7.22.6968. Epub 2008 Nov 9.
• [624] Integrin and transcriptomic profiles identify a distinctive synovial CD8+ T cell subpopulation in spondyloarthritis.Ann Rheum Dis. 2019 Nov;78(11):1566-1575. doi: 10.1136/annrheumdis-2019-215349. Epub 2019 Aug 30.
• [625] The association between the lymphocyte-monocyte ratio and disease activity in rheumatoid arthritis.Clin Rheumatol. 2017 Dec;36(12):2689-2695. doi: 10.1007/s10067-017-3815-2. Epub 2017 Sep 14.
• [626] Dendritic Cells from Rheumatoid Arthritis Patient Peripheral Blood Induce Th17 Cell Differentiation via miR-363/Integrin v/TGF- Axis.Scand J Immunol. 2017 Jun;85(6):441-449. doi: 10.1111/sji.12550.
• [627] Decreased RAGE expression in peripheral blood mononuclear cells of patients with rheumatoid arthritis.Clin Exp Rheumatol. 2009 May-Jun;27(3):483-90.
• [628] Preferential Inhibition of JAK1 Relative to JAK3 by Upadacitinib: Exposure-Response Analyses of Ex Vivo Data From 2 Phase 1 Clinical Trials and Comparison to Tofacitinib.J Clin Pharmacol. 2020 Feb;60(2):188-197. doi: 10.1002/jcph.1513. Epub 2019 Aug 25.
• [629] Safety profile of baricitinib in Japanese patients with active rheumatoid arthritis with over 1.6 years median time in treatment: An integrated analysis of Phases 2 and 3 trials.Mod Rheumatol. 2020 Jan;30(1):36-43. doi: 10.1080/14397595.2019.1583711. Epub 2019 Mar 21.
• [630] Astragalin Suppresses Inflammatory Responses and Bone Destruction in Mice With Collagen-Induced Arthritis and in Human Fibroblast-Like Synoviocytes.Front Pharmacol. 2019 Feb 12;10:94. doi: 10.3389/fphar.2019.00094. eCollection 2019.
• [631] Arsenic Trioxide in Synergy with Vitamin D Rescues the Defective VDR-PPAR- Functional Module of Autophagy in Rheumatoid Arthritis.PPAR Res. 2019 May 7;2019:6403504. doi: 10.1155/2019/6403504. eCollection 2019.
• [632] Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study.Arthritis Rheumatol. 2019 Mar;71(3):351-360. doi: 10.1002/art.40734. Epub 2019 Jan 18.
• [633] Novel rheumatoid arthritis susceptibility locus at 22q12 identified in an extended UK genome-wide association study.Arthritis Rheumatol. 2014 Jan;66(1):24-30. doi: 10.1002/art.38196.
• [634] Association of Killer Cell Immunoglobulin- Like Receptor Genes in Iranian Patients with Rheumatoid Arthritis.PLoS One. 2015 Dec 11;10(12):e0143757. doi: 10.1371/journal.pone.0143757. eCollection 2015.
• [635] Association of KIR2DL2 gene with anti-cyclic citrullinated protein antibodies for serodiagnosis in rheumatoid arthritis.Medicina (B Aires). 2019;79(3):161-166.
• [636] Association study between KIR polymorphisms and rheumatoid arthritis disease: an updated meta-analysis.BMC Med Genet. 2019 Jan 29;20(1):24. doi: 10.1186/s12881-019-0754-6.
• [637] KIR2DL2 and KIR2DS2 as genetic markers to the methotrexate response in rheumatoid arthritis patients.Immunopharmacol Immunotoxicol. 2016 Aug;38(4):303-9. doi: 10.1080/08923973.2016.1194429.
• [638] Inhibition of hexokinases holds potential as treatment strategy for rheumatoid arthritis.Arthritis Res Ther. 2019 Apr 3;21(1):87. doi: 10.1186/s13075-019-1865-3.
• [639] Potential of sulfasalazine as a therapeutic sensitizer for CD44 splice variant 9-positive urogenital cancer.Med Oncol. 2016 May;33(5):45. doi: 10.1007/s12032-016-0760-x. Epub 2016 Apr 4.
• [640] Association of NKG2D gene variants with susceptibility and severity of rheumatoid arthritis.Clin Exp Immunol. 2017 Mar;187(3):369-375. doi: 10.1111/cei.12891. Epub 2016 Dec 18.
• [641] Association of MICA-129 polymorphism and circulating soluble MICA level with rheumatoid arthritis in a south Indian Tamil population.Int J Rheum Dis. 2018 Mar;21(3):656-663. doi: 10.1111/1756-185X.13138. Epub 2017 Jul 27.
• [642] LAIR-1 shedding from human fibroblast-like synoviocytes in rheumatoid arthritis following TNF- stimulation.Clin Exp Immunol. 2018 May;192(2):193-205. doi: 10.1111/cei.13100. Epub 2018 Feb 20.
• [643] IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis.Arthritis Res Ther. 2018 Jun 7;20(1):115. doi: 10.1186/s13075-018-1582-3.
• [644] Physical Therapists' Ability to Distinguish Between Inflammatory and Noninflammatory Arthritis and to Appropriately Refer Patients to a Rheumatologist.Arthritis Care Res (Hoboken). 2020 Dec;72(12):1747-1754. doi: 10.1002/acr.24081. Epub 2020 Nov 6.
• [645] A sandwich enzyme immunoassay for the determination of neutrophil lipocalin in body fluids.Clin Chim Acta. 1995 Mar 31;235(2):137-45. doi: 10.1016/0009-8981(95)06020-7.
• [646] Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.Sci Rep. 2017 Jan 6;7:40303. doi: 10.1038/srep40303.
• [647] Role and translational implication of galectins in arthritis pathophysiology and treatment: A systematic literature review.J Cell Physiol. 2019 Feb;234(2):1588-1605. doi: 10.1002/jcp.27026. Epub 2018 Aug 24.
• [648] Measurement of Neutral and Sialylated IgG N-Glycome at Asn-297 by CE-LIF to Assess Hypogalactosylation in Rheumatoid Arthritis.Methods Mol Biol. 2019;1972:77-93. doi: 10.1007/978-1-4939-9213-3_6.
• [649] Elevated expression of ciRS-7 in peripheral blood mononuclear cells from rheumatoid arthritis patients.Diagn Pathol. 2019 Feb 2;14(1):11. doi: 10.1186/s13000-019-0783-7.
• [650] IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium.J Immunol. 1992 Aug 1;149(3):1054-62.
• [651] In-silico Studies of Isolated Phytoalkaloid Against Lipoxygenase: Study Based on Possible Correlation.Comb Chem High Throughput Screen. 2018;21(3):215-221. doi: 10.2174/1386207321666180220125406.
• [652] Serum lipoprotein(a) is not modified by interleukin-6 receptor antagonism or associated with inflammation in non-ST-elevation myocardial infarction.Int J Cardiol. 2019 Jan 1;274:348-350. doi: 10.1016/j.ijcard.2018.06.093. Epub 2018 Jun 27.
• [653] Berberine Modulates LPA Function to Inhibit the Proliferation and Inflammation of FLS-RA via p38/ERK MAPK Pathway Mediated by LPA(1).Evid Based Complement Alternat Med. 2019 Nov 3;2019:2580207. doi: 10.1155/2019/2580207. eCollection 2019.
• [654] Lysophosphatidic acid receptor 1 suppression sensitizes rheumatoid fibroblast-like synoviocytes to tumor necrosis factor-induced apoptosis.Arthritis Rheum. 2012 Aug;64(8):2460-70. doi: 10.1002/art.34443.
• [655] LRP5 gene polymorphisms and radiographic joint damage in rheumatoid arthritis patients.Osteoporos Int. 2018 Oct;29(10):2355-2368. doi: 10.1007/s00198-018-4625-3. Epub 2018 Jul 17.
• [656] Tertiary Lymphoid Structures in Rheumatoid Arthritis: NF-B-Inducing Kinase-Positive Endothelial Cells as Central Players.Am J Pathol. 2015 Jul;185(7):1935-43. doi: 10.1016/j.ajpath.2015.03.012. Epub 2015 May 9.
• [657] LTB(4) and BLT1 in inflammatory arthritis.Semin Immunol. 2017 Oct;33:52-57. doi: 10.1016/j.smim.2017.09.009.
• [658] Differential expression of leukotriene B4 receptor subtypes (BLT1 and BLT2) in human synovial tissues and synovial fluid leukocytes of patients with rheumatoid arthritis.J Rheumatol. 2003 Aug;30(8):1712-8.
• [659] LIGHT induces cell proliferation and inflammatory responses of rheumatoid arthritis synovial fibroblasts via lymphotoxin beta receptor.J Rheumatol. 2008 Jun;35(6):960-8. Epub 2008 Apr 15.
• [660] Deletion of Mucosa-Associated Lymphoid Tissue Lymphoma Translocation Protein 1 in Mouse T Cells Protects Against Development of Autoimmune Arthritis but Leads to Spontaneous Osteoporosis.Arthritis Rheumatol. 2019 Dec;71(12):2005-2015. doi: 10.1002/art.41029. Epub 2019 Nov 9.
• [661] XBP1 activation enhances MANF expression via binding to endoplasmic reticulum stress response elements within MANF promoter region in hepatitis B.Int J Biochem Cell Biol. 2018 Jun;99:140-146. doi: 10.1016/j.biocel.2018.04.007. Epub 2018 Apr 9.
• [662] Inflammatory but not mitogenic contexts prime synovial fibroblasts for compensatory signaling responses to p38 inhibition.Sci Signal. 2018 Mar 6;11(520):eaal1601. doi: 10.1126/scisignal.aal1601.
• [663] Regulation of c-Jun N-terminal kinase by MEKK-2 and mitogen-activated protein kinase kinase kinases in rheumatoid arthritis.J Immunol. 2004 Feb 1;172(3):1612-8. doi: 10.4049/jimmunol.172.3.1612.
• [664] Regulation and function of apoptosis signal-regulating kinase 1 in rheumatoid arthritis.Biochem Pharmacol. 2018 May;151:282-290. doi: 10.1016/j.bcp.2018.01.041. Epub 2018 Feb 6.
• [665] IL-17A upregulates P-glycoprotein expression in peripheral blood lymphocytes of patients with rheumatoid arthritis through TAK1.Clin Exp Rheumatol. 2020 Mar-Apr;38(2):299-305. doi: 10.55563/clinexprheumatol/b23ohc. Epub 2019 Jul 19.
• [666] Protease-activated receptor 2, rather than protease-activated receptor 1, contributes to the aggressive properties of synovial fibroblasts in rheumatoid arthritis.Arthritis Rheum. 2012 Jan;64(1):88-98. doi: 10.1002/art.33323.
• [667] Diagnostic value of the serum Midkine in patients with rheumatoid arthritis.J Investig Med. 2020 Jan;68(1):37-44. doi: 10.1136/jim-2019-001097. Epub 2019 Jul 19.
• [668] Single nucleotide polymorphism of Methyl-CpG-binding protein 2 gene associates with juvenile idiopathic arthritis.Clin Rheumatol. 2018 Feb;37(2):375-381. doi: 10.1007/s10067-017-3968-z. Epub 2017 Dec 29.
• [669] Differential Expression of Renin-Angiotensin System-related Components in Patients with Rheumatoid Arthritis and Osteoarthritis.Am J Med Sci. 2020 Jan;359(1):17-26. doi: 10.1016/j.amjms.2019.10.014. Epub 2019 Nov 5.
• [670] Myelin oligodendrocyte basic protein and prognosis in behavioral-variant frontotemporal dementia.Neurology. 2014 Aug 5;83(6):502-9. doi: 10.1212/WNL.0000000000000668. Epub 2014 Jul 3.
• [671] Autoantibodies against myelin sheath and S100 are associated with cognitive dysfunction in patients with rheumatoid arthritis.Clin Rheumatol. 2017 Sep;36(9):1959-1968. doi: 10.1007/s10067-017-3724-4. Epub 2017 Jun 27.
• [672] Activated neutrophil carbamylates albumin via the release of myeloperoxidase and reactive oxygen species regardless of NETosis.Mod Rheumatol. 2020 Mar;30(2):345-349. doi: 10.1080/14397595.2019.1583819. Epub 2019 May 2.
• [673] Studying the effects of haplotype partitioning methods on the RA-associated genomic results from the North American Rheumatoid Arthritis Consortium (NARAC) dataset.J Adv Res. 2019 Jan 18;18:113-126. doi: 10.1016/j.jare.2019.01.006. eCollection 2019 Jul.
• [674] Myostatin induces tumor necrosis factor- expression in rheumatoid arthritis synovial fibroblasts through the PI3K-Akt signaling pathway.J Cell Physiol. 2019 Jun;234(6):9793-9801. doi: 10.1002/jcp.27665. Epub 2018 Oct 30.
• [675] Nonassociation of homocysteine gene polymorphisms with treatment outcome in South Indian Tamil Rheumatoid Arthritis patients.Clin Exp Med. 2018 Feb;18(1):101-107. doi: 10.1007/s10238-017-0469-y. Epub 2017 Aug 18.
• [676] Polymorphism and protein expression of MUTYH gene for risk of rheumatoid arthritis.BMC Musculoskelet Disord. 2017 Feb 7;18(1):69. doi: 10.1186/s12891-017-1437-0.
• [677] NAMPT Is an Essential Regulator of RA-Mediated Periodontal Inflammation.J Dent Res. 2017 Jun;96(6):703-711. doi: 10.1177/0022034517690389. Epub 2017 Feb 6.
• [678] CD38 and E2F transcription factor 2 have uniquely increased expression in rheumatoid arthritis synovial tissues.Clin Exp Immunol. 2014 May;176(2):222-31. doi: 10.1111/cei.12268.
• [679] IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis.Sci Rep. 2017 Jan 30;7:41629. doi: 10.1038/srep41629.
• [680] Role of NOD1 polymorphism in susceptibility and clinical progression of rheumatoid arthritis.Rheumatology (Oxford). 2013 May;52(5):806-14. doi: 10.1093/rheumatology/kes404. Epub 2013 Jan 25.
• [681] Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients.Sci Rep. 2016 Feb 3;6:20223. doi: 10.1038/srep20223.
• [682] Exome sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2.J Hum Genet. 2013 Apr;58(4):210-5. doi: 10.1038/jhg.2013.2. Epub 2013 Jan 31.
• [683] Physiology, pharmacology, and pathophysiology of neuropeptide S receptor.Prog Mol Biol Transl Sci. 2019;161:125-148. doi: 10.1016/bs.pmbts.2018.11.001. Epub 2019 Jan 29.
• [684] Methotrexate upregulates circadian transcriptional factors PAR bZIP to induce apoptosis on rheumatoid arthritis synovial fibroblasts.Arthritis Res Ther. 2018 Mar 22;20(1):55. doi: 10.1186/s13075-018-1552-9.
• [685] Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity.Am J Pathol. 2013 Oct;183(4):1243-1257. doi: 10.1016/j.ajpath.2013.06.029. Epub 2013 Aug 6.
• [686] Association between Negatively Charged Low-Density Lipoprotein L5 and Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.J Clin Med. 2019 Feb 3;8(2):177. doi: 10.3390/jcm8020177.
• [687] Resveratrol reduces store-operated Ca(2+) entry and enhances the apoptosis of fibroblast-like synoviocytes in adjuvant arthritis rats model via targeting ORAI1-STIM1 complex.Biol Res. 2019 Aug 19;52(1):45. doi: 10.1186/s40659-019-0250-7.
• [688] Osteoclast-Associated Receptor (OSCAR) Distribution in the Synovial Tissues of Patients with Active RA and TNF- and RANKL Regulation of Expression... Inflammation. 2017 Oct;40(5):1566-1575.
• [689] Osteopontin Promotes Oncostatin M Production in Human Osteoblasts: Implication of Rheumatoid Arthritis Therapy.J Immunol. 2015 Oct 1;195(7):3355-64. doi: 10.4049/jimmunol.1403191. Epub 2015 Aug 24.
• [690] Association of OSMR gene polymorphisms with rheumatoid arthritis and systemic lupus erythematosus patients.Autoimmunity. 2014 Feb;47(1):23-6. doi: 10.3109/08916934.2013.849701. Epub 2013 Nov 12.
• [691] Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis.Hum Immunol. 2010 Aug;71(8):818-25. doi: 10.1016/j.humimm.2010.05.008. Epub 2010 May 20.
• [692] Epigenomic elements enriched in the promoters of autoimmunity susceptibility genes.Epigenetics. 2014 Feb;9(2):276-85. doi: 10.4161/epi.27021. Epub 2013 Nov 8.
• [693] Proprotein convertase subtilisin/kexin type 6 promotes invitro proliferation, migration and inflammatory cytokine secretion of synovial fibroblastlike cells from rheumatoid arthritis via nuclearB, signal transducer and activator of transcription 3 and extracellular signal regulated 1/2 pathways.Mol Med Rep. 2017 Dec;16(6):8477-8484. doi: 10.3892/mmr.2017.7595. Epub 2017 Sep 25.
• [694] Effect of IL-6 Receptor Blockade on Proprotein Convertase Subtilisin/Kexin Type-9 and Cholesterol Efflux Capacity in Rheumatoid Arthritis Patients.Horm Metab Res. 2019 Mar;51(3):200-209. doi: 10.1055/a-0833-4627. Epub 2019 Jan 29.
• [695] Ibudilast Inhibits Chemokine Expression in Rheumatoid Arthritis Synovial Fibroblasts and Exhibits Immunomodulatory Activity in Experimental Arthritis.Arthritis Rheumatol. 2019 May;71(5):703-711. doi: 10.1002/art.40787. Epub 2019 Apr 12.
• [696] Prealbumin, platelet factor 4 and S100A12 combination at baseline predicts good response to TNF alpha inhibitors in rheumatoid arthritis.Joint Bone Spine. 2019 Mar;86(2):195-201. doi: 10.1016/j.jbspin.2018.05.006. Epub 2018 Jun 6.
• [697] Inhibition of 6-phosphofructo-2-kinase suppresses fibroblast-like synoviocytes-mediated synovial inflammation and joint destruction in rheumatoid arthritis.Br J Pharmacol. 2017 May;174(9):893-908. doi: 10.1111/bph.13762. Epub 2017 Mar 27.
• [698] Placental growth factor-1 and -2 induce hyperplasia and invasiveness of primary rheumatoid synoviocytes.J Immunol. 2015 Mar 15;194(6):2513-21. doi: 10.4049/jimmunol.1402900. Epub 2015 Feb 18.
• [699] PBT-6, a Novel PI3KC2 Inhibitor in Rheumatoid Arthritis.Biomol Ther (Seoul). 2020 Mar 1;28(2):172-183. doi: 10.4062/biomolther.2019.153.
• [700] A bifunctional role for group IIA secreted phospholipase A2 in human rheumatoid fibroblast-like synoviocyte arachidonic acid metabolism.J Biol Chem. 2011 Jan 28;286(4):2492-503. doi: 10.1074/jbc.M110.123927. Epub 2010 Nov 10.
• [701] TLR4-dependent induction of vascular adhesion molecule-1 in rheumatoid arthritis synovial fibroblasts: Roles of cytosolic phospholipase A(2)alpha/cyclooxygenase-2.J Cell Physiol. 2010 May;223(2):480-91. doi: 10.1002/jcp.22059.
• [702] The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets.Curr Drug Targets. 2019;20(9):970-981. doi: 10.2174/1389450120666181204164140.
• [703] Expression of CD147 (EMMPRIN) on neutrophils in rheumatoid arthritis enhances chemotaxis, matrix metalloproteinase production and invasiveness of synoviocytes.J Cell Mol Med. 2011 Apr;15(4):850-60. doi: 10.1111/j.1582-4934.2010.01084.x.
• [704] Cartilage oligomeric matrix protein forms protein complexes with synovial lubricin via non-covalent and covalent interactions.Osteoarthritis Cartilage. 2017 Sep;25(9):1496-1504. doi: 10.1016/j.joca.2017.03.016. Epub 2017 Apr 1.
• [705] Protein kinase C- upregulates sodium channel Nav1.9 in nociceptive dorsal root ganglion neurons in an inflammatory arthritis pain model of rat.J Cell Biochem. 2020 Jan;121(1):768-778. doi: 10.1002/jcb.29322. Epub 2019 Aug 5.
• [706] Protein kinase C-theta inhibitors: a novel therapy for inflammatory disorders.Curr Pharm Des. 2012;18(30):4725-46. doi: 10.2174/138161212802651625.
• [707] PKC-zeta expression is lower in osteoblasts from arthritic patients: IL1-beta and TNF-alpha induce a similar decrease in non-arthritic human osteoblasts.J Cell Biochem. 2008 Feb 1;103(2):547-55. doi: 10.1002/jcb.21424.
• [708] PRL -1149T allele (rs1341239) is associated with decreased risk of rheumatoid arthritis in population from southern Mexico: analysis of mRNA expression and PRL serum levels.Clin Rheumatol. 2019 Aug;38(8):2089-2097. doi: 10.1007/s10067-019-04517-1. Epub 2019 Mar 25.
• [709] Activated protein C targets immune cells and rheumatoid synovial fibroblasts to prevent inflammatory arthritis in mice.Rheumatology (Oxford). 2019 Oct 1;58(10):1850-1860. doi: 10.1093/rheumatology/key429.
• [710] Investigation of anti-DFS70 antibody in patients with systemic autoimmune rheumatic diseases.Clin Rheumatol. 2019 Dec;38(12):3627-3633. doi: 10.1007/s10067-019-04730-y. Epub 2019 Aug 8.
• [711] Suppressing mPGES-1 expression by sinomenine ameliorates inflammation and arthritis.Biochem Pharmacol. 2017 Oct 15;142:133-144. doi: 10.1016/j.bcp.2017.07.010. Epub 2017 Jul 13.
• [712] Circulating levels of free 25(OH)D increase at the onset of rheumatoid arthritis.PLoS One. 2019 Sep 26;14(9):e0219109. doi: 10.1371/journal.pone.0219109. eCollection 2019.
• [713] Elevated plasma midkine and pleiotrophin levels in patients with systemic lupus erythematosus.Oncotarget. 2017 Jun 20;8(25):40181-40189. doi: 10.18632/oncotarget.13658.
• [714] Regulation of Myelination by Exosome Associated Retinoic Acid Release from NG2-Positive Cells.J Neurosci. 2019 Apr 17;39(16):3013-3027. doi: 10.1523/JNEUROSCI.2922-18.2019. Epub 2019 Feb 13.
• [715] Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with rheumatoid arthritis.Ann Rheum Dis. 2005 Mar;64(3):368-74. doi: 10.1136/ard.2004.027870. Epub 2004 Oct 14.
• [716] Protein prenylation restrains innate immunity by inhibiting Rac1 effector interactions.Nat Commun. 2019 Sep 4;10(1):3975. doi: 10.1038/s41467-019-11606-x.
• [717] Retinoic Acid Receptor-Related Receptor Alpha Ameliorates Autoimmune Arthritis via Inhibiting of Th17 Cells and Osteoclastogenesis.Front Immunol. 2019 Oct 4;10:2270. doi: 10.3389/fimmu.2019.02270. eCollection 2019.
• [718] A novel function of artesunate on inhibiting migration and invasion of fibroblast-like synoviocytes from rheumatoid arthritis patients.Arthritis Res Ther. 2019 Jun 24;21(1):153. doi: 10.1186/s13075-019-1935-6.
• [719] Differential expression and regulation of the non-integrin 37/67-kDa laminin receptor on peripheral blood leukocytes of healthy individuals and patients with rheumatoid arthritis.Sci Rep. 2019 Feb 4;9(1):1149. doi: 10.1038/s41598-018-37907-7.
• [720] The Multifaceted S100A4 Protein in Cancer and Inflammation.Methods Mol Biol. 2019;1929:339-365. doi: 10.1007/978-1-4939-9030-6_22.
• [721] Targeted proteomics reveals serum amyloid A variants and alarmins S100A8-S100A9 as key plasma biomarkers of rheumatoid arthritis.Talanta. 2019 Nov 1;204:507-517. doi: 10.1016/j.talanta.2019.06.044. Epub 2019 Jun 11.
• [722] Host-Microbiome Synergistic Control on Sphingolipid Metabolism by Mechanotransduction in Model Arthritis.Biomolecules. 2019 Apr 9;9(4):144. doi: 10.3390/biom9040144.
• [723] Nurse-like cells in rheumatoid arthritis: Formation of survival niches cooperating between the cell types.Mod Rheumatol. 2019 May;29(3):401-405. doi: 10.1080/14397595.2018.1483305. Epub 2018 Jun 29.
• [724] Wnt signaling genes of murine chromosome 15 are involved in sex-affected pathways of inflammatory arthritis.Arthritis Rheum. 2012 Apr;64(4):1057-68. doi: 10.1002/art.33414. Epub 2011 Oct 17.
• [725] A novel splice variant of human L-selectin encodes a soluble molecule that is elevated in serum of patients with rheumatic diseases.Biochem Biophys Res Commun. 2015 Jul 10;462(4):371-7. doi: 10.1016/j.bbrc.2015.05.002. Epub 2015 May 14.
• [726] Decreased Expression of Semaphorin 3A and Semaphorin 7A Levels and Its Association with Systemic Lupus Erythematosus.Immunol Invest. 2020 Feb;49(1-2):69-80. doi: 10.1080/08820139.2019.1649280. Epub 2019 Aug 15.
• [727] Epigenetics and rheumatoid arthritis: the role of SENP1 in the regulation of MMP-1 expression.J Autoimmun. 2010 Aug;35(1):15-22. doi: 10.1016/j.jaut.2009.12.010. Epub 2010 Jan 15.
• [728] Thrombin in the synovial fluid of patients with rheumatoid arthritis mediates proliferation of synovial fibroblast-like cells by induction of platelet derived growth factor.J Rheumatol. 1996 Sep;23(9):1505-11.
• [729] Chemerin and PEDF Are Metaflammation-Related Biomarkers of Disease Activity and Obesity in Rheumatoid Arthritis.Front Med (Lausanne). 2018 Aug 3;5:207. doi: 10.3389/fmed.2018.00207. eCollection 2018.
• [730] Downregulation of rheumatoid arthritis-related antigen RA-A47 (HSP47/colligin-2) in chondrocytic cell lines induces apoptosis and cell-surface expression of RA-A47 in association with CD9.J Cell Physiol. 2005 Jan;202(1):191-204. doi: 10.1002/jcp.20112.
• [731] Real benefits of ultrasound evaluation of hand and foot synovitis for better characterisation of the disease activity in rheumatoid arthritis.Eur Radiol. 2019 Nov;29(11):6345-6354. doi: 10.1007/s00330-019-06187-8. Epub 2019 Apr 26.
• [732] Myeloid sirtuin 6 deficiency accelerates experimental rheumatoid arthritis by enhancing macrophage activation and infiltration into synovium.EBioMedicine. 2018 Dec;38:228-237. doi: 10.1016/j.ebiom.2018.11.005. Epub 2018 Nov 11.
• [733] Monocarboxylate transporter 4, associated with the acidification of synovial fluid, is a novel therapeutic target for inflammatory arthritis.Arthritis Rheumatol. 2015 Nov;67(11):2888-96. doi: 10.1002/art.39270.
• [734] Validation of the fibrosis-4 (FIB-4) index in the diagnosis of liver disease of rheumatoid arthritis patients treated with methotrexate.Mod Rheumatol. 2019 Nov;29(6):936-942. doi: 10.1080/14397595.2018.1542962. Epub 2019 Mar 21.
• [735] Membrane-Spanning Protein Genetic Polymorphisms Related to Methotrexate Therapeutic Outcomes in a Chinese Rheumatoid Arthritis Population.J Clin Pharmacol. 2019 Nov;59(11):1471-1476. doi: 10.1002/jcph.1446. Epub 2019 May 17.
• [736] Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts.Sci Rep. 2017 Apr 28;7(1):1258. doi: 10.1038/s41598-017-01438-4.
• [737] Key role of organic cation transporter 2 for the nephrotoxicity effect of triptolide in rheumatoid arthritis.Int Immunopharmacol. 2019 Dec;77:105959. doi: 10.1016/j.intimp.2019.105959. Epub 2019 Oct 20.
• [738] Increased expression of alpha 1-anti-trypsin in the synovial tissues of patients with ankylosing spondylitis.Clin Exp Rheumatol. 2012 Jan-Feb;30(1):39-44. Epub 2012 Mar 6.
• [739] Expression of choline and acetylcholine transporters in synovial tissue and cartilage of patients with rheumatoid arthritis and osteoarthritis.Cell Tissue Res. 2015 Feb;359(2):465-477. doi: 10.1007/s00441-014-2036-0. Epub 2014 Nov 25.
• [740] Role of SLC7A5 in Metabolic Reprogramming of Human Monocyte/Macrophage Immune Responses.Front Immunol. 2018 Jan 25;9:53. doi: 10.3389/fimmu.2018.00053. eCollection 2018.
• [741] Enhanced suppressor of cytokine signaling 3 in arthritic cartilage dysregulates human chondrocyte function.Arthritis Rheum. 2012 Oct;64(10):3313-23. doi: 10.1002/art.34529.
• [742] miR-212-3p reduced proliferation, and promoted apoptosis of fibroblast-like synoviocytes via down-regulating SOX5 in rheumatoid arthritis.Eur Rev Med Pharmacol Sci. 2018 Jan;22(2):461-471. doi: 10.26355/eurrev_201801_14196.
• [743] Mir223 restrains autophagy and promotes CNS inflammation by targeting ATG16L1.Autophagy. 2019 Mar;15(3):478-492. doi: 10.1080/15548627.2018.1522467. Epub 2018 Sep 22.
• [744] High mobility group box protein 1-A prognostic marker for structural joint damage in 10-year follow-up of patients with juvenile idiopathic arthritis.Semin Arthritis Rheum. 2017 Feb;46(4):444-450. doi: 10.1016/j.semarthrit.2016.08.017. Epub 2016 Aug 26.
• [745] DNA methylation and not allelic variation regulates STAT6 expression in human T cells.Clin Exp Med. 2010 Sep;10(3):143-52. doi: 10.1007/s10238-009-0083-8. Epub 2009 Dec 1.
• [746] Upregulation of HRD1 promotes cell migration and invasion in colon cancer.Mol Cell Biochem. 2019 Apr;454(1-2):1-9. doi: 10.1007/s11010-018-3447-0. Epub 2018 Oct 10.
• [747] Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):1628-1634. doi: 10.1080/21691401.2019.1573177.
• [748] Regulation of neurokinin-1 receptor messenger RNA expression in synovial fibroblasts of patients with rheumatoid arthritis. Neuropeptides. 2005 Oct;39(5):467-74. doi: 10.1016/j.npep.2005.07.005. Epub 2005 Sep 9.
• [749] Effects of all-trans retinoic acid on the in vitro maturation of camel (Camelus dromedarius) cumulus-oocyte complexes.J Reprod Dev. 2019 Jun 14;65(3):215-221. doi: 10.1262/jrd.2018-073. Epub 2019 Feb 14.
• [750] Association of TAP2 gene polymorphisms in Chinese patients with rheumatoid arthritis.Clin Rheumatol. 2004 Feb;23(1):35-9. doi: 10.1007/s10067-003-0769-3. Epub 2003 Nov 18.
• [751] Genetics of rheumatoid arthritis contributes to biology and drug discovery.Nature. 2014 Feb 20;506(7488):376-81. doi: 10.1038/nature12873. Epub 2013 Dec 25.
• [752] Promotion of macrophage activation by Tie2 in the context of the inflamed synovia of rheumatoid arthritis and psoriatic arthritis patients.Rheumatology (Oxford). 2020 Feb 1;59(2):426-438. doi: 10.1093/rheumatology/kez315.
• [753] Causal graph-based analysis of genome-wide association data in rheumatoid arthritis.Biol Direct. 2011 May 18;6:25. doi: 10.1186/1745-6150-6-25.
• [754] Expression of Toll-like receptors and their signaling pathways in rheumatoid synovitis.J Rheumatol. 2011 May;38(5):810-20. doi: 10.3899/jrheum.100732. Epub 2011 Feb 15.
• [755] Evaluation of Toll-like-receptor gene family variants as prognostic biomarkers in rheumatoid arthritis.Immunol Lett. 2017 Jul;187:35-40. doi: 10.1016/j.imlet.2017.04.011. Epub 2017 May 7.
• [756] TLR3 Ligand Poly(I:C) Exerts Distinct Actions in Synovial Fibroblasts When Delivered by Extracellular Vesicles.Front Immunol. 2018 Jan 29;9:28. doi: 10.3389/fimmu.2018.00028. eCollection 2018.
• [757] MiR-3926 inhibits synovial fibroblasts proliferation and inflammatory cytokines secretion through targeting toll like receptor 5.Gene. 2019 Mar 1;687:200-206. doi: 10.1016/j.gene.2018.11.014. Epub 2018 Nov 6.
• [758] Mosaicism of XX and XXY cells accounts for high copy number of Toll like Receptor 7 and 8 genes in peripheral blood of men with Rheumatoid Arthritis.Sci Rep. 2019 Sep 9;9(1):12880. doi: 10.1038/s41598-019-49309-4.
• [759] Amelioration of collagen antibody induced arthritis in mice by an antibody directed against the fibronectin type III repeats of tenascin-C: Targeting fibronectin type III repeats of tenascin-C in rheumatoid arthritis.Int Immunopharmacol. 2018 May;58:15-23. doi: 10.1016/j.intimp.2018.02.022. Epub 2018 Mar 9.
• [760] Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes.Nat Genet. 2018 Oct;50(10):1366-1374. doi: 10.1038/s41588-018-0216-7. Epub 2018 Sep 17.
• [761] Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces rheumatoid arthritis synovial fibroblast proliferation through mitogen-activated protein kinases and phosphatidylinositol 3-kinase/Akt.J Biol Chem. 2005 Apr 22;280(16):15709-18. doi: 10.1074/jbc.M414469200. Epub 2005 Jan 31.
• [762] Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes.Cell Immunol. 2012;272(2):293-8. doi: 10.1016/j.cellimm.2011.09.004. Epub 2011 Sep 22.
• [763] B cell activating factor (BAFF) and BAFF receptors: fakes and facts.Clin Exp Immunol. 2017 Dec;190(3):291-292. doi: 10.1111/cei.13039. Epub 2017 Sep 28.
• [764] Soluble Markers of Antibody Secreting Cell Function as Predictors of Infection Risk in Rheumatoid Arthritis.J Immunol Res. 2019 Apr 28;2019:3658215. doi: 10.1155/2019/3658215. eCollection 2019.
• [765] A variant of death-receptor 3 associated with rheumatoid arthritis interferes with apoptosis-induction of T cell.J Biol Chem. 2018 Feb 9;293(6):1933-1943. doi: 10.1074/jbc.M117.798884. Epub 2017 Nov 27.
• [766] Pathophysiological functions of CD30+ CD4+ T cells in rheumatoid arthritis.Acta Med Okayama. 2003 Dec;57(6):267-77. doi: 10.18926/AMO/32814.
• [767] The Study of Natural Compounds Targeting RANKL Signaling Pathway for the Treatment of Bone Diseases.Curr Drug Targets. 2020;21(4):344-357. doi: 10.2174/1389450120666190930145144.
• [768] A prioritization analysis of disease association by data-mining of functional annotation of human genes.Genomics. 2012 Jan;99(1):1-9. doi: 10.1016/j.ygeno.2011.10.002. Epub 2011 Oct 14.
• [769] The role of BAFF and APRIL in rheumatoid arthritis.J Cell Physiol. 2019 Aug;234(10):17050-17063. doi: 10.1002/jcp.28445. Epub 2019 Apr 2.
• [770] Gene polymorphisms and serum levels of TL1A in patients with rheumatoid arthritis.J Cell Physiol. 2019 Jul;234(7):11760-11767. doi: 10.1002/jcp.27834. Epub 2018 Nov 29.
• [771] Influence of the TNFSF4 rs1234315 polymorphism in the susceptibility to systemic lupus erythematosus and rheumatoid arthritis.Hum Immunol. 2019 Apr;80(4):270-275. doi: 10.1016/j.humimm.2018.11.006. Epub 2018 Nov 20.
• [772] Altered expression of TPP1 in fibroblast-like synovial cells might be involved in the pathogenesis of rheumatoid arthritis.Rheumatol Int. 2012 Aug;32(8):2503-10. doi: 10.1007/s00296-011-1992-x. Epub 2011 Jul 16.
• [773] Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis.Clin Rheumatol. 2007 Aug;26(8):1284-92. doi: 10.1007/s10067-006-0495-8. Epub 2007 Jan 5.
• [774] Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer.Front Immunol. 2018 Jul 13;9:1595. doi: 10.3389/fimmu.2018.01595. eCollection 2018.
• [775] Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts.Autophagy. 2020 May;16(5):946-955. doi: 10.1080/15548627.2019.1664144. Epub 2019 Sep 8.
• [776] Thioredoxin 1 is associated with the proliferation and apoptosis of rheumatoid arthritis fibroblast-like synoviocytes.Clin Rheumatol. 2018 Jan;37(1):117-125. doi: 10.1007/s10067-017-3832-1. Epub 2017 Sep 15.
• [777] A Network Pharmacology Approach to Explore Mechanism of Action of Longzuan Tongbi Formula on Rheumatoid Arthritis.Evid Based Complement Alternat Med. 2019 Jan 17;2019:5191362. doi: 10.1155/2019/5191362. eCollection 2019.
• [778] Inflammation and Lymphatic Function.Front Immunol. 2019 Feb 26;10:308. doi: 10.3389/fimmu.2019.00308. eCollection 2019.
• [779] Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.Clin Cancer Res. 2017 Jun 15;23(12):2934-2941. doi: 10.1158/1078-0432.CCR-15-2440. Epub 2017 Mar 21.
• [780] Amelioration of Experimentally Induced Arthritis by Reducing Reactive Oxygen Species Production through the Intra-Articular Injection of Water-Soluble Fullerenol.Nanomaterials (Basel). 2019 Jun 23;9(6):909. doi: 10.3390/nano9060909.
• [781] Down-regulation of microRNA-142-3p inhibits the aggressive phenotypes of rheumatoid arthritis fibroblast-like synoviocytes through inhibiting nuclear factor-B signaling.Biosci Rep. 2019 Jul 8;39(7):BSR20190700. doi: 10.1042/BSR20190700. Print 2019 Jul 31.
• [782] Increased circulating Wnt5a protein in patients with rheumatoid arthritis-associated interstitial pneumonia (RA-ILD).Immunobiology. 2019 Jul;224(4):551-559. doi: 10.1016/j.imbio.2019.04.006. Epub 2019 Apr 30.
• [783] ZAP-70 Regulates Autoimmune Arthritis via Alterations in T Cell Activation and Apoptosis.Cells. 2019 May 24;8(5):504. doi: 10.3390/cells8050504.
• [784] Detecting novel micro RNAs in rheumatoid arthritis with gene-based association testing.Clin Exp Rheumatol. 2017 Jul-Aug;35(4):586-592. Epub 2017 Jan 27.
• [785] Potential role of platelets for atherosclerotic events in rheumatoid arthritis.FEBS Open Bio. 2018 Nov 6;8(12):1888-1896. doi: 10.1002/2211-5463.12531. eCollection 2018 Dec.
• [786] Comparison of fetuin-A and transforming growth factor beta 1 levels in patients with spondyloarthropathies and rheumatoid arthritis.Int J Rheum Dis. 2017 Dec;20(12):2020-2027. doi: 10.1111/1756-185X.12791. Epub 2016 Jan 22.
• [787] Th17 and IL-17 Cause Acceleration of Inflammation and Fat Loss by Inducing (2)-Glycoprotein 1 (AZGP1) in Rheumatoid Arthritis with High-Fat Diet.Am J Pathol. 2017 May;187(5):1049-1058. doi: 10.1016/j.ajpath.2016.12.023. Epub 2017 Mar 8.
• [788] Tie2 regulates endocardial sprouting and myocardial trabeculation.JCI Insight. 2019 May 21;5(13):e96002. doi: 10.1172/jci.insight.96002.
• [789] Evaluating the bromodomain protein BRD1 as a therapeutic target in rheumatoid arthritis.Sci Rep. 2018 Jul 24;8(1):11125. doi: 10.1038/s41598-018-29127-w.
• [790] CTLA-4Ig (abatacept) balances bone anabolic effects of T cells and Wnt-10b with antianabolic effects of osteoblastic sclerostin.Ann N Y Acad Sci. 2018 Mar;1415(1):21-33. doi: 10.1111/nyas.13643. Epub 2018 Mar 3.
• [791] CDK7 inhibition suppresses rheumatoid arthritis inflammation via blockage of NF-B activation and IL-1/IL-6 secretion.J Cell Mol Med. 2018 Feb;22(2):1292-1301. doi: 10.1111/jcmm.13414. Epub 2017 Oct 30.
• [792] Fibroblast-like synoviocyte migration is enhanced by IL-17-mediated overexpression of L-type amino acid transporter 1 (LAT1) via the mTOR/4E-BP1 pathway.Amino Acids. 2018 Feb;50(2):331-340. doi: 10.1007/s00726-017-2520-4. Epub 2017 Dec 2.
• [793] Expression and localization analyses of the cholinergic anti-inflammatory pathway and 7nAchR in different tissues of rats with rheumatoid arthritis.Acta Histochem. 2019 Aug;121(6):742-749. doi: 10.1016/j.acthis.2019.07.001. Epub 2019 Jul 3.
• [794] The association between insulin-like growth factor 1 (IGF-1), IGF-binding proteins (IGFBPs), and the carboxyterminal propeptide of type I procollagen (PICP) in pre- and postmenopausal women with rheumatoid arthritis.Scand J Rheumatol. 2017 May;46(3):171-179. doi: 10.1080/03009742.2016.1203020. Epub 2016 Oct 24.
• [795] Serum Cesium, Rhenium, and Rubidium in Rheumatoid Arthritis Patients.Biol Trace Elem Res. 2019 Jun;189(2):379-386. doi: 10.1007/s12011-018-1497-5. Epub 2018 Aug 31.
• [796] Assessment of hemostatic disturbances in women with established rheumatoid arthritis.Clin Rheumatol. 2019 Nov;38(11):3005-3014. doi: 10.1007/s10067-019-04629-8. Epub 2019 Jun 17.
• [797] Increased DOT1L in synovial biopsies of patients with OA and RA.Clin Rheumatol. 2018 May;37(5):1327-1332. doi: 10.1007/s10067-017-3941-x. Epub 2017 Dec 13.
• [798] Thrombin inhibits the anti-myeloperoxidase and ferroxidase functions of ceruloplasmin: relevance in rheumatoid arthritis. Free Radic Biol Med. 2015 Sep;86:279-94.
• [799] Rheumatic Disease: Protease-Activated Receptor-2 in Synovial Joint Pathobiology.Front Endocrinol (Lausanne). 2018 May 23;9:257. doi: 10.3389/fendo.2018.00257. eCollection 2018.
• [800] Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia.Sci Rep. 2018 Jun 7;8(1):8731. doi: 10.1038/s41598-018-26027-x.
• [801] BMP9 inhibits the proliferation and migration of fibroblast-like synoviocytes in rheumatoid arthritis via the PI3K/AKT signaling pathway.Int Immunopharmacol. 2019 Sep;74:105685. doi: 10.1016/j.intimp.2019.105685. Epub 2019 Jun 13.
• [802] Protective Role of the MER Tyrosine Kinase via Efferocytosis in Rheumatoid Arthritis Models.Front Immunol. 2018 Apr 13;9:742. doi: 10.3389/fimmu.2018.00742. eCollection 2018.
• [803] The protective effects of the GPR39 agonist TC-G 1008 against TNF--induced inflammation in human fibroblast-like synoviocytes (FLSs).Eur J Pharmacol. 2019 Dec 15;865:172663. doi: 10.1016/j.ejphar.2019.172663. Epub 2019 Sep 17.
• [804] mGlu1 tonically regulates levels of calcium-permeable AMPA receptors in cultured nucleus accumbens neurons through retinoic acid signaling and protein translation.Eur J Neurosci. 2019 Aug;50(3):2590-2601. doi: 10.1111/ejn.14151. Epub 2018 Oct 14.
• [805] Anti-inflammatory Effects of a Small Molecule Gastrin-Releasing Peptide Receptor Antagonist on Adjuvant-Induced Rheumatoid Arthritis in Rats.Chem Pharm Bull (Tokyo). 2018 Apr 1;66(4):410-415. doi: 10.1248/cpb.c17-00887. Epub 2018 Feb 8.
• [806] Orexin A may suppress inflammatory response in fibroblast-like synoviocytes.Biomed Pharmacother. 2018 Nov;107:763-768. doi: 10.1016/j.biopha.2018.07.159. Epub 2018 Aug 21.
• [807] Amylin in the insulin resistance of patients with rheumatoid arthritis.Clin Exp Rheumatol. 2018 May-Jun;36(3):421-427. Epub 2018 Jan 15.
• [808] Therapeutic antibody targeting of indoleamine-2,3-dioxygenase (IDO2) inhibits autoimmune arthritis.Clin Immunol. 2017 Jun;179:8-16. doi: 10.1016/j.clim.2017.01.016. Epub 2017 Feb 20.
• [809] Analysis of Helios gene expression and Foxp3 TSDR methylation in the newly diagnosed Rheumatoid Arthritis patients.Immunol Invest. 2018 Aug;47(6):632-642. doi: 10.1080/08820139.2018.1480029. Epub 2018 May 31.
• [810] Pharmacodynamic biomarkers and differential effects of TNF- and GM-CSF-targeting biologics in rheumatoid arthritis.Int J Rheum Dis. 2019 Apr;22(4):646-653. doi: 10.1111/1756-185X.13395. Epub 2018 Oct 24.
• [811] Systematic Analysis of Differential Expression Profile in Rheumatoid Arthritis Chondrocytes Using Next-Generation Sequencing and Bioinformatics Approaches.Int J Med Sci. 2018 Jul 13;15(11):1129-1142. doi: 10.7150/ijms.27056. eCollection 2018.
• [812] Synovial tissue quantitative proteomics analysis reveals paeoniflorin decreases LIFR and ASPN proteins in experimental rheumatoid arthritis.Drug Des Devel Ther. 2018 Mar 6;12:463-473. doi: 10.2147/DDDT.S153927. eCollection 2018.
• [813] PIM-1 kinase is a novel regulator of proinflammatory cytokine-mediated responses in rheumatoid arthritis fibroblast-like synoviocytes.Rheumatology (Oxford). 2019 Jan 1;58(1):154-164. doi: 10.1093/rheumatology/key261.
• [814] Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis.Inflammopharmacology. 2019 Dec;27(6):1217-1227. doi: 10.1007/s10787-019-00593-6. Epub 2019 Apr 29.
• [815] Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis--a genome-wide study combined with immunological analyses.PLoS One. 2011;6(6):e20457. doi: 10.1371/journal.pone.0020457. Epub 2011 Jun 3.
• [816] Retinoid interferon-induced mortality19 (GRIM19) inhibits proliferation and invasion in rheumatoid arthritis fibroblast-like synoviocytes.Biomed Pharmacother. 2018 Feb;98:719-725. doi: 10.1016/j.biopha.2017.12.114. Epub 2018 Jan 4.
• [817] Methotrexate Restores CD73 Expression on Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis Patients and May Contribute to Its Anti-Inflammatory Effect through Ado Production.J Clin Med. 2019 Nov 3;8(11):1859. doi: 10.3390/jcm8111859.
• [818] P2Y11 receptor antagonist NF340 ameliorates inflammation in human fibroblast-like synoviocytes: An implication in rheumatoid arthritis.IUBMB Life. 2019 Oct;71(10):1552-1560. doi: 10.1002/iub.2077. Epub 2019 Jul 13.
• [819] Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro.Pharmacol Rep. 2019 Dec;71(6):1034-1043. doi: 10.1016/j.pharep.2019.06.004. Epub 2019 Jun 6.
• [820] miR-125 regulates PI3K/Akt/mTOR signaling pathway in rheumatoid arthritis rats via PARP2.Biosci Rep. 2019 Jan 8;39(1):BSR20180890. doi: 10.1042/BSR20180890. Print 2019 Jan 31.
• [821] PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.PLoS One. 2018 Mar 22;13(3):e0193815. doi: 10.1371/journal.pone.0193815. eCollection 2018.
• [822] Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event.J Neurovirol. 2018 Jun;24(3):323-331. doi: 10.1007/s13365-018-0615-7. Epub 2018 Mar 5.
• [823] Inhibition of protein phosphatase PPM1D enhances retinoic acid-induced differentiation in human embryonic carcinoma cell line.J Biochem. 2019 Jun 1;165(6):471-477. doi: 10.1093/jb/mvy119.
• [824] Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis.J Cell Mol Med. 2017 Apr;21(4):781-790. doi: 10.1111/jcmm.13020. Epub 2016 Nov 17.
• [825] Osteogenic differentiation of fibroblast-like synovial cells in rheumatoid arthritis is induced by microRNA-218 through a ROBO/Slit pathway.Arthritis Res Ther. 2018 Aug 29;20(1):189. doi: 10.1186/s13075-018-1703-z.
• [826] An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposomeprotamine-DNA-siRNA complex with cell permeable peptides.Int J Mol Med. 2018 Nov;42(5):2393-2402. doi: 10.3892/ijmm.2018.3815. Epub 2018 Aug 8.
• [827] How kinematic disturbance in the deformed rheumatoid thumb impacts on hand function: a biomechanical and functional perspective.Disabil Rehabil. 2017 Feb;39(4):338-345. doi: 10.3109/09638288.2016.1141244. Epub 2016 Feb 17.
• [828] CD147-mediated chemotaxis of CD4(+)CD161(+) T cells may contribute to local inflammation in rheumatoid arthritis.Clin Rheumatol. 2018 Jan;37(1):59-66. doi: 10.1007/s10067-017-3800-9. Epub 2017 Sep 25.
• [829] miR-26a-5p Regulates Synovial Fibroblast Invasion in Patients with Rheumatoid Arthritis by Targeting Smad 1.Med Sci Monit. 2018 Jul 26;24:5178-5184. doi: 10.12659/MSM.907816.
• [830] High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis.Rheumatology (Oxford). 2018 Jun 1;57(6):1080-1088. doi: 10.1093/rheumatology/key057.
• [831] A TRAF6 genetic variant is associated with low bone mineral density in rheumatoid arthritis.Clin Rheumatol. 2019 Apr;38(4):1067-1074. doi: 10.1007/s10067-018-4362-1. Epub 2018 Dec 1.
• [832] Modulator role of infliximab and methotrexate through the transient receptor potential melastatin 2 (TRPM2) channel in neutrophils of patients with rheumatoid arthritis: a pilot study.Arch Med Sci. 2019 Oct;15(6):1415-1424. doi: 10.5114/aoms.2018.79485. Epub 2018 Nov 19.
• [833] Tyro3/Axl/Mertk-deficient mice develop bone marrow edema which is an early pathological marker in rheumatoid arthritis.PLoS One. 2018 Oct 18;13(10):e0205902. doi: 10.1371/journal.pone.0205902. eCollection 2018.
• [834] The 3'-UTR (CA)n microsatellite on CD40LG gene as a possible genetic marker for rheumatoid arthritis in Mexican population: impact on CD40LG mRNA expression.Clin Rheumatol. 2018 Feb;37(2):345-353. doi: 10.1007/s10067-017-3853-9. Epub 2017 Sep 30.
• [835] Central role of RIPK1-VDAC1 pathway on cardiac impairment in a non-human primate model of rheumatoid arthritis.J Mol Cell Cardiol. 2018 Dec;125:50-60. doi: 10.1016/j.yjmcc.2018.10.015. Epub 2018 Oct 17.
• [836] A genome-wide association study identifies SLC8A3 as a susceptibility locus for ACPA-positive rheumatoid arthritis.Rheumatology (Oxford). 2016 Jun;55(6):1106-11. doi: 10.1093/rheumatology/kew035. Epub 2016 Mar 15.
• [837] Influence of genetic copy number variants of the human GLUT3 glucose transporter gene SLC2A3 on protein expression, glycolysis and rheumatoid arthritis risk: A genetic replication study.Mol Genet Metab Rep. 2019 Apr 6;19:100470. doi: 10.1016/j.ymgmr.2019.100470. eCollection 2019 Jun.
• [838] Coexistent rheumatoid arthritis and gout: a case series and review of the literature.Clin Rheumatol. 2017 Dec;36(12):2835-2838. doi: 10.1007/s10067-017-3856-6. Epub 2017 Oct 12.
• [839] A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis.Atherosclerosis. 2018 Apr;271:92-101. doi: 10.1016/j.atherosclerosis.2017.11.024. Epub 2017 Nov 26.
• [840] Pharmacological and pathophysiological roles of carnitine/organic cation transporters (OCTNs: SLC22A4, SLC22A5 and Slc22a21).Biopharm Drug Dispos. 2013 Jan;34(1):29-44. doi: 10.1002/bdd.1816. Epub 2012 Oct 14.
• [841] PAR(2) expression in peripheral blood monocytes of patients with rheumatoid arthritis.Ann Rheum Dis. 2012 Jun;71(6):1049-54. doi: 10.1136/annrheumdis-2011-200703. Epub 2012 Jan 30.
• [842] BAT1 promoter polymorphism is associated with rheumatoid arthritis susceptibility.J Rheumatol. 2008 May;35(5):741-4. Epub 2008 Mar 15.
• [843] 1,4-Galactosyltransferase-I contributes to the inflammatory processes in synovial tissue of patients with rheumatoid arthritis.Inflamm Res. 2010 Dec;59(12):1009-18. doi: 10.1007/s00011-010-0217-1. Epub 2010 May 20.
• [844] CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women.Arthritis Res Ther. 2015 Mar 11;17(1):56. doi: 10.1186/s13075-015-0574-9.
• [845] Enrichment of vitamin D response elements in RA-associated loci supports a role for vitamin D in the pathogenesis of RA.Genes Immun. 2013 Jul-Aug;14(5):325-9. doi: 10.1038/gene.2013.23. Epub 2013 May 2.
• [846] CYP7B expression and activity in fibroblast-like synoviocytes from patients with rheumatoid arthritis: regulation by proinflammatory cytokines.Arthritis Rheum. 2005 Mar;52(3):770-8. doi: 10.1002/art.20950.
• [847] Association of tri-nucleotide (CAG and GGC) repeat polymorphism of androgen receptor gene in Taiwanese women with refractory or remission rheumatoid arthritis.Clin Rheumatol. 2007 Dec;26(12):2051. doi: 10.1007/s10067-007-0616-z. Epub 2007 Apr 13.
• [848] Genes associated with rheumatoid arthritis and mild inflammatory arthritis. I. Major histocompatibility complex class I, II, and III allotypes.Ann Rheum Dis. 1990 Apr;49(4):219-24. doi: 10.1136/ard.49.4.219.
• [849] HPRT- mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis.Arthritis Rheum. 1998 Oct;41(10):1772-82. doi: 10.1002/1529-0131(199810)41:10<1772::AID-ART9>3.0.CO;2-C.
• [850] Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.Rheumatology (Oxford). 2007 Jul;46(7):1092-5. doi: 10.1093/rheumatology/kem006. Epub 2007 Mar 6.
• [851] The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype.Ann Rheum Dis. 2011 Jan;70(1):117-21. doi: 10.1136/ard.2010.129171. Epub 2010 Oct 26.
• [852] Tocilizumab-induced hyperbilirubinemia in Japanese patients with rheumatoid arthritis: its association with UDP glucuronosyltransferase 1A1 gene polymorphisms.Mod Rheumatol. 2012 Aug;22(4):515-23. doi: 10.1007/s10165-011-0537-1. Epub 2011 Oct 13.
• [853] Survival of lymphocytes is not restricted by IDO-expressing fibroblast from rheumatoid arthritis patients.Immunopharmacol Immunotoxicol. 2019 Apr;41(2):214-223. doi: 10.1080/08923973.2019.1569048. Epub 2019 Feb 4.
• [854] Clinical and genetic characteristics of upper gastrointestinal disease in rheumatoid arthritis.J Rheumatol. 1987 Aug;14(4):692-9.
• [855] Increased amount of phosphorylated proinflammatory osteopontin in rheumatoid arthritis synovia is associated to decreased tartrate-resistant acid phosphatase 5B/5A ratio.PLoS One. 2017 Aug 8;12(8):e0182904. doi: 10.1371/journal.pone.0182904. eCollection 2017.
• [856] Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis.Sci Rep. 2019 Feb 22;9(1):2546. doi: 10.1038/s41598-019-38756-8.
• [857] Glutaminase 1 plays a key role in the cell growth of fibroblast-like synoviocytes in rheumatoid arthritis.Arthritis Res Ther. 2017 Apr 11;19(1):76. doi: 10.1186/s13075-017-1283-3.
• [858] Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: A long-term follow-up of predictors, surveillance, and outcome in clinical practice.Int J Rheum Dis. 2019 Jul;22(7):1226-1232. doi: 10.1111/1756-185X.13576. Epub 2019 Apr 22.
• [859] MSRA polymorphism is associated with the risk of rheumatoid arthritis in a Chinese population.Scand J Rheumatol. 2013;42(2):91-6. doi: 10.3109/03009742.2012.730626. Epub 2012 Dec 18.
• [860] Impact of interactions of cigarette smoking with NAT2 polymorphisms on rheumatoid arthritis risk in African Americans.Arthritis Rheum. 2012 Mar;64(3):655-64. doi: 10.1002/art.33408.
• [861] Red cell enzyme types in rheumatic diseases.Hum Hered. 1985;35(2):107-10. doi: 10.1159/000153525.
• [862] Differential expression of vitamin D associated genes in the aorta of coronary artery disease patients with and without rheumatoid arthritis.PLoS One. 2018 Aug 23;13(8):e0202346. doi: 10.1371/journal.pone.0202346. eCollection 2018.
• [863] Inhibition of spermidine/spermine N1-acetyltransferase activity: a new therapeutic concept in rheumatoid arthritis.Arthritis Rheumatol. 2014 Jul;66(7):1723-33. doi: 10.1002/art.38574.
• [864] Rheumatoid arthritis and schizophrenia: a negative association at a dimensional level.Schizophr Res. 2004 Jan 1;66(1):21-9. doi: 10.1016/s0920-9964(03)00017-3.
• [865] Sepiapterin Reductase Inhibition Leading to Selective Reduction of Inflammatory Joint Pain in Mice and Increased Urinary Sepiapterin Levels in Humans and Mice.Arthritis Rheumatol. 2020 Jan;72(1):57-66. doi: 10.1002/art.41060. Epub 2019 Nov 28.
• [866] Modification of Sexual Hormones in Rheumatoid Arthritis Patients by M2000 (-D-mannuronic Acid) as a Novel NSAID with Immunosuppressive Property.Endocr Metab Immune Disord Drug Targets. 2018;18(5):530-536. doi: 10.2174/1871530318666180418111354.
• [867] High frequency of mutant thiopurine S-methyltransferase genotypes in Mexican patients with systemic lupus erythematosus and rheumatoid arthritis.Clin Rheumatol. 2018 Apr;37(4):963-970. doi: 10.1007/s10067-017-3955-4. Epub 2017 Dec 20.
• [868] IL-12B Gene Polymorphisms and IL-12 p70 Serum Levels Among Patients with Rheumatoid Arthritis.Scand J Immunol. 2017 Feb;85(2):147-154. doi: 10.1111/sji.12514.
• [869] Circulating Biomarkers for Predicting Infliximab Response in Rheumatoid Arthritis: A Systematic Bioinformatics Analysis.Med Sci Monit. 2017 Apr 17;23:1849-1855. doi: 10.12659/msm.900897.
• [870] Aberrant expression of aldehyde dehydrogenase 1A (ALDH1A) subfamily genes in acute lymphoblastic leukaemia is a common feature of T-lineage tumours.Br J Haematol. 2015 Jan;168(2):246-57. doi: 10.1111/bjh.13120. Epub 2014 Sep 11.
• [871] Direct activation of chordoblasts by retinoic acid is required for segmented centra mineralization during zebrafish spine development.Development. 2018 May 8;145(9):dev159418. doi: 10.1242/dev.159418.
• [872] Metabolomic profiles of induced pluripotent stem cells derived from patients with rheumatoid arthritis and osteoarthritis.Stem Cell Res Ther. 2019 Nov 15;10(1):319. doi: 10.1186/s13287-019-1408-5.
• [873] Smoothened Regulates Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis via Activation of Rho GTPase Signaling.Front Immunol. 2017 Feb 15;8:159. doi: 10.3389/fimmu.2017.00159. eCollection 2017.
• [874] Superinduction of interleukin 8 mRNA in activated monocyte derived macrophages from rheumatoid arthritis patients.Ann Rheum Dis. 1999 Oct;58(10):648-52. doi: 10.1136/ard.58.10.648.
• [875] AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts.Oncotarget. 2016 Sep 27;7(39):64221-64232. doi: 10.18632/oncotarget.11890.
• [876] Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance.Arthritis Res Ther. 2010;12(3):R116. doi: 10.1186/ar3053. Epub 2010 Jun 16.
• [877] ADAMTS-7: a metalloproteinase that directly binds to and degrades cartilage oligomeric matrix protein.FASEB J. 2006 May;20(7):988-90. doi: 10.1096/fj.05-3877fje. Epub 2006 Apr 3.
• [878] Deletion of either CD55 or CD97 ameliorates arthritis in mouse models.Arthritis Rheum. 2010 Apr;62(4):1036-42. doi: 10.1002/art.27347.
• [879] The Rheumatoid Arthritis Risk Gene AIRE Is Induced by Cytokines in Fibroblast-Like Synoviocytes and Augments the Pro-inflammatory Response.Front Immunol. 2019 Jun 18;10:1384. doi: 10.3389/fimmu.2019.01384. eCollection 2019.
• [880] The transcription factor FBI-1/OCZF/LRF is expressed in osteoclasts and regulates RANKL-induced osteoclast formation in vitro and in vivo.Arthritis Rheum. 2011 Sep;63(9):2744-54. doi: 10.1002/art.30455.
• [881] Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling.Mol Oncol. 2015 Jan;9(1):17-31. doi: 10.1016/j.molonc.2014.07.010. Epub 2014 Jul 24.
• [882] Analysis of the candidate gene NRAMP1 in the first 61 ARC National Repository families for rheumatoid arthritis.J Rheumatol. 1997 Jan;24(1):212-4.
• [883] Activation of nuclear orphan receptor NURR1 transcription by NF-kappa B and cyclic adenosine 5'-monophosphate response element-binding protein in rheumatoid arthritis synovial tissue.J Immunol. 2002 Mar 15;168(6):2979-87. doi: 10.4049/jimmunol.168.6.2979.
• [884] Phenome-Wide Association Study to Explore Relationships between Immune System Related Genetic Loci and Complex Traits and Diseases.PLoS One. 2016 Aug 10;11(8):e0160573. doi: 10.1371/journal.pone.0160573. eCollection 2016.
• [885] Gene expression of MASH-1, MATH-1, neuroD and NSCL-2, basic helix-loop-helix proteins, during neural differentiation in P19 embryonal carcinoma cells.Tohoku J Exp Med. 1997 Aug;182(4):327-36. doi: 10.1620/tjem.182.327.
• [886] A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III region.Genomics. 2001 Feb 1;71(3):263-70. doi: 10.1006/geno.2000.6371.
• [887] A new look at the shared epitope hypothesis.Am J Med. 1988 Dec 23;85(6A):20-2. doi: 10.1016/0002-9343(88)90375-0.
• [888] Distinctive gene expression signatures in rheumatoid arthritis synovial tissue fibroblast cells: correlates with disease activity.Genes Immun. 2007 Sep;8(6):480-91. doi: 10.1038/sj.gene.6364400. Epub 2007 Jun 14.
• [889] Role of Bcl-3 in the development of follicular helper T cells and in the pathogenesis of rheumatoid arthritis.Arthritis Rheumatol. 2015 Oct;67(10):2651-60. doi: 10.1002/art.39266.
• [890] Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.Arthritis Res Ther. 2006;8(3):R58. doi: 10.1186/ar1923. Epub 2006 Mar 15.
• [891] HLA-DPB1-COL11A2 and three additional xMHC loci are independently associated with RA in a UK cohort.Genes Immun. 2011 Apr;12(3):169-75. doi: 10.1038/gene.2010.57. Epub 2011 Feb 3.
• [892] Tacrolimus, a calcineurin inhibitor, overcomes treatment unresponsiveness mediated by P-glycoprotein on lymphocytes in refractory rheumatoid arthritis.J Rheumatol. 2010 Mar;37(3):512-20. doi: 10.3899/jrheum.090048. Epub 2010 Jan 15.
• [893] Detection of differentially expressed genes in synovial fibroblasts by restriction fragment differential display.Rheumatology (Oxford). 2004 Nov;43(11):1346-52. doi: 10.1093/rheumatology/keh347. Epub 2004 Aug 3.
• [894] CARD9 mediates dendritic cell-induced development of Lyn deficiency-associated autoimmune and inflammatory diseases.Sci Signal. 2019 Oct 8;12(602):eaao3829. doi: 10.1126/scisignal.aao3829.
• [895] CASPASE-12 and rheumatoid arthritis in African-Americans.Immunogenetics. 2014 Apr;66(4):281-5. doi: 10.1007/s00251-014-0762-9. Epub 2014 Feb 11.
• [896] Familial rheumatoid arthritis in patients referred to rheumatology clinics of Tabriz, Iran.Int J Rheum Dis. 2012 Feb;15(1):110-5. doi: 10.1111/j.1756-185X.2011.01664.x. Epub 2011 Sep 14.
• [897] A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility.Nat Genet. 2010 Jun;42(6):515-9. doi: 10.1038/ng.583. Epub 2010 May 9.
• [898] Eosinophilic myositis as first manifestation in a patient with type 2 myotonic dystrophy CCTG expansion mutation and rheumatoid arthritis.Neuromuscul Disord. 2015 Feb;25(2):149-52. doi: 10.1016/j.nmd.2014.09.009. Epub 2014 Sep 28.
• [899] TCR-CD3 gene polymorphisms and expression profile in rheumatoid arthritis.Autoimmunity. 2016 Nov;49(7):466-471. doi: 10.1080/08916934.2016.1174855. Epub 2016 Apr 26.
• [900] The significance of platelet activation in rheumatoid arthritis.Clin Rheumatol. 2007 May;26(5):768-71. doi: 10.1007/s10067-007-0550-0. Epub 2007 Feb 6.
• [901] CD84 cell surface signaling molecule: An emerging biomarker and target for cancer and autoimmune disorders.Clin Immunol. 2019 Jul;204:43-49. doi: 10.1016/j.clim.2018.10.017. Epub 2018 Oct 26.
• [902] Increased expression of C1q receptors on neutrophils from inflammatory joint fluids.Immunol Lett. 1993 May;36(2):195-201. doi: 10.1016/0165-2478(93)90052-4.
• [903] PSORS1C1 may be involved in rheumatoid arthritis.Immunol Lett. 2013 Jun;153(1-2):9-14. doi: 10.1016/j.imlet.2013.06.001. Epub 2013 Jun 14.
• [904] High levels of the proNGF peptides LIP1 and LIP2 in the serum and synovial fluid of rheumatoid arthritis patients: evidence for two new cytokines.J Neuroimmunol. 2008 Feb;194(1-2):143-6. doi: 10.1016/j.jneuroim.2007.11.002. Epub 2007 Dec 27.
• [905] Human secreted stabilin-1-interacting chitinase-like protein aggravates the inflammation associated with rheumatoid arthritis and is a potential macrophage inflammatory regulator in rodents.Arthritis Rheumatol. 2014 May;66(5):1141-52. doi: 10.1002/art.38356.
• [906] Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis.Clin Chim Acta. 2010 Dec 14;411(23-24):2049-53. doi: 10.1016/j.cca.2010.08.043. Epub 2010 Sep 15.
• [907] Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia.J Rheumatol. 2006 Jan;33(1):16-23.
• [908] Clinicopathological correlations of podoplanin (gp38) expression in rheumatoid synovium and its potential contribution to fibroblast platelet crosstalk.PLoS One. 2014 Jun 16;9(6):e99607. doi: 10.1371/journal.pone.0099607. eCollection 2014.
• [909] Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population.Eur J Hum Genet. 2005 Jul;13(7):823-8. doi: 10.1038/sj.ejhg.5201423.
• [910] Association of serum lipids with autoantibodies and inflammatory markers in rheumatoid arthritis patients.Clin Chim Acta. 2018 Nov;486:282-290. doi: 10.1016/j.cca.2018.08.028. Epub 2018 Aug 18.
• [911] Expression and function of microRNA-188-5p in activated rheumatoid arthritis synovial fibroblasts.Int J Clin Exp Pathol. 2015 May 1;8(5):4953-62. eCollection 2015.
• [912] FK506 augments glucocorticoid-mediated cyclooxygenase-2 down-regulation in human rheumatoid synovial fibroblasts.Lab Invest. 2000 Feb;80(2):135-41. doi: 10.1038/labinvest.3780017.
• [913] CD13/aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis.Arthritis Rheum. 2002 Sep;46(9):2330-8. doi: 10.1002/art.10517.
• [914] CRABP1 is associated with a poor prognosis in breast cancer: adding to the complexity of breast cancer cell response to retinoic acid.Mol Cancer. 2015 Jul 5;14:129. doi: 10.1186/s12943-015-0380-7.
• [915] Suppression of vascular permeability and inflammation by targeting of the transcription factor c-Jun.Nat Biotechnol. 2006 Jul;24(7):856-63. doi: 10.1038/nbt1225. Epub 2006 Jul 2.
• [916] HLA-DR versus HLA-B5-CREG antigens in rheumatoid arthritis (RA).Scand J Rheumatol. 1987;16(4):285-9. doi: 10.3109/03009748709102930.
• [917] From desk to bed: computational simulations provide indication for rheumatoid arthritis clinical trials.BMC Syst Biol. 2013 Jan 22;7:10. doi: 10.1186/1752-0509-7-10.
• [918] Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.Rheumatology (Oxford). 2012 Nov;51(11):2064-9. doi: 10.1093/rheumatology/kes190. Epub 2012 Aug 9.
• [919] Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins.Arthritis Rheum. 2005 Nov;52(11):3433-8. doi: 10.1002/art.21385.
• [920] Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA.Ann Rheum Dis. 2016 Oct;75(10):1891-8. doi: 10.1136/annrheumdis-2015-207802. Epub 2015 Dec 29.
• [921] Reduction of in vitro invasion and in vivo cartilage degradation in a SCID mouse model by loss of function of the fibrinolytic system of rheumatoid arthritis synovial fibroblasts.Arthritis Rheum. 2011 Sep;63(9):2584-94. doi: 10.1002/art.30439.
• [922] Phenotypic and genotypic analysis of mononuclear cells from patients with Felty's syndrome.Ann Rheum Dis. 1990 Feb;49(2):103-6. doi: 10.1136/ard.49.2.103.
• [923] Isolation of an IgG monoclonal anti-dnaJ antibody from an immunoglobulin combinatorial library from a patient with rheumatoid arthritis.J Rheumatol. 1999 Jul;26(7):1439-45.
• [924] Smoking induces transcription of the heat shock protein system in the joints.Ann Rheum Dis. 2014 Jul;73(7):1423-6. doi: 10.1136/annrheumdis-2013-204486. Epub 2014 Feb 18.
• [925] Simultaneous evaluation of in vivo glucocorticoid sensitivity and expression of glucocorticoid receptor alpha-isoform in rheumatoid arthritis patients.Arq Bras Endocrinol Metabol. 2009 Feb;53(1):24-30. doi: 10.1590/s0004-27302009000100005.
• [926] Downregulation of RCAS1 and upregulation of cytotoxic T cells affects synovial proliferation and apoptosis in rheumatoid arthritis.J Rheumatol. 2008 Sep;35(9):1716-22. Epub 2008 Aug 1.
• [927] Role of EFNB1 and EFNB2 in Mouse Collagen-Induced Arthritis and Human Rheumatoid Arthritis.Arthritis Rheumatol. 2015 Jul;67(7):1778-88. doi: 10.1002/art.39116.
• [928] Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus.Hum Mol Genet. 2010 Jun 1;19(11):2313-20. doi: 10.1093/hmg/ddq092. Epub 2010 Mar 1.
• [929] Identification of citrullinated eukaryotic translation initiation factor 4G1 as novel autoantigen in rheumatoid arthritis.Biochem Biophys Res Commun. 2006 Mar 3;341(1):94-100. doi: 10.1016/j.bbrc.2005.12.160. Epub 2006 Jan 6.
• [930] Synovial fluid exoglycosidases are predictors of rheumatoid arthritis and are effective in cartilage glycosaminoglycan depletion.Arthritis Rheum. 2003 Aug;48(8):2163-72. doi: 10.1002/art.11093.
• [931] Comparative Price Analysis of Biological Products for Treatment of Rheumatoid Arthritis.Front Pharmacol. 2018 Sep 20;9:1070. doi: 10.3389/fphar.2018.01070. eCollection 2018.
• [932] Association between single-nucleotide polymorphisms in the SEC8L1 gene, which encodes a subunit of the exocyst complex, and rheumatoid arthritis in a Japanese population.Arthritis Rheum. 2005 May;52(5):1371-80. doi: 10.1002/art.21013.
• [933] High-specificity bioinformatics framework for epigenomic profiling of discordant twins reveals specific and shared markers for ACPA and ACPA-positive rheumatoid arthritis.Genome Med. 2016 Nov 22;8(1):124. doi: 10.1186/s13073-016-0374-0.
• [934] Evaluation of 19 autoimmune disease-associated loci with rheumatoid arthritis in a Colombian population: evidence for replication and gene-gene interaction.J Rheumatol. 2011 Sep;38(9):1866-70. doi: 10.3899/jrheum.110199. Epub 2011 Jul 15.
• [935] Novel approach to identifying autoantibodies in rheumatoid synovitis with a biotinylated human autoantigen library and the enzyme-labeled antigen method.J Immunol Methods. 2013 Jan 31;387(1-2):57-70. doi: 10.1016/j.jim.2012.09.011. Epub 2012 Oct 5.
• [936] B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis.J Autoimmun. 2017 Jul;81:34-43. doi: 10.1016/j.jaut.2017.03.004. Epub 2017 Mar 24.
• [937] Association of forkhead box J3 (FOXJ3) polymorphisms with rheumatoid arthritis.Mol Med Rep. 2013 Oct;8(4):1235-41. doi: 10.3892/mmr.2013.1623. Epub 2013 Aug 9.
• [938] Peripheral blood gene expression profiling in rheumatoid arthritis.Genes Immun. 2005 Aug;6(5):388-97. doi: 10.1038/sj.gene.6364209.
• [939] Involvement of membrane protein GDE2 in retinoic acid-induced neurite formation in Neuro2A cells.FEBS Lett. 2007 Feb 20;581(4):712-8. doi: 10.1016/j.febslet.2007.01.035. Epub 2007 Jan 24.
• [940] Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis.Rheumatol Int. 2015 Aug;35(8):1325-33. doi: 10.1007/s00296-015-3235-z. Epub 2015 Feb 28.
• [941] Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts).Joint Bone Spine. 2014 May;81(3):228-34. doi: 10.1016/j.jbspin.2013.10.002. Epub 2013 Nov 5.
• [942] Lack of an association of GNB3 C825T polymorphism and blood pressure in patients with rheumatoid arthritis.Clin Exp Hypertens. 2009 Jul;31(5):428-39. doi: 10.1080/10641960802668748.
• [943] Induction of a CXCL8 binding site on endothelial syndecan-3 in rheumatoid synovium.Arthritis Rheum. 2005 Aug;52(8):2331-42. doi: 10.1002/art.21222.
• [944] Genetic variations in GPSM3 associated with protection from rheumatoid arthritis affect its transcript abundance.Genes Immun. 2016 Mar;17(2):139-47. doi: 10.1038/gene.2016.3. Epub 2016 Jan 28.
• [945] Modulation of synovial cell function by somatostatin in patients with rheumatoid arthritis.Arthritis Rheum. 1997 Dec;40(12):2128-38. doi: 10.1002/art.1780401206.
• [946] Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway.Peptides. 2017 Sep;95:57-61. doi: 10.1016/j.peptides.2017.07.008. Epub 2017 Jul 18.
• [947] Use of a multiethnic approach to identify rheumatoid- arthritis-susceptibility loci, 1p36 and 17q12.Am J Hum Genet. 2012 Mar 9;90(3):524-32. doi: 10.1016/j.ajhg.2012.01.010. Epub 2012 Feb 23.
• [948] Glucocorticoids inhibit induced and non-induced mRNA accumulation of genes encoding hyaluronan synthases (HAS): hydrocortisone inhibits HAS1 activation by blocking the p38 mitogen-activated protein kinase signalling pathway.Rheumatology (Oxford). 2004 Feb;43(2):164-9. doi: 10.1093/rheumatology/keh014. Epub 2003 Sep 16.
• [949] Occurrence of autoimmune diseases and relationship of autoantibody expression with HLA phenotypes in multicase rheumatoid arthritis families.Scand J Rheumatol. 1993;22(4):152-7. doi: 10.3109/03009749309099263.
• [950] Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes.Nat Commun. 2018 May 15;9(1):1921. doi: 10.1038/s41467-018-04310-9.
• [951] Genome-wide DNA methylation patterns in CD4+ T cells from Chinese Han patients with rheumatoid arthritis. Mod Rheumatol. 2017 May;27(3):441-447.
• [952] Up-regulation of HOXC6, HOXD1, and HOXD8 homeobox gene expression in human neuroblastoma cells following chemical induction of differentiation.Tumour Biol. 1996;17(1):34-47. doi: 10.1159/000217965.
• [953] Heat shock protein gene expression profile may differentiate between rheumatoid arthritis, osteoarthritis, and healthy controls.Scand J Rheumatol. 2011;40(5):354-7. doi: 10.3109/03009742.2011.552522. Epub 2011 Mar 21.
• [954] The physiologic increase in expression of some type I IFN-inducible genes during pregnancy is not associated with improved disease activity in pregnant patients with rheumatoid arthritis.Transl Res. 2013 Jun;161(6):505-12. doi: 10.1016/j.trsl.2013.02.007. Epub 2013 Mar 16.
• [955] MMP-3 expression and release by rheumatoid arthritis fibroblast-like synoviocytes induced with a bacterial ligand of integrin alpha5beta1.Arthritis Res Ther. 2005;7(1):R118-26. doi: 10.1186/ar1462. Epub 2004 Nov 24.
• [956] Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritis.Arthritis Res Ther. 2010;12(4):R129. doi: 10.1186/ar3067. Epub 2010 Jul 6.
• [957] The correlation between interleukin-34 and bone erosion under ultrasound in rheumatoid arthritis.Mod Rheumatol. 2020 Mar;30(2):269-275. doi: 10.1080/14397595.2019.1593576. Epub 2019 Apr 16.
• [958] The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes.Arthritis Res Ther. 2006;8(3):R80. doi: 10.1186/ar1946. Epub 2006 Apr 28.
• [959] Identification of a two-loci epistatic interaction associated with susceptibility to rheumatoid arthritis through reverse engineering and multifactor dimensionality reduction.Genomics. 2007 Jul;90(1):6-13. doi: 10.1016/j.ygeno.2007.03.011. Epub 2007 May 4.
• [960] IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.Front Immunol. 2019 Jan 7;9:3085. doi: 10.3389/fimmu.2018.03085. eCollection 2018.
• [961] Inducible but not endothelial nitric oxide synthase polymorphism is associated with susceptibility to rheumatoid arthritis in northwest Spain.Rheumatology (Oxford). 2004 Sep;43(9):1182-5. doi: 10.1093/rheumatology/keh283. Epub 2004 Jun 29.
• [962] Polymorphism and expression of the galactosyltransferase-associated protein kinase gene in normal individuals and galactosylation-defective rheumatoid arthritis patients.Arthritis Rheum. 1990 Nov;33(11):1655-64. doi: 10.1002/art.1780331108.
• [963] Human parvovirus B19 transgenic mice become susceptible to polyarthritis.J Immunol. 2004 Oct 1;173(7):4675-83. doi: 10.4049/jimmunol.173.7.4675.
• [964] Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.Nat Commun. 2016 Aug 23;7:12460. doi: 10.1038/ncomms12460.
• [965] Associations of killer cell immunoglobulin like receptors with rheumatoid arthritis among North Indian population.Hum Immunol. 2014 Aug;75(8):802-7. doi: 10.1016/j.humimm.2014.05.014. Epub 2014 Jun 6.
• [966] Killer cell immunoglobulin-like receptor gene's repertoire in rheumatoid arthritis.Scand J Rheumatol. 2006 Mar-Apr;35(2):124-7. doi: 10.1080/03009740500381252.
• [967] FGF23-Klotho axis in patients with rheumatoid arthritis.Clin Exp Rheumatol. 2020 Jan-Feb;38(1):50-57. Epub 2019 Apr 16.
• [968] KPNA2 Contributes to the Inflammatory Processes in Synovial Tissue of Patients with Rheumatoid Arthritis and SW982 Cells.Inflammation. 2015 Dec;38(6):2224-34. doi: 10.1007/s10753-015-0205-2.
• [969] KRN/I-Ag7 mouse arthritis is independent of complement C3.J Clin Immunol. 2011 Oct;31(5):857-63. doi: 10.1007/s10875-011-9562-2. Epub 2011 Jul 6.
• [970] Association of chondromodulin-II Val58Ile polymorphism with radiographic joint destruction in rheumatoid arthritis.J Rheumatol. 2005 Sep;32(9):1654-61.
• [971] Association of LILRA2 (ILT1, LIR7) splice site polymorphism with systemic lupus erythematosus and microscopic polyangiitis.Genes Immun. 2008 Apr;9(3):214-23. doi: 10.1038/gene.2008.5. Epub 2008 Feb 14.
• [972] Retinoic acid receptors and GATA transcription factors activate the transcription of the human lecithin:retinol acyltransferase gene.Int J Biochem Cell Biol. 2009 Mar;41(3):546-53. doi: 10.1016/j.biocel.2008.06.007. Epub 2008 Jul 4.
• [973] Leucine rich -2 glycoprotein is a potential urinary biomarker for renal tubular injury.Biochem Biophys Res Commun. 2018 Apr 15;498(4):1045-1051. doi: 10.1016/j.bbrc.2018.03.111. Epub 2018 Mar 17.
• [974] Leukocyte-specific protein 1 regulates T-cell migration in rheumatoid arthritis.Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6535-43. doi: 10.1073/pnas.1514152112. Epub 2015 Nov 9.
• [975] Identification of genes modulated in rheumatoid arthritis using complementary DNA microarray analysis of lymphoblastoid B cell lines from disease-discordant monozygotic twins.Arthritis Rheum. 2006 Jul;54(7):2047-60. doi: 10.1002/art.21953.
• [976] Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort).Arthritis Rheum. 2006 Apr;54(4):1122-31. doi: 10.1002/art.21749.
• [977] The L1 retroelement-related p40 protein induces p38delta MAP kinase.Autoimmunity. 2004 Feb;37(1):57-65. doi: 10.1080/08916930310001637977.
• [978] Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in black South Africans.Mol Med. 2014 Aug 14;20(1):341-9. doi: 10.2119/molmed.2014.00097.
• [979] CD161 receptor participates in both impairing NK cell cytotoxicity and the response to glycans and vimentin in patients with rheumatoid arthritis.Clin Immunol. 2010 Jul;136(1):139-47. doi: 10.1016/j.clim.2010.03.005. Epub 2010 Mar 31.
• [980] MICB*002 and MICB*014 protect against rheumatoid arthritis, whereas MICA*009 and MICA*A6 are associated with rheumatoid arthritis in a Hainan Han Chinese population.Int J Rheum Dis. 2019 Jan;22(1):90-95. doi: 10.1111/1756-185X.13302. Epub 2018 Apr 17.
• [981] Diet-induced obesity and reduced skin cancer susceptibility in matrix metalloproteinase 19-deficient mice.Mol Cell Biol. 2004 Jun;24(12):5304-13. doi: 10.1128/MCB.24.12.5304-5313.2004.
• [982] Expression of cAMP response element binding protein (CREB)-binding protein (CBP) and the implication in retinoic acid-inducible transcription activation in human salivary gland adenocarcinoma cell line HSG.Endocr Res. 2003 Aug;29(3):277-89. doi: 10.1081/erc-120025035.
• [983] miR?60 regulates skeletal muscle proliferation in rheumatoid arthritis by targeting Myo18b.Mol Med Rep. 2019 Dec;20(6):4843-4854. doi: 10.3892/mmr.2019.10775. Epub 2019 Oct 29.
• [984] Aggregation of rare/low-frequency variants of the mitochondria respiratory chain-related proteins in rheumatoid arthritis patients.J Hum Genet. 2015 Aug;60(8):449-54. doi: 10.1038/jhg.2015.50. Epub 2015 May 28.
• [985] Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rbeta2 inhibition.Ann Rheum Dis. 2010 Aug;69(8):1562-7. doi: 10.1136/ard.2009.111757. Epub 2010 Jun 11.
• [986] Association of the Smad3 and NFATc2 gene polymorphisms and their serum levels with susceptibility to rheumatoid arthritis in Polish cohorts.Clin Exp Immunol. 2015 Mar;179(3):444-53. doi: 10.1111/cei.12482.
• [987] TNF- modulates expression of the circadian clock gene Per2 in rheumatoid synovial cells.Scand J Rheumatol. 2013;42(4):276-80. doi: 10.3109/03009742.2013.765031. Epub 2013 Mar 16.
• [988] Identification of the NF-B activating protein-like locus as a risk locus for rheumatoid arthritis.Ann Rheum Dis. 2013 Jul;72(7):1249-54. doi: 10.1136/annrheumdis-2012-202076. Epub 2012 Dec 6.
• [989] Association of polymorphisms in SPARC and NLRP2 genes with rheumatoid arthritis in a Chinese Han population.Mod Rheumatol. 2015 Jan;25(1):67-71. doi: 10.3109/14397595.2014.903595. Epub 2014 Apr 23.
• [990] Somatic cell plasticity and Niemann-Pick type C2 protein: fibroblast activation.J Biol Chem. 2011 Jan 21;286(3):2078-87. doi: 10.1074/jbc.M110.135897. Epub 2010 Nov 17.
• [991] COUP-TFI (chicken ovalbumin upstream promoter-transcription factor I) regulates cell migration and axogenesis in differentiating P19 embryonal carcinoma cells.Mol Endocrinol. 2000 Dec;14(12):1918-33. doi: 10.1210/mend.14.12.0562.
• [992] Expression analysis of Notch-related molecules in peripheral blood T helper cells of patients with rheumatoid arthritis.Scand J Rheumatol. 2010;39(1):26-32. doi: 10.3109/03009740903124424.
• [993] Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus.Arthritis Res Ther. 2010;12(2):R59. doi: 10.1186/ar2972. Epub 2010 Apr 1.
• [994] Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor.Arthritis Rheum. 2000 Feb;43(2):250-8. doi: 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P.
• [995] Putative role of functional interferon regulatory factor 5 (IRF5) polymorphism in rheumatoid arthritis in a Korean population.J Rheumatol. 2008 Nov;35(11):2106-18. doi: 10.3899/jrheum.080114. Epub 2008 Oct 1.
• [996] Identification of candidate synovial membrane biomarkers after Achyranthes aspera treatment for rheumatoid arthritis.Biochim Biophys Acta. 2016 Mar;1864(3):308-316. doi: 10.1016/j.bbapap.2015.12.010. Epub 2015 Dec 24.
• [997] Circadian rhythms of cellular immunity in rheumatoid arthritis: a hypothesis-generating study.Clin Exp Rheumatol. 2015 Jan-Feb;33(1):34-43. Epub 2014 Dec 22.
• [998] PGK1, a glucose metabolism enzyme, may play an important role in rheumatoid arthritis.Inflamm Res. 2016 Oct;65(10):815-25. doi: 10.1007/s00011-016-0965-7. Epub 2016 Jun 24.
• [999] Vitamin A is required for regulation of polymeric immunoglobulin receptor (pIgR) expression by interleukin-4 and interferon-gamma in a human intestinal epithelial cell line.J Nutr. 1998 Jul;128(7):1063-9. doi: 10.1093/jn/128.7.1063.
• [1000] Proteins related to the functions of fibroblast-like synoviocytes identified by proteomic analysis.Clin Exp Rheumatol. 2012 Mar-Apr;30(2):213-21. Epub 2012 Apr 13.
• [1001] Induction of p21(CIP1/Waf1) and activation of p34(cdc2) involved in retinoic acid-induced apoptosis in human hepatoma Hep3B cells.Exp Cell Res. 1999 Apr 10;248(1):87-96. doi: 10.1006/excr.1999.4397.
• [1002] Evaluation of SUMO1 and POU2AF1 in whole blood from rheumatoid arthritis patients and at risk relatives.Int J Immunogenet. 2019 Apr;46(2):59-66. doi: 10.1111/iji.12414. Epub 2019 Jan 25.
• [1003] Involvement of simultaneous multiple transcription factor expression, including cAMP responsive element binding protein and OCT-1, for synovial cell outgrowth in patients with rheumatoid arthritis.Ann Rheum Dis. 1998 Aug;57(8):487-94. doi: 10.1136/ard.57.8.487.
• [1004] Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes.Rheumatology (Oxford). 2005 Oct;44(10):1255-62. doi: 10.1093/rheumatology/kei006. Epub 2005 Jul 5.
• [1005] The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis.Clin Exp Rheumatol. 2012 Nov-Dec;30(6):939-42. Epub 2012 Dec 17.
• [1006] Prothymosin alpha lacking the nuclear localization signal as an effective gene therapeutic strategy in collagen-induced arthritis.J Immunol. 2007 Apr 1;178(7):4688-94. doi: 10.4049/jimmunol.178.7.4688.
• [1007] The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources. Genet Med. 2022 Aug;24(8):1732-1742. doi: 10.1016/j.gim.2022.04.017. Epub 2022 May 4.
• [1008] CTLA-4IG suppresses reactive oxygen species by preventing synovial adherent cell-induced inactivation of Rap1, a Ras family GTPASE mediator of oxidative stress in rheumatoid arthritis T cells.Arthritis Rheum. 2006 Oct;54(10):3135-43. doi: 10.1002/art.22139.
• [1009] Transmembrane BAFF from rheumatoid synoviocytes requires interleukin-6 to induce the expression of recombination-activating gene in B lymphocytes.Arthritis Rheum. 2009 May;60(5):1261-71. doi: 10.1002/art.24498.
• [1010] Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab.Arthritis Rheumatol. 2018 Jan;70(1):60-68. doi: 10.1002/art.40324. Epub 2017 Dec 7.
• [1011] Transcriptional regulation of Rex1 (zfp42) in normal prostate epithelial cells and prostate cancer cells.J Cell Physiol. 2010 Jul;224(1):17-27. doi: 10.1002/jcp.22071.
• [1012] Influence of Extracellular RNAs, Released by Rheumatoid Arthritis Synovial Fibroblasts, on Their Adhesive and Invasive Properties.J Immunol. 2016 Oct 1;197(7):2589-97. doi: 10.4049/jimmunol.1501580. Epub 2016 Aug 22.
• [1013] Slit3 inhibits Robo3-induced invasion of synovial fibroblasts in rheumatoid arthritis.Arthritis Res Ther. 2010;12(2):R45. doi: 10.1186/ar2955. Epub 2010 Mar 18.
• [1014] Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.Clin Exp Immunol. 2013 Apr;172(1):44-53. doi: 10.1111/cei.12033.
• [1015] Functional variants in NFKBIE and RTKN2 involved in activation of the NF-B pathway are associated with rheumatoid arthritis in Japanese.PLoS Genet. 2012 Sep;8(9):e1002949. doi: 10.1371/journal.pgen.1002949. Epub 2012 Sep 13.
• [1016] SPACIA1/SAAL1 Deletion Results in a Moderate Delay in Collagen-Induced Arthritis Activity, along with mRNA Decay of Cyclin-dependent Kinase 6 Gene.Int J Mol Sci. 2018 Nov 30;19(12):3828. doi: 10.3390/ijms19123828.
• [1017] DNA polymorphism of immunoglobulin kappa confers risk of rheumatoid arthritis.Arthritis Rheum. 1989 May;32(5):634-7. doi: 10.1002/anr.1780320518.
• [1018] Evidence of epistasis between interleukin 1 and selenoprotein-S with susceptibility to rheumatoid arthritis.Ann Rheum Dis. 2009 Sep;68(9):1494-7. doi: 10.1136/ard.2008.090001. Epub 2008 Aug 26.
• [1019] Gingival crevicular fluid tissue/blood vessel-type plasminogen activator and plasminogen activator inhibitor-2 levels in patients with rheumatoid arthritis: effects of nonsurgical periodontal therapy.J Periodontal Res. 2017 Jun;52(3):574-581. doi: 10.1111/jre.12425. Epub 2016 Oct 26.
• [1020] Secreted frizzled-related protein 5 suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes through down-regulation of c-Jun N-terminal kinase.Rheumatology (Oxford). 2014 Sep;53(9):1704-11. doi: 10.1093/rheumatology/keu167. Epub 2014 Apr 24.
• [1021] Loss of SH3 domain-binding protein 2 function suppresses bone destruction in tumor necrosis factor-driven and collagen-induced arthritis in mice.Arthritis Rheumatol. 2015 Mar;67(3):656-67. doi: 10.1002/art.38975.
• [1022] Lack of association between rare mutations of the SIAE gene and rheumatoid arthritis in a Han Chinese population.Genet Mol Res. 2015 Oct 30;14(4):14162-8. doi: 10.4238/2015.October.29.38.
• [1023] Expression of soluble human signaling lymphocytic activation molecule in vivo.J Allergy Clin Immunol. 1999 Jan;103(1 Pt 1):114-8. doi: 10.1016/s0091-6749(99)70534-8.
• [1024] Polymorphism of the human immunoglobulin heavy chain locus in rheumatoid arthritis.Autoimmunity. 1997;25(2):109-16. doi: 10.3109/08916939708996277.
• [1025] A Multinational Arab Genome-Wide Association Study Identifies New Genetic Associations for Rheumatoid Arthritis.Arthritis Rheumatol. 2017 May;69(5):976-985. doi: 10.1002/art.40051. Epub 2017 Mar 31.
• [1026] SNAPIN: an endogenous Toll-like receptor ligand in rheumatoid arthritis.Ann Rheum Dis. 2012 Aug;71(8):1411-7. doi: 10.1136/annrheumdis-2011-200899. Epub 2012 Apr 20.
• [1027] Developmental considerations of sperm protein 17 gene expression in rheumatoid arthritis synoviocytes.Dev Immunol. 2002 Jun;9(2):97-102. doi: 10.1080/1044667021000095186.
• [1028] Identification of a genetic variant for joint damage progression in autoantibody-positive rheumatoid arthritis.Ann Rheum Dis. 2014 Nov;73(11):2038-46. doi: 10.1136/annrheumdis-2013-204050. Epub 2013 Aug 16.
• [1029] Serum response elements activate and cAMP responsive elements inhibit expression of transcription factor Egr-1 in synovial fibroblasts of rheumatoid arthritis patients.Int Immunol. 1999 Jan;11(1):47-61. doi: 10.1093/intimm/11.1.47.
• [1030] Association of increased frequencies of HLA-DPB1*05:01 with the presence of anti-Ro/SS-A and anti-La/SS-B antibodies in Japanese rheumatoid arthritis and systemic lupus erythematosus patients.PLoS One. 2013;8(1):e53910. doi: 10.1371/journal.pone.0053910. Epub 2013 Jan 8.
• [1031] Association of familial and sporadic rheumatoid arthritis with a single corticotropin-releasing hormone genomic region (8q12.3) haplotype.Arthritis Rheum. 2002 Jan;46(1):75-82. doi: 10.1002/1529-0131(200201)46:1<75::AID-ART10034>3.0.CO;2-3.
• [1032] Stra6, a retinoic acid-responsive gene, participates in p53-induced apoptosis after DNA damage.Cell Death Differ. 2013 Jul;20(7):910-9. doi: 10.1038/cdd.2013.14. Epub 2013 Mar 1.
• [1033] CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritis.PLoS One. 2012;7(6):e38539. doi: 10.1371/journal.pone.0038539. Epub 2012 Jun 7.
• [1034] A novel nonsense variant in SUPT20H gene associated with Rheumatoid Arthritis identified by Whole Exome Sequencing of multiplex families.PLoS One. 2019 Mar 7;14(3):e0213387. doi: 10.1371/journal.pone.0213387. eCollection 2019.
• [1035] SUMO4 and MAP3K7IP2 single nucleotide polymorphisms and susceptibility to rheumatoid arthritis.J Rheumatol. 2006 Jun;33(6):1048-51.
• [1036] A specific p47phox -serine phosphorylated by convergent MAPKs mediates neutrophil NADPH oxidase priming at inflammatory sites.J Clin Invest. 2006 Jul;116(7):2033-43. doi: 10.1172/JCI27544. Epub 2006 Jun 15.
• [1037] Tespa1 is associated with susceptibility but not severity of rheumatoid arthritis in the Zhejiang Han population in China.Clin Rheumatol. 2015 Apr;34(4):665-71. doi: 10.1007/s10067-015-2900-7. Epub 2015 Mar 4.
• [1038] Evaluation of amplicor chlamydia PCR and LCX chlamydia LCR to detect Chlamydia trachomatis in synovial fluid.Clin Exp Rheumatol. 2002 Mar-Apr;20(2):185-92.
• [1039] Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies.PeerJ. 2018 Jan 4;6:e4216. doi: 10.7717/peerj.4216. eCollection 2018.
• [1040] A novel T cell cytokine, secreted osteoclastogenic factor of activated T cells, induces osteoclast formation in a RANKL-independent manner.Arthritis Rheum. 2009 Nov;60(11):3324-35. doi: 10.1002/art.24877.
• [1041] TMEM187-IRAK1 Polymorphisms Associated with Rheumatoid Arthritis Susceptibility in Tunisian and French Female Populations: Influence of Geographic Origin.J Immunol Res. 2017;2017:4915950. doi: 10.1155/2017/4915950. Epub 2017 Feb 8.
• [1042] Serum concentrations of soluble 4-1BB and 4-1BB ligand correlated with the disease severity in rheumatoid arthritis.Exp Mol Med. 2004 Feb 29;36(1):13-22. doi: 10.1038/emm.2004.2.
• [1043] A pro-inflammatory role for A20 and ABIN family proteins in human fibroblast-like synoviocytes in rheumatoid arthritis.Immunol Lett. 2012 Jan 30;141(2):246-53. doi: 10.1016/j.imlet.2011.10.011. Epub 2011 Nov 9.
• [1044] Investigation of association between the TRAF family genes and RA susceptibility.Ann Rheum Dis. 2007 Oct;66(10):1322-6. doi: 10.1136/ard.2006.065706. Epub 2007 Feb 2.
• [1045] Clinical associations of the positive anti Ro52 without Ro60 autoantibodies: undifferentiated connective tissue diseases.J Clin Pathol. 2018 Jan;71(1):12-19. doi: 10.1136/jclinpath-2015-203587. Epub 2017 Jun 29.
• [1046] Deduction of Novel Genes Potentially Involved in Osteoblasts of Rheumatoid Arthritis Using Next-Generation Sequencing and Bioinformatic Approaches.Int J Mol Sci. 2017 Nov 11;18(11):2396. doi: 10.3390/ijms18112396.
• [1047] Brief Report: Peripheral Osteolysis in Adults Linked to ASAH1 (Acid Ceramidase) Mutations: A New Presentation of Farber's Disease.Arthritis Rheumatol. 2016 Sep;68(9):2323-7. doi: 10.1002/art.39659. Epub 2016 Jul 29.
• [1048] The Role of Cdkn1A-Interacting Zinc Finger Protein 1 (CIZ1) in DNA Replication and Pathophysiology.Int J Mol Sci. 2016 Feb 5;17(2):212. doi: 10.3390/ijms17020212.
• [1049] A combined large-scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus.Ann Rheum Dis. 2017 Jan;76(1):286-294. doi: 10.1136/annrheumdis-2016-209436. Epub 2016 May 18.
• [1050] A Retrospective Analysis of Subaxial Subluxation After Atlanto-axial Arthrodesis in Patients With Rheumatoid Arthritis Based on Annual Radiographs Obtained for 5 Years.Clin Spine Surg. 2017 Jun;30(5):E598-E602. doi: 10.1097/BSD.0000000000000277.
• [1051] TDAG8, TRPV1, and ASIC3 involved in establishing hyperalgesic priming in experimental rheumatoid arthritis.Sci Rep. 2017 Aug 21;7(1):8870. doi: 10.1038/s41598-017-09200-6.
• [1052] Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF- and IL-17A induced osteoblastic differentiation.Bone. 2016 Jun;87:89-96. doi: 10.1016/j.bone.2016.04.008. Epub 2016 Apr 9.
• [1053] Imbalance of circulating Tfr/Tfh ratio in patients with rheumatoid arthritis.Clin Exp Med. 2019 Feb;19(1):55-64. doi: 10.1007/s10238-018-0530-5. Epub 2018 Oct 4.
• [1054] Rheumatoid arthritis and periodontal disease: What are the similarities and differences?.Int J Rheum Dis. 2017 Dec;20(12):1887-1901. doi: 10.1111/1756-185X.13240. Epub 2018 Jan 9.
• [1055] IL-9 receptor: Regulatory role on FLS and pannus formation.Cytokine. 2018 Nov;111:58-62. doi: 10.1016/j.cyto.2018.08.001. Epub 2018 Aug 14.
• [1056] Constitutive Activation of Integrin 9 Augments Self-Directed Hyperplastic and Proinflammatory Properties of Fibroblast-like Synoviocytes of Rheumatoid Arthritis.J Immunol. 2017 Nov 15;199(10):3427-3436. doi: 10.4049/jimmunol.1700941. Epub 2017 Oct 16.
• [1057] Upregulated KAT7 in synovial fibroblasts promotes Th17cell differentiation and infiltration in rheumatoid arthritis.Biochem Biophys Res Commun. 2017 Jul 22;489(2):235-241. doi: 10.1016/j.bbrc.2017.05.143. Epub 2017 May 26.
• [1058] Cross talk between progesterone receptors and retinoic acid receptors in regulation of cytokeratin 5-positive breast cancer cells.Oncogene. 2017 Nov 2;36(44):6074-6084. doi: 10.1038/onc.2017.204. Epub 2017 Jul 10.
• [1059] Meta-analysis: diagnostic accuracy of antibody against peptidylarginine deiminase 4 by ELISA for rheumatoid arthritis.Clin Rheumatol. 2017 Nov;36(11):2431-2438. doi: 10.1007/s10067-017-3809-0. Epub 2017 Sep 8.
• [1060] Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker.Front Immunol. 2018 Jan 16;8:2007. doi: 10.3389/fimmu.2017.02007. eCollection 2017.
• [1061] Pharmacokinetics of LBPT and its primary metabolites, as well as tolerability in the first-in-human study.Eur J Pharm Sci. 2017 Mar 30;100:87-93. doi: 10.1016/j.ejps.2016.12.038. Epub 2017 Jan 3.
• [1062] TIPE2 expression is increased in peripheral blood mononuclear cells from patients with rheumatoid arthritis.Oncotarget. 2017 Sep 23;8(50):87472-87479. doi: 10.18632/oncotarget.21267. eCollection 2017 Oct 20.
• [1063] Osteoblastic PLEKHO1 contributes to joint inflammation in rheumatoid arthritis.EBioMedicine. 2019 Mar;41:538-555. doi: 10.1016/j.ebiom.2019.02.009. Epub 2019 Feb 26.
• [1064] Identification of novel genetic loci for osteoporosis and/or rheumatoid arthritis using cFDR approach.PLoS One. 2017 Aug 30;12(8):e0183842. doi: 10.1371/journal.pone.0183842. eCollection 2017.
• [1065] Unfolded protein response gene GADD34 is overexpressed in rheumatoid arthritis and related to the presence of circulating anti-citrullinated protein antibodies.Autoimmunity. 2016;49(3):172-8. doi: 10.3109/08916934.2016.1138220. Epub 2016 Feb 1.
• [1066] Exacerbation of collagen antibody-induced arthritis in transgenic mice overexpressing peroxiredoxin 6.Arthritis Rheumatol. 2015 Nov;67(11):3058-69. doi: 10.1002/art.39284.
• [1067] Muscle Deficits in Rheumatoid Arthritis Contribute to Inferior Cortical Bone Structure and Trabecular Bone Mineral Density.J Rheumatol. 2017 Dec;44(12):1777-1785. doi: 10.3899/jrheum.170513. Epub 2017 Sep 15.
• [1068] Lipopolysaccharide mediates hepatic stellate cell activation by regulating autophagy and retinoic acid signaling.Autophagy. 2017;13(11):1813-1827. doi: 10.1080/15548627.2017.1356550. Epub 2017 Nov 21.
• [1069] Identification and Validation of SAA4 as a Rheumatoid Arthritis Prescreening Marker by Liquid Chromatography Tandem-mass Spectrometry.Molecules. 2017 May 14;22(5):805. doi: 10.3390/molecules22050805.
• [1070] Biological function integrated prediction of severe radiographic progression in rheumatoid arthritis: a nested case control study.Arthritis Res Ther. 2017 Oct 25;19(1):244. doi: 10.1186/s13075-017-1414-x.
• [1071] Genetic regulation of dimethylarginines and endothelial dysfunction in rheumatoid arthritis.Amino Acids. 2019 Jul;51(7):983-990. doi: 10.1007/s00726-019-02740-3. Epub 2019 May 6.
• [1072] The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
• [1073] Cross-Sectional Evaluation of Periodontal Status and Microbiologic and Rheumatoid Parameters in a Large Cohort of Patients With Rheumatoid Arthritis.J Periodontol. 2017 Apr;88(4):368-379. doi: 10.1902/jop.2016.160355. Epub 2016 Nov 18.
• [1074] Functional characterisation of ADP ribosylation factor-like protein 15 in rheumatoid arthritis synovial fibroblasts.Clin Exp Rheumatol. 2018 Jul-Aug;36(4):581-588. Epub 2018 Feb 14.
• [1075] Rheumatoid arthritis reprograms circadian output pathways.Arthritis Res Ther. 2019 Feb 6;21(1):47. doi: 10.1186/s13075-019-1825-y.
• [1076] Self nanoemulsifying granules (SNEGs) of meloxicam: preparation, characterization, molecular modeling and evaluation of in vivo anti-inflammatory activity.Drug Dev Ind Pharm. 2017 Apr;43(4):600-610. doi: 10.1080/03639045.2016.1275665. Epub 2017 Jan 17.
• [1077] Investigation of gene expression profiles in a rat adjuvant arthritis model suggests an effective role of triptolide via PI3K-AKT signaling.Exp Ther Med. 2019 May;17(5):3999-4006. doi: 10.3892/etm.2019.7425. Epub 2019 Mar 20.
• [1078] Diagnostic test accuracy of magnetic resonance imaging and ultrasound for detecting bone erosion in patients with rheumatoid arthritis.Clin Rheumatol. 2020 Apr;39(4):1283-1293. doi: 10.1007/s10067-019-04825-6. Epub 2019 Nov 12.
• [1079] Systemic Resolvin E1 (RvE1) Treatment Does Not Ameliorate the Severity of Collagen-Induced Arthritis (CIA) in Mice: A Randomized, Prospective, and Controlled Proof of Concept Study.Mediators Inflamm. 2019 Oct 31;2019:5689465. doi: 10.1155/2019/5689465. eCollection 2019.
• [1080] Soluble syndecan-3 binds chemokines, reduces leukocyte migration in vitro and ameliorates disease severity in models of rheumatoid arthritis.Arthritis Res Ther. 2019 Jul 12;21(1):172. doi: 10.1186/s13075-019-1939-2.
• [1081] Decoy receptor 3 down-regulates centrosomal protein 70kDa specifically in rheumatoid synovial fibroblasts.Mod Rheumatol. 2018 Mar;28(2):287-292. doi: 10.1080/14397595.2017.1341593. Epub 2017 Jul 11.
• [1082] CHD7 represses the retinoic acid synthesis enzyme ALDH1A3 during inner ear development.JCI Insight. 2018 Feb 22;3(4):e97440. doi: 10.1172/jci.insight.97440. eCollection 2018 Feb 22.
• [1083] Localization of quantitative trait loci regulating adjuvant-induced arthritis in rats: evidence for genetic factors common to multiple autoimmune diseases.J Immunol. 1998 Oct 15;161(8):4411-9.
• [1084] Serum and synovial fluid concentrations of cold-inducible RNA-binding protein in patients with rheumatoid arthritis.Int J Rheum Dis. 2018 Jan;21(1):148-154. doi: 10.1111/1756-185X.12892. Epub 2016 Jun 17.
• [1085] TNF-induced inflammatory genes escape repression in fibroblast-like synoviocytes: transcriptomic and epigenomic analysis.Ann Rheum Dis. 2019 Sep;78(9):1205-1214. doi: 10.1136/annrheumdis-2018-214783. Epub 2019 May 16.
• [1086] Synovial GATA1 mediates rheumatoid arthritis progression via transcriptional activation of NOS2 signaling.Microbiol Immunol. 2018 Sep;62(9):594-606. doi: 10.1111/1348-0421.12637. Epub 2018 Aug 13.
• [1087] Effects of non-surgical periodontal therapy on periodontal laboratory and clinical data as well as on disease activity in patients with rheumatoid arthritis.Clin Oral Investig. 2019 Jan;23(1):141-151. doi: 10.1007/s00784-018-2420-3. Epub 2018 Mar 27.
• [1088] Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints. J Clin Invest. 2017 Aug 1;127(8):2946-2956.
• [1089] RHAMM induces progression of rheumatoid arthritis by enhancing the functions of fibroblast-like synoviocytes.BMC Musculoskelet Disord. 2018 Dec 26;19(1):455. doi: 10.1186/s12891-018-2370-6.
• [1090] Gene expression profiling meta-analysis reveals novel gene signatures and pathways shared between tuberculosis and rheumatoid arthritis.PLoS One. 2019 Mar 7;14(3):e0213470. doi: 10.1371/journal.pone.0213470. eCollection 2019.
• [1091] Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis.Arthritis Care Res (Hoboken). 2018 Jul;70(7):970-978. doi: 10.1002/acr.23539. Epub 2018 May 21.
• [1092] Discovery of circulating proteins associated to knee radiographic osteoarthritis.Sci Rep. 2017 Mar 9;7(1):137. doi: 10.1038/s41598-017-00195-8.
• [1093] Impaired Tip60-mediated Foxp3 acetylation attenuates regulatory T cell development in rheumatoid arthritis.J Autoimmun. 2019 Jun;100:27-39. doi: 10.1016/j.jaut.2019.02.007. Epub 2019 Apr 4.
• [1094] Associative role of HLA-DRB1 SNP genotypes as risk factors for susceptibility and severity of rheumatoid arthritis: A North-east Indian population-based study.Int J Immunogenet. 2018 Feb;45(1):1-7. doi: 10.1111/iji.12347. Epub 2017 Nov 23.
• [1095] Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjgren's syndrome.Ann Rheum Dis. 2015 Nov;74(11):2070-5. doi: 10.1136/annrheumdis-2013-204441. Epub 2014 Jun 6.
• [1096] Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity.Clin Exp Rheumatol. 2020 Jan-Feb;38(1):122-128. Epub 2019 Aug 27.
• [1097] The DNA Repair Nuclease MRE11A Functions as a Mitochondrial Protector and Prevents T Cell Pyroptosis and Tissue Inflammation.Cell Metab. 2019 Sep 3;30(3):477-492.e6. doi: 10.1016/j.cmet.2019.06.016. Epub 2019 Jul 18.
• [1098] Role of NFAT5 in the Immune System and Pathogenesis of Autoimmune Diseases.Front Immunol. 2019 Feb 19;10:270. doi: 10.3389/fimmu.2019.00270. eCollection 2019.
• [1099] Impaired NFKBIE gene function decreases cellular uptake of methotrexate by down-regulating SLC19A1 expression in a human rheumatoid arthritis cell line.Mod Rheumatol. 2016 Jul;26(4):507-16. doi: 10.3109/14397595.2015.1112481. Epub 2016 Jan 4.
• [1100] Rising Incidence of Acute Hospital Admissions due to Gout.J Rheumatol. 2020 Apr;47(4):619-623. doi: 10.3899/jrheum.190257. Epub 2019 Sep 15.
• [1101] Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis.Clin Exp Rheumatol. 2017 Jul-Aug;35(4):630-637. Epub 2017 Feb 24.
• [1102] Secreted Protein Acidic and Rich in Cysteine Mediated Biomimetic Delivery of Methotrexate by Albumin-Based Nanomedicines for Rheumatoid Arthritis Therapy.ACS Nano. 2019 May 28;13(5):5036-5048. doi: 10.1021/acsnano.9b01710. Epub 2019 Apr 25.
• [1103] Serum PGLYRP? is a highly discriminatory biomarker for the diagnosis of rheumatoid arthritis.Mol Med Rep. 2019 Jan;19(1):589-594. doi: 10.3892/mmr.2018.9632. Epub 2018 Nov 8.
• [1104] Trypsin-2 degrades human type II collagen and is expressed and activated in mesenchymally transformed rheumatoid arthritis synovitis tissue.Am J Pathol. 2005 Oct;167(4):1119-24. doi: 10.1016/S0002-9440(10)61200-X.
• [1105] RETRACTED: Bone marrow-derived mesenchymal stem cells-secreted exosomal microRNA-192-5p delays inflammatory response in rheumatoid arthritis.Int Immunopharmacol. 2020 Jan;78:105985. doi: 10.1016/j.intimp.2019.105985. Epub 2019 Nov 24.
• [1106] Ectopic RASGRP2 (CalDAG-GEFI) expression in rheumatoid synovium contributes to the development of destructive arthritis.Ann Rheum Dis. 2018 Dec;77(12):1765-1772. doi: 10.1136/annrheumdis-2018-213588. Epub 2018 Aug 3.
• [1107] Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis.Arthritis Res Ther. 2017 Apr 26;19(1):79. doi: 10.1186/s13075-017-1288-y.
• [1108] The efficacy of motivational counselling and SMS reminders on daily sitting time in patients with rheumatoid arthritis: a randomised controlled trial.Ann Rheum Dis. 2017 Sep;76(9):1603-1606. doi: 10.1136/annrheumdis-2016-210953. Epub 2017 Jun 5.
• [1109] Pain Relieving Effect of-NSAIDs-CAIs Hybrid Molecules: Systemic and Intra-Articular Treatments against Rheumatoid Arthritis.Int J Mol Sci. 2019 Apr 18;20(8):1923. doi: 10.3390/ijms20081923.
• [1110] Hepatocyte growth factor receptor signaling mediates the anti-fibrotic action of 9-cis-retinoic acid in glomerular mesangial cells. Am J Pathol. 2005 Oct;167(4):947-57. doi: 10.1016/S0002-9440(10)61185-6.
• [1111] Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry.Nat Immunol. 2019 Jul;20(7):928-942. doi: 10.1038/s41590-019-0378-1. Epub 2019 May 6.
• [1112] Citrullinated Aggrecan Epitopes as Targets of Autoreactive CD4+ T Cells in Patients With Rheumatoid Arthritis.Arthritis Rheumatol. 2019 Apr;71(4):518-528. doi: 10.1002/art.40768. Epub 2019 Mar 8.
• [1113] Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients.Arthritis Res Ther. 2011 Jul 18;13(4):R116. doi: 10.1186/ar3401.
• [1114] Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.Mod Rheumatol. 2017 Sep;27(5):773-777. doi: 10.1080/14397595.2016.1259714. Epub 2016 Dec 15.
• [1115] Counter-regulation of regulatory T cells by autoreactive CD8(+) T cells in rheumatoid arthritis.J Autoimmun. 2019 May;99:81-97. doi: 10.1016/j.jaut.2019.02.001. Epub 2019 Feb 16.
• [1116] Novel insight into the role of -actinin-1 in rheumatoid arthritis.Discov Med. 2014 Feb;17(92):75-80.
• [1117] A study of Adenosine-Deaminase genetic polymorphism in rheumatoid arthritis.Int J Immunopathol Pharmacol. 2010 Jul-Sep;23(3):791-5. doi: 10.1177/039463201002300313.
• [1118] Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.Cytokine. 2010 Jan;49(1):24-9. doi: 10.1016/j.cyto.2009.10.005. Epub 2009 Nov 25.
• [1119] ADAM15 in Apoptosis Resistance of Synovial Fibroblasts: Converting Fas/CD95 Death Signals Into the Activation of Prosurvival Pathways by Calmodulin Recruitment.Arthritis Rheumatol. 2019 Jan;71(1):63-72. doi: 10.1002/art.40667. Epub 2018 Nov 20.
• [1120] Role of ADAMTS-12 in Protecting Against Inflammatory Arthritis in Mice By Interacting With and Inactivating Proinflammatory Connective Tissue Growth Factor.Arthritis Rheumatol. 2018 Nov;70(11):1745-1756. doi: 10.1002/art.40552. Epub 2018 Sep 24.
• [1121] Increased adenosine-to-inosine RNA editing in rheumatoid arthritis.J Autoimmun. 2020 Jan;106:102329. doi: 10.1016/j.jaut.2019.102329. Epub 2019 Sep 5.
• [1122] APL-1, an altered peptide ligand derived from heat-shock protein, alone or combined with methotrexate attenuates murine collagen-induced arthritis.Clin Exp Med. 2017 May;17(2):209-216. doi: 10.1007/s10238-016-0412-7. Epub 2016 May 9.
• [1123] Adiponectin receptor 1 mediates the difference in adiponectin- induced prostaglandin E2 production in rheumatoid arthritis and osteoarthritis synovial fibroblasts.Chin Med J (Engl). 2011 Dec;124(23):3919-24.
• [1124] Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: an update.Joint Bone Spine. 2007 Oct;74(5):418-26. doi: 10.1016/j.jbspin.2007.05.001. Epub 2007 Jun 8.
• [1125] The role of synthetic manufactured peptides containing common citrullinated epitopes in rheumatoid arthritis diagnosis.Clin Immunol. 2019 Feb;199:7-11. doi: 10.1016/j.clim.2018.12.004. Epub 2018 Dec 10.
• [1126] Identification of AHNAK as a novel autoantigen in systemic lupus erythematosus.Biochem Biophys Res Commun. 2002 Mar 8;291(4):951-8. doi: 10.1006/bbrc.2002.6534.
• [1127] Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2006 Sep;54(9):2830-9. doi: 10.1002/art.22032.
• [1128] Apolipoprotein m (APOM) levels and APOM rs805297 G/T polymorphism are associated with increased risk of rheumatoid arthritis.Joint Bone Spine. 2014 Jan;81(1):32-6. doi: 10.1016/j.jbspin.2013.03.017. Epub 2013 May 6.
• [1129] TIM family gene polymorphism and susceptibility to rheumatoid arthritis: Systematic review and meta-analysis.PLoS One. 2019 Feb 7;14(2):e0211146. doi: 10.1371/journal.pone.0211146. eCollection 2019.
• [1130] A Truncated Variant of ASCC1, a Novel Inhibitor of NF-B, Is Associated with Disease Severity in Patients with Rheumatoid Arthritis.J Immunol. 2015 Dec 1;195(11):5415-20. doi: 10.4049/jimmunol.1501532. Epub 2015 Oct 26.
• [1131] HTLV-1, Immune Response and Autoimmunity.Viruses. 2015 Dec 24;8(1):5. doi: 10.3390/v8010005.
• [1132] Correlations Between Sagittal Spinal Balance and Quality of Life in Rheumatoid Arthritis.Clin Spine Surg. 2017 May;30(4):E412-E417. doi: 10.1097/BSD.0000000000000246.
• [1133] Substance P receptor (NK1) gene expression in synovial tissue in rheumatoid arthritis and osteoarthritis.Scand J Rheumatol. 1998;27(2):135-41. doi: 10.1080/030097498441010.
• [1134] Transcriptome study of differential expression in schizophrenia.Hum Mol Genet. 2013 Dec 15;22(24):5001-14. doi: 10.1093/hmg/ddt350. Epub 2013 Jul 30.
• [1135] Regulation of T cell lineage commitment by SMAR1 during inflammatory & autoimmune diseases.Indian J Med Res. 2015 Oct;142(4):405-13. doi: 10.4103/0971-5916.169198.
• [1136] Effective quantification of 11 tyrosine kinase inhibitors and caffeine in human plasma by validated LC-MS/MS method with potent phospholipids clean-up procedure. Application to therapeutic drug monitoring.Talanta. 2020 Feb 1;208:120450. doi: 10.1016/j.talanta.2019.120450. Epub 2019 Oct 11.
• [1137] Osteogenic circulating endothelial progenitor cells are linked to electrocardiographic conduction abnormalities in rheumatic patients.Ann Noninvasive Electrocardiol. 2019 Sep;24(5):e12651. doi: 10.1111/anec.12651. Epub 2019 Apr 24.
• [1138] Differentially Expressed in Chondrocytes 2 (DEC2) Increases the Expression of IL-1 and Is Abundantly Present in Synovial Membrane in Rheumatoid Arthritis.PLoS One. 2015 Dec 28;10(12):e0145279. doi: 10.1371/journal.pone.0145279. eCollection 2015.
• [1139] Prevalence of autoimmune diseases and clinical significance of autoantibody profile: Data from National Institute of Hygiene in Rabat, Morocco.Hum Immunol. 2019 Jul;80(7):523-532. doi: 10.1016/j.humimm.2019.02.012. Epub 2019 Feb 23.
• [1140] CTRP6 is an endogenous complement regulator that can effectively treat induced arthritis.Nat Commun. 2015 Sep 25;6:8483. doi: 10.1038/ncomms9483.
• [1141] Properdin factor B and complement factor C4 allotypes in rheumatoid arthritis: results of a follow-up study.Hum Immunol. 1992 Feb;33(2):148-51. doi: 10.1016/0198-8859(92)90066-v.
• [1142] Tylophorine-based compounds are therapeutic in rheumatoid arthritis by targeting the caprin-1 ribonucleoprotein complex and inhibiting expression of associated c-Myc and HIF-1.Pharmacol Res. 2020 Feb;152:104581. doi: 10.1016/j.phrs.2019.104581. Epub 2019 Nov 30.
• [1143] FLIP and MAPK play crucial roles in the MLN51-mediated hyperproliferation of fibroblast-like synoviocytes in the pathogenesis of rheumatoid arthritis.FEBS J. 2008 Jul;275(14):3546-55. doi: 10.1111/j.1742-4658.2008.06500.x.
• [1144] Overexpression of a minimal domain of calpastatin suppresses IL-6 production and Th17 development via reduced NF-B and increased STAT5 signals.PLoS One. 2011;6(10):e27020. doi: 10.1371/journal.pone.0027020. Epub 2011 Oct 27.
• [1145] Genetic variants of CC chemokine genes in experimental autoimmune encephalomyelitis, multiple sclerosis and rheumatoid arthritis.Genes Immun. 2010 Mar;11(2):142-54. doi: 10.1038/gene.2009.82. Epub 2009 Oct 29.
• [1146] Stimulation of osteoclast migration and bone resorption by C-C chemokine ligands 19 and 21.Exp Mol Med. 2017 Jul 21;49(7):e358. doi: 10.1038/emm.2017.100.
• [1147] Eotaxin-3 gene polymorphisms are associated with rheumatoid arthritis in a Korean population.Hum Immunol. 2005 Mar;66(3):314-20. doi: 10.1016/j.humimm.2005.01.002.
• [1148] Th22 Cells Promote Osteoclast Differentiation via Production of IL-22 in Rheumatoid Arthritis.Front Immunol. 2018 Dec 10;9:2901. doi: 10.3389/fimmu.2018.02901. eCollection 2018.
• [1149] Chemokine expression in rheumatoid arthritis (RA): evidence of RANTES and macrophage inflammatory protein (MIP)-1 beta production by synovial T cells.Clin Exp Immunol. 1995 Sep;101(3):398-407. doi: 10.1111/j.1365-2249.1995.tb03126.x.
• [1150] Expression profiles of human CCN genes in patients with osteoarthritis or rheumatoid arthritis.J Orthop Sci. 2015 Jul;20(4):708-16. doi: 10.1007/s00776-015-0727-3. Epub 2015 May 19.
• [1151] Association of Dendritic Cell Signatures With Autoimmune Inflammation Revealed by Single-Cell Profiling.Arthritis Rheumatol. 2019 May;71(5):817-828. doi: 10.1002/art.40793. Epub 2019 Apr 6.
• [1152] Low levels of soluble CD1d protein alters NKT cell function in patients with rheumatoid arthritis.Int J Mol Med. 2009 Oct;24(4):481-6. doi: 10.3892/ijmm_00000256.
• [1153] Restriction fragment length polymorphism of a lymphocyte surface antigen, Blast-1, in Japanese and Caucasians, and in patients with rheumatoid arthritis.Tissue Antigens. 1990 May;35(5):203-5. doi: 10.1111/j.1399-0039.1990.tb01783.x.
• [1154] Decrease of CD68 Synovial Macrophages in Celastrol Treated Arthritic Rats.PLoS One. 2015 Dec 11;10(12):e0142448. doi: 10.1371/journal.pone.0142448. eCollection 2015.
• [1155] Analysis of vascular gene expression in arthritic synovium by laser-mediated microdissection.Arthritis Rheum. 2007 Apr;56(4):1094-105. doi: 10.1002/art.22450.
• [1156] Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-nave patients with rheumatoid arthritis.Semin Arthritis Rheum. 2020 Feb;50(1):17-24. doi: 10.1016/j.semarthrit.2019.06.020. Epub 2019 Jun 28.
• [1157] MicroRNA-27a Inhibits Cell Migration and Invasion of Fibroblast-Like Synoviocytes by Targeting Follistatin-Like Protein 1 in Rheumatoid Arthritis.Mol Cells. 2016 Aug 31;39(8):611-8. doi: 10.14348/molcells.2016.0103. Epub 2016 Aug 8.
• [1158] CD318 is a ligand for CD6.Proc Natl Acad Sci U S A. 2017 Aug 15;114(33):E6912-E6921. doi: 10.1073/pnas.1704008114. Epub 2017 Jul 31.
• [1159] Myeloid calcium binding proteins: expression in the differentiated HL-60 cells and detection in sera of patients with connective tissue diseases.J Biochem. 1990 Oct;108(4):650-3. doi: 10.1093/oxfordjournals.jbchem.a123257.
• [1160] Novel risk loci for rheumatoid arthritis in Han Chinese and congruence with risk variants in Europeans.Arthritis Rheumatol. 2014 May;66(5):1121-32. doi: 10.1002/art.38353.
• [1161] Identifying Clinical Factors Associated With Low Disease Activity and Remission of Rheumatoid Arthritis During Pregnancy.Arthritis Care Res (Hoboken). 2017 Sep;69(9):1297-1303. doi: 10.1002/acr.23143. Epub 2017 Aug 13.
• [1162] Genome-wide association study of rheumatoid arthritis in Koreans: population-specific loci as well as overlap with European susceptibility loci.Arthritis Rheum. 2011 Apr;63(4):884-93. doi: 10.1002/art.30235.
• [1163] A HEV-restricted sulfotransferase is expressed in rheumatoid arthritis synovium and is induced by lymphotoxin-alpha/beta and TNF-alpha in cultured endothelial cells.BMC Immunol. 2005 Mar 7;6:6. doi: 10.1186/1471-2172-6-6.
• [1164] Treat to target approach for asthma.J Asthma. 2020 Jun;57(6):687-690. doi: 10.1080/02770903.2019.1591443. Epub 2019 Mar 23.
• [1165] Proteomic surveillance of autoimmunity in osteoarthritis: identification of triosephosphate isomerase as an autoantigen in patients with osteoarthritis.Arthritis Rheum. 2004 May;50(5):1511-21. doi: 10.1002/art.20189.
• [1166] CIP2A facilitates apoptotic resistance of fibroblast-like synoviocytes in rheumatoid arthritis independent of c-Myc expression.Rheumatol Int. 2013 Sep;33(9):2241-8. doi: 10.1007/s00296-013-2711-6. Epub 2013 Mar 2.
• [1167] SOCS3 participates in cholinergic pathway regulation of synovitis in rheumatoid arthritis.Connect Tissue Res. 2018 May;59(3):287-294. doi: 10.1080/03008207.2017.1380633. Epub 2017 Oct 4.
• [1168] A potential role of myeloid DAP12-associating lectin (MDL)-1 in the regulation of inflammation in rheumatoid arthritis patients.PLoS One. 2014 Jan 21;9(1):e86105. doi: 10.1371/journal.pone.0086105. eCollection 2014.
• [1169] Expression and function of dectin-1 is defective in monocytes from patients with systemic lupus erythematosus and rheumatoid arthritis.J Clin Immunol. 2013 Feb;33(2):368-77. doi: 10.1007/s10875-012-9821-x. Epub 2012 Oct 25.
• [1170] Expressions of circadian clock genes represent disease activities of RA patients treated with biological DMARDs.Mod Rheumatol. 2020 Mar;30(2):293-300. doi: 10.1080/14397595.2019.1602242. Epub 2019 May 2.
• [1171] A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides.Ann Rheum Dis. 2015 Mar;74(3):e15. doi: 10.1136/annrheumdis-2013-204591. Epub 2014 Feb 14.
• [1172] Increased antibody levels to stage-specific Epstein-Barr virus antigens in systemic autoimmune diseases reveal a common pathology.Scand J Clin Lab Invest. 2019 Feb-Apr;79(1-2):7-16. doi: 10.1080/00365513.2018.1550807. Epub 2019 Feb 6.
• [1173] Polymorphisms of COTL1 gene identified by proteomic approach and their association with autoimmune disorders.Exp Mol Med. 2009 May 31;41(5):354-61. doi: 10.3858/emm.2009.41.5.040.
• [1174] Mediators of inflammation are down-regulated while apoptosis is up-regulated in rheumatoid arthritis synovial tissue by polymerized collagen.Clin Exp Immunol. 2002 Oct;130(1):140-9. doi: 10.1046/j.1365-2249.2002.01955.x.
• [1175] Synergistic effect of glucosamine and vitamin E against experimental rheumatoid arthritis in neonatal rats.Biomed Pharmacother. 2018 Sep;105:835-840. doi: 10.1016/j.biopha.2018.05.136. Epub 2018 Jun 18.
• [1176] Inhibition of angiogenesis by arsenic trioxide via TSP-1-TGF-1-CTGF-VEGF functional module in rheumatoid arthritis.Oncotarget. 2017 Aug 3;8(43):73529-73546. doi: 10.18632/oncotarget.19867. eCollection 2017 Sep 26.
• [1177] CTHRC1: A New Candidate Biomarker for Improved Rheumatoid Arthritis Diagnosis.Front Immunol. 2019 Jun 12;10:1353. doi: 10.3389/fimmu.2019.01353. eCollection 2019.
• [1178] Association of Cullin1 haplotype variants with rheumatoid arthritis and response to methotrexate.Pharmacogenet Genomics. 2011 Sep;21(9):590-3. doi: 10.1097/FPC.0b013e3283492af7.
• [1179] Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis.Clin Exp Rheumatol. 2019 May-Jun;37(3):373-379. Epub 2018 Sep 17.
• [1180] Initiation of Disease-Modifying Therapies in Rheumatoid Arthritis Is Associated With Changes in Blood Pressure.J Clin Rheumatol. 2018 Jun;24(4):203-209. doi: 10.1097/RHU.0000000000000736.
• [1181] Hydroxytyrosol promotes autophagy by regulating SIRT1 against advanced oxidation protein productinduced NADPH oxidase and inflammatory response.Int J Mol Med. 2019 Oct;44(4):1531-1540. doi: 10.3892/ijmm.2019.4300. Epub 2019 Aug 5.
• [1182] Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.J Clin Immunol. 2010 Sep;30(5):649-58. doi: 10.1007/s10875-010-9429-y. Epub 2010 Jun 9.
• [1183] Extracellular traps and PAD4 released by macrophages induce citrullination and auto-antibody production in autoimmune arthritis.J Autoimmun. 2019 Dec;105:102297. doi: 10.1016/j.jaut.2019.06.008. Epub 2019 Jul 2.
• [1184] Genetic and expression analysis of SNPs in the human deoxyribonuclease II: SNPs in the promoter region reduce its in vivo activity through decreased promoter activity.Electrophoresis. 2012 Sep;33(18):2852-8. doi: 10.1002/elps.201200260.
• [1185] A noncanonical role for the engulfment gene ELMO1 in neutrophils that promotes inflammatory arthritis.Nat Immunol. 2019 Feb;20(2):141-151. doi: 10.1038/s41590-018-0293-x. Epub 2019 Jan 14.
• [1186] Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).Am J Med Sci. 2004 Apr;327(4):169-79. doi: 10.1097/00000441-200404000-00002.
• [1187] Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis.Mol Cells. 2013 Apr;35(4):298-304. doi: 10.1007/s10059-013-2302-0. Epub 2013 Feb 26.
• [1188] Fibulin-4 is a target of autoimmunity predominantly in patients with osteoarthritis.J Immunol. 2006 Mar 1;176(5):3196-204. doi: 10.4049/jimmunol.176.5.3196.
• [1189] EF-hand domain containing 2 (Efhc2) is crucial for distal segmentation of pronephros in zebrafish.Cell Biosci. 2018 Oct 16;8:53. doi: 10.1186/s13578-018-0253-z. eCollection 2018.
• [1190] ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation.J Biol Chem. 2004 Mar 26;279(13):12794-803. doi: 10.1074/jbc.M308593200. Epub 2004 Jan 8.
• [1191] ENHO gene expression and serum adropin level in rheumatoid arthritis and systemic lupus erythematosus.Adv Clin Exp Med. 2018 Dec;27(12):1637-1641. doi: 10.17219/acem/75944.
• [1192] Local production of complement proteins in rheumatoid arthritis synovium.Arthritis Rheum. 2002 Apr;46(4):934-45. doi: 10.1002/art.10183.
• [1193] Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases.PLoS One. 2019 Oct 9;14(10):e0223246. doi: 10.1371/journal.pone.0223246. eCollection 2019.
• [1194] Detection of TT virus in patients with idiopathic inflammatory myopathies.Ann N Y Acad Sci. 2005 Jun;1050:304-13. doi: 10.1196/annals.1313.032.
• [1195] Expression of TNF-alpha and related signaling molecules in the peripheral blood mononuclear cells of rheumatoid arthritis patients.Mediators Inflamm. 2006;2006(3):12682. doi: 10.1155/MI/2006/12682.
• [1196] Reduction of SR Ca(2+) leak and arrhythmogenic cellular correlates by SMP-114, a novel CaMKII inhibitor with oral bioavailability.Basic Res Cardiol. 2017 Jul;112(4):45. doi: 10.1007/s00395-017-0637-y. Epub 2017 Jun 13.
• [1197] Fibrosis-4 index at diagnosis can predict all-cause mortality in patients with rheumatoid arthritis: A retrospective monocentric study.Mod Rheumatol. 2020 Jan;30(1):70-77. doi: 10.1080/14397595.2018.1558760. Epub 2019 Jan 15.
• [1198] Highly Expression of CD11b and CD32 on Peripheral Blood Mononuclear Cells from Patients with Adult-Onset Still's Disease.Int J Mol Sci. 2017 Jan 19;18(1):202. doi: 10.3390/ijms18010202.
• [1199] Brief Report: Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis Patients Are Reactive With Specific Epitopes of the Human Fibrinogen -Chain.Arthritis Rheumatol. 2017 Jul;69(7):1381-1386. doi: 10.1002/art.40098. Epub 2017 Jun 5.
• [1200] A mutation in a CD44 variant of inflammatory cells enhances the mitogenic interaction of FGF with its receptor.J Clin Invest. 2003 Apr;111(8):1211-20. doi: 10.1172/JCI17100.
• [1201] FHL2 regulates the resolution of tissue damage in chronic inflammatory arthritis.Ann Rheum Dis. 2015 Dec;74(12):2216-23. doi: 10.1136/annrheumdis-2013-205061. Epub 2014 Aug 14.
• [1202] Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study.Postgrad Med. 2018 Jan;130(1):137-141. doi: 10.1080/00325481.2018.1399774. Epub 2017 Nov 3.
• [1203] Analysis of TAP and HLA-DM polymorphism in thai rheumatoid arthritis.Hum Immunol. 2000 Mar;61(3):309-13. doi: 10.1016/s0198-8859(99)00163-9.
• [1204] Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis.PLoS One. 2013;8(1):e54884. doi: 10.1371/journal.pone.0054884. Epub 2013 Jan 21.
• [1205] Association of FOXJ1 polymorphisms with systemic lupus erythematosus and rheumatoid arthritis in Korean population.Exp Mol Med. 2007 Dec 31;39(6):805-11. doi: 10.1038/emm.2007.87.
• [1206] Rosmarinic acid reduces the resistance of gastric carcinoma cells to 5-fluorouracil by downregulating FOXO4-targeting miR-6785-5p.Biomed Pharmacother. 2019 Jan;109:2327-2334. doi: 10.1016/j.biopha.2018.10.061. Epub 2018 Nov 30.
• [1207] Discovery and analysis of inflammatory disease-related genes using cDNA microarrays.Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2150-5. doi: 10.1073/pnas.94.6.2150.
• [1208] Gene expression profile predicting the response to anti-TNF treatment in patients with rheumatoid arthritis; analysis of GEO datasets.Joint Bone Spine. 2014 Jul;81(4):325-30. doi: 10.1016/j.jbspin.2014.01.013. Epub 2014 Feb 20.
• [1209] CR6-interacting factor 1 controls autoimmune arthritis by regulation of signal transducer and activator of transcription 3 pathway and T helper type 17 cells.Immunology. 2019 Apr;156(4):413-421. doi: 10.1111/imm.13042. Epub 2019 Jan 28.
• [1210] MicroRNAs in rheumatoid arthritis: From pathogenesis to clinical impact.Autoimmun Rev. 2019 Nov;18(11):102391. doi: 10.1016/j.autrev.2019.102391. Epub 2019 Sep 11.
• [1211] GDF11 antagonizes TNF--induced inflammation and protects against the development of inflammatory arthritis in mice.FASEB J. 2019 Mar;33(3):3317-3329. doi: 10.1096/fj.201801375RR. Epub 2018 Nov 8.
• [1212] A longitudinal genome-wide association study of anti-tumor necrosis factor response among Japanese patients with rheumatoid arthritis.Arthritis Res Ther. 2016 Jan 18;18:12. doi: 10.1186/s13075-016-0920-6.
• [1213] RNA sequencing to predict response to TNF- inhibitors reveals possible mechanism for nonresponse in smokers.Expert Rev Clin Immunol. 2018 Jul;14(7):623-633. doi: 10.1080/1744666X.2018.1480937. Epub 2018 Jun 6.
• [1214] Measurement of absolute copy number variation of Glutathione S-Transferase M1 gene by digital droplet PCR and association analysis in Tunisian Rheumatoid Arthritis population.J Clin Lab Anal. 2018 Mar;32(3):e22300. doi: 10.1002/jcla.22300. Epub 2017 Jul 13.
• [1215] Association of GTF2IRD1-GTF2I polymorphisms with neuromyelitis optica spectrum disorders in Han Chinese patients.Neural Regen Res. 2019 Feb;14(2):346-353. doi: 10.4103/1673-5374.244800.
• [1216] Granzyme A Contributes to Inflammatory Arthritis in Mice Through Stimulation of Osteoclastogenesis.Arthritis Rheumatol. 2017 Feb;69(2):320-334. doi: 10.1002/art.39857.
• [1217] Increased intra-articular granzyme M may trigger local IFN-1/IL-29 response in rheumatoid arthritis.Clin Exp Rheumatol. 2020 Mar-Apr;38(2):220-226. doi: 10.55563/clinexprheumatol/ffb107. Epub 2019 Jun 6.
• [1218] Histone Protein Epitope Mapping for Autoantibody Recognition in Rheumatoid Arthritis.Methods Mol Biol. 2019;1901:221-228. doi: 10.1007/978-1-4939-8949-2_18.
• [1219] The potential role of human endogenous retrovirus K10 in the pathogenesis of rheumatoid arthritis: a preliminary study.Ann Rheum Dis. 2006 May;65(5):612-6. doi: 10.1136/ard.2004.031146. Epub 2005 Sep 28.
• [1220] Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction.Arthritis Res Ther. 2004;6(6):R514-20. doi: 10.1186/ar1223. Epub 2004 Sep 22.
• [1221] Manifestation of rheumatoid arthritis in a patient with hereditary haemochromatosis.Rheumatol Int. 2006 Aug;26(10):939-41. doi: 10.1007/s00296-006-0113-8. Epub 2006 Feb 9.
• [1222] Contribution of a Non-classical HLA Gene, HLA-DOA, to the Risk of Rheumatoid Arthritis.Am J Hum Genet. 2016 Aug 4;99(2):366-74. doi: 10.1016/j.ajhg.2016.06.019.
• [1223] An Immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis.Rheumatology (Oxford). 2016 Jan;55(1):149-55. doi: 10.1093/rheumatology/kev285. Epub 2015 Aug 13.
• [1224] Association of biomarkers of inflammation and HLA-DRB1 gene locus with risk of developing rheumatoid arthritis in females.Rheumatol Int. 2019 Dec;39(12):2147-2157. doi: 10.1007/s00296-019-04429-y. Epub 2019 Aug 26.
• [1225] Polymorphisms within the human leucocyte antigen-E gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy. Clin Exp Immunol. 2015 Dec;182(3):270-7.
• [1226] Identification of autoantibodies to the I protein of the heterogeneous nuclear ribonucleoprotein complex in patients with systemic sclerosis.Arthritis Rheum. 1996 Oct;39(10):1669-76. doi: 10.1002/art.1780391009.
• [1227] Expression of HOXB2, a retinoic acid signaling target in pancreatic cancer and pancreatic intraepithelial neoplasia.Clin Cancer Res. 2005 May 1;11(9):3587-96. doi: 10.1158/1078-0432.CCR-04-1813.
• [1228] Regulatory effects of paeoniflorin-6'-O-benzene sulfonate (CP-25) on dendritic cells maturation and activation via PGE2-EP4 signaling in adjuvant-induced arthritic rats.Inflammopharmacology. 2019 Oct;27(5):997-1010. doi: 10.1007/s10787-019-00575-8. Epub 2019 Feb 15.
• [1229] HOXD10 silencing suppresses human fibroblast-like synoviocyte migration in rheumatoid arthritis via downregulation of the p38/JNK pathway.Exp Ther Med. 2018 Sep;16(3):1621-1628. doi: 10.3892/etm.2018.6432. Epub 2018 Jul 9.
• [1230] Expression of HOXD9 in fibroblast-like synoviocytes from rheumatoid arthritis patients.Int J Mol Med. 2002 Jul;10(1):41-8.
• [1231] Expression and Functions of Immediate Early Response Gene X-1 (IEX-1) in Rheumatoid Arthritis Synovial Fibroblasts.PLoS One. 2016 Oct 13;11(10):e0164350. doi: 10.1371/journal.pone.0164350. eCollection 2016.
• [1232] IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus.Ann Rheum Dis. 2016 Nov;75(11):1998-2006. doi: 10.1136/annrheumdis-2015-208410. Epub 2016 Jan 19.
• [1233] NF-B1/IKK Gene Expression and Clinical Activity in Patients With Rheumatoid Arthritis.Lab Med. 2017 Dec 22;49(1):11-17. doi: 10.1093/labmed/lmx033.
• [1234] Genetic variant of IL-10RA and susceptibility to rheumatoid arthritis in a Chinese population.Clin Rheumatol. 2017 Apr;36(4):825-830. doi: 10.1007/s10067-016-3449-9. Epub 2016 Oct 29.
• [1235] IL-18BP is decreased in osteoporotic women: Prevents Inflammasome mediated IL-18 activation and reduces Th17 differentiation.Sci Rep. 2016 Sep 21;6:33680. doi: 10.1038/srep33680.
• [1236] IL-38: A New Player in Inflammatory Autoimmune Disorders.Biomolecules. 2019 Aug 5;9(8):345. doi: 10.3390/biom9080345.
• [1237] The IL-20 Cytokine Family in Rheumatoid Arthritis and Spondyloarthritis.Front Immunol. 2018 Sep 25;9:2226. doi: 10.3389/fimmu.2018.02226. eCollection 2018.
• [1238] IMPACT: Genomic Annotation of Cell-State-Specific Regulatory Elements Inferred from the Epigenome of Bound Transcription Factors.Am J Hum Genet. 2019 May 2;104(5):879-895. doi: 10.1016/j.ajhg.2019.03.012. Epub 2019 Apr 18.
• [1239] Identification of IRX1 as a Risk Locus for Rheumatoid Factor Positivity in Rheumatoid Arthritis in a Genome-Wide Association Study.Arthritis Rheumatol. 2016 Jun;68(6):1384-91. doi: 10.1002/art.39591.
• [1240] Iroquois transcription factor irx2a is required for multiciliated and transporter cell fate decisions during zebrafish pronephros development.Sci Rep. 2019 Apr 23;9(1):6454. doi: 10.1038/s41598-019-42943-y.
• [1241] High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis.Med Sci Monit. 2018 Aug 14;24:5660-5667. doi: 10.12659/MSM.909254.
• [1242] Persistence of a large population of exhausted monoclonal B cells in mixed cryoglobuliemia after the eradication of hepatitis C virus infection.J Clin Immunol. 2012 Aug;32(4):729-35. doi: 10.1007/s10875-012-9677-0. Epub 2012 Mar 2.
• [1243] Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium.Arthritis Rheum. 2008 Oct;58(10):3020-9. doi: 10.1002/art.23867.
• [1244] Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.Eur J Immunol. 1992 Jul;22(7):1907-12. doi: 10.1002/eji.1830220734.
• [1245] Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model.Arthritis Res Ther. 2019 Feb 22;21(1):68. doi: 10.1186/s13075-019-1819-9.
• [1246] Induction of Krppel-like factor 2 reduces K/BxN serum-induced arthritis.J Cell Mol Med. 2019 Feb;23(2):1386-1395. doi: 10.1111/jcmm.14041. Epub 2018 Dec 3.
• [1247] Inhibitory NKG2A and activating NKG2D and NKG2C natural killer cell receptor genes: susceptibility for rheumatoid arthritis.Tissue Antigens. 2008 Oct;72(4):342-6. doi: 10.1111/j.1399-0039.2008.01110.x. Epub 2008 Aug 12.
• [1248] Influence of CD94 and NKG2A variants on susceptibility to rheumatoid arthritis and efficacy of anti-TNF treatment.Joint Bone Spine. 2016 Jan;83(1):75-9. doi: 10.1016/j.jbspin.2015.06.010. Epub 2015 Oct 6.
• [1249] An SNP-guided microRNA map of fifteen common human disorders identifies a consensus disease phenocode aiming at principal components of the nuclear import pathway.Cell Cycle. 2008 Aug 15;7(16):2570-83. doi: 10.4161/cc.7.16.6524. Epub 2008 Aug 30.
• [1250] Association of Distinct Fine Specificities of Anti-Citrullinated Peptide Antibodies With Elevated Immune Responses to Prevotella intermedia in a Subgroup of Patients With Rheumatoid Arthritis and Periodontitis.Arthritis Rheumatol. 2017 Dec;69(12):2303-2313. doi: 10.1002/art.40227. Epub 2017 Oct 30.
• [1251] The soluble leukocyte-associated Ig-like receptor (LAIR)-2 antagonizes the collagen/LAIR-1 inhibitory immune interaction.J Immunol. 2008 Feb 1;180(3):1662-9. doi: 10.4049/jimmunol.180.3.1662.
• [1252] LBH Gene Transcription Regulation by the Interplay of an Enhancer Risk Allele and DNA Methylation in Rheumatoid Arthritis.Arthritis Rheumatol. 2016 Nov;68(11):2637-2645. doi: 10.1002/art.39746.
• [1253] Non-synonymous single nucleotide polymorphisms in genes for immunoregulatory galectins: association of galectin-8 (F19Y) occurrence with autoimmune diseases in a Caucasian population.Biochim Biophys Acta. 2012 Oct;1820(10):1512-8. doi: 10.1016/j.bbagen.2012.05.015. Epub 2012 Jun 7.
• [1254] Galectin-9 Is a Possible Promoter of Immunopathology in Rheumatoid Arthritis by Activation of Peptidyl Arginine Deiminase 4 (PAD-4) in Granulocytes.Int J Mol Sci. 2019 Aug 19;20(16):4046. doi: 10.3390/ijms20164046.
• [1255] Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis.J Exp Med. 2009 Jun 8;206(6):1435-49. doi: 10.1084/jem.20082251. Epub 2009 May 18.
• [1256] Evaluation of differentially expressed genes by a combination of cDNA array and RAP-PCR using the AtlasImage 2.0 software.J Autoimmun. 2003 Sep;21(2):161-6. doi: 10.1016/s0896-8411(03)00088-x.
• [1257] Gene-gene interaction and RNA splicing profiles of MAP2K4 gene in rheumatoid arthritis.Clin Immunol. 2015 May;158(1):19-28. doi: 10.1016/j.clim.2015.02.011. Epub 2015 Feb 27.
• [1258] MAST3 modulates the inflammatory response and proliferation of fibroblast-like synoviocytes in rheumatoid arthritis.Int Immunopharmacol. 2019 Dec;77:105900. doi: 10.1016/j.intimp.2019.105900. Epub 2019 Oct 20.
• [1259] Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients.DNA Cell Biol. 2012 Aug;31(8):1412-7. doi: 10.1089/dna.2012.1672. Epub 2012 May 11.
• [1260] HLA haplotypes and susceptibility to rheumatoid arthritis. More than class II genes.Scand J Rheumatol. 2002;31(5):275-8. doi: 10.1080/030097402760375160.
• [1261] Regulation of CCR5 expression and MIP-1alpha production in CD4+ T cells from patients with rheumatoid arthritis.Clin Exp Immunol. 2003 May;132(2):371-8. doi: 10.1046/j.1365-2249.2003.02126.x.
• [1262] Platelets induce a proinflammatory phenotype in monocytes via the CD147 pathway in rheumatoid arthritis.Arthritis Res Ther. 2014 Nov 18;16(6):478. doi: 10.1186/s13075-014-0478-0.
• [1263] Evaluation of pain intensity in people with rheumatoid arthritis using the MOS intensity scale.Med Clin (Barc). 2019 Aug 2;153(3):106-111. doi: 10.1016/j.medcli.2018.04.017. Epub 2018 May 25.
• [1264] The possible role of heat shock protein-70 induction in collagen-induced arthritis in rats.Physiol Int. 2019 Jun 1;106(2):128-139. doi: 10.1556/2060.106.2019.17. Epub 2019 Jul 2.
• [1265] Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions?.Arthritis Res Ther. 2019 Nov 13;21(1):239. doi: 10.1186/s13075-019-2014-8.
• [1266] New trajectories in the treatment of interstitial lung disease: treat the disease or treat the underlying pattern?.Curr Opin Pulm Med. 2019 Sep;25(5):442-449. doi: 10.1097/MCP.0000000000000600.
• [1267] Myosin IXB gene region and gluten intolerance: linkage to coeliac disease and a putative dermatitis herpetiformis association.J Med Genet. 2008 Apr;45(4):222-7. doi: 10.1136/jmg.2007.053991. Epub 2007 Dec 12.
• [1268] Variants in TNFAIP3, STAT4, and C12orf30 loci associated with multiple autoimmune diseases are also associated with juvenile idiopathic arthritis.Arthritis Rheum. 2009 Jul;60(7):2124-30. doi: 10.1002/art.24618.
• [1269] Identification of Naf1/ABIN-1 among TNF-alpha-induced expressed genes in human synoviocytes using oligonucleotide microarrays.FEBS Lett. 2003 Sep 11;551(1-3):8-12. doi: 10.1016/s0014-5793(03)00823-8.
• [1270] A case-control study of rheumatoid arthritis identifies an associated single nucleotide polymorphism in the NCF4 gene, supporting a role for the NADPH-oxidase complex in autoimmunity.Arthritis Res Ther. 2007;9(5):R98. doi: 10.1186/ar2299.
• [1271] Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.Arthritis Rheum. 2006 Jun;54(6):1906-16. doi: 10.1002/art.21890.
• [1272] Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes.Arthritis Res Ther. 2005;7(4):R844-51. doi: 10.1186/ar1752. Epub 2005 Apr 28.
• [1273] RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis.J Transl Med. 2019 Mar 15;17(1):84. doi: 10.1186/s12967-019-1809-3.
• [1274] -2,3-Sialyltransferase 1 and neuraminidase-3 from monocytes in patients with rheumatoid arthritis correlate with disease activity measures: A pilot study.J Chin Med Assoc. 2019 Mar;82(3):179-185. doi: 10.1097/JCMA.0000000000000027.
• [1275] Identification of transcription regulatory relationships in rheumatoid arthritis and osteoarthritis.Clin Rheumatol. 2013 May;32(5):609-15. doi: 10.1007/s10067-012-2143-9. Epub 2013 Jan 8.
• [1276] NLRP6 facilitates the interaction between TAB2/3 and TRIM38 in rheumatoid arthritis fibroblast-like synoviocytes.FEBS Lett. 2017 Apr;591(8):1141-1149. doi: 10.1002/1873-3468.12622. Epub 2017 Mar 30.
• [1277] N-myristoyltransferase deficiency impairs activation of kinase AMPK and promotes synovial tissue inflammation.Nat Immunol. 2019 Mar;20(3):313-325. doi: 10.1038/s41590-018-0296-7. Epub 2019 Feb 4.
• [1278] Development of PEGylated carboxylic acid-modified polyamidoamine dendrimers as bone-targeting carriers for the treatment of bone diseases.J Control Release. 2017 Sep 28;262:10-17. doi: 10.1016/j.jconrel.2017.07.018. Epub 2017 Jul 11.
• [1279] TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study.N Engl J Med. 2007 Sep 20;357(12):1199-209. doi: 10.1056/NEJMoa073491. Epub 2007 Sep 5.
• [1280] Whole exome sequencing in Finnish families identifies new candidate genes for osteoarthritis.PLoS One. 2018 Aug 29;13(8):e0203313. doi: 10.1371/journal.pone.0203313. eCollection 2018.
• [1281] Peptidyl arginine deiminase type 2 (PAD-2) and PAD-4 but not PAD-1, PAD-3, and PAD-6 are expressed in rheumatoid arthritis synovium in close association with tissue inflammation.Arthritis Rheum. 2007 Nov;56(11):3541-53. doi: 10.1002/art.22983.
• [1282] Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells.Cancer Res. 2008 Jul 15;68(14):5888-95. doi: 10.1158/0008-5472.CAN-08-0438.
• [1283] Association of Autoimmune Regulator Gene Rs2075876 Variant, but Not Gene Expression with Alopecia Areata in Males: A Case-control Study.Immunol Invest. 2020 Feb;49(1-2):146-165. doi: 10.1080/08820139.2019.1671450. Epub 2019 Oct 11.
• [1284] Plasma and synovial fluid programmed cell death 5 (PDCD5) levels are inversely associated with TNF- and disease activity in patients with rheumatoid arthritis.Biomarkers. 2013 Mar;18(2):155-9. doi: 10.3109/1354750X.2012.759277. Epub 2013 Jan 18.
• [1285] Podoplanin in Inflammation and Cancer.Int J Mol Sci. 2019 Feb 6;20(3):707. doi: 10.3390/ijms20030707.
• [1286] PER2 is downregulated by the LPS-induced inflammatory response in synoviocytes in rheumatoid arthritis and is implicated in disease susceptibility.Mol Med Rep. 2017 Jul;16(1):422-428. doi: 10.3892/mmr.2017.6578. Epub 2017 May 11.
• [1287] Serum alarm antiproteases in systemic sclerosis patients.Hum Immunol. 2017 Sep;78(9):559-564. doi: 10.1016/j.humimm.2017.06.002. Epub 2017 Jun 9.
• [1288] Downregulated microRNA-135a ameliorates rheumatoid arthritis by inactivation of the phosphatidylinositol 3-kinase/AKT signaling pathway via phosphatidylinositol 3-kinase regulatory subunit 2.J Cell Physiol. 2019 Aug;234(10):17663-17676. doi: 10.1002/jcp.28390. Epub 2019 Mar 25.
• [1289] Metastable Atrial State Underlies the Primary Genetic Substrate for MYL4 Mutation-Associated Atrial Fibrillation.Circulation. 2020 Jan 28;141(4):301-312. doi: 10.1161/CIRCULATIONAHA.119.044268. Epub 2019 Nov 16.
• [1290] Expression and Regulation of PIWIL-Proteins and PIWI-Interacting RNAs in Rheumatoid Arthritis.PLoS One. 2016 Nov 28;11(11):e0166920. doi: 10.1371/journal.pone.0166920. eCollection 2016.
• [1291] Tumor-necrosis factor-alpha induces retinoic acid-inducible gene-I in rheumatoid fibroblast-like synoviocytes.Immunol Lett. 2009 Jan 29;122(1):89-93. doi: 10.1016/j.imlet.2008.12.005. Epub 2009 Jan 4.
• [1292] Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene.PLoS One. 2014 Feb 10;9(2):e87645. doi: 10.1371/journal.pone.0087645. eCollection 2014.
• [1293] PLD3 and PLD4 are single-stranded acid exonucleases that regulate endosomal nucleic-acid sensing.Nat Immunol. 2018 Sep;19(9):942-953. doi: 10.1038/s41590-018-0179-y. Epub 2018 Aug 13.
• [1294] Molecular signature of retinoic acid treatment in acute promyelocytic leukemia.Oncogene. 2005 May 5;24(20):3358-68. doi: 10.1038/sj.onc.1208498.
• [1295] Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 Genes Are Associated with the Response to TNF Inhibitors in Patients with Rheumatoid Arthritis.PLoS One. 2017 Jan 20;12(1):e0169956. doi: 10.1371/journal.pone.0169956. eCollection 2017.
• [1296] Identification of novel mutations in CD2BP1 gene in clinically proven rheumatoid arthritis patients of south India.Eur J Med Genet. 2016 Aug;59(8):404-12. doi: 10.1016/j.ejmg.2016.05.009. Epub 2016 May 13.
• [1297] Anti-TNF treatment decreases the previously increased serum Indian Hedgehog levels in patients with ankylosing spondylitis and affects the expression of functional Hedgehog pathway target genes.Semin Arthritis Rheum. 2015 Jun;44(6):646-51. doi: 10.1016/j.semarthrit.2015.01.004. Epub 2015 Jan 23.
• [1298] TGF responsive tyrosine phosphatase promotes rheumatoid synovial fibroblast invasiveness.Ann Rheum Dis. 2016 Jan;75(1):295-302. doi: 10.1136/annrheumdis-2014-205790. Epub 2014 Nov 6.
• [1299] The prevalence and clinical significance of anti-PUF60 antibodies in patients with idiopathic inflammatory myopathy.Clin Rheumatol. 2018 Jun;37(6):1573-1580. doi: 10.1007/s10067-018-4031-4. Epub 2018 Mar 15.
• [1300] TNF-/calreticulin dual signaling induced NLRP3 inflammasome activation associated with HuR nucleocytoplasmic shuttling in rheumatoid arthritis.Inflamm Res. 2019 Jul;68(7):597-611. doi: 10.1007/s00011-019-01244-w. Epub 2019 May 22.
• [1301] Inflammasomes and human autoimmunity: A comprehensive review.J Autoimmun. 2015 Jul;61:1-8. doi: 10.1016/j.jaut.2015.05.001. Epub 2015 May 23.
• [1302] Tocilizumab modulates serum levels of adiponectin and chemerin in patients with rheumatoid arthritis: potential cardiovascular protective role of IL-6 inhibition.Clin Exp Rheumatol. 2019 Mar-Apr;37(2):293-300. Epub 2018 Aug 27.
• [1303] Expression and functional influence of cellular retinoic acid-binding protein II in renal cell carcinoma.Urol Int. 2005;75(3):269-76. doi: 10.1159/000087807.
• [1304] Changes in Radixin Expression and Interaction with Efflux Transporters in the Liver of Adjuvant-Induced Arthritic Rats.Inflammation. 2020 Feb;43(1):85-94. doi: 10.1007/s10753-019-01097-9.
• [1305] A novel gene-expression-signature-based model for prediction of response to Tripterysium glycosides tablet for rheumatoid arthritis patients.J Transl Med. 2018 Jul 4;16(1):187. doi: 10.1186/s12967-018-1549-9.
• [1306] Extracellular Vesicles Transfer the Receptor Programmed Death-1 in Rheumatoid Arthritis.Front Immunol. 2017 Jul 24;8:851. doi: 10.3389/fimmu.2017.00851. eCollection 2017.
• [1307] Generation of a robust model for inducing autoimmune arthritis in Sprague Dawley rats.J Pharmacol Toxicol Methods. 2020 Mar-Apr;102:106659. doi: 10.1016/j.vascn.2019.106659. Epub 2019 Dec 16.
• [1308] Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metalloproteinase production in patients with inflammatory arthritis.Arthritis Rheum. 2004 Jun;50(6):1788-99. doi: 10.1002/art.20301.
• [1309] SAMD9 is a (epi-) genetically regulated anti-inflammatory factor activated in RA patients.Mol Cell Biochem. 2019 Jun;456(1-2):135-144. doi: 10.1007/s11010-019-03499-7. Epub 2019 Feb 4.
• [1310] Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts.Arthritis Res Ther. 2007;9(3):R59. doi: 10.1186/ar2217.
• [1311] Synthesis and activity of substituted 4-(indazol-3-yl)phenols as pathway-selective estrogen receptor ligands useful in the treatment of rheumatoid ... J Med Chem. 2004 Dec 16;47(26):6435-8.
• [1312] Analysis of critical molecules and signaling pathways in osteoarthritis and rheumatoid arthritis.Mol Med Rep. 2013 Feb;7(2):603-7. doi: 10.3892/mmr.2012.1224. Epub 2012 Dec 4.
• [1313] Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production.Clin Exp Immunol. 2014 Sep;177(3):641-51. doi: 10.1111/cei.12374.
• [1314] Expression of the precursor of secretoneurin, secretogranin II, in the synovium of patients with rheumatoid arthritis and osteoarthritis.J Rheumatol. 2000 Oct;27(10):2347-50.
• [1315] Syndecan-4 involves in the pathogenesis of rheumatoid arthritis by regulating the inflammatory response and apoptosis of fibroblast-like synoviocytes.J Cell Physiol. 2020 Feb;235(2):1746-1758. doi: 10.1002/jcp.29093. Epub 2019 Jul 15.
• [1316] Increased prevalence of semaphorin 3C, a repellent of sympathetic nerve fibers, in the synovial tissue of patients with rheumatoid arthritis.Arthritis Rheum. 2004 Apr;50(4):1156-63. doi: 10.1002/art.20110.
• [1317] Expression of Semaphorin 4A and its potential role in rheumatoid arthritis.Arthritis Res Ther. 2015 Aug 25;17(1):227. doi: 10.1186/s13075-015-0734-y.
• [1318] Ellagic acid attenuates testicular disruption in rheumatoid arthritis via targeting inflammatory signals, oxidative perturbations and apoptosis.Life Sci. 2019 Dec 15;239:117012. doi: 10.1016/j.lfs.2019.117012. Epub 2019 Oct 31.
• [1319] Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages.Arthritis Rheum. 2006 Sep;54(9):2711-21. doi: 10.1002/art.22055.
• [1320] The RA-MAP Consortium: a working model for academia-industry collaboration.Nat Rev Rheumatol. 2018 Jan;14(1):53-60. doi: 10.1038/nrrheum.2017.200. Epub 2017 Dec 7.
• [1321] The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.Clin Rheumatol. 2016 Jun;35(6):1457-62. doi: 10.1007/s10067-016-3223-z. Epub 2016 Mar 7.
• [1322] Calreticulin induced endothelial ICAM-1 up-regulation associated with tristetraprolin expression alteration through PI3K/Akt/eNOS/p38 MAPK signaling pathway in rheumatoid arthritis.Mol Immunol. 2019 Mar;107:10-20. doi: 10.1016/j.molimm.2019.01.005. Epub 2019 Jan 9.
• [1323] Gene transfer of a cell cycle modulator exerts anti-inflammatory effects in the treatment of arthritis.J Immunol. 2003 Nov 1;171(9):4913-9. doi: 10.4049/jimmunol.171.9.4913.
• [1324] Proinflammatory Differentiation of Macrophages Through Microparticles That Form Immune Complexes Leads to T- and B-Cell Activation in Systemic Autoimmune Diseases.Front Immunol. 2019 Aug 28;10:2058. doi: 10.3389/fimmu.2019.02058. eCollection 2019.
• [1325] Systemic treatment with resveratrol alleviates adjuvant arthritis-interstitial lung disease in rats via modulation of JAK/STAT/RANKL signaling pathway.Pulm Pharmacol Ther. 2019 Jun;56:69-74. doi: 10.1016/j.pupt.2019.03.011. Epub 2019 Mar 28.
• [1326] The analysis of CIS, SOCS1, SOSC2 and SOCS3 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients.Clin Exp Med. 2008 Dec;8(4):179-85. doi: 10.1007/s10238-008-0006-0. Epub 2008 Sep 27.
• [1327] Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients.Dis Markers. 2009;26(1):41-8. doi: 10.3233/DMA-2009-0603.
• [1328] Dyrk1A promotes the proliferation, migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis via down-regulating Spry2 and activating the ERK MAPK pathway.Tissue Cell. 2018 Dec;55:63-70. doi: 10.1016/j.tice.2018.10.002. Epub 2018 Oct 28.
• [1329] Novel gene variants associated with cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis.Ann Rheum Dis. 2018 Jul;77(7):1063-1069. doi: 10.1136/annrheumdis-2017-212614. Epub 2018 Mar 7.
• [1330] Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.Cells. 2019 Jun 9;8(6):561. doi: 10.3390/cells8060561.
• [1331] Clinical and functional significance of STEAP4-splice variant in CD14(+) monocytes in patients with rheumatoid arthritis.Clin Exp Immunol. 2018 Mar;191(3):338-348. doi: 10.1111/cei.13076. Epub 2017 Nov 16.
• [1332] Flexible two-layer dissolving and safing microneedle transdermal of neurotoxin: A biocomfortable attempt to treat Rheumatoid Arthritis.Int J Pharm. 2019 May 30;563:91-100. doi: 10.1016/j.ijpharm.2019.03.033. Epub 2019 Mar 16.
• [1333] Serum substance P: an indicator of disease activity and subclinical inflammation in rheumatoid arthritis.Clin Rheumatol. 2018 Apr;37(4):901-908. doi: 10.1007/s10067-017-3929-6. Epub 2017 Dec 18.
• [1334] T cell activation Rho GTPase activating protein (TAGAP) is upregulated in clinical and experimental arthritis.Cytokine. 2018 Apr;104:130-135. doi: 10.1016/j.cyto.2017.10.002. Epub 2017 Oct 7.
• [1335] A cell-penetrating peptide blocks Toll-like receptor-mediated downstream signaling and ameliorates autoimmune and inflammatory diseases in mice.Exp Mol Med. 2019 Apr 26;51(4):1-19. doi: 10.1038/s12276-019-0244-0.
• [1336] Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in South Indian Tamil rheumatoid arthritis. Eur J Clin Pharmacol. 2015 Aug;71(8):959-65.
• [1337] The oncoprotein TBX3 is controlling severity in experimental arthritis.Arthritis Res Ther. 2019 Jan 10;21(1):16. doi: 10.1186/s13075-018-1797-3.
• [1338] Down-regulation of miR-10a-5p promotes proliferation and restricts apoptosis via targeting T-box transcription factor 5 in inflamed synoviocytes.Biosci Rep. 2018 Apr 13;38(2):BSR20180003. doi: 10.1042/BSR20180003. Print 2018 Apr 27.
• [1339] Suicidal Behavior Among Hospitalized Adults With Inflammatory Bowel Disease: A United States Nationwide Analysis.Inflamm Bowel Dis. 2017 Dec 19;24(1):25-34. doi: 10.1093/ibd/izx005.
• [1340] Associations between single-nucleotide polymorphisms of RFC-1, GGH, MTHFR , TYMS, and TCII genes and the efficacy and toxicity of methotrexate treatment in patients with rheumatoid arthritis.Pol Arch Med Wewn. 2015;125(3):152-61. doi: 10.20452/pamw.2707. Epub 2015 Jan 19.
• [1341] LncRNA DILC participates in rheumatoid arthritis by inducing apoptosis of fibroblast-like synoviocytes and down-regulating IL-6.Biosci Rep. 2019 May 2;39(5):BSR20182374. doi: 10.1042/BSR20182374. Print 2019 May 31.
• [1342] MMP-8 and TIMP-1 are associated to periodontal inflammation in patients with rheumatoid arthritis under methotrexate immunosuppression - First results of a cross-sectional study.J Microbiol Immunol Infect. 2019 Jun;52(3):386-394. doi: 10.1016/j.jmii.2017.07.016. Epub 2017 Sep 4.
• [1343] Increased circulating myeloid-derived suppressor cells correlated negatively with Th17 cells in patients with rheumatoid arthritis.Scand J Rheumatol. 2013;42(2):85-90. doi: 10.3109/03009742.2012.716450. Epub 2012 Nov 6.
• [1344] Erratum to "Increased Expression of TLR10 in B Cell Subsets Correlates with Disease Activity in Rheumatoid Arthritis".Mediators Inflamm. 2019 Mar 10;2019:8419439. doi: 10.1155/2019/8419439. eCollection 2019.
• [1345] Role of Chondrocytes in the Development of Rheumatoid Arthritis Via Transmembrane Protein 147-Mediated NF-B Activation.Arthritis Rheumatol. 2020 Jun;72(6):931-942. doi: 10.1002/art.41182. Epub 2020 May 2.
• [1346] Topical all-trans retinoic acid (RA) induces an early, coordinated increase in RA-inducible skin-specific gene/psoriasin and cellular RA-binding protein II mRNA levels which precedes skin erythema.Arch Dermatol Res. 1996 Oct;288(11):664-9. doi: 10.1007/BF02505275.
• [1347] Dihydroartemisinin derivative DC32 attenuates collagen-induced arthritis in mice by restoring the Treg/Th17 balance and inhibiting synovitis through down-regulation of IL-6.Int Immunopharmacol. 2018 Dec;65:233-243. doi: 10.1016/j.intimp.2018.10.015. Epub 2018 Oct 15.
• [1348] Trex-1 deficiency in rheumatoid arthritis synovial fibroblasts.Arthritis Rheum. 2010 Sep;62(9):2673-9. doi: 10.1002/art.27567.
• [1349] Forkhead box o3a suppresses lipopolysaccharide-stimulated proliferation and inflammation in fibroblast-like synoviocytes through regulating tripartite motif-containing protein 3.J Cell Physiol. 2019 Nov;234(11):20139-20148. doi: 10.1002/jcp.28615. Epub 2019 Apr 13.
• [1350] GILZ: a new link between the hypothalamic pituitary adrenal axis and rheumatoid arthritis?.Immunol Cell Biol. 2014 Oct;92(9):747-51. doi: 10.1038/icb.2014.56. Epub 2014 Jul 22.
• [1351] MiR-338-5p suppresses rheumatoid arthritis synovial fibroblast proliferation and invasion by targeting ADAMTS-9.Clin Exp Rheumatol. 2018 Mar-Apr;36(2):195-202. Epub 2017 Aug 28.
• [1352] High levels of soluble GPR56/ADGRG1 are associated with positive rheumatoid factor and elevated tumor necrosis factor in patients with rheumatoid arthritis.J Microbiol Immunol Infect. 2018 Aug;51(4):485-491. doi: 10.1016/j.jmii.2016.11.010. Epub 2017 Jun 28.
• [1353] Association study of AFF1 rs340630 polymorphism with genetic susceptibility to rheumatoid arthritis in Chinese population.Braz J Med Biol Res. 2018;51(7):e7126. doi: 10.1590/1414-431x20187126. Epub 2018 May 17.
• [1354] Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles.J Rheumatol. 2002 Oct;29(10):2159-64.
• [1355] Fertility and Ovarian Reserve among Women with Rheumatoid Arthritis.J Rheumatol. 2019 May;46(5):455-459. doi: 10.3899/jrheum.180176. Epub 2018 Nov 15.
• [1356] Phosphoproteome analysis of synoviocytes from patients with rheumatoid arthritis.Int J Rheum Dis. 2017 Jun;20(6):708-721. doi: 10.1111/1756-185X.12997. Epub 2017 Mar 5.
• [1357] Contribution of Genetic Factors to Lower DHEAS in Patients with Rheumatoid Arthritis.Cell Mol Neurobiol. 2018 Jan;38(1):379-383. doi: 10.1007/s10571-017-0522-0. Epub 2017 Jul 15.
• [1358] The 4GalT1 affects the fibroblast-like synoviocytes invasion in rheumatoid arthritis by modifying N-linked glycosylation of CXCR3.Eur J Cell Biol. 2017 Mar;96(2):172-181. doi: 10.1016/j.ejcb.2017.02.001. Epub 2017 Feb 10.
• [1359] Bcl2 like protein-12 suppresses Foxp3(+) regulatory T cells in patients with rheumatoid arthritis.Am J Transl Res. 2019 May 15;11(5):3048-3055. eCollection 2019.
• [1360] Amelioration of adjuvant-induced arthritis in CCDC134-overexpressing transgenic mice.Biochem Biophys Res Commun. 2017 Aug 19;490(2):111-116. doi: 10.1016/j.bbrc.2017.05.166. Epub 2017 May 29.
• [1361] Associations between WNT1-inducible signaling pathway protein-1 (WISP-1) genetic polymorphisms and clinical aspects of rheumatoid arthritis among Chinese Han subjects.Medicine (Baltimore). 2019 Nov;98(44):e17604. doi: 10.1097/MD.0000000000017604.
• [1362] CD109 regulates the inflammatory response and is required for the pathogenesis of rheumatoid arthritis.Ann Rheum Dis. 2019 Dec;78(12):1632-1641. doi: 10.1136/annrheumdis-2019-215473. Epub 2019 Aug 27.
• [1363] Placement of selected new FDA-approved drugs in Medicare Part D formularies, 2009-2013.Am J Manag Care. 2018 Jun 1;24(6):e175-e182.
• [1364] Different Contributions of CDKAL1, KIF21B, and LRRK2/MUC19 Polymorphisms to SAPHO Syndrome, Rheumatoid Arthritis, Ankylosing Spondylitis, and Seronegative Spondyloarthropathy.Genet Test Mol Biomarkers. 2017 Feb;21(2):122-126. doi: 10.1089/gtmb.2016.0112. Epub 2016 Dec 12.
• [1365] Extracellular Chromatin Triggers Release of Soluble CEACAM8 Upon Activation of Neutrophils.Front Immunol. 2019 Jun 14;10:1346. doi: 10.3389/fimmu.2019.01346. eCollection 2019.
• [1366] Vitamin A and Retinoic Acid Exhibit Protective Effects on Necrotizing Enterocolitis by Regulating Intestinal Flora and Enhancing the IntestinalEpithelial Barrier.Arch Med Res. 2018 Jan;49(1):1-9. doi: 10.1016/j.arcmed.2018.04.003. Epub 2018 Apr 24.
• [1367] Deletion of calponin 2 in macrophages attenuates the severity of inflammatory arthritis in mice.Am J Physiol Cell Physiol. 2016 Oct 1;311(4):C673-C685. doi: 10.1152/ajpcell.00331.2015. Epub 2016 Aug 3.
• [1368] An overlap of Alport syndrome and rheumatoid arthritis in a patient and literature review.BMC Nephrol. 2019 Jul 23;20(1):277. doi: 10.1186/s12882-019-1462-3.
• [1369] Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.Immunity. 2017 Jul 18;47(1):66-79.e5. doi: 10.1016/j.immuni.2017.06.018.
• [1370] A phase III study of BCD-055 compared with innovator infliximab in patients with active rheumatoid arthritis: 54-week results from the LIRA study.Rheumatol Int. 2019 Sep;39(9):1537-1546. doi: 10.1007/s00296-019-04359-9. Epub 2019 Jul 10.
• [1371] Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.J Immunol. 2017 May 1;198(9):3436-3447. doi: 10.4049/jimmunol.1601716. Epub 2017 Mar 17.
• [1372] DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study.Diabetes Ther. 2018 Feb;9(1):141-151. doi: 10.1007/s13300-017-0353-5. Epub 2017 Dec 13.
• [1373] Hypomethylation of CYP2E1 and DUSP22 Promoters Associated With Disease Activity and Erosive Disease Among Rheumatoid Arthritis Patients.Arthritis Rheumatol. 2018 Apr;70(4):528-536. doi: 10.1002/art.40408. Epub 2018 Feb 18.
• [1374] Dishevelled2 promotes apoptosis and inhibits inflammatory cytokine secretion in rheumatoid arthritis fibroblast-like synoviocytes through crosstalk with the NF-B pathway.Oncotarget. 2017 Feb 21;8(8):12649-12663. doi: 10.18632/oncotarget.15172.
• [1375] STA-21, a STAT-3 inhibitor, attenuates the development and progression of inflammation in collagen antibody-induced arthritis.Immunobiology. 2017 Feb;222(2):206-217. doi: 10.1016/j.imbio.2016.10.001. Epub 2016 Oct 3.
• [1376] EOMES-positive CD4(+) Tcells are increased in PTPN22 (1858T) risk allele carriers.Eur J Immunol. 2018 Apr;48(4):655-669. doi: 10.1002/eji.201747296. Epub 2018 Feb 28.
• [1377] Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.Pharmacoeconomics. 2018 Jul;36(7):769-778. doi: 10.1007/s40273-018-0616-7.
• [1378] Genetic deletion of GIT2 prolongs functional recovery and suppresses chondrocyte differentiation in rats with rheumatoid arthritis.J Cell Biochem. 2018 Feb;119(2):1538-1547. doi: 10.1002/jcb.26313. Epub 2017 Sep 18.
• [1379] Glycogen Metabolism and Rheumatoid Arthritis: The Role of Glycogen Synthase 1 in Regulation of Synovial Inflammation via Blocking AMP-Activated Protein Kinase Activation.Front Immunol. 2018 Jul 27;9:1714. doi: 10.3389/fimmu.2018.01714. eCollection 2018.
• [1380] Proteomics analysis reveals differential pattern of widespread protein expression and novel role of histidine-rich glycoprotein and lipopolysaccharide-binding protein in rheumatoid arthritis.Int J Biol Macromol. 2018 Apr 1;109:704-710. doi: 10.1016/j.ijbiomac.2017.12.075. Epub 2017 Dec 13.
• [1381] Absence of Pharmacokinetic Interactions between the Bruton's Tyrosine Kinase Inhibitor Fenebrutinib and Methotrexate.J Pharmacol Exp Ther. 2019 Oct;371(1):202-207. doi: 10.1124/jpet.119.257089. Epub 2019 Aug 1.
• [1382] Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production.Front Immunol. 2017 Mar 20;8:285. doi: 10.3389/fimmu.2017.00285. eCollection 2017.
• [1383] Type-III interferons and rheumatoid arthritis: Correlation between interferon lambda 1 (interleukin 29) and antimutated citrullinated vimentin antibody levels.Autoimmunity. 2017 Mar;50(2):82-85. doi: 10.1080/08916934.2017.1289181. Epub 2017 Feb 14.
• [1384] The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells.PLoS One. 2017 Jan 5;12(1):e0169702. doi: 10.1371/journal.pone.0169702. eCollection 2017.
• [1385] Characterization of novel anti-IL-26 neutralizing monoclonal antibodies for the treatment of inflammatory diseases including psoriasis.MAbs. 2019 Nov-Dec;11(8):1428-1442. doi: 10.1080/19420862.2019.1654305. Epub 2019 Aug 18.
• [1386] IRAK2 is associated with susceptibility to rheumatoid arthritis.Clin Rheumatol. 2018 Apr;37(4):927-933. doi: 10.1007/s10067-017-3906-0. Epub 2017 Nov 11.
• [1387] Identification of novel biomarker as citrullinated inter-alpha-trypsin inhibitor heavy chain 4, specifically increased in sera with experimental and rheumatoid arthritis.Arthritis Res Ther. 2018 Apr 10;20(1):66. doi: 10.1186/s13075-018-1562-7.
• [1388] Downregulation of lncRNA ITSN1-2 correlates with decreased disease risk and activity of rheumatoid arthritis (RA), and reduces RA fibroblast-like synoviocytes proliferation and inflammation via inhibiting NOD2/RIP2 signaling pathway.Am J Transl Res. 2019 Aug 15;11(8):4650-4666. eCollection 2019.
• [1389] Diencephalic Size Is Restricted by a Novel Interplay Between GCN5 Acetyltransferase Activity and Retinoic Acid Signaling.J Neurosci. 2017 Mar 8;37(10):2565-2579. doi: 10.1523/JNEUROSCI.2121-16.2017. Epub 2017 Feb 2.
• [1390] New genes associated with rheumatoid arthritis identified by gene expression profiling.Int J Immunogenet. 2017 Jun;44(3):107-113. doi: 10.1111/iji.12313. Epub 2017 Apr 2.
• [1391] Enhanced neutrophil autophagy and increased concentrations of IL-6, IL-8, IL-10 and MCP-1 in rheumatoid arthritis.Int Immunopharmacol. 2018 Dec;65:119-128. doi: 10.1016/j.intimp.2018.09.011. Epub 2018 Oct 9.
• [1392] Association of MTMR3 rs12537 at miR-181a binding site with rheumatoid arthritis and systemic lupus erythematosus risk in Egyptian patients.Sci Rep. 2019 Aug 23;9(1):12299. doi: 10.1038/s41598-019-48770-5.
• [1393] Expression of host defense scavenger receptors in spondylarthropathy.Arthritis Rheum. 2001 Apr;44(4):931-9. doi: 10.1002/1529-0131(200104)44:4<931::AID-ANR150>3.0.CO;2-T.
• [1394] Retinoic acid enhances germ cell differentiation of mouse skin-derived stem cells.J Ovarian Res. 2018 Mar 1;11(1):19. doi: 10.1186/s13048-018-0390-3.
• [1395] CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway.J Cell Physiol. 2019 Aug;234(10):18748-18762. doi: 10.1002/jcp.28514. Epub 2019 May 7.
• [1396] Mannan-Binding Lectin-Associated Serine Protease 1/3 Cleavage of Pro-Factor D into Factor D In Vivo and Attenuation of Collagen Antibody-Induced Arthritis through Their Targeted Inhibition by RNA Interference-Mediated Gene Silencing.J Immunol. 2016 Nov 1;197(9):3680-3694. doi: 10.4049/jimmunol.1600719. Epub 2016 Oct 5.
• [1397] Two new inflammatory markers associated with disease activity score-28 in patients with rheumatoid arthritis: Albumin to fibrinogen ratio and C-reactive protein to albumin ratio.Int Immunopharmacol. 2018 Sep;62:293-298. doi: 10.1016/j.intimp.2018.07.007. Epub 2018 Jul 23.
• [1398] METTL3 Attenuates LPS-Induced Inflammatory Response in Macrophages via NF-B Signaling Pathway.Mediators Inflamm. 2019 Oct 24;2019:3120391. doi: 10.1155/2019/3120391. eCollection 2019.
• [1399] Conserved 33-kb haplotype in the MHC class III region regulates chronic arthritis.Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3716-24. doi: 10.1073/pnas.1600567113. Epub 2016 Jun 14.
• [1400] Nesfatin-1 and visfatin expression is associated with reduced atherosclerotic disease risk in patients with rheumatoid arthritis.Peptides. 2018 Apr;102:31-37. doi: 10.1016/j.peptides.2018.02.002. Epub 2018 Feb 21.
• [1401] TNF- induces expression of the circadian clock gene Bmal1 via dual calcium-dependent pathways in rheumatoid synovial cells.Biochem Biophys Res Commun. 2018 Jan 8;495(2):1675-1680. doi: 10.1016/j.bbrc.2017.12.015. Epub 2017 Dec 5.
• [1402] Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog.Clin Immunol. 2017 Jul;180:45-57. doi: 10.1016/j.clim.2017.03.014. Epub 2017 Apr 4.
• [1403] Rheumatoid arthritis-associated DNA methylation sites in peripheral blood mononuclear cells.Ann Rheum Dis. 2019 Jan;78(1):36-42. doi: 10.1136/annrheumdis-2018-213970. Epub 2018 Oct 8.
• [1404] lncRNA NTT/PBOV1 Axis Promotes Monocyte Differentiation and Is Elevated in Rheumatoid Arthritis.Int J Mol Sci. 2018 Sep 18;19(9):2806. doi: 10.3390/ijms19092806.
• [1405] Integrative analysis for identification of shared markers from various functional cells/tissues for rheumatoid arthritis.Immunogenetics. 2017 Feb;69(2):77-86. doi: 10.1007/s00251-016-0956-4. Epub 2016 Nov 3.
• [1406] Hypericin-photodynamic therapy inhibits proliferation and induces apoptosis in human rheumatoid arthritis fibroblast-like synoviocytes cell line MH7A.Iran J Basic Med Sci. 2018 Feb;21(2):130-137. doi: 10.22038/IJBMS.2018.23871.5991.
• [1407] A Comprehensive Gene Expression Meta-analysis Identifies Novel Immune Signatures in Rheumatoid Arthritis Patients.Front Immunol. 2017 Feb 2;8:74. doi: 10.3389/fimmu.2017.00074. eCollection 2017.
• [1408] Expression of chemokines CXCL4 and CXCL7 by synovial macrophages defines an early stage of rheumatoid arthritis.Ann Rheum Dis. 2016 Apr;75(4):763-71. doi: 10.1136/annrheumdis-2014-206921. Epub 2015 Apr 9.
• [1409] Disease-Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis.Clin Pharmacokinet. 2017 Jun;56(6):607-615. doi: 10.1007/s40262-016-0462-8.
• [1410] Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in Rheumatoid Arthritis.Sci Rep. 2017 Feb 22;7:43165. doi: 10.1038/srep43165.
• [1411] Oligomeric S100A4 Is Associated With Monocyte Innate Immune Memory and Bypass of Tolerance to Subsequent Stimulation With Lipopolysaccharides.Front Immunol. 2019 Apr 15;10:791. doi: 10.3389/fimmu.2019.00791. eCollection 2019.
• [1412] Retinoic acid signalling is a candidate regulator of the expression of pituitary-specific transcription factor Prop1 in the developing rodent pituitary.J Neuroendocrinol. 2018 Mar;30(3):e12570. doi: 10.1111/jne.12570.
• [1413] Effects of once-monthly minodronate versus risedronate in osteoporosis patients with rheumatoid arthritis: a 12-month randomized head-to-head comparison.Osteoporos Int. 2018 Jul;29(7):1637-1642. doi: 10.1007/s00198-018-4494-9. Epub 2018 Mar 24.
• [1414] Regulator of Calcineurin 3 Ameliorates Autoimmune Arthritis by Suppressing Th17 Cell Differentiation.Am J Pathol. 2017 Sep;187(9):2034-2045. doi: 10.1016/j.ajpath.2017.05.008. Epub 2017 Jul 10.
• [1415] Maresin 1 improves the Treg/Th17 imbalance in rheumatoid arthritis through miR-21.Ann Rheum Dis. 2018 Nov;77(11):1644-1652. doi: 10.1136/annrheumdis-2018-213511. Epub 2018 Jul 25.
• [1416] Hypoxiainduced autophagy is inhibited by PADI4 knockdown, which promotes apoptosis of fibroblastlike synoviocytes in rheumatoid arthritis.Mol Med Rep. 2018 Apr;17(4):5116-5124. doi: 10.3892/mmr.2018.8501. Epub 2018 Jan 26.
• [1417] Siglec-9 is upregulated in rheumatoid arthritis and suppresses collagen-induced arthritis through reciprocal regulation of Th17-/Treg-cell differentiation.Scand J Immunol. 2017 Jun;85(6):433-440. doi: 10.1111/sji.12543.
• [1418] Dissecting the Role of NF-b Protein Family and Its Regulators in Rheumatoid Arthritis Using Weighted Gene Co-Expression Network.Front Genet. 2019 Nov 20;10:1163. doi: 10.3389/fgene.2019.01163. eCollection 2019.
• [1419] A pure polysaccharide from Ephedra sinica treating on arthritis and inhibiting cytokines expression.Int J Biol Macromol. 2016 May;86:177-88. doi: 10.1016/j.ijbiomac.2016.01.010. Epub 2016 Mar 17.
• [1420] Association of CD8(+) T-cells with bone erosion in patients with rheumatoid arthritis.Int J Rheum Dis. 2018 Feb;21(2):440-446. doi: 10.1111/1756-185X.13090. Epub 2017 May 16.
• [1421] Bone Remodeling and the Role of TRAF3 in Osteoclastic Bone Resorption.Front Immunol. 2018 Sep 28;9:2263. doi: 10.3389/fimmu.2018.02263. eCollection 2018.